sample,barcodeID,ENSG00000049768.15,ENST00000376207.9,ENST00000376199.7,dE2_fullLength,patientID,TNBC_type,Diagnosis_Age,Disease_Free_.Months.,Disease_Free_Status,Overall_Survival_.Months.,Overall_Survival_Status,Mutation_Count,Fraction_Genome_Altered,American_Joint_Committee_on_Cancer_Metastasis_Stage_Code,Neoplasm_Disease_Lymph_Node_Stage_American_Joint_Committee_on_Cancer_Code,Neoplasm_Disease_Stage_American_Joint_Committee_on_Cancer_Code,American_Joint_Committee_on_Cancer_Tumor_Stage_Code,Cancer_Type_Detailed,Days_to_Sample_Collection.,ER_Status_By_IHC,Ethnicity_Category,Form_completion_date,Neoplasm_Histologic_Type_Name,Tumor_Other_Histologic_Subtype,Neoadjuvant_Therapy_Type_Administered_Prior_To_Resection_Text,Prior_Cancer_Diagnosis_Occurence,IHC.HER2,Informed_consent_verified,Year_Cancer_Initial_Diagnosis,Primary_Lymph_Node_Presentation_Assessment_Ind.3,Positive_Finding_Lymph_Node_Hematoxylin_and_Eosin_Staining_Microscopy_Count,Positive_Finding_Lymph_Node_Keratin_Immunohistochemistry_Staining_Method_Count,Lymph_Node.s._Examined_Number,Margin_status_reexcision,Menopause_Status,Metastatic_Site_Other,Patient_Metastatic_Sites,Metastatic_tumor_indicator,Oncotree_Code,Disease_Surgical_Margin_Status,Patient_Primary_Tumor_Site,PR_status_by_ihc,Race_Category,Did_patient_start_adjuvant_postoperative_radiotherapy.,Tissue_Retrospective_Collection_Indicator,Number_of_Samples_Per_Patient,Sample_Initial_Weight,Sample_Type,Sex
TCGA.A1.A0SK.01,TCGA.A1.A0SK.01A.12R.A084.07,0.362888,0.338199,0,0,TCGA-A1-A0SK,YES,54,NA,NA,31.77,DECEASED,83,0.4163,M0,N0 (i-),Stage IIA,T2,Invasive Breast Carcinoma,1164,Negative,NOT HISPANIC OR LATINO,2012/6/10,"Other, specify",NA,No,No,Negative,YES,2007,NA,0,NA,4,Negative,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,BRCA,Positive,Right Upper Outer Quadrant,Negative,ASIAN,NA,YES,1,160,Primary,Female
TCGA.A1.A0SO.01,TCGA.A1.A0SO.01A.22R.A084.07,0.094388,0.094388,0,0,TCGA-A1-A0SO,YES,67,27.99,DiseaseFree,27.99,LIVING,NA,0.77,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1057,Negative,NOT HISPANIC OR LATINO,2012/6/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2007,NA,1,NA,9,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Negative,WHITE,NA,YES,1,210,Primary,Female
TCGA.A1.A0SP.01,TCGA.A1.A0SP.01A.11R.A084.07,0.145032,0.145032,0,0,TCGA-A1-A0SP,YES,40,19.19,DiseaseFree,19.19,LIVING,34,0.3918,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,958,Negative,NOT HISPANIC OR LATINO,2012/6/10,Infiltrating Ductal Carcinoma,NA,NA,Yes,Negative,YES,2007,NA,0,NA,3,NA,NA,NA,NA,NA,IDC,Negative,Right,Negative,NA,NA,YES,1,40,Primary,Female
TCGA.A2.A04P.01,TCGA.A2.A04P.01A.31R.A034.07,1.536429,1.526452,0,0,TCGA-A2-A04P,YES,36,10.28,Recurred/Progressed,18,DECEASED,87,0.6407,M0,N3c,Stage IIIC,T2,Breast Invasive Ductal Carcinoma,2623,Negative,NA,8/26/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2003,NA,18,0,20,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Positive,Left,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,250,Primary,Female
TCGA.A2.A04Q.01,TCGA.A2.A04Q.01A.21R.A034.07,0.096845,0.096845,0,0,TCGA-A2-A04Q,YES,48,78.35,DiseaseFree,78.35,LIVING,8,0.0853,M0,N0 (i-),Stage IA,T1,Breast Invasive Ductal Carcinoma,2260,Negative,NA,2008/10/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2004,NA,0,0,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant|Right,Negative,WHITE,NA,YES,1,230,Primary,Female
TCGA.A2.A04T.01,TCGA.A2.A04T.01A.21R.A034.07,0.555091,0.53033,0,0,TCGA-A2-A04T,YES,62,73.78,DiseaseFree,73.78,LIVING,65,0.6936,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,1979,Negative,NA,2008/9/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2004,NA,0,0,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant,Negative,WHITE,NA,YES,1,200,Primary,Female
TCGA.A2.A0CM.01,TCGA.A2.A0CM.01A.31R.A034.07,0.279332,0.279332,0,0,TCGA-A2-A0CM,YES,40,12.55,Recurred/Progressed,24.77,DECEASED,43,0.3928,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,2546,Negative,NOT HISPANIC OR LATINO,2009/6/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2003,NA,0,0,1,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,300,Primary,Female
TCGA.A2.A0D0.01,TCGA.A2.A0D0.01A.11R.A00Z.07,0.23428,0.23428,0,0,TCGA-A2-A0D0,YES,60,67.28,DiseaseFree,67.28,LIVING,46,0.7061,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,720,Negative,NOT HISPANIC OR LATINO,9/16/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,0,0,8,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,500,Primary,Female
TCGA.A2.A0D2.01,TCGA.A2.A0D2.01A.21R.A034.07,0.735874,0.721219,0,0,TCGA-A2-A0D2,YES,45,33.74,DiseaseFree,33.74,LIVING,61,0.5025,M0,N0 (i+),Stage IIA,T2,Breast Invasive Ductal Carcinoma,614,Negative,NOT HISPANIC OR LATINO,9/16/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,0,4,5,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Lower Outer Quadrant,Negative,WHITE,NA,YES,1,330,Primary,Female
TCGA.A2.A0ST.01,TCGA.A2.A0ST.01A.12R.A084.07,0.326886,0.319208,0.007678,0.024053282,TCGA-A2-A0ST,YES,62,99.11,DiseaseFree,99.11,LIVING,4,0.0109,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,2597,Negative,NOT HISPANIC OR LATINO,2011/9/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2003,NA,3,0,9,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,210,Primary,Female
TCGA.A2.A0SX.01,TCGA.A2.A0SX.01A.12R.A084.07,3.909809,3.909809,0,0,TCGA-A2-A0SX,YES,48,40.7,Recurred/Progressed,50.39,LIVING,21,0.3822,M0,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,1177,Negative,NOT HISPANIC OR LATINO,2011/9/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,NA,0,0,1,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Positive,Left Upper Inner Quadrant,Negative,WHITE,NA,YES,1,910,Primary,Female
TCGA.A2.A0T0.01,TCGA.A2.A0T0.01A.22R.A084.07,1.330847,0.865198,0.011345,0.013112605,TCGA-A2-A0T0,YES,59,17.51,DiseaseFree,17.51,LIVING,130,0.4533,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,268,Negative,NOT HISPANIC OR LATINO,2011/12/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,2,NA,14,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Outer Quadrant,Negative,WHITE,NA,YES,1,190,Primary,Female
TCGA.A2.A0T2.01,TCGA.A2.A0T2.01A.11R.A084.07,0.119777,0.119777,0,0,TCGA-A2-A0T2,YES,66,NA,NA,8.38,DECEASED,35,0.9463,M1,N3,Stage IV,T3,Breast Invasive Ductal Carcinoma,261,Negative,NOT HISPANIC OR LATINO,2011/12/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,10,NA,14,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Abdomen,Liver,NA,IDC,Close,Right,Negative,WHITE,NA,YES,1,270,Primary,Female
TCGA.A2.A0YE.01,TCGA.A2.A0YE.01A.11R.A109.07,0.105581,0.105581,0,0,TCGA-A2-A0YE,YES,48,18.2,DiseaseFree,18.2,LIVING,32,0.781,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,238,Negative,NOT HISPANIC OR LATINO,2012/10/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,1,NA,19,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,240,Primary,Female
TCGA.A2.A0YM.01,TCGA.A2.A0YM.01A.11R.A109.07,1.294479,1.294479,0,0,TCGA-A2-A0YM,YES,67,31.7,DiseaseFree,31.7,LIVING,47,0.434,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,691,Negative,NOT HISPANIC OR LATINO,2012/8/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2008,NA,0,0,5,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,360,Primary,Female
TCGA.A2.A1G6.01,TCGA.A2.A1G6.01A.11R.A13Q.07,0.090417,0.090417,0,0,TCGA-A2-A1G6,YES,50,16.46,DiseaseFree,16.46,LIVING,4,1.00E-04,M0,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,229,Negative,NOT HISPANIC OR LATINO,4/22/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,4,NA,9,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right,Negative,WHITE,NA,NO,1,770,Primary,Female
TCGA.A2.A3XS.01,TCGA.A2.A3XS.01A.11R.A22U.07,1.894184,1.655344,0,0,TCGA-A2-A3XS,YES,62,22.4,Recurred/Progressed,33.9,DECEASED,17,0.5445,M0,N2a,Stage IIIA,T1,Breast Invasive Ductal Carcinoma,3355,Negative,NOT HISPANIC OR LATINO,8/15/12,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2003,YES,9,0,19,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,YES,IDC,Positive,Left Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,40,Primary,Female
TCGA.A2.A3XT.01,TCGA.A2.A3XT.01A.11R.A22U.07,0.471998,0.419956,0.033118,0.078860643,TCGA-A2-A3XT,YES,45,91,DiseaseFree,91,LIVING,62,0.4752,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,2164,Negative,NOT HISPANIC OR LATINO,8/17/12,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,YES,1,NA,13,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left,Negative,BLACK OR AFRICAN AMERICAN,YES,YES,1,340,Primary,Female
TCGA.A2.A3XU.01,TCGA.A2.A3XU.01A.12R.A22U.07,0.024697,0.024697,0,0,TCGA-A2-A3XU,YES,35,21.91,Recurred/Progressed,29.96,DECEASED,17,0.3244,M0,N1mi,Stage IIB,T2,Breast Invasive Ductal Carcinoma,2089,Negative,NOT HISPANIC OR LATINO,8/29/12,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2006,YES,3,0,12,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Negative,BLACK OR AFRICAN AMERICAN,YES,YES,1,350,Primary,Female
TCGA.A2.A3XX.01,TCGA.A2.A3XX.01A.21R.A239.07,1.410468,1.397896,0,0,TCGA-A2-A3XX,YES,49,NA,NA,47.27,DECEASED,30,0.555,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,1143,Negative,NOT HISPANIC OR LATINO,8/15/12,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,YES,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Lower Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,NO,1,780,Primary,Female
TCGA.A2.A3XY.01,TCGA.A2.A3XY.01A.11R.A239.07,3.335418,3.025683,0,0,TCGA-A2-A3XY,YES,49,35.22,Recurred/Progressed,35.91,DECEASED,36,0.1367,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,703,Negative,NOT HISPANIC OR LATINO,8/14/12,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,3,NA,16,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,NO,1,950,Primary,Female
TCGA.A7.A0CE.01,TCGA.A7.A0CE.01A.11R.A00Z.07,0.057419,0.057419,0,0,TCGA-A7-A0CE,YES,57,35.28,DiseaseFree,35.28,LIVING,90,0.4998,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,129,Negative,NOT HISPANIC OR LATINO,2010/4/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2009,NA,0,0,1,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Negative,Left,Negative,WHITE,NA,NO,1,330,Primary,Female
TCGA.A7.A0DA.01,TCGA.A7.A0DA.01A.31R.A115.07,0.08977,0.08977,0,0,TCGA-A7-A0DA,YES,62,35.64,DiseaseFree,35.64,LIVING,103,0.7563,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,177,Negative,NOT HISPANIC OR LATINO,2001/10/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,0,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Outer Quadrant,Negative,WHITE,NA,NO,1,350,Primary,Female
TCGA.A7.A26F.01,TCGA.A7.A26F.01A.21R.A169.07,0.118562,0.02545,0.021305,0.837131631,TCGA-A7-A26F,YES,55,24.24,DiseaseFree,24.24,LIVING,59,0.3177,M0,N0,Stage IA,T1,Metaplastic Breast Cancer,173,Negative,NOT HISPANIC OR LATINO,2008/8/11,"Other, specify",NA,No,Yes,Equivocal,YES,2010,YES,0,NA,1,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,MBC,Close,Left,Negative,WHITE,NA,NO,1,190,Primary,Female
TCGA.A7.A26G.01,TCGA.A7.A26G.01A.21R.A169.07,3.069025,3.042952,0.026073,0.008568324,TCGA-A7-A26G,YES,50,23.72,DiseaseFree,23.72,LIVING,35,0.249,M0,N0 (i+),Stage IIA,T2,Metaplastic Breast Cancer,161,Negative,NOT HISPANIC OR LATINO,2008/10/11,"Other, specify",NA,No,No,Negative,YES,2010,YES,0,NA,2,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,MBC,Negative,Right,Negative,BLACK OR AFRICAN AMERICAN,NA,NO,1,410,Primary,Female
TCGA.A7.A26I.01,TCGA.A7.A26I.01A.11R.A169.07,0.021211,0.021211,0,0,TCGA-A7-A26I,YES,65,21.71,DiseaseFree,21.71,LIVING,27,0.6589,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,40,Negative,NOT HISPANIC OR LATINO,7/29/11,Infiltrating Ductal Carcinoma,NA,No,Yes,Equivocal,YES,2011,YES,0,NA,2,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Close,Left,Negative,WHITE,NA,NO,1,120,Primary,Female
TCGA.A7.A4SD.01,TCGA.A7.A4SD.01A.11R.A266.07,0.811702,0.811702,0,0,TCGA-A7-A4SD,YES,52,14.49,DiseaseFree,14.49,LIVING,35,0.3712,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,63,Negative,NOT HISPANIC OR LATINO,2/19/13,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2012,YES,0,0,6,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Negative,BLACK OR AFRICAN AMERICAN,NO,NO,1,230,Primary,Female
TCGA.A7.A4SE.01,TCGA.A7.A4SE.01A.11R.A266.07,1.675981,0.687442,0,0,TCGA-A7-A4SE,YES,54,21.16,DiseaseFree,21.16,LIVING,73,0.7743,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,306,Negative,NOT HISPANIC OR LATINO,2/22/13,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2011,YES,0,0,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Negative,BLACK OR AFRICAN AMERICAN,NO,NO,1,160,Primary,Female
TCGA.A7.A5ZV.01,TCGA.A7.A5ZV.01A.11R.A28M.07,0.072939,0.072939,0,0,TCGA-A7-A5ZV,YES,62,12.09,DiseaseFree,12.09,LIVING,139,0.5955,M0,N0,Stage IIA,T2,"Breast Invasive Carcinoma, NOS",154,Negative,NOT HISPANIC OR LATINO,5/14/13,Infiltrating Carcinoma NOS,NA,No,No,Equivocal,YES,2012,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,BRCNOS,Negative,Left,Negative,BLACK OR AFRICAN AMERICAN,NO,NO,1,940,Primary,Female
TCGA.A7.A6VV.01,TCGA.A7.A6VV.01A.22R.A33J.07,0.063494,0.063494,0,0,TCGA-A7-A6VV,YES,51,10.28,DiseaseFree,10.28,LIVING,NA,0.6645,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,85,Negative,NOT HISPANIC OR LATINO,10/22/13,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2013,YES,0,NA,5,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,IDC,Negative,Right,Negative,BLACK OR AFRICAN AMERICAN,NO,NO,1,1100,Primary,Female
TCGA.A7.A6VW.01,TCGA.A7.A6VW.01A.21R.A33J.07,0.046909,0.046909,0,0,TCGA-A7-A6VW,YES,48,9.36,DiseaseFree,9.36,LIVING,NA,0.5937,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,71,Negative,NOT HISPANIC OR LATINO,10/29/13,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2013,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Close,Left,Negative,BLACK OR AFRICAN AMERICAN,NO,NO,1,370,Primary,Female
TCGA.A7.A6VY.01,TCGA.A7.A6VY.01A.12R.A33J.07,3.049157,2.809271,0.192546,0.068539489,TCGA-A7-A6VY,YES,48,8.74,DiseaseFree,8.74,LIVING,NA,0.4614,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,29,Negative,NOT HISPANIC OR LATINO,10/25/13,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2013,YES,2,NA,14,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right|Right Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NO,NO,1,70,Primary,Female
TCGA.A8.A07C.01,TCGA.A8.A07C.01A.11R.A034.07,0.55664,0.55664,0,0,TCGA-A8-A07C,YES,57,33.97,DiseaseFree,33.97,LIVING,103,NA,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,637,Negative,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,NA,NA,YES,1,80,Primary,Female
TCGA.A8.A07O.01,TCGA.A8.A07O.01A.11R.A00Z.07,0.030808,0.030808,0,0,TCGA-A8-A07O,YES,51,9.99,DiseaseFree,9.99,LIVING,31,0.3136,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,180,Negative,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,NA,NA,YES,1,220,Primary,Female
TCGA.A8.A08R.01,TCGA.A8.A08R.01A.11R.A034.07,0.157504,0.134817,0.022687,0.168279965,TCGA-A8-A08R,YES,52,0.99,DiseaseFree,0.99,LIVING,123,0.5152,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,728,Negative,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Negative,NA,NA,YES,1,90,Primary,Female
TCGA.A8.A09X.01,TCGA.A8.A09X.01A.11R.A00Z.07,0.482737,0.482737,0,0,TCGA-A8-A09X,YES,62,NA,NA,13.99,DECEASED,46,0.1791,M0,N3a,Stage IIIC,T2,Breast Invasive Lobular Carcinoma,302,Negative,NA,5/27/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,NA,Left Upper Inner Quadrant,Negative,NA,NA,YES,1,150,Primary,Female
TCGA.AC.A2BK.01,TCGA.AC.A2BK.01A.11R.A21T.07,0.074372,0.074372,0,0,TCGA-AC-A2BK,YES,78,73,DiseaseFree,73,LIVING,59,0.5065,MX,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,1717,Negative,NA,9/16/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,YES,6,NA,23,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,140,Primary,Female
TCGA.AC.A2QH.01,TCGA.AC.A2QH.01A.11R.A18M.07,0.008247,0,0.008247,Inf,TCGA-AC-A2QH,YES,58,33.02,DiseaseFree,33.02,LIVING,52,0.4092,MX,N0,Stage IIB,T3,Metaplastic Breast Cancer,108,Negative,NOT HISPANIC OR LATINO,10/18/11,Metaplastic Carcinoma,NA,No,No,Negative,YES,2011,YES,0,0,22,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,MBC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,NO,1,150,Primary,Female
TCGA.AC.A2QJ.01,TCGA.AC.A2QJ.01A.12R.A19W.07,0.188376,0.188376,0,0,TCGA-AC-A2QJ,YES,48,7.79,Recurred/Progressed,14.65,DECEASED,33,0.1854,M0,N0,Stage IIIB,T4b,Metaplastic Breast Cancer,160,Negative,HISPANIC OR LATINO,10/18/11,Metaplastic Carcinoma,NA,No,No,Negative,YES,2011,YES,0,NA,2,NA,Peri (6-12 months since last menstrual period),NA,NA,NO,MBC,Negative,Left Upper Outer Quadrant|Left Lower Outer Quadrant,Negative,WHITE,NA,NO,1,150,Primary,Female
TCGA.AC.A6IW.01,TCGA.AC.A6IW.01A.12R.A33J.07,1.85686,1.780905,0,0,TCGA-AC-A6IW,YES,73,13.57,DiseaseFree,13.57,LIVING,NA,0.1742,MX,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,74,Negative,NOT HISPANIC OR LATINO,10/15/13,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2013,YES,0,0,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,NO,1,120,Primary,Female
TCGA.AC.A7VC.01,TCGA.AC.A7VC.01A.11R.A352.07,0.177542,0.177542,0,0,TCGA-AC-A7VC,YES,56,0.03,DiseaseFree,0.03,LIVING,NA,0.2899,MX,N0,Stage IIB,T3,Metaplastic Breast Cancer,63,Negative,NOT HISPANIC OR LATINO,3/29/14,Metaplastic Carcinoma,NA,No,No,Negative,YES,2013,YES,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,MBC,Negative,Left,Negative,WHITE,NA,NO,1,80,Primary,Female
TCGA.AN.A04D.01,TCGA.AN.A04D.01A.21R.A034.07,0.015851,0.015851,0,0,TCGA-AN-A04D,YES,58,1.71,DiseaseFree,1.71,LIVING,70,0.3686,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,676,Negative,NOT HISPANIC OR LATINO,12/20/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,2,0,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Positive,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,260,Primary,Female
TCGA.AN.A0AL.01,TCGA.AN.A0AL.01A.11R.A00Z.07,0.150917,0.150917,0,0,TCGA-AN-A0AL,YES,41,7.46,DiseaseFree,7.46,LIVING,63,0.4407,M0,N0,Stage IIIB,T4,Breast Invasive Ductal Carcinoma,49,Negative,NOT HISPANIC OR LATINO,12/21/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,0,0,5,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Lower Outer Quadrant,Negative,WHITE,NA,YES,1,300,Primary,Female
TCGA.AN.A0AR.01,TCGA.AN.A0AR.01A.11R.A00Z.07,0.100046,0.100046,0,0,TCGA-AN-A0AR,YES,55,0.33,DiseaseFree,0.33,LIVING,87,0.5378,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,34,Negative,NOT HISPANIC OR LATINO,12/28/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,0,0,17,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant,Negative,WHITE,NA,YES,1,150,Primary,Female
TCGA.AN.A0AT.01,TCGA.AN.A0AT.01A.11R.A034.07,0.054471,0.042173,0,0,TCGA-AN-A0AT,YES,62,0.33,DiseaseFree,0.33,LIVING,87,0.4552,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,28,Negative,NOT HISPANIC OR LATINO,12/28/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,0,0,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant,Negative,WHITE,NA,YES,1,170,Primary,Female
TCGA.AN.A0G0.01,TCGA.AN.A0G0.01A.11R.A034.07,0.016285,0.016285,0,0,TCGA-AN-A0G0,YES,56,0.53,DiseaseFree,0.53,LIVING,31,NA,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,34,Negative,NOT HISPANIC OR LATINO,12/29/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,0,0,23,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant,Negative,WHITE,NA,YES,1,210,Primary,Female
TCGA.AN.A0XU.01,TCGA.AN.A0XU.01A.11R.A109.07,0.044882,0.044882,0,0,TCGA-AN-A0XU,YES,54,0.33,DiseaseFree,0.33,LIVING,75,0.4834,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,106,Negative,NOT HISPANIC OR LATINO,3/28/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,0,NA,16,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,180,Primary,Female
TCGA.AO.A03U.01,TCGA.AO.A03U.01B.21R.A10J.07,0.077943,0.077943,0,0,TCGA-AO-A03U,YES,31,53.02,Recurred/Progressed,58.9,DECEASED,7,0.001,M0,N0 (i-),Stage I,T1c,Invasive Breast Carcinoma,3254,Negative,NOT HISPANIC OR LATINO,2001/9/11,"Other, specify",NA,No,No,Negative,YES,2001,NA,0,0,8,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,BRCA,Negative,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left,Negative,WHITE,NA,YES,1,170,Primary,Female
TCGA.AO.A0J2.01,TCGA.AO.A0J2.01A.11R.A034.07,0.607205,0.589636,0,0,TCGA-AO-A0J2,YES,41,32.75,DiseaseFree,32.75,LIVING,47,0.7158,M0,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,668,Negative,NOT HISPANIC OR LATINO,9/19/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2008,NA,0,0,5,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Lower Inner Quadrant|Left,Negative,WHITE,NA,YES,1,260,Primary,Female
TCGA.AO.A0J4.01,TCGA.AO.A0J4.01A.11R.A034.07,0.176766,0.142929,0,0,TCGA-AO-A0J4,YES,41,52.14,DiseaseFree,52.14,LIVING,68,0.4434,M0,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,224,Negative,NOT HISPANIC OR LATINO,9/19/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,0,0,4,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant|Left,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,130,Primary,Female
TCGA.AO.A0J6.01,TCGA.AO.A0J6.01A.11R.A034.07,1.486887,0.594063,0,0,TCGA-AO-A0J6,YES,61,37.45,DiseaseFree,37.45,LIVING,84,0.4668,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,748,Negative,NOT HISPANIC OR LATINO,9/19/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,0,0,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant|Left,Negative,WHITE,NA,YES,1,390,Primary,Female
TCGA.AO.A124.01,TCGA.AO.A124.01A.11R.A10J.07,0.290218,0.290218,0,0,TCGA-AO-A124,YES,38,115.18,DiseaseFree,115.18,LIVING,112,0.7327,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,3213,Negative,NOT HISPANIC OR LATINO,2012/7/10,"Other, specify",NA,No,No,Negative,YES,2002,NA,0,0,18,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left,Negative,WHITE,NA,YES,1,730,Primary,Female
TCGA.AO.A128.01,TCGA.AO.A128.01A.11R.A10J.07,5.094264,3.760229,0,0,TCGA-AO-A128,YES,61,106.7,DiseaseFree,106.7,LIVING,663,0.1548,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,2960,Negative,NOT HISPANIC OR LATINO,2012/7/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2002,NA,0,0,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Lower Outer Quadrant|Right,Negative,WHITE,NA,YES,1,590,Primary,Female
TCGA.AO.A129.01,TCGA.AO.A129.01A.21R.A10J.07,0.809787,0.662432,0,0,TCGA-AO-A129,YES,29,107.95,DiseaseFree,107.95,LIVING,64,0.3991,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,2915,Negative,NOT HISPANIC OR LATINO,2012/8/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2002,NA,2,NA,21,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Lower Outer Quadrant|Left,Negative,WHITE,NA,YES,1,320,Primary,Female
TCGA.AO.A12F.01,TCGA.AO.A12F.01A.11R.A115.07,0.010566,0.010566,0,0,TCGA-AO-A12F,YES,36,60.51,DiseaseFree,60.51,LIVING,26,0.6214,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,1578,Negative,NOT HISPANIC OR LATINO,2012/8/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,NA,0,0,17,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant|Right,Negative,WHITE,NA,YES,1,600,Primary,Female
TCGA.AO.A1KR.01,TCGA.AO.A1KR.01A.12R.A144.07,0.024226,0.024226,0,0,TCGA-AO-A1KR,YES,51,82.56,DiseaseFree,82.56,LIVING,46,0.4509,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,1932,Negative,NOT HISPANIC OR LATINO,9/15/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2005,YES,0,0,4,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right Upper Inner Quadrant,Negative,WHITE,NA,YES,1,190,Primary,Female
TCGA.AQ.A04J.01,TCGA.AQ.A04J.01A.02R.A034.07,0.350687,0.350687,0,0,TCGA-AQ-A04J,YES,45,26.91,DiseaseFree,26.91,LIVING,44,0.3431,M0,N0 (i+),Stage IIA,T2,Breast Invasive Ductal Carcinoma,118,Negative,NOT HISPANIC OR LATINO,10/15/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,0,0,20,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,160,Primary,Female
TCGA.AQ.A54N.01,TCGA.AQ.A54N.01A.11R.A266.07,0.114246,0.114246,0,0,TCGA-AQ-A54N,YES,51,2.56,DiseaseFree,2.56,LIVING,58,0.6816,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,639,Negative,HISPANIC OR LATINO,2/26/13,Infiltrating Ductal Carcinoma,NA,No,Yes,Equivocal,YES,2011,YES,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Inner Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NO,NO,1,360,Primary,Female
TCGA.AR.A0TS.01,TCGA.AR.A0TS.01A.11R.A115.07,1.575527,1.557459,0,0,TCGA-AR-A0TS,YES,46,84.03,DiseaseFree,84.03,LIVING,29,0.0895,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1549,Negative,NOT HISPANIC OR LATINO,2003/8/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,NA,2,NA,16,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right,Negative,WHITE,NA,YES,1,250,Primary,Female
TCGA.AR.A0TU.01,TCGA.AR.A0TU.01A.31R.A109.07,0.227523,0.227523,0,0,TCGA-AR-A0TU,YES,35,23.29,DiseaseFree,23.29,LIVING,53,NA,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,1633,Negative,NA,2003/10/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,NA,0,NA,4,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Lower Outer Quadrant,Negative,NA,NA,YES,1,830,Primary,Female
TCGA.AR.A0U4.01,TCGA.AR.A0U4.01A.11R.A109.07,1.239142,1.239142,0,0,TCGA-AR-A0U4,YES,54,107.13,DiseaseFree,107.13,LIVING,NA,0.4452,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,1517,Negative,NOT HISPANIC OR LATINO,2003/10/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,NA,0,NA,10,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,530,Primary,Female
TCGA.AR.A1AI.01,TCGA.AR.A1AI.01A.11R.A12P.07,0.63944,0.63944,0,0,TCGA-AR-A1AI,YES,47,19.32,Recurred/Progressed,108.28,LIVING,51,0.4681,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,1939,Negative,NOT HISPANIC OR LATINO,6/15/11,Medullary Carcinoma,NA,No,No,Equivocal,YES,2005,YES,0,NA,5,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,1050,Primary,Female
TCGA.AR.A1AQ.01,TCGA.AR.A1AQ.01A.11R.A12P.07,0.222516,0.222516,0,0,TCGA-AR-A1AQ,YES,49,99.24,DiseaseFree,99.24,LIVING,35,0.4982,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,1424,Negative,NOT HISPANIC OR LATINO,6/14/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2007,YES,0,NA,6,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,180,Primary,Female
TCGA.AR.A1AR.01,TCGA.AR.A1AR.01A.31R.A137.07,2.210886,1.771171,0,0,TCGA-AR-A1AR,YES,50,12.71,Recurred/Progressed,17.21,DECEASED,40,0.4696,M0,N2,Stage IIIA,T1,Breast Invasive Ductal Carcinoma,1416,Negative,NOT HISPANIC OR LATINO,6/28/11,Infiltrating Ductal Carcinoma,NA,No,Yes,Negative,YES,2007,NA,5,NA,14,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Inner Quadrant,Negative,WHITE,NA,YES,1,250,Primary,Female
TCGA.AR.A1AY.01,TCGA.AR.A1AY.01A.21R.A12P.07,0.028937,0.028937,0,0,TCGA-AR-A1AY,YES,65,33.71,DiseaseFree,33.71,LIVING,39,0.5101,M0,N0,Stage I,T1,Breast Invasive Ductal Carcinoma,1085,Negative,NOT HISPANIC OR LATINO,6/14/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,YES,0,NA,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,110,Primary,Female
TCGA.AR.A256.01,TCGA.AR.A256.01A.11R.A169.07,0.211989,0.211989,0,0,TCGA-AR-A256,YES,45,53.88,Recurred/Progressed,93.76,DECEASED,136,0.6832,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,3740,Negative,NA,8/31/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2001,YES,0,NA,5,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Lower Inner Quadrant,Negative,WHITE,NA,YES,1,210,Primary,Female
TCGA.AR.A2LH.01,TCGA.AR.A2LH.01A.31R.A18M.07,0.385826,0.31745,0,0,TCGA-AR-A2LH,YES,55,14.26,Recurred/Progressed,20.24,DECEASED,18,0,M0,N3,Stage III,T3,Breast Invasive Lobular Carcinoma,1661,Negative,NOT HISPANIC OR LATINO,2001/12/12,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2007,YES,29,NA,39,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Bone|Liver,YES,ILC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,1100,Primary,Female
TCGA.AR.A2LR.01,TCGA.AR.A2LR.01A.12R.A18M.07,0.02172,0.02172,0,0,TCGA-AR-A2LR,YES,49,57.23,DiseaseFree,57.23,LIVING,45,0.4915,M0,N0,Stage I,T1,Metaplastic Breast Cancer,447,Negative,NOT HISPANIC OR LATINO,2/14/12,Metaplastic Carcinoma,NA,No,Yes,Negative,YES,2010,YES,0,NA,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,MBC,Negative,Right,Negative,WHITE,NA,YES,1,800,Primary,Female
TCGA.AR.A5QQ.01,TCGA.AR.A5QQ.01A.11R.A28M.07,0.77309,0.77309,0,0,TCGA-AR-A5QQ,YES,68,9.89,Recurred/Progressed,10.58,DECEASED,41,4.00E-04,M0,N1,Stage IIIA,T3,Metaplastic Breast Cancer,576,Negative,NOT HISPANIC OR LATINO,5/15/13,"Other, specify",NA,No,No,Negative,YES,2011,YES,1,NA,24,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,MBC,NA,Right,Negative,WHITE,YES,YES,1,800,Primary,Female
TCGA.B6.A3ZX.01,TCGA.B6.A3ZX.01A.11R.A239.07,0.111578,0.111578,0,0,TCGA-B6-A3ZX,YES,50,32.65,Recurred/Progressed,37.84,DECEASED,33,0.0451,M1,N1,Stage IV,T3,Breast Mixed Ductal and Lobular Carcinoma,1954,Negative,NOT HISPANIC OR LATINO,9/20/12,Mixed Histology (please specify),ductal and lobular,No,No,Negative,YES,2007,YES,1,NA,7,Negative,NA,NA,Bone,NA,MDLC,Close,Left Upper Inner Quadrant,Negative,BLACK OR AFRICAN AMERICAN,YES,YES,1,5,Primary,Female
TCGA.B6.A400.01,TCGA.B6.A400.01A.11R.A239.07,1.784627,1.631758,0,0,TCGA-B6-A400,YES,43,7.06,DiseaseFree,7.06,LIVING,83,0.3384,M0,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,1610,Negative,NOT HISPANIC OR LATINO,9/20/12,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,YES,4,NA,5,NA,NA,NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,YES,YES,1,20,Primary,Female
TCGA.B6.A402.01,TCGA.B6.A402.01A.11R.A239.07,0.010104,0.010104,0,0,TCGA-B6-A402,YES,47,76.54,Recurred/Progressed,74.93,LIVING,33,0.5552,M0,N0 (i-),Stage I,T1c,Breast Invasive Ductal Carcinoma,1563,Negative,NOT HISPANIC OR LATINO,9/20/12,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,YES,0,0,3,NA,NA,NA,NA,NA,IDC,Negative,Right Lower Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,YES,YES,1,10,Primary,Female
TCGA.B6.A409.01,TCGA.B6.A409.01A.11R.A24H.07,0.12428,0.12428,0,0,TCGA-B6-A409,YES,44,14.98,Recurred/Progressed,18.82,DECEASED,23,0.5715,M0,N2a,Stage IIIA,T1c,Breast Invasive Ductal Carcinoma,1480,Negative,NOT HISPANIC OR LATINO,9/20/12,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2008,YES,6,NA,22,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NO,YES,1,20,Primary,Female
TCGA.BH.A0AV.01,TCGA.BH.A0AV.01A.31R.A115.07,0.334908,0.334908,0,0,TCGA-BH-A0AV,YES,52,59.79,DiseaseFree,59.79,LIVING,45,0.6161,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,761,Negative,NA,2008/2/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2008,YES,0,NA,2,NA,NA,NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,250,Primary,Female
TCGA.BH.A0B3.01,TCGA.BH.A0B3.01A.11R.A056.07,0.1147,0.1147,0,0,TCGA-BH-A0B3,YES,53,39.52,DiseaseFree,39.52,LIVING,26,0.2146,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1030,Negative,NA,2011/3/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,NA,2,NA,29,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right,Negative,WHITE,NA,YES,1,280,Primary,Female
TCGA.BH.A0B9.01,TCGA.BH.A0B9.01A.11R.A056.07,0.50089,0.50089,0,0,TCGA-BH-A0B9,YES,44,51.64,DiseaseFree,51.64,LIVING,31,0.307,M0,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,1391,Negative,NA,2011/4/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,NA,0,NA,1,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right,Negative,WHITE,NA,YES,1,190,Primary,Female
TCGA.BH.A0BG.01,TCGA.BH.A0BG.01A.11R.A115.07,0.153029,0.153029,0,0,TCGA-BH-A0BG,YES,73,61.47,DiseaseFree,61.47,LIVING,26,0.4262,M0,N0,Stage I,T1,Breast Invasive Ductal Carcinoma,798,Negative,NOT HISPANIC OR LATINO,2008/8/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,YES,0,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Lower Outer Quadrant,Negative,WHITE,NA,YES,1,50,Primary,Female
TCGA.BH.A0BL.01,TCGA.BH.A0BL.01A.11R.A115.07,0.475302,0.41706,0,0,TCGA-BH-A0BL,YES,35,74.84,DiseaseFree,74.84,LIVING,47,0.3435,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,1135,Negative,NOT HISPANIC OR LATINO,2008/8/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,YES,0,NA,2,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,60,Primary,Female
TCGA.BH.A0BW.01,TCGA.BH.A0BW.01A.11R.A115.07,2.985663,2.834333,0,0,TCGA-BH-A0BW,YES,71,77.89,DiseaseFree,77.89,LIVING,70,0.3953,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,1344,Negative,NOT HISPANIC OR LATINO,2008/10/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2006,YES,0,NA,8,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Lower Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,170,Primary,Female
TCGA.BH.A0E0.01,TCGA.BH.A0E0.01A.11R.A056.07,1.427654,0.958808,0,0,TCGA-BH-A0E0,YES,38,4.4,DiseaseFree,4.4,LIVING,25,0.6731,M0,N3a,Stage IIIC,T3,Breast Invasive Ductal Carcinoma,136,Negative,NA,2011/9/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,10,NA,21,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left,Negative,WHITE,NA,YES,1,620,Primary,Female
TCGA.BH.A0E6.01,TCGA.BH.A0E6.01A.11R.A034.07,0.312758,0.312758,0,0,TCGA-BH-A0E6,YES,69,9.63,DiseaseFree,9.63,LIVING,42,0.617,M0,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,134,Negative,NA,2011/9/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2009,NA,0,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left,Negative,WHITE,NA,YES,1,80,Primary,Female
TCGA.BH.A0RX.01,TCGA.BH.A0RX.01A.21R.A084.07,0.624963,0.624963,0,0,TCGA-BH-A0RX,YES,59,5.58,DiseaseFree,5.58,LIVING,14,0.095,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,63,Negative,NA,2011/11/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,0,NA,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant|Left,Negative,WHITE,NA,YES,1,170,Primary,Female
TCGA.BH.A0WA.01,TCGA.BH.A0WA.01A.11R.A109.07,0.065482,0.065482,0,0,TCGA-BH-A0WA,YES,82,23.03,DiseaseFree,23.03,LIVING,68,0.606,M0,N0 (i-),Stage I,T1c,Metaplastic Breast Cancer,724,Negative,NOT HISPANIC OR LATINO,2/16/11,NA,NA,No,No,Negative,YES,2008,NA,0,NA,3,NA,NA,NA,NA,NA,MBC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,80,Primary,Female
TCGA.BH.A18G.01,TCGA.BH.A18G.01A.11R.A12D.07,0.766654,0.766654,0,0,TCGA-BH-A18G,YES,81,4.89,DiseaseFree,4.89,LIVING,1038,0.071,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,78,Negative,NOT HISPANIC OR LATINO,2006/1/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,0,NA,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Negative,WHITE,NA,YES,1,100,Primary,Female
TCGA.BH.A18V.01,TCGA.BH.A18V.01A.11R.A12D.07,0.565935,0.565935,0,0,TCGA-BH-A18V,YES,48,NA,NA,51.12,DECEASED,130,0.7015,M0,N1b,Stage IIB,T2,Breast Invasive Ductal Carcinoma,3621,Negative,NOT HISPANIC OR LATINO,2007/2/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2001,YES,0,NA,25,NA,NA,axilaary node negative but intrammary node positive,"Other, specify",YES,IDC,Negative,Right,Negative,WHITE,NA,YES,2,300,Primary,Female
TCGA.BH.A1EW.01,TCGA.BH.A1EW.01A.11R.A137.07,0.17465,0.17465,0,0,TCGA-BH-A1EW,YES,38,NA,NA,55.65,DECEASED,9,0.3453,M0,N1b,Stage IIA,T2,Breast Invasive Ductal Carcinoma,4230,Negative,NOT HISPANIC OR LATINO,2009/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,1999,YES,1,NA,16,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,NA,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,550,Primary,Female
TCGA.BH.A1F6.01,TCGA.BH.A1F6.01A.11R.A13Q.07,0.359817,0.359817,0,0,TCGA-BH-A1F6,YES,51,NA,NA,97.4,DECEASED,41,0.5787,MX,N2a,NA,T4d,Breast Invasive Ductal Carcinoma,5230,Negative,NOT HISPANIC OR LATINO,2009/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,1996,YES,6,NA,6,NA,NA,NA,NA,NA,IDC,NA,Left,Negative,WHITE,NA,YES,1,360,Primary,Female
TCGA.BH.A1FC.01,TCGA.BH.A1FC.01A.11R.A13Q.07,1.055174,1.055174,0,0,TCGA-BH-A1FC,YES,78,NA,NA,114.06,DECEASED,59,0.4675,M0,N1b,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,4456,Negative,NOT HISPANIC OR LATINO,2009/8/11,Medullary Carcinoma,NA,No,No,Negative,YES,1998,YES,1,NA,23,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,NA,Right Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,90,Primary,Female
TCGA.BH.A42U.01,TCGA.BH.A42U.01A.12R.A24H.07,0.187603,0.187603,0,0,TCGA-BH-A42U,YES,80,110.51,DiseaseFree,110.51,LIVING,9,0,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,3080,Negative,NOT HISPANIC OR LATINO,2010/1/12,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2004,YES,NA,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right,Negative,BLACK OR AFRICAN AMERICAN,NO,NO,1,290,Primary,Female
TCGA.C8.A12V.01,TCGA.C8.A12V.01A.11R.A115.07,4.036923,3.974806,0.062117,0.015627681,TCGA-C8-A12V,YES,55,12.65,DiseaseFree,12.65,LIVING,12,0.0027,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,57,Negative,NOT HISPANIC OR LATINO,3/22/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,0,NA,5,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,NA,Right,Negative,ASIAN,NA,NO,1,540,Primary,Female
TCGA.C8.A131.01,TCGA.C8.A131.01A.11R.A115.07,0.917492,0.917492,0,0,TCGA-C8-A131,YES,82,13.5,DiseaseFree,13.5,LIVING,43,0.2303,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,163,Negative,NOT HISPANIC OR LATINO,4/15/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,4,NA,8,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left,Negative,ASIAN,NA,NO,1,460,Primary,Female
TCGA.C8.A134.01,TCGA.C8.A134.01A.11R.A115.07,0.208718,0.208718,0,0,TCGA-C8-A134,YES,52,12.58,DiseaseFree,12.58,LIVING,69,0.4432,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,162,Negative,NOT HISPANIC OR LATINO,4/15/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,NA,NA,NA,7,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,IDC,Negative,Left,Negative,ASIAN,NA,NO,1,530,Primary,Female
TCGA.C8.A1HJ.01,TCGA.C8.A1HJ.01A.11R.A13Q.07,0.535188,0.535188,0,0,TCGA-C8-A1HJ,YES,53,0.16,DiseaseFree,0.16,LIVING,87,0.5135,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,121,Negative,NOT HISPANIC OR LATINO,2006/1/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,NA,NA,10,NA,Peri (6-12 months since last menstrual period),NA,NA,NO,IDC,Negative,Right,Negative,ASIAN,NA,NO,1,1070,Primary,Female
TCGA.C8.A26X.01,TCGA.C8.A26X.01A.31R.A16F.07,0.091983,0.091983,0,0,TCGA-C8-A26X,YES,58,12.35,DiseaseFree,12.35,LIVING,38,0.3564,M0,N1,Stage IIA,T1,Breast Invasive Ductal Carcinoma,136,Negative,NOT HISPANIC OR LATINO,7/21/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NO,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,ASIAN,NA,NO,1,190,Primary,Female
TCGA.C8.A26Y.01,TCGA.C8.A26Y.01A.11R.A16F.07,0.410718,0.394453,0,0,TCGA-C8-A26Y,YES,90,12.94,DiseaseFree,12.94,LIVING,503,0.588,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,134,Negative,NOT HISPANIC OR LATINO,7/21/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NO,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,ASIAN,NA,NO,1,140,Primary,Female
TCGA.C8.A27B.01,TCGA.C8.A27B.01A.11R.A169.07,0.158192,0.147975,0.010217,0.069045447,TCGA-C8-A27B,YES,48,14.42,DiseaseFree,14.42,LIVING,106,0.7389,M0,N0,Stage IIB,T3,Breast Invasive Ductal Carcinoma,93,Negative,NOT HISPANIC OR LATINO,7/21/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2011,NO,NA,NA,NA,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,IDC,Negative,Left,Negative,ASIAN,NA,NO,1,240,Primary,Female
TCGA.C8.A3M7.01,TCGA.C8.A3M7.01A.12R.A21T.07,0.038354,0.038354,0,0,TCGA-C8-A3M7,YES,60,33.97,Recurred/Progressed,33.97,DECEASED,107,0.1781,M0,N0,Stage IIIB,T4b,Breast Invasive Lobular Carcinoma,401,Negative,NOT HISPANIC OR LATINO,2003/6/12,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2010,YES,0,NA,6,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Left Upper Inner Quadrant,Negative,ASIAN,NA,NO,1,970,Primary,Female
TCGA.D8.A13Z.01,TCGA.D8.A13Z.01A.11R.A115.07,0.649036,0.4485,0,0,TCGA-D8-A13Z,YES,51,20.86,DiseaseFree,20.86,LIVING,55,0.4986,M0,N2a,NA,T2,Breast Invasive Ductal Carcinoma,214,Negative,NOT HISPANIC OR LATINO,2/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,9,NA,11,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Lower Outer Quadrant,Negative,WHITE,NA,NO,1,470,Primary,Female
TCGA.D8.A142.01,TCGA.D8.A142.01A.11R.A115.07,0.466661,0.454481,0,0,TCGA-D8-A142,YES,74,13.96,DiseaseFree,13.96,LIVING,41,0.5222,M0,N0,Stage IIB,T3,Breast Invasive Ductal Carcinoma,212,Negative,NOT HISPANIC OR LATINO,2/25/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,YES,0,NA,14,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Outer Quadrant|Left,Negative,WHITE,NA,NO,1,490,Primary,Female
TCGA.D8.A143.01,TCGA.D8.A143.01A.11R.A115.07,0.098509,0.098509,0,0,TCGA-D8-A143,YES,51,14.16,DiseaseFree,14.16,LIVING,36,0.5356,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,211,Negative,NOT HISPANIC OR LATINO,2/25/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,0,NA,11,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Inner Quadrant,Negative,WHITE,NA,NO,1,200,Primary,Female
TCGA.D8.A147.01,TCGA.D8.A147.01A.11R.A115.07,0.618484,0.618484,0,0,TCGA-D8-A147,YES,45,19.19,DiseaseFree,19.19,LIVING,89,0.5742,M0,N0,NA,T2,Breast Invasive Ductal Carcinoma,163,Negative,NOT HISPANIC OR LATINO,2/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,0,NA,1,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Negative,Right Lower Outer Quadrant,Negative,WHITE,NA,NO,1,130,Primary,Female
TCGA.D8.A1JF.01,TCGA.D8.A1JF.01A.11R.A13Q.07,0.448189,0.448189,0,0,TCGA-D8-A1JF,YES,79,12.02,DiseaseFree,12.02,LIVING,36,0.414,M0,N2a,Stage IIIA,T1c,Breast Invasive Ductal Carcinoma,203,Negative,NOT HISPANIC OR LATINO,3/28/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,8,NA,25,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,NO,1,180,Primary,Female
TCGA.D8.A1JG.01,TCGA.D8.A1JG.01B.11R.A13Q.07,0.558338,0.520435,0.023373,0.044910508,TCGA-D8-A1JG,YES,62,52.96,DiseaseFree,52.96,LIVING,84,0.2687,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,215,Negative,NOT HISPANIC OR LATINO,3/28/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,YES,0,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,NO,1,250,Primary,Female
TCGA.D8.A1JL.01,TCGA.D8.A1JL.01A.11R.A13Q.07,1.214608,1.214608,0,0,TCGA-D8-A1JL,YES,72,20.07,DiseaseFree,20.07,LIVING,70,0.3656,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,264,Negative,NOT HISPANIC OR LATINO,3/29/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,0,NA,11,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Inner Quadrant,Negative,WHITE,NA,NO,1,430,Primary,Female
TCGA.D8.A1XK.01,TCGA.D8.A1XK.01A.21R.A14M.07,1.050172,1.040191,0,0,TCGA-D8-A1XK,YES,55,14.49,DiseaseFree,14.49,LIVING,706,0.6388,MX,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,275,Negative,NOT HISPANIC OR LATINO,2006/9/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,3,NA,18,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Lower Inner Quadrant,Negative,WHITE,NA,NO,1,260,Primary,Female
TCGA.D8.A1XQ.01,TCGA.D8.A1XQ.01A.11R.A14M.07,0.058503,0.027529,0,0,TCGA-D8-A1XQ,YES,69,16.39,DiseaseFree,16.39,LIVING,548,0.3387,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,158,Negative,NOT HISPANIC OR LATINO,5/16/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,0,0,7,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,NO,1,100,Primary,Female
TCGA.D8.A27F.01,TCGA.D8.A27F.01A.11R.A16F.07,0.10402,0.10402,0,0,TCGA-D8-A27F,YES,40,16.03,DiseaseFree,16.03,LIVING,38,0.6698,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,166,Negative,NOT HISPANIC OR LATINO,7/18/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,0,0,11,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,NO,1,320,Primary,Female
TCGA.D8.A27H.01,TCGA.D8.A27H.01A.11R.A16F.07,0.441681,0.441681,0,0,TCGA-D8-A27H,YES,72,13.04,DiseaseFree,13.04,LIVING,90,0.4824,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,84,Negative,NOT HISPANIC OR LATINO,7/18/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2011,YES,NA,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,NO,1,170,Primary,Female
TCGA.D8.A27M.01,TCGA.D8.A27M.01A.11R.A16F.07,0.169413,0.169413,0,0,TCGA-D8-A27M,YES,59,13.47,DiseaseFree,13.47,LIVING,44,0.2982,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,83,Negative,NOT HISPANIC OR LATINO,7/17/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2011,YES,NA,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,NO,1,140,Primary,Female
TCGA.E2.A14N.01,TCGA.E2.A14N.01A.31R.A137.07,0.24375,0.24375,0,0,TCGA-E2-A14N,YES,37,47.11,DiseaseFree,47.11,LIVING,41,0.0848,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1240,Negative,NOT HISPANIC OR LATINO,5/31/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,YES,1,NA,38,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right Upper Inner Quadrant,Negative,WHITE,NA,YES,1,440,Primary,Female
TCGA.E2.A14R.01,TCGA.E2.A14R.01A.11R.A115.07,0.755443,0.732963,0.008858,0.012085194,TCGA-E2-A14R,YES,62,31.9,Recurred/Progressed,38.57,LIVING,88,0.7127,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,910,Negative,NOT HISPANIC OR LATINO,2004/6/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,YES,0,NA,8,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left,Negative,WHITE,NA,YES,1,190,Primary,Female
TCGA.E2.A14X.01,TCGA.E2.A14X.01A.11R.A115.07,0.724074,0.503863,0.071269,0.141445194,TCGA-E2-A14X,YES,55,31.93,DiseaseFree,31.93,LIVING,15,0.332,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,652,Negative,NOT HISPANIC OR LATINO,2004/6/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,YES,5,NA,21,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,130,Primary,Female
TCGA.E2.A150.01,TCGA.E2.A150.01A.11R.A12D.07,0.508304,0.508304,0,0,TCGA-E2-A150,YES,48,63.57,DiseaseFree,63.57,LIVING,34,0.671,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,506,Negative,NOT HISPANIC OR LATINO,2004/6/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,180,Primary,Female
TCGA.E2.A158.01,TCGA.E2.A158.01A.11R.A12D.07,0.189319,0.076856,0,0,TCGA-E2-A158,YES,43,14.78,DiseaseFree,14.78,LIVING,69,0.4764,M0,N1mi,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,436,Negative,NOT HISPANIC OR LATINO,2004/7/11,Infiltrating Ductal Carcinoma,NA,No,Yes,Negative,YES,2009,YES,1,NA,2,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,200,Primary,Female
TCGA.E2.A159.01,TCGA.E2.A159.01A.11R.A115.07,0.0985,0.0985,0,0,TCGA-E2-A159,YES,50,25.03,DiseaseFree,25.03,LIVING,104,0.3468,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,434,Negative,NOT HISPANIC OR LATINO,2004/7/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2009,YES,0,NA,4,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Lower Outer Quadrant,Negative,WHITE,NA,YES,1,240,Primary,Female
TCGA.E2.A1AZ.01,TCGA.E2.A1AZ.01A.11R.A12P.07,2.401406,2.401406,0,0,TCGA-E2-A1AZ,YES,63,76.51,DiseaseFree,76.51,LIVING,38,0.2665,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,2527,Negative,HISPANIC OR LATINO,4/25/11,Infiltrating Ductal Carcinoma,NA,No,No,Indeterminate,YES,2004,YES,1,NA,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant,Negative,WHITE,NA,YES,1,250,Primary,Female
TCGA.E2.A1B6.01,TCGA.E2.A1B6.01A.31R.A12P.07,18.277984,18.16852,0.068737,0.003783302,TCGA-E2-A1B6,YES,44,28.48,DiseaseFree,28.48,LIVING,7,2.00E-04,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,729,Negative,NOT HISPANIC OR LATINO,4/25/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2008,YES,0,NA,5,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left,Negative,WHITE,NA,YES,1,290,Primary,Female
TCGA.E2.A1L7.01,TCGA.E2.A1L7.01A.11R.A144.07,0.109796,0.109796,0,0,TCGA-E2-A1L7,YES,40,53.19,Recurred/Progressed,60.32,LIVING,53,0.4586,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,548,Negative,NOT HISPANIC OR LATINO,2006/1/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,YES,7,NA,20,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,150,Primary,Female
TCGA.E2.A1LG.01,TCGA.E2.A1LG.01A.21R.A14M.07,0.28816,0.28816,0,0,TCGA-E2-A1LG,YES,50,50.03,DiseaseFree,50.03,LIVING,85,0.5605,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,252,Negative,NOT HISPANIC OR LATINO,2006/3/11,Infiltrating Lobular Carcinoma,NA,No,Yes,Equivocal,YES,2010,YES,0,NA,19,NA,Peri (6-12 months since last menstrual period),NA,NA,NO,ILC,Negative,Left Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,310,Primary,Female
TCGA.E2.A1LH.01,TCGA.E2.A1LH.01A.11R.A14D.07,0.573786,0.573786,0,0,TCGA-E2-A1LH,YES,59,106.67,DiseaseFree,106.67,LIVING,117,0.1889,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,2998,Negative,NOT HISPANIC OR LATINO,2006/3/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2002,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right,Negative,WHITE,NA,YES,1,130,Primary,Female
TCGA.E2.A1LI.01,TCGA.E2.A1LI.01A.12R.A157.07,0.051614,0.051614,0,0,TCGA-E2-A1LI,YES,57,102.53,DiseaseFree,102.53,LIVING,9,0.4015,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,2815,Negative,NOT HISPANIC OR LATINO,2006/3/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2003,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Close,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,80,Primary,Female
TCGA.E2.A1LK.01,TCGA.E2.A1LK.01A.21R.A14D.07,0.173288,0.173288,0,0,TCGA-E2-A1LK,YES,84,5.09,Recurred/Progressed,8.74,DECEASED,27,0.3805,M0,N3a,Stage IIIC,T4b,Breast Invasive Ductal Carcinoma,1051,Negative,NOT HISPANIC OR LATINO,2006/3/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2008,YES,11,NA,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant|Left Lower Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,70,Primary,Female
TCGA.E2.A1LL.01,TCGA.E2.A1LL.01A.11R.A144.07,0.25092,0.25092,0,0,TCGA-E2-A1LL,YES,73,42.81,Recurred/Progressed,43,LIVING,18,0.3672,MX,N2a,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,988,Negative,NOT HISPANIC OR LATINO,2006/3/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,YES,5,NA,44,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,290,Primary,Female
TCGA.E2.A1LS.01,TCGA.E2.A1LS.01A.12R.A157.07,0.01562,0.01562,0,0,TCGA-E2-A1LS,YES,46,52.69,DiseaseFree,52.69,LIVING,58,NA,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,176,Negative,NA,2006/3/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,0,NA,5,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right Lower Outer Quadrant,Negative,WHITE,NA,YES,1,100,Primary,Female
TCGA.E2.A573.01,TCGA.E2.A573.01A.11R.A29R.07,0.153884,0.153884,0,0,TCGA-E2-A573,YES,48,34.89,DiseaseFree,34.89,LIVING,40,0.3,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,595,Negative,NOT HISPANIC OR LATINO,6/20/13,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2011,YES,0,NA,4,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,YES,YES,1,70,Primary,Female
TCGA.E2.A574.01,TCGA.E2.A574.01A.11R.A29R.07,0.011106,0.011106,0,0,TCGA-E2-A574,YES,44,38.73,DiseaseFree,38.73,LIVING,73,0.6276,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,429,Negative,NOT HISPANIC OR LATINO,6/20/13,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2011,YES,0,NA,4,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left,Negative,BLACK OR AFRICAN AMERICAN,YES,YES,1,170,Primary,Female
TCGA.E9.A5FL.01,TCGA.E9.A5FL.01A.11R.A27Q.07,0.069078,0.069078,0,0,TCGA-E9-A5FL,YES,65,0.79,DiseaseFree,0.79,LIVING,63,0.3713,M0,N0,Stage IIB,T3,Metaplastic Breast Cancer,73,Negative,NOT HISPANIC OR LATINO,5/22/13,Metaplastic Carcinoma,NA,No,No,Negative,YES,2012,YES,0,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,MBC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,NO,1,590,Primary,Female
TCGA.EW.A1OV.01,TCGA.EW.A1OV.01A.11R.A144.07,4.929583,4.768508,0,0,TCGA-EW-A1OV,YES,56,25.92,DiseaseFree,25.92,LIVING,67,0.3884,MX,N1mi,Stage IIB,T2,Breast Invasive Ductal Carcinoma,469,Negative,HISPANIC OR LATINO,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,YES,0,1,6,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Close,Right Lower Outer Quadrant,Negative,WHITE,NA,YES,1,130,Primary,Female
TCGA.EW.A1OW.01,TCGA.EW.A1OW.01A.21R.A144.07,2.485664,2.485664,0,0,TCGA-EW-A1OW,YES,58,22.8,DiseaseFree,22.8,LIVING,NA,0.4637,MX,N0,Stage IIA,T2,Basal Cell Carcinoma,444,Negative,NOT HISPANIC OR LATINO,5/18/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,YES,0,0,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,BCC,Negative,Left Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,100,Primary,Female
TCGA.EW.A1P1.01,TCGA.EW.A1P1.01A.31R.A14D.07,0.717158,0.717158,0,0,TCGA-EW-A1P1,YES,68,33.31,Recurred/Progressed,39.75,LIVING,1,8.00E-04,MX,N3b,Stage IIIC,T2,Breast Invasive Ductal Carcinoma,850,Negative,HISPANIC OR LATINO,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2008,YES,11,NA,32,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Lung,YES,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,200,Primary,Female
TCGA.EW.A1P4.01,TCGA.EW.A1P4.01A.21R.A144.07,0.013133,0,0.013133,Inf,TCGA-EW-A1P4,YES,43,29.8,DiseaseFree,29.8,LIVING,46,0.4697,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,525,Negative,HISPANIC OR LATINO,2005/11/11,Medullary Carcinoma,NA,No,No,Negative,YES,2009,YES,0,0,3,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,290,Primary,Female
TCGA.EW.A1P7.01,TCGA.EW.A1P7.01A.21R.A144.07,2.259272,2.23434,0,0,TCGA-EW-A1P7,YES,59,23.95,Recurred/Progressed,30.06,LIVING,6,0.0027,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,604,Negative,HISPANIC OR LATINO,5/18/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2009,YES,0,0,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,210,Primary,Female
TCGA.EW.A1P8.01,TCGA.EW.A1P8.01A.11R.A144.07,1.345103,1.327094,0,0,TCGA-EW-A1P8,YES,58,6.8,Recurred/Progressed,7.85,DECEASED,29,0.9462,M0,N3b,Stage IIIC,T2,Breast Invasive Ductal Carcinoma,224,Negative,NOT HISPANIC OR LATINO,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,14,NA,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),skin,"Lung|Bone|Liver|Other, specify",YES,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,160,Primary,Female
TCGA.EW.A1PB.01,TCGA.EW.A1PB.01A.11R.A144.07,0.124347,0.124347,0,0,TCGA-EW-A1PB,YES,70,19.97,DiseaseFree,19.97,LIVING,104,0.1579,MX,N1a,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,569,Negative,NOT HISPANIC OR LATINO,5/18/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,YES,2,NA,8,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,320,Primary,Female
TCGA.EW.A1PH.01,TCGA.EW.A1PH.01A.11R.A14M.07,0.126434,0.126434,0,0,TCGA-EW-A1PH,YES,52,19.94,DiseaseFree,19.94,LIVING,34,0.4664,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,77,Negative,HISPANIC OR LATINO,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,1,0,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,70,Primary,Female
TCGA.EW.A3U0.01,TCGA.EW.A3U0.01A.11R.A22K.07,1.694224,1.678008,0,0,TCGA-EW-A3U0,YES,61,17.48,DiseaseFree,17.48,LIVING,94,0.4676,M0,N1a,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,182,Negative,NOT HISPANIC OR LATINO,5/24/12,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2011,YES,1,NA,25,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left,Negative,BLACK OR AFRICAN AMERICAN,NA,NO,1,280,Primary,Female
TCGA.EW.A6SB.01,TCGA.EW.A6SB.01A.12R.A32P.07,0.202554,0.197118,0,0,TCGA-EW-A6SB,YES,62,24.97,DiseaseFree,24.97,LIVING,NA,0.2153,M0,N0,Stage II,T2,Breast Invasive Ductal Carcinoma,244,Negative,NOT HISPANIC OR LATINO,2003/12/15,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2012,YES,0,0,8,NA,NA,NA,NA,NA,IDC,Negative,Left|Left Upper Inner Quadrant,Negative,BLACK OR AFRICAN AMERICAN,YES,NA,1,200,Primary,Female
TCGA.GI.A2C9.01,TCGA.GI.A2C9.01A.11R.A21T.07,0.083379,0.083379,0,0,TCGA-GI-A2C9,YES,58,109.79,DiseaseFree,109.79,LIVING,98,0.5638,MX,N0,Stage IIB,T3,Breast Invasive Ductal Carcinoma,2979,Negative,NOT HISPANIC OR LATINO,10/21/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2003,YES,0,0,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,120,Primary,Female
TCGA.GM.A2DB.01,TCGA.GM.A2DB.01A.31R.A18M.07,2.112889,2.112889,0,0,TCGA-GM-A2DB,YES,62,79.04,DiseaseFree,79.04,LIVING,81,0.2286,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,1644,Negative,NOT HISPANIC OR LATINO,9/28/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,YES,0,0,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,190,Primary,Female
TCGA.GM.A2DD.01,TCGA.GM.A2DD.01A.11R.A180.07,9.539952,9.539952,0,0,TCGA-GM-A2DD,YES,53,74.97,DiseaseFree,74.97,LIVING,36,0.117,M0,N0 (i-),Stage I,T1c,Breast Invasive Ductal Carcinoma,1490,Negative,NOT HISPANIC OR LATINO,9/29/11,Infiltrating Ductal Carcinoma,NA,No,Yes,Equivocal,YES,2007,YES,0,0,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right,Negative,WHITE,NA,YES,1,130,Primary,Female
TCGA.GM.A2DF.01,TCGA.GM.A2DF.01A.11R.A180.07,0.44209,0.426076,0,0,TCGA-GM-A2DF,YES,53,70.8,DiseaseFree,70.8,LIVING,22,0.1934,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,1372,Negative,NOT HISPANIC OR LATINO,9/29/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,YES,1,0,32,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Lower Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,100,Primary,Female
TCGA.GM.A2DH.01,TCGA.GM.A2DH.01A.11R.A180.07,3.934652,3.884056,0.017849,0.004595454,TCGA-GM-A2DH,YES,58,72.04,DiseaseFree,72.04,LIVING,86,0.2932,M0,N0 (i+),Stage I,T1c,Breast Invasive Ductal Carcinoma,1464,Negative,NOT HISPANIC OR LATINO,9/29/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,YES,0,1,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,110,Primary,Female
TCGA.GM.A2DI.01,TCGA.GM.A2DI.01A.31R.A18M.07,2.030727,1.981105,0.049622,0.025047638,TCGA-GM-A2DI,YES,52,85.09,DiseaseFree,85.09,LIVING,20,0.0143,M0,N0 (i+),Stage I,T1c,Breast Invasive Ductal Carcinoma,2144,Negative,NOT HISPANIC OR LATINO,9/29/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2005,YES,0,1,9,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant,Negative,WHITE,NA,YES,1,150,Primary,Female
TCGA.GM.A3XL.01,TCGA.GM.A3XL.01A.11R.A22U.07,0.04252,0.04252,0,0,TCGA-GM-A3XL,YES,49,69.25,DiseaseFree,69.25,LIVING,66,0.4806,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,1779,Negative,NOT HISPANIC OR LATINO,2010/1/12,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2007,YES,0,0,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right|Right Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,YES,YES,1,120,Primary,Female
TCGA.HN.A2NL.01,TCGA.HN.A2NL.01A.11R.A18M.07,0.432053,0.432053,0,0,TCGA-HN-A2NL,YES,56,2.6,DiseaseFree,2.6,LIVING,52,0.9228,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,NA,Negative,NA,5/30/14,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,NA,YES,0,0,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left Upper Outer Quadrant,Negative,NA,NA,YES,1,170,Primary,Female
TCGA.LL.A441.01,TCGA.LL.A441.01A.11R.A24H.07,0.295481,0.269436,0,0,TCGA-LL-A441,YES,62,32.72,DiseaseFree,32.72,LIVING,42,0.1771,MX,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,37,Negative,NOT HISPANIC OR LATINO,2011/5/12,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2012,YES,0,0,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NO,NO,1,300,Primary,Female
TCGA.LL.A5YO.01,TCGA.LL.A5YO.01A.21R.A28M.07,1.046617,1.046617,0,0,TCGA-LL-A5YO,YES,50,14.45,DiseaseFree,14.45,LIVING,27,0.057,MX,N0,Stage IA,T1b,Breast Invasive Ductal Carcinoma,47,Negative,NOT HISPANIC OR LATINO,2005/8/13,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2013,YES,0,0,1,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NO,NO,1,260,Primary,Female
TCGA.LL.A73Y.01,TCGA.LL.A73Y.01A.11R.A33J.07,0.582696,0.554689,0.028007,0.050491356,TCGA-LL-A73Y,YES,67,15.67,DiseaseFree,15.67,LIVING,NA,0.2373,MX,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,55,Negative,NOT HISPANIC OR LATINO,2011/12/13,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2013,YES,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right|Right Upper Inner Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NO,NO,1,60,Primary,Female
TCGA.LL.A740.01,TCGA.LL.A740.01A.21R.A32P.07,1.044787,1.029016,0,0,TCGA-LL-A740,YES,61,14.49,DiseaseFree,14.49,LIVING,NA,0.1924,MX,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,37,Negative,NOT HISPANIC OR LATINO,2011/12/13,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2013,YES,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NO,NO,1,410,Primary,Female
TCGA.OL.A5D6.01,TCGA.OL.A5D6.01A.21R.A27Q.07,1.974238,1.742146,0,0,TCGA-OL-A5D6,YES,71,NA,NA,36.27,DECEASED,28,0.1517,MX,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,1378,Negative,NOT HISPANIC OR LATINO,4/19/13,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2009,YES,NA,0,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NO,YES,1,200,Primary,Female
TCGA.OL.A5D7.01,TCGA.OL.A5D7.01A.11R.A27Q.07,3.7296,3.717859,0,0,TCGA-OL-A5D7,YES,70,58.48,DiseaseFree,58.48,LIVING,36,0.3616,MX,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,1415,Negative,NOT HISPANIC OR LATINO,4/19/13,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2009,YES,NA,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,YES,YES,1,370,Primary,Female
TCGA.OL.A5RW.01,TCGA.OL.A5RW.01A.11R.A28M.07,0.059954,0.059954,0,0,TCGA-OL-A5RW,YES,40,36.33,DiseaseFree,36.33,LIVING,119,0.7465,MX,N1,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,771,Negative,NA,5/16/13,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2010,YES,1,NA,4,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,YES,YES,1,240,Primary,Female
TCGA.OL.A66I.01,TCGA.OL.A66I.01A.21R.A29R.07,4.056566,3.521993,0.177165,0.050302485,TCGA-OL-A66I,YES,36,23.46,DiseaseFree,23.46,LIVING,22,0.409,MX,N1mi,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,1715,Negative,NOT HISPANIC OR LATINO,2006/11/13,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2008,YES,0,NA,13,NA,NA,NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,YES,YES,1,240,Primary,Female
TCGA.OL.A66P.01,TCGA.OL.A66P.01A.11R.A31O.07,0.020923,0.020923,0,0,TCGA-OL-A66P,YES,75,14.06,DiseaseFree,14.06,LIVING,NA,0.1324,MX,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,98,Negative,NOT HISPANIC OR LATINO,2006/11/13,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2013,YES,NA,NA,2,NA,NA,NA,NA,NA,IDC,Negative,Right,Negative,BLACK OR AFRICAN AMERICAN,NO,YES,1,140,Primary,Female
TCGA.OL.A6VO.01,TCGA.OL.A6VO.01A.12R.A33J.07,0.427706,0.427706,0,0,TCGA-OL-A6VO,YES,43,28.19,DiseaseFree,28.19,LIVING,NA,0.4348,MX,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,507,Negative,NOT HISPANIC OR LATINO,2012/5/13,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2012,YES,0,NA,7,NA,NA,NA,NA,NA,IDC,Negative,Right|Right Lower Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,YES,YES,1,120,Primary,Female
TCGA.OL.A97C.01,TCGA.OL.A97C.01A.32R.A41B.07,0.260804,0.214066,0,0,TCGA-OL-A97C,YES,67,9.03,Recurred/Progressed,8.9,LIVING,NA,0.2079,M0,N0,Stage IIB,T3,Malignant Phyllodes Tumor of the Breast,216,Negative,NOT HISPANIC OR LATINO,3/18/14,"Other, specify",NA,No,No,NA,YES,2013,YES,0,NA,6,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,MPT,NA,Left,Negative,BLACK OR AFRICAN AMERICAN,NO,YES,1,410,Primary,Female
TCGA.S3.AA10.01,TCGA.S3.AA10.01A.21R.A41B.07,2.664977,1.551464,0,0,TCGA-S3-AA10,YES,65,19.25,DiseaseFree,19.25,LIVING,NA,0.5359,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,168,Negative,NOT HISPANIC OR LATINO,4/18/14,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2013,YES,0,NA,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right|Right Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NO,NO,1,410,Primary,Female
TCGA.S3.AA15.01,TCGA.S3.AA15.01A.11R.A41B.07,0.14027,0.14027,0,0,TCGA-S3-AA15,YES,51,17.25,DiseaseFree,17.25,LIVING,NA,0.0014,cM0 (i+),N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,93,Negative,NOT HISPANIC OR LATINO,4/18/14,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2013,YES,2,0,13,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right|Right Upper Inner Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NO,NO,1,990,Primary,Female
TCGA.3C.AAAU.01,TCGA.3C.AAAU.01A.11R.A41B.07,0.401249,0.365508,0,0,TCGA-3C-AAAU,NO,55,59.4,Recurred/Progressed,132.95,LIVING,NA,0.7787,MX,NX,Stage X,TX,NA,3599,Positive,NOT HISPANIC OR LATINO,1/13/14,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2004,YES,4,NA,13,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,BRCA,Negative,Left Lower Outer Quadrant,Positive,WHITE,NO,YES,1,60,Primary,Female
TCGA.3C.AALI.01,TCGA.3C.AALI.01A.11R.A41B.07,2.813649,2.202271,0.014782,0.006712162,TCGA-3C-AALI,NO,50,131.57,DiseaseFree,131.57,LIVING,NA,0.7164,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,3772,Positive,NOT HISPANIC OR LATINO,7/28/14,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2003,YES,1,NA,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,YES,YES,1,120,Primary,Female
TCGA.3C.AALJ.01,TCGA.3C.AALJ.01A.31R.A41B.07,0.23109,0.23109,0,0,TCGA-3C-AALJ,NO,62,48.42,DiseaseFree,48.42,LIVING,NA,0.534,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1026,Positive,NOT HISPANIC OR LATINO,7/28/14,Infiltrating Ductal Carcinoma,NA,No,No,Indeterminate,YES,2011,YES,1,NA,23,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Positive,BLACK OR AFRICAN AMERICAN,NO,YES,1,420,Primary,Female
TCGA.3C.AALK.01,TCGA.3C.AALK.01A.11R.A41B.07,1.35079,1.101471,0,0,TCGA-3C-AALK,NO,52,47.57,DiseaseFree,47.57,LIVING,NA,0.0764,M0,N0 (i+),Stage IA,T1c,Breast Invasive Ductal Carcinoma,1022,Positive,NOT HISPANIC OR LATINO,7/28/14,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2011,YES,0,1,2,NA,NA,NA,NA,NA,IDC,Close,Right,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,140,Primary,Female
TCGA.4H.AAAK.01,TCGA.4H.AAAK.01A.12R.A41B.07,0.787696,0.787696,0,0,TCGA-4H-AAAK,NO,50,11.43,DiseaseFree,11.43,LIVING,NA,0.2364,M0,N2a,Stage IIIA,T2,Breast Invasive Lobular Carcinoma,35,Positive,NOT HISPANIC OR LATINO,11/13/14,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2013,YES,4,NA,14,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left|Left Upper Outer Quadrant,Positive,WHITE,NO,NO,1,770,Primary,Female
TCGA.5L.AAT0.01,TCGA.5L.AAT0.01A.12R.A41B.07,0.102114,0.102114,0,0,TCGA-5L-AAT0,NO,42,48.52,DiseaseFree,48.52,LIVING,NA,0.0702,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,1320,Positive,HISPANIC OR LATINO,8/15/14,Infiltrating Lobular Carcinoma,NA,No,Yes,Negative,YES,2010,YES,0,0,8,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Positive,Right|Right Lower Outer Quadrant,Positive,WHITE,YES,YES,1,80,Primary,Female
TCGA.5L.AAT1.01,TCGA.5L.AAT1.01A.12R.A41B.07,5.755268,5.647761,0.05388,0.009540064,TCGA-5L-AAT1,NO,63,48.32,DiseaseFree,48.32,LIVING,NA,0.0798,M1,N0,Stage IV,T2,Breast Invasive Lobular Carcinoma,1259,Positive,HISPANIC OR LATINO,8/15/14,Infiltrating Lobular Carcinoma,NA,No,Yes,Equivocal,YES,2010,YES,0,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Bone,NA,ILC,Negative,Left,Positive,WHITE,NO,YES,1,130,Primary,Female
TCGA.5T.A9QA.01,TCGA.5T.A9QA.01A.11R.A41B.07,0.081599,0.081599,0,0,TCGA-5T-A9QA,NO,52,9.95,DiseaseFree,9.95,LIVING,NA,0.4133,MX,NX,Stage IIA,T2,Breast Invasive Ductal Carcinoma,31,Positive,NOT HISPANIC OR LATINO,12/23/13,"Other, specify",NA,No,No,Equivocal,YES,2013,NO,NA,NA,NA,NA,NA,NA,NA,NA,IDC,NA,Left,Negative,BLACK OR AFRICAN AMERICAN,NA,NO,1,650,Primary,Female
TCGA.A1.A0SB.01,TCGA.A1.A0SB.01A.11R.A144.07,0.146423,0.146423,0,0,TCGA-A1-A0SB,NO,70,8.51,DiseaseFree,8.51,LIVING,16,8.00E-04,M0,N0,Stage I,T1c,Adenoid Cystic Breast Cancer,764,Positive,NOT HISPANIC OR LATINO,6/30/11,"Other, specify",NA,No,No,Negative,YES,2008,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ACBC,Negative,Left,Negative,WHITE,NA,YES,1,120,Primary,Female
TCGA.A1.A0SD.01,TCGA.A1.A0SD.01A.11R.A115.07,0.170094,0.170094,0,0,TCGA-A1-A0SD,NO,59,14.36,DiseaseFree,14.36,LIVING,24,0.2474,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,1697,Positive,NOT HISPANIC OR LATINO,2009/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2005,YES,0,0,3,Negative,NA,NA,NA,NA,IDC,Positive,Left,Positive,WHITE,NA,YES,1,50,Primary,Female
TCGA.A1.A0SE.01,TCGA.A1.A0SE.01A.11R.A084.07,0.623746,0.052253,0,0,TCGA-A1-A0SE,NO,56,43.4,DiseaseFree,43.4,LIVING,15,0.2134,M0,N0 (i-),Stage I,T1c,Breast Mixed Ductal and Lobular Carcinoma,1672,Positive,NOT HISPANIC OR LATINO,2012/6/10,Mixed Histology (please specify),invasive ductal and lobular carcinoma,No,No,Negative,YES,2005,NA,0,NA,8,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,MDLC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,90,Primary,Female
TCGA.A1.A0SF.01,TCGA.A1.A0SF.01A.11R.A144.07,0.439628,0.3825,0.057128,0.149354248,TCGA-A1-A0SF,NO,54,48.06,DiseaseFree,48.06,LIVING,32,0.2015,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,1648,Positive,NOT HISPANIC OR LATINO,5/24/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,YES,0,NA,2,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left,Positive,WHITE,NA,YES,1,190,Primary,Female
TCGA.A1.A0SG.01,TCGA.A1.A0SG.01A.11R.A144.07,0.03352,0.03352,0,0,TCGA-A1-A0SG,NO,61,14.26,DiseaseFree,14.26,LIVING,25,0.0969,M0,N1a,Stage IIB,T2,Invasive Breast Carcinoma,1581,Positive,NOT HISPANIC OR LATINO,5/31/11,"Other, specify",NA,No,No,Negative,YES,2006,YES,1,NA,11,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,BRCA,Negative,Right,Positive,WHITE,NA,YES,1,120,Primary,Female
TCGA.A1.A0SH.01,TCGA.A1.A0SH.01A.11R.A084.07,0.165682,0.165682,0,0,TCGA-A1-A0SH,NO,39,47.21,DiseaseFree,47.21,LIVING,72,0.1789,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,1305,Negative,NOT HISPANIC OR LATINO,2012/6/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2006,NA,0,NA,2,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,YES,1,240,Primary,Female
TCGA.A1.A0SI.01,TCGA.A1.A0SI.01A.11R.A144.07,0.072712,0.072712,0,0,TCGA-A1-A0SI,NO,52,20.86,DiseaseFree,20.86,LIVING,130,0.3313,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1267,Positive,NOT HISPANIC OR LATINO,6/30/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,YES,1,NA,23,NA,NA,NA,NA,NO,IDC,Negative,Right,Positive,WHITE,NA,YES,1,40,Primary,Female
TCGA.A1.A0SJ.01,TCGA.A1.A0SJ.01A.11R.A084.07,0.016201,0.016201,0,0,TCGA-A1-A0SJ,NO,39,13.67,DiseaseFree,13.67,LIVING,25,0.46,M0,N1a,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,1399,Positive,NOT HISPANIC OR LATINO,2012/6/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2006,NA,3,NA,19,NA,NA,NA,NA,NA,IDC,Negative,Left,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,140,Primary,Female
TCGA.A1.A0SM.01,TCGA.A1.A0SM.01A.11R.A084.07,0.100841,0.100841,0,0,TCGA-A1-A0SM,NO,77,7.95,DiseaseFree,7.95,LIVING,22,0.1807,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,1115,Positive,NOT HISPANIC OR LATINO,2012/6/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2007,NA,0,NA,3,NA,NA,NA,NA,NA,IDC,Negative,Left,Negative,WHITE,NA,YES,1,120,Primary,Male
TCGA.A1.A0SN.01,TCGA.A1.A0SN.01A.11R.A144.07,0.156621,0.156621,0,0,TCGA-A1-A0SN,NO,50,39.29,DiseaseFree,39.29,LIVING,38,0.5518,MX,N1,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,1091,Positive,NOT HISPANIC OR LATINO,5/23/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2007,YES,4,NA,13,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Positive,WHITE,NA,YES,1,120,Primary,Female
TCGA.A1.A0SQ.01,TCGA.A1.A0SQ.01A.21R.A144.07,0.022614,0.022614,0,0,TCGA-A1-A0SQ,NO,45,18.2,DiseaseFree,18.2,LIVING,19,0.1094,MX,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,967,Positive,NOT HISPANIC OR LATINO,6/30/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,YES,1,NA,15,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left,Positive,WHITE,NA,YES,1,200,Primary,Female
TCGA.A2.A04N.01,TCGA.A2.A04N.01A.11R.A115.07,0.435967,0.435967,0,0,TCGA-A2-A04N,NO,66,143.04,DiseaseFree,143.04,LIVING,32,0.0862,M0,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,2850,Positive,HISPANIC OR LATINO,1/27/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2002,NA,0,0,6,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Positive,WHITE,NA,YES,1,130,Primary,Female
TCGA.A2.A04R.01,TCGA.A2.A04R.01A.41R.A109.07,0,0,0,NA,TCGA-A2-A04R,NO,36,121.85,DiseaseFree,121.85,LIVING,60,0.2643,M0,N0 (i-),Stage IA,T1,Breast Invasive Ductal Carcinoma,2233,Positive,NOT HISPANIC OR LATINO,2010/8/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2004,NA,0,0,1,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,160,Primary,Female
TCGA.A2.A04U.01,TCGA.A2.A04U.01A.11R.A115.07,0.661726,0.661726,0,0,TCGA-A2-A04U,NO,47,87.19,DiseaseFree,87.19,LIVING,47,0.6677,M0,N0 (i+),Stage IIA,T2,Breast Invasive Ductal Carcinoma,1924,Negative,NOT HISPANIC OR LATINO,2001/5/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2004,NA,0,1,3,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,IDC,Negative,Right,Negative,WHITE,NA,YES,1,170,Primary,Female
TCGA.A2.A04V.01,TCGA.A2.A04V.01A.21R.A034.07,0.057253,0.057253,0,0,TCGA-A2-A04V,NO,39,48.29,Recurred/Progressed,63.07,DECEASED,24,0.1132,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,1812,Positive,NOT HISPANIC OR LATINO,2008/10/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2005,NA,0,0,2,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Lower Outer Quadrant|Right,Positive,WHITE,NA,YES,1,200,Primary,Female
TCGA.A2.A04W.01,TCGA.A2.A04W.01A.31R.A115.07,0.079634,0.079634,0,0,TCGA-A2-A04W,NO,50,101.91,DiseaseFree,101.91,LIVING,79,0.1065,M0,N1mi,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1630,Negative,NOT HISPANIC OR LATINO,2001/5/11,"Other, specify",NA,No,No,Positive,YES,2005,NA,1,NA,19,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,420,Primary,Female
TCGA.A2.A04X.01,TCGA.A2.A04X.01A.21R.A034.07,0.656244,0.656244,0,0,TCGA-A2-A04X,NO,34,55.39,DiseaseFree,55.39,LIVING,18,0.2434,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,1390,Positive,NA,2008/9/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2006,NA,0,0,3,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left,Positive,WHITE,NA,YES,1,180,Primary,Female
TCGA.A2.A04Y.01,TCGA.A2.A04Y.01A.21R.A034.07,0.022904,0.022904,0,0,TCGA-A2-A04Y,NO,53,36.1,DiseaseFree,36.1,LIVING,44,0.147,M0,N1mi,Stage IIB,T2,Breast Invasive Ductal Carcinoma,756,Positive,NA,2008/9/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,1,0,13,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,220,Primary,Female
TCGA.A2.A0CK.01,TCGA.A2.A0CK.01A.11R.A22K.07,0.025935,0.025935,0,0,TCGA-A2-A0CK,NO,60,44.81,Recurred/Progressed,136.63,LIVING,10,0.1005,M0,N2a,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,3080,Positive,NOT HISPANIC OR LATINO,5/21/12,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2001,YES,4,NA,20,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Positive,Right,Positive,WHITE,NA,YES,1,230,Primary,Female
TCGA.A2.A0CL.01,TCGA.A2.A0CL.01A.11R.A115.07,1.192467,1.10571,0.086757,0.078462707,TCGA-A2-A0CL,NO,37,99.05,DiseaseFree,99.05,LIVING,15,0.0591,M0,N2a,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,1552,Positive,NOT HISPANIC OR LATINO,1/28/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,NA,9,0,14,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Positive,Right Lower Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,230,Primary,Female
TCGA.A2.A0CO.01,TCGA.A2.A0CO.01A.13R.A22K.07,2.982202,2.757946,0.194945,0.07068485,TCGA-A2-A0CO,NO,85,NA,NA,114.72,DECEASED,18,0.1329,M0,N0,Stage IIB,T3,Breast Invasive Lobular Carcinoma,2709,Positive,NOT HISPANIC OR LATINO,5/21/12,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2002,YES,0,0,11,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Positive,Right,Positive,WHITE,NA,YES,1,260,Primary,Female
TCGA.A2.A0CP.01,TCGA.A2.A0CP.01A.11R.A034.07,0.475853,0.463525,0,0,TCGA-A2-A0CP,NO,60,92.41,DiseaseFree,92.41,LIVING,70,0.087,M0,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,2445,Positive,NOT HISPANIC OR LATINO,2009/8/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2003,NA,0,0,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Positive,WHITE,NA,YES,1,160,Primary,Female
TCGA.A2.A0CQ.01,TCGA.A2.A0CQ.01A.21R.A034.07,0.476997,0.476997,0,0,TCGA-A2-A0CQ,NO,62,88.53,DiseaseFree,88.53,LIVING,26,0.1198,M0,N0 (i-),Stage IA,T1,Breast Invasive Ductal Carcinoma,2310,Positive,NOT HISPANIC OR LATINO,2008/10/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2003,NA,0,0,1,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Positive,Right,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,210,Primary,Female
TCGA.A2.A0CR.01,TCGA.A2.A0CR.01A.11R.A22K.07,0.142791,0.142791,0,0,TCGA-A2-A0CR,NO,54,107.85,DiseaseFree,107.85,LIVING,90,0,M0,N0,Stage IIB,T3,Breast Invasive Lobular Carcinoma,2191,Positive,NOT HISPANIC OR LATINO,2006/5/12,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2004,YES,0,0,16,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Close,Left Upper Inner Quadrant,Positive,ASIAN,NA,YES,1,280,Primary,Female
TCGA.A2.A0CS.01,TCGA.A2.A0CS.01A.11R.A115.07,1.756657,1.756657,0,0,TCGA-A2-A0CS,NO,73,NA,NA,77.14,DECEASED,24,0.1967,M1,N3a,Stage IV,T4b,Breast Invasive Ductal Carcinoma,2030,Positive,NOT HISPANIC OR LATINO,1/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2004,NA,12,0,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Ovary,"Other, specify",NA,IDC,Positive,Left,Positive,WHITE,NA,YES,1,220,Primary,Female
TCGA.A2.A0CT.01,TCGA.A2.A0CT.01A.31R.A056.07,0.073419,0.073419,0,0,TCGA-A2-A0CT,NO,71,75.2,DiseaseFree,75.2,LIVING,56,0.7056,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,1931,Positive,NOT HISPANIC OR LATINO,2009/9/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2005,NA,0,0,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,190,Primary,Female
TCGA.A2.A0CU.01,TCGA.A2.A0CU.01A.12R.A034.07,0.056344,0.056344,0,0,TCGA-A2-A0CU,NO,73,NA,NA,5.19,DECEASED,37,0.4388,M0,N0 (i+),Stage IIA,T2,Breast Invasive Ductal Carcinoma,1911,Positive,NOT HISPANIC OR LATINO,2009/9/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2005,NA,0,1,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Close,Right Lower Outer Quadrant,Positive,WHITE,NA,YES,1,190,Primary,Female
TCGA.A2.A0CV.01,TCGA.A2.A0CV.01A.31R.A115.07,0.041212,0.015755,0,0,TCGA-A2-A0CV,NO,41,98.92,DiseaseFree,98.92,LIVING,18,0.6142,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1574,Positive,NOT HISPANIC OR LATINO,1/28/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2005,NA,4,0,18,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Outer Quadrant,Positive,ASIAN,NA,YES,1,310,Primary,Female
TCGA.A2.A0CW.01,TCGA.A2.A0CW.01A.21R.A115.07,0.173096,0.16663,0,0,TCGA-A2-A0CW,NO,67,107.85,DiseaseFree,107.85,LIVING,47,0.3083,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1533,Positive,NOT HISPANIC OR LATINO,1/28/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2006,NA,2,0,19,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Positive,WHITE,NA,YES,1,290,Primary,Female
TCGA.A2.A0CX.01,TCGA.A2.A0CX.01A.21R.A00Z.07,0.090415,0.090415,0,0,TCGA-A2-A0CX,NO,52,56.77,DiseaseFree,56.77,LIVING,150,0.3591,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,1316,Positive,NOT HISPANIC OR LATINO,2009/10/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2006,NA,0,0,2,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left,Negative,WHITE,NA,YES,1,560,Primary,Female
TCGA.A2.A0CY.01,TCGA.A2.A0CY.01A.12R.A034.07,0.030273,0.030273,0,0,TCGA-A2-A0CY,NO,63,54.96,DiseaseFree,54.96,LIVING,NA,NA,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1274,Positive,NOT HISPANIC OR LATINO,2009/10/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,NA,1,0,22,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Outer Quadrant,Positive,WHITE,NA,YES,1,220,Primary,Female
TCGA.A2.A0CZ.01,TCGA.A2.A0CZ.01A.11R.A034.07,0.094123,0.094123,0,0,TCGA-A2-A0CZ,NO,46,53.09,DiseaseFree,53.09,LIVING,14,NA,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,1204,Positive,NOT HISPANIC OR LATINO,9/14/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,NA,0,0,2,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,IDC,Positive,Right Upper Inner Quadrant,Positive,WHITE,NA,YES,1,240,Primary,Female
TCGA.A2.A0D1.01,TCGA.A2.A0D1.01A.11R.A034.07,0.258243,0.258243,0,0,TCGA-A2-A0D1,NO,76,34.53,DiseaseFree,34.53,LIVING,52,0.2609,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,637,Negative,NOT HISPANIC OR LATINO,9/21/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2008,NA,0,0,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Inner Quadrant,Negative,WHITE,NA,YES,1,340,Primary,Female
TCGA.A2.A0D3.01,TCGA.A2.A0D3.01A.11R.A115.07,0.204544,0.204544,0,0,TCGA-A2-A0D3,NO,42,61.53,DiseaseFree,61.53,LIVING,19,0.1108,M0,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,545,Positive,NOT HISPANIC OR LATINO,1/28/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Outer Quadrant,Positive,WHITE,NA,YES,1,420,Primary,Female
TCGA.A2.A0D4.01,TCGA.A2.A0D4.01A.11R.A00Z.07,0.279803,0.240749,0,0,TCGA-A2-A0D4,NO,37,25.2,DiseaseFree,25.2,LIVING,24,0.3856,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,384,Positive,NOT HISPANIC OR LATINO,9/21/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,1,0,23,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,220,Primary,Female
TCGA.A2.A0EM.01,TCGA.A2.A0EM.01A.11R.A034.07,0.199887,0.199887,0,0,TCGA-A2-A0EM,NO,73,101.64,DiseaseFree,101.64,LIVING,26,0.1025,M0,N0 (i-),Stage IA,T1,Breast Invasive Ductal Carcinoma,2696,Positive,NOT HISPANIC OR LATINO,2009/6/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2002,NA,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant,Positive,WHITE,NA,YES,1,20,Primary,Female
TCGA.A2.A0EN.01,TCGA.A2.A0EN.01A.13R.A084.07,0.663428,0.647456,0.015972,0.024668858,TCGA-A2-A0EN,NO,70,134.3,DiseaseFree,134.3,LIVING,27,0.2206,M0,N0 (i+),Stage IIA,T2,Breast Invasive Lobular Carcinoma,2348,Positive,NOT HISPANIC OR LATINO,2/27/15,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2003,NA,0,1,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right,Positive,WHITE,NA,YES,1,110,Primary,Female
TCGA.A2.A0EO.01,TCGA.A2.A0EO.01A.11R.A034.07,0.08719,0.08719,0,0,TCGA-A2-A0EO,NO,54,80.22,DiseaseFree,80.22,LIVING,22,0.2512,M0,N0 (i-),Stage IA,T1,Breast Invasive Ductal Carcinoma,2331,Positive,NOT HISPANIC OR LATINO,2008/10/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2003,NA,0,0,3,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,IDC,Close,Left,Positive,WHITE,NA,YES,1,200,Primary,Female
TCGA.A2.A0EP.01,TCGA.A2.A0EP.01A.52R.A22U.07,1.365047,1.365047,0,0,TCGA-A2-A0EP,NO,56,118.36,DiseaseFree,118.36,LIVING,3,0,M0,N0 (i+),Stage I,T1,Breast Invasive Lobular Carcinoma,2198,Positive,NOT HISPANIC OR LATINO,8/16/12,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2004,YES,0,1,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right Lower Inner Quadrant,Negative,WHITE,NO,YES,1,560,Primary,Female
TCGA.A2.A0EQ.01,TCGA.A2.A0EQ.01A.11R.A034.07,2.998161,2.657459,0.256224,0.096416916,TCGA-A2-A0EQ,NO,64,79.7,DiseaseFree,79.7,LIVING,65,0.2545,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,2038,Negative,NOT HISPANIC OR LATINO,2008/11/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2004,NA,0,0,2,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Positive,Left,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,600,Primary,Female
TCGA.A2.A0ER.01,TCGA.A2.A0ER.01A.21R.A034.07,0.214378,0.214378,0,0,TCGA-A2-A0ER,NO,63,74.34,DiseaseFree,74.34,LIVING,21,0.0756,M0,N1mi,Stage IB,T1c,Breast Invasive Ductal Carcinoma,1862,Positive,NOT HISPANIC OR LATINO,8/13/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2005,NA,1,0,14,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Positive,Right Lower Inner Quadrant,Positive,WHITE,NA,YES,1,300,Primary,Female
TCGA.A2.A0ES.01,TCGA.A2.A0ES.01A.11R.A115.07,0.121095,0.121095,0,0,TCGA-A2-A0ES,NO,52,71.94,DiseaseFree,71.94,LIVING,3,0.0056,M0,N0 (i-),Stage IIA,T2,Breast Invasive Lobular Carcinoma,756,Positive,NOT HISPANIC OR LATINO,1/25/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2008,NA,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,460,Primary,Female
TCGA.A2.A0ET.01,TCGA.A2.A0ET.01A.31R.A034.07,0.242836,0.242836,0,0,TCGA-A2-A0ET,NO,58,35.02,DiseaseFree,35.02,LIVING,22,0.5078,M0,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,674,Positive,NOT HISPANIC OR LATINO,9/20/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2008,NA,5,0,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,890,Primary,Female
TCGA.A2.A0EU.01,TCGA.A2.A0EU.01A.22R.A056.07,0.231795,0.231795,0,0,TCGA-A2-A0EU,NO,79,34.26,DiseaseFree,34.26,LIVING,33,0.5175,M0,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,644,Positive,NOT HISPANIC OR LATINO,2008/11/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,0,0,1,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Positive,Right Lower Outer Quadrant,Positive,WHITE,NA,YES,1,610,Primary,Female
TCGA.A2.A0EV.01,TCGA.A2.A0EV.01A.11R.A034.07,0.243296,0.243296,0,0,TCGA-A2-A0EV,NO,80,31.8,DiseaseFree,31.8,LIVING,49,0.2086,M0,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,590,Positive,NOT HISPANIC OR LATINO,2008/11/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,0,0,6,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Positive,WHITE,NA,YES,1,960,Primary,Female
TCGA.A2.A0EW.01,TCGA.A2.A0EW.01A.21R.A115.07,0.079482,0.079482,0,0,TCGA-A2-A0EW,NO,53,44.45,Recurred/Progressed,61.89,DECEASED,11,0.0724,M0,N3a,Stage IIIC,T1b,Breast Invasive Lobular Carcinoma,542,Positive,NOT HISPANIC OR LATINO,2001/5/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2008,NA,26,0,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Positive,Right Lower Outer Quadrant,Positive,WHITE,NA,YES,1,1710,Primary,Female
TCGA.A2.A0EX.01,TCGA.A2.A0EX.01A.21R.A034.07,0.086253,0.086253,0,0,TCGA-A2-A0EX,NO,46,24.7,DiseaseFree,24.7,LIVING,25,0.1003,M0,N0 (i+),Stage IIB,T3,Breast Invasive Lobular Carcinoma,468,Positive,NOT HISPANIC OR LATINO,8/13/10,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2009,NA,0,1,1,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Positive,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,650,Primary,Female
TCGA.A2.A0EY.01,TCGA.A2.A0EY.01A.11R.A034.07,0.286446,0.286446,0,0,TCGA-A2-A0EY,NO,62,63.24,DiseaseFree,63.24,LIVING,140,0.6388,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,358,Positive,NOT HISPANIC OR LATINO,9/21/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2009,NA,1,0,23,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,580,Primary,Female
TCGA.A2.A0SU.01,TCGA.A2.A0SU.01A.11R.A084.07,0.213142,0.179799,0.033343,0.18544597,TCGA-A2-A0SU,NO,66,54.6,DiseaseFree,54.6,LIVING,15,0.1178,M0,N0 (i+),Stage IIA,T2,Breast Invasive Ductal Carcinoma,1317,Positive,NOT HISPANIC OR LATINO,11/17/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,NA,0,1,7,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Positive,WHITE,NA,YES,1,380,Primary,Female
TCGA.A2.A0SV.01,TCGA.A2.A0SV.01A.11R.A084.07,0.884183,0.884183,0,0,TCGA-A2-A0SV,NO,63,NA,NA,27.1,DECEASED,25,0.3799,M1,N2a,Stage IV,T2,Breast Invasive Ductal Carcinoma,1513,Positive,NOT HISPANIC OR LATINO,11/15/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2006,NA,8,NA,9,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Bone,NA,IDC,Positive,Right,Positive,WHITE,NA,YES,1,600,Primary,Female
TCGA.A2.A0SW.01,TCGA.A2.A0SW.01A.11R.A084.07,0.445007,0.436285,0,0,TCGA-A2-A0SW,NO,82,21.45,Recurred/Progressed,44.84,DECEASED,40,0.4298,M1,N2,Stage IV,T2,Breast Invasive Ductal Carcinoma,1337,Positive,NOT HISPANIC OR LATINO,2011/8/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2006,NA,4,NA,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Liver,NA,IDC,Negative,Right,Negative,WHITE,NA,YES,1,680,Primary,Female
TCGA.A2.A0SY.01,TCGA.A2.A0SY.01A.31R.A084.07,0.335691,0.335691,0,0,TCGA-A2-A0SY,NO,62,44.25,DiseaseFree,44.25,LIVING,93,0.1043,M0,N1,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,1083,Positive,NOT HISPANIC OR LATINO,2011/12/10,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2007,NA,1,0,14,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,510,Primary,Female
TCGA.A2.A0T1.01,TCGA.A2.A0T1.01A.21R.A084.07,0.081382,0.081382,0,0,TCGA-A2-A0T1,NO,55,17.12,DiseaseFree,17.12,LIVING,12,0.1868,M0,N3,Stage IIIC,T3,Breast Invasive Ductal Carcinoma,233,Negative,NOT HISPANIC OR LATINO,2011/12/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2009,NA,10,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,AMERICAN INDIAN OR ALASKA NATIVE,NA,YES,1,230,Primary,Female
TCGA.A2.A0T3.01,TCGA.A2.A0T3.01A.21R.A115.07,0.032792,0.032792,0,0,TCGA-A2-A0T3,NO,37,49.8,DiseaseFree,49.8,LIVING,23,0.5528,M0,N1mi,Stage IB,T1c,Breast Invasive Ductal Carcinoma,303,Positive,NOT HISPANIC OR LATINO,2/21/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2009,YES,2,0,13,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Positive,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,270,Primary,Female
TCGA.A2.A0T4.01,TCGA.A2.A0T4.01A.31R.A084.07,0.269934,0.269934,0,0,TCGA-A2-A0T4,NO,62,20.5,DiseaseFree,20.5,LIVING,26,0.2209,M0,N0 (i-),Stage IIA,T2,Breast Invasive Lobular Carcinoma,303,Positive,NOT HISPANIC OR LATINO,11/17/10,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2009,NA,0,0,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right Upper Inner Quadrant,Positive,WHITE,NA,YES,1,1500,Primary,Female
TCGA.A2.A0T5.01,TCGA.A2.A0T5.01A.21R.A084.07,0.146367,0.146367,0,0,TCGA-A2-A0T5,NO,39,17.44,DiseaseFree,17.44,LIVING,1067,0.1153,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,263,Positive,NOT HISPANIC OR LATINO,2011/9/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,0,0,4,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left,Positive,WHITE,NA,YES,1,1740,Primary,Female
TCGA.A2.A0T6.01,TCGA.A2.A0T6.01A.11R.A084.07,1.283348,1.283348,0,0,TCGA-A2-A0T6,NO,50,18.89,DiseaseFree,18.89,LIVING,91,0.1161,M0,N0 (i-),Stage IIB,T3,Breast Invasive Lobular Carcinoma,343,Positive,NOT HISPANIC OR LATINO,11/17/10,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2009,NA,0,0,3,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,ILC,Negative,Left,Positive,WHITE,NA,YES,1,1020,Primary,Female
TCGA.A2.A0T7.01,TCGA.A2.A0T7.01A.21R.A084.07,0.120197,0.120197,0,0,TCGA-A2-A0T7,NO,51,20.73,DiseaseFree,20.73,LIVING,16,0.3425,M0,N0 (i+),Stage IIA,T2,Breast Invasive Ductal Carcinoma,280,Positive,NOT HISPANIC OR LATINO,11/17/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,0,1,2,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Positive,Right Upper Inner Quadrant,Positive,WHITE,NA,YES,1,990,Primary,Female
TCGA.A2.A0YC.01,TCGA.A2.A0YC.01A.11R.A109.07,0.158208,0.158208,0,0,TCGA-A2-A0YC,NO,59,26.22,Recurred/Progressed,32.52,LIVING,16,0.111,M0,N1mi,Stage IIB,T2,Breast Invasive Ductal Carcinoma,673,Positive,NOT HISPANIC OR LATINO,2012/8/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2008,NA,1,0,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Close,Right Upper Inner Quadrant,Positive,WHITE,NA,YES,1,1170,Primary,Female
TCGA.A2.A0YD.01,TCGA.A2.A0YD.01A.11R.A109.07,0.398631,0.398631,0,0,TCGA-A2-A0YD,NO,63,25.26,DiseaseFree,25.26,LIVING,44,0.0935,M0,N0 (i+),Stage IIB,T3,Breast Invasive Lobular Carcinoma,572,Positive,NOT HISPANIC OR LATINO,2012/8/10,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2009,NA,0,1,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,740,Primary,Female
TCGA.A2.A0YF.01,TCGA.A2.A0YF.01A.21R.A109.07,0.220724,0.220724,0,0,TCGA-A2-A0YF,NO,67,50.43,DiseaseFree,50.43,LIVING,15,0.1229,M0,N0 (i+),Stage I,T1b,Breast Invasive Ductal Carcinoma,343,Positive,NOT HISPANIC OR LATINO,2012/2/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,0,1,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,600,Primary,Female
TCGA.A2.A0YG.01,TCGA.A2.A0YG.01A.21R.A109.07,0.135233,0.135233,0,0,TCGA-A2-A0YG,NO,63,21.88,DiseaseFree,21.88,LIVING,37,0.3672,M0,N3a,Stage IIIC,T2,Breast Invasive Ductal Carcinoma,329,Positive,NOT HISPANIC OR LATINO,2001/3/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2009,NA,14,NA,18,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,1530,Primary,Female
TCGA.A2.A0YH.01,TCGA.A2.A0YH.01A.11R.A109.07,0.214498,0.214498,0,0,TCGA-A2-A0YH,NO,53,21.65,DiseaseFree,21.65,LIVING,47,0.3154,M0,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,321,Positive,NOT HISPANIC OR LATINO,12/14/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,5,NA,28,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Outer Quadrant,Positive,WHITE,NA,YES,1,480,Primary,Female
TCGA.A2.A0YI.01,TCGA.A2.A0YI.01A.31R.A10J.07,0.141751,0.141751,0,0,TCGA-A2-A0YI,NO,62,49.44,DiseaseFree,49.44,LIVING,10,0.1891,M0,N0 (i+),Stage I,T1c,Breast Mixed Ductal and Lobular Carcinoma,303,Positive,NOT HISPANIC OR LATINO,12/14/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,0,1,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,MDLC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,340,Primary,Female
TCGA.A2.A0YJ.01,TCGA.A2.A0YJ.01A.11R.A109.07,0.030017,0.030017,0,0,TCGA-A2-A0YJ,NO,39,18.36,Recurred/Progressed,18.59,LIVING,44,0.5313,M0,N2a,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,264,Positive,NOT HISPANIC OR LATINO,12/28/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,5,NA,18,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left,Negative,WHITE,NA,YES,1,1080,Primary,Female
TCGA.A2.A0YK.01,TCGA.A2.A0YK.01A.22R.A109.07,0.056812,0.056812,0,0,TCGA-A2-A0YK,NO,61,19.32,DiseaseFree,19.32,LIVING,134,0.1055,M0,N0 (i-),Stage IIA,T2,Breast Invasive Lobular Carcinoma,280,Positive,NOT HISPANIC OR LATINO,12/28/10,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2009,NA,0,0,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Close,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant,Negative,WHITE,NA,YES,1,620,Primary,Female
TCGA.A2.A0YL.01,TCGA.A2.A0YL.01A.21R.A109.07,0.239695,0.239695,0,0,TCGA-A2-A0YL,NO,48,48.42,DiseaseFree,48.42,LIVING,7,0.1036,M0,N2a,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,205,Positive,NOT HISPANIC OR LATINO,12/27/10,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2010,NA,4,0,29,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,ILC,Negative,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant,Positive,WHITE,NA,YES,1,730,Primary,Female
TCGA.A2.A0YT.01,TCGA.A2.A0YT.01A.11R.A109.07,0.07591,0.07591,0,0,TCGA-A2-A0YT,NO,56,NA,NA,23.75,DECEASED,40,0.5755,M0,N2a,Stage IIIB,T4b,Breast Invasive Ductal Carcinoma,884,Positive,NOT HISPANIC OR LATINO,2012/10/10,Infiltrating Ductal Carcinoma,NA,Yes,No,NA,YES,2008,NA,5,NA,5,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,950,Primary,Female
TCGA.A2.A1FV.01,TCGA.A2.A1FV.01A.11R.A13Q.07,0.027982,0.027982,0,0,TCGA-A2-A1FV,NO,74,23.46,DiseaseFree,23.46,LIVING,31,0.3999,M0,N0 (i+),Stage IIB,T3,Breast Invasive Lobular Carcinoma,372,Positive,NOT HISPANIC OR LATINO,5/26/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2010,YES,0,1,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Left,Positive,WHITE,NA,NO,1,150,Primary,Female
TCGA.A2.A1FW.01,TCGA.A2.A1FW.01A.11R.A13Q.07,0.019934,0.019934,0,0,TCGA-A2-A1FW,NO,62,17.35,DiseaseFree,17.35,LIVING,41,0.6055,M0,N2a,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,198,Positive,NOT HISPANIC OR LATINO,2005/11/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,5,NA,19,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,NO,1,640,Primary,Female
TCGA.A2.A1FX.01,TCGA.A2.A1FX.01A.11R.A13Q.07,0.068053,0.068053,0,0,TCGA-A2-A1FX,NO,61,60.68,DiseaseFree,60.68,LIVING,16,0.4239,M0,N2a,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,937,Positive,NOT HISPANIC OR LATINO,2005/12/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2008,YES,6,NA,24,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Positive,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,360,Primary,Female
TCGA.A2.A1FZ.01,TCGA.A2.A1FZ.01A.51R.A14D.07,0.341384,0.341384,0,0,TCGA-A2-A1FZ,NO,63,22.44,DiseaseFree,22.44,LIVING,23,0.1009,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,335,Positive,NOT HISPANIC OR LATINO,4/21/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,0,0,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right,Positive,WHITE,NA,NO,1,740,Primary,Female
TCGA.A2.A1G0.01,TCGA.A2.A1G0.01A.11R.A13Q.07,0.110982,0.089063,0,0,TCGA-A2-A1G0,NO,49,20.24,DiseaseFree,20.24,LIVING,17,0.1485,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,315,Positive,NOT HISPANIC OR LATINO,4/21/11,"Other, specify",NA,No,No,Equivocal,YES,2010,YES,2,NA,19,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,NO,1,730,Primary,Female
TCGA.A2.A1G1.01,TCGA.A2.A1G1.01A.21R.A13Q.07,0.203334,0.189262,0,0,TCGA-A2-A1G1,NO,85,19.19,DiseaseFree,19.19,LIVING,21,0.1756,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,338,Negative,NOT HISPANIC OR LATINO,2005/12/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,YES,1,NA,13,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,NO,1,280,Primary,Female
TCGA.A2.A1G4.01,TCGA.A2.A1G4.01A.11R.A13Q.07,0.625372,0.361526,0,0,TCGA-A2-A1G4,NO,71,19.55,DiseaseFree,19.55,LIVING,25,0.1531,M0,N1a,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,310,Positive,NOT HISPANIC OR LATINO,4/22/11,Infiltrating Ductal Carcinoma,NA,No,Yes,Negative,YES,2010,YES,2,NA,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Lower Outer Quadrant,Positive,WHITE,NA,NO,1,710,Primary,Female
TCGA.A2.A259.01,TCGA.A2.A259.01A.11R.A16F.07,0.089073,0.089073,0,0,TCGA-A2-A259,NO,70,52.43,DiseaseFree,52.43,LIVING,11,0.1071,M0,N0 (i-),Stage I,T1c,Breast Invasive Ductal Carcinoma,1238,Positive,NOT HISPANIC OR LATINO,6/20/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,YES,0,0,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Close,Left,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,280,Primary,Female
TCGA.A2.A25A.01,TCGA.A2.A25A.01A.12R.A16F.07,0.062128,0.062128,0,0,TCGA-A2-A25A,NO,44,107.62,DiseaseFree,107.62,LIVING,75,0.1189,M0,N0 (i-),Stage IIA,T2,Breast Invasive Lobular Carcinoma,2927,Positive,NOT HISPANIC OR LATINO,6/21/11,Infiltrating Lobular Carcinoma,NA,No,Yes,Equivocal,YES,2003,YES,0,0,14,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,ILC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,YES,1,160,Primary,Female
TCGA.A2.A25B.01,TCGA.A2.A25B.01A.11R.A169.07,1.059174,1.033448,0,0,TCGA-A2-A25B,NO,39,42.38,Recurred/Progressed,42.41,LIVING,59,0.4302,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,183,Positive,NOT HISPANIC OR LATINO,7/15/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,YES,2,NA,8,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Close,Left Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NA,NO,1,840,Primary,Female
TCGA.A2.A25C.01,TCGA.A2.A25C.01A.11R.A169.07,0.265613,0.230685,0.019255,0.083468799,TCGA-A2-A25C,NO,50,17.18,DiseaseFree,17.18,LIVING,19,0.3264,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,215,Positive,NOT HISPANIC OR LATINO,7/15/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,3,NA,14,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Lower Outer Quadrant,Positive,WHITE,NA,NO,1,730,Primary,Female
TCGA.A2.A25D.01,TCGA.A2.A25D.01A.12R.A16F.07,0.090253,0.090253,0,0,TCGA-A2-A25D,NO,90,18.13,DiseaseFree,18.13,LIVING,40,0.2363,M0,N3a,Stage IIIC,T2,Breast Invasive Lobular Carcinoma,224,Positive,NOT HISPANIC OR LATINO,6/21/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2010,YES,22,NA,24,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Positive,Right Upper Outer Quadrant,Negative,WHITE,NA,NO,1,430,Primary,Female
TCGA.A2.A25E.01,TCGA.A2.A25E.01A.11R.A169.07,0.627874,0.566377,0,0,TCGA-A2-A25E,NO,34,98.19,Recurred/Progressed,105.26,LIVING,47,0.3373,M0,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,2441,Positive,NOT HISPANIC OR LATINO,7/21/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2004,YES,6,NA,10,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,200,Primary,Female
TCGA.A2.A25F.01,TCGA.A2.A25F.01A.11R.A169.07,1.070045,0.455849,0.567282,1.244451562,TCGA-A2-A25F,NO,66,10.58,DiseaseFree,10.58,LIVING,3,0.0021,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,86,Negative,NOT HISPANIC OR LATINO,7/26/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2011,YES,0,0,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,390,Primary,Female
TCGA.A2.A3KC.01,TCGA.A2.A3KC.01A.11R.A213.07,0.094016,0.094016,0,0,TCGA-A2-A3KC,NO,55,36.2,DiseaseFree,36.2,LIVING,23,0.1404,M0,N1a,Stage IIB,T2,Breast Invasive Lobular Carcinoma,299,Positive,NOT HISPANIC OR LATINO,3/14/12,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2011,YES,2,0,19,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,ILC,Negative,Right Lower Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NA,NO,1,780,Primary,Female
TCGA.A2.A3KD.01,TCGA.A2.A3KD.01A.12R.A213.07,0.087347,0.018304,0,0,TCGA-A2-A3KD,NO,47,39.62,DiseaseFree,39.62,LIVING,4,0.2021,M0,N1mi,Stage IIIA,T3,Breast Invasive Mixed Mucinous Carcinoma,700,Positive,NOT HISPANIC OR LATINO,2004/2/12,Mucinous Carcinoma,NA,No,No,Negative,YES,2010,YES,1,1,19,Close,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IMMC,Positive,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,770,Primary,Female
TCGA.A2.A3XV.01,TCGA.A2.A3XV.01A.21R.A239.07,0.080356,0.080356,0,0,TCGA-A2-A3XV,NO,46,32.72,DiseaseFree,32.72,LIVING,37,0.1244,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,344,Positive,NOT HISPANIC OR LATINO,8/24/12,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2011,YES,0,0,4,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right,Negative,BLACK OR AFRICAN AMERICAN,YES,NO,1,360,Primary,Female
TCGA.A2.A3XW.01,TCGA.A2.A3XW.01A.11R.A239.07,0.218313,0.218313,0,0,TCGA-A2-A3XW,NO,42,56.24,DiseaseFree,56.24,LIVING,3,0.0011,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1148,Positive,NOT HISPANIC OR LATINO,8/15/12,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,YES,3,0,18,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right,Negative,BLACK OR AFRICAN AMERICAN,NA,NO,1,690,Primary,Female
TCGA.A2.A3XZ.01,TCGA.A2.A3XZ.01A.42R.A239.07,1.026783,0.932703,0.09408,0.100868122,TCGA-A2-A3XZ,NO,46,50.33,DiseaseFree,50.33,LIVING,34,0.1157,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,909,Negative,NOT HISPANIC OR LATINO,8/21/12,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2009,YES,0,0,3,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NO,YES,1,1100,Primary,Female
TCGA.A2.A3Y0.01,TCGA.A2.A3Y0.01A.11R.A239.07,2.035099,1.898151,0.041182,0.02169585,TCGA-A2-A3Y0,NO,57,50.79,DiseaseFree,50.79,LIVING,135,0.4308,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,845,Positive,NOT HISPANIC OR LATINO,8/24/12,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,1,0,39,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Close,Left Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NO,YES,1,850,Primary,Female
TCGA.A2.A4RW.01,TCGA.A2.A4RW.01A.21R.A266.07,0.542375,0.542375,0,0,TCGA-A2-A4RW,NO,49,7.29,DiseaseFree,7.29,LIVING,85,0.3425,M0,N3a,Stage IIIC,T2,Breast Invasive Lobular Carcinoma,567,Positive,NOT HISPANIC OR LATINO,2/27/13,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2011,YES,27,0,27,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,ILC,Negative,Right|Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,1550,Primary,Female
TCGA.A2.A4RX.01,TCGA.A2.A4RX.01A.11R.A266.07,0.168056,0.088572,0,0,TCGA-A2-A4RX,NO,67,24.38,DiseaseFree,24.38,LIVING,13,0.3733,M0,N0,Stage IIA,T2,Metaplastic Breast Cancer,210,Positive,NOT HISPANIC OR LATINO,2/28/13,Metaplastic Carcinoma,NA,No,No,Negative,YES,2012,YES,0,0,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,MBC,Negative,Right Lower Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NA,NO,1,920,Primary,Female
TCGA.A2.A4RY.01,TCGA.A2.A4RY.01A.31R.A266.07,0.755464,0.732334,0,0,TCGA-A2-A4RY,NO,46,21.29,DiseaseFree,21.29,LIVING,10,0.004,M0,N3a,Stage IIIC,T3,Breast Invasive Lobular Carcinoma,149,Positive,NOT HISPANIC OR LATINO,2/26/13,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2012,YES,18,0,30,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,ILC,Negative,Right,Positive,WHITE,YES,NO,1,1180,Primary,Female
TCGA.A2.A4S0.01,TCGA.A2.A4S0.01A.21R.A266.07,0.129883,0.129883,0,0,TCGA-A2-A4S0,NO,77,23.19,DiseaseFree,23.19,LIVING,6,1.00E-04,M0,N0,Stage IIA,T2,Breast Invasive Mixed Mucinous Carcinoma,159,Positive,NOT HISPANIC OR LATINO,2/26/13,Mucinous Carcinoma,NA,No,No,Negative,YES,2012,YES,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IMMC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NO,NO,1,960,Primary,Female
TCGA.A2.A4S1.01,TCGA.A2.A4S1.01A.21R.A266.07,0.025632,0.011763,0,0,TCGA-A2-A4S1,NO,66,26.94,DiseaseFree,26.94,LIVING,60,0.3185,M0,N0,Stage IIA,T2,Metaplastic Breast Cancer,282,Positive,NOT HISPANIC OR LATINO,2/26/13,Metaplastic Carcinoma,NA,No,No,Negative,YES,2012,YES,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,MBC,Negative,Right Upper Outer Quadrant,Negative,WHITE,YES,NO,1,350,Primary,Female
TCGA.A2.A4S2.01,TCGA.A2.A4S2.01A.12R.A266.07,1.140686,1.140686,0,0,TCGA-A2-A4S2,NO,62,21.12,DiseaseFree,21.12,LIVING,30,0.328,M0,N2,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,112,Positive,NOT HISPANIC OR LATINO,2/28/13,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2012,YES,5,0,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right,Positive,WHITE,NO,NO,1,1390,Primary,Female
TCGA.A2.A4S3.01,TCGA.A2.A4S3.01A.21R.A266.07,1.776874,1.588425,0.070571,0.044428286,TCGA-A2-A4S3,NO,59,21.88,DiseaseFree,21.88,LIVING,47,0.4494,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,147,Positive,NOT HISPANIC OR LATINO,2/28/13,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2012,YES,2,0,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NA,NO,1,1500,Primary,Female
TCGA.A7.A0CD.01,TCGA.A7.A0CD.01A.11R.A00Z.07,0.045271,0.031262,0,0,TCGA-A7-A0CD,NO,66,38.27,DiseaseFree,38.27,LIVING,24,0.5843,M0,N0,Stage I,T1,Breast Invasive Ductal Carcinoma,157,Positive,NOT HISPANIC OR LATINO,2010/5/10,Infiltrating Ductal Carcinoma,NA,No,Yes,Equivocal,YES,2009,NA,0,NA,2,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Negative,Left,Positive,WHITE,NA,NO,1,420,Primary,Female
TCGA.A7.A0CG.01,TCGA.A7.A0CG.01A.12R.A056.07,2.085461,2.085461,0,0,TCGA-A7-A0CG,NO,78,34.26,DiseaseFree,34.26,LIVING,28,0.1221,M0,N0 (i-),Stage IIA,T2,Breast Mixed Ductal and Lobular Carcinoma,93,Positive,NOT HISPANIC OR LATINO,2010/7/10,Mixed Histology (please specify),Mixed infiltrating lobular and grade 1 ductal carcinoma,No,No,Negative,YES,2010,NA,0,0,5,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,MDLC,Close,Right Upper Outer Quadrant|Right,Negative,WHITE,NA,NO,1,200,Primary,Female
TCGA.A7.A0CH.01,TCGA.A7.A0CH.01A.21R.A00Z.07,0.094909,0.057913,0,0,TCGA-A7-A0CH,NO,79,35.45,DiseaseFree,35.45,LIVING,26,0.0627,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,121,NA,NOT HISPANIC OR LATINO,2010/4/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2009,NA,0,0,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant|Left,NA,WHITE,NA,NO,1,360,Primary,Female
TCGA.A7.A0CJ.01,TCGA.A7.A0CJ.01A.21R.A00Z.07,0.086713,0.086713,0,0,TCGA-A7-A0CJ,NO,57,30.58,DiseaseFree,30.58,LIVING,37,0.5648,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,36,Positive,NOT HISPANIC OR LATINO,2010/7/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Positive,Left,Positive,WHITE,NA,NO,1,310,Primary,Female
TCGA.A7.A0D9.01,TCGA.A7.A0D9.01A.31R.A056.07,0.326809,0.326809,0,0,TCGA-A7-A0D9,NO,37,37.42,DiseaseFree,37.42,LIVING,21,0.1867,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,173,Positive,NOT HISPANIC OR LATINO,2010/4/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,0,0,1,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant|Left,Negative,WHITE,NA,NO,1,1760,Primary,Female
TCGA.A7.A0DB.01,TCGA.A7.A0DB.01C.02R.A277.07,0.190647,0.190647,0,0,TCGA-A7-A0DB,NO,56,33.08,DiseaseFree,33.08,LIVING,50,0.3296,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,167,Positive,NOT HISPANIC OR LATINO,2010/4/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,0,0,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Close,Right,Positive,WHITE,NA,NO,1,300,Primary,Female
TCGA.A7.A0DC.01,TCGA.A7.A0DC.01A.11R.A00Z.07,0.026397,0.005714,0,0,TCGA-A7-A0DC,NO,63,29.76,DiseaseFree,29.76,LIVING,1,0.3192,M0,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,238,Positive,NOT HISPANIC OR LATINO,2010/4/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,0,0,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant|Right,Negative,WHITE,NA,NO,1,200,Primary,Female
TCGA.A7.A13D.01,TCGA.A7.A13D.01B.04R.A277.07,0.918544,0.381964,0,0,TCGA-A7-A13D,NO,46,31.7,DiseaseFree,31.7,LIVING,85,0.7824,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,240,Negative,NOT HISPANIC OR LATINO,2/23/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,NA,0,NA,4,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Close,Right Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NA,NO,1,240,Primary,Female
TCGA.A7.A13E.01,TCGA.A7.A13E.01B.06R.A277.07,0.41617,0.41617,0,0,TCGA-A7-A13E,NO,62,18.27,Recurred/Progressed,20.17,DECEASED,116,0.6513,MX,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,220,Positive,NOT HISPANIC OR LATINO,2/28/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,NA,2,NA,12,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,NO,1,730,Primary,Female
TCGA.A7.A13F.01,TCGA.A7.A13F.01A.11R.A12P.07,0.039944,0.039944,0,0,TCGA-A7-A13F,NO,44,25.13,DiseaseFree,25.13,LIVING,27,0.2607,M0,N1a,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,121,Positive,NOT HISPANIC OR LATINO,2003/2/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,NA,3,NA,11,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,600,Primary,Female
TCGA.A7.A13G.01,TCGA.A7.A13G.01A.11R.A13Q.07,0.028014,0.028014,0,0,TCGA-A7-A13G,NO,79,19.25,Recurred/Progressed,23.59,LIVING,16,0.115,MX,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,69,Positive,NOT HISPANIC OR LATINO,5/16/11,Infiltrating Ductal Carcinoma,NA,No,Yes,Negative,YES,2010,YES,0,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left,Positive,WHITE,NA,NO,1,120,Primary,Female
TCGA.A7.A13H.01,TCGA.A7.A13H.01A.11R.A22K.07,0.11375,0.11375,0,0,TCGA-A7-A13H,NO,61,26.12,Recurred/Progressed,29.53,LIVING,18,0.1215,MX,N1a,Stage IIB,T2,Breast Invasive Lobular Carcinoma,62,Positive,NOT HISPANIC OR LATINO,6/22/12,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2010,YES,2,2,12,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Right,Positive,WHITE,NA,NO,1,140,Primary,Female
TCGA.A7.A26E.01,TCGA.A7.A26E.01A.11R.A169.07,0.056889,0.056889,0,0,TCGA-A7-A26E,NO,71,31.34,DiseaseFree,31.34,LIVING,208,0.1074,MX,N1a,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,372,Positive,NOT HISPANIC OR LATINO,7/28/11,Infiltrating Lobular Carcinoma,NA,No,Yes,Negative,YES,2010,YES,0,NA,16,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Left,Positive,WHITE,NA,NO,1,230,Primary,Female
TCGA.A7.A26H.01,TCGA.A7.A26H.01A.11R.A169.07,0.161438,0.161438,0,0,TCGA-A7-A26H,NO,72,10.22,Recurred/Progressed,23.78,LIVING,69,0.2219,M0,N1a,Stage IIA,T1,Breast Invasive Ductal Carcinoma,79,Positive,NOT HISPANIC OR LATINO,2008/4/11,Infiltrating Ductal Carcinoma,NA,No,Yes,Equivocal,YES,2011,YES,0,1,5,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left,Negative,WHITE,NA,NO,1,280,Primary,Female
TCGA.A7.A26J.01,TCGA.A7.A26J.01B.02R.A277.07,0.409443,0.280436,0,0,TCGA-A7-A26J,NO,49,20.6,DiseaseFree,20.6,LIVING,122,0.3864,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,54,Positive,NOT HISPANIC OR LATINO,7/28/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2011,YES,0,NA,4,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left,Positive,WHITE,NA,NO,1,60,Primary,Female
TCGA.A7.A2KD.01,TCGA.A7.A2KD.01A.31R.A21T.07,0.945678,0.945678,0,0,TCGA-A7-A2KD,NO,53,22.31,DiseaseFree,22.31,LIVING,27,0.376,MX,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,141,Positive,NOT HISPANIC OR LATINO,2010/11/11,Infiltrating Ductal Carcinoma,NA,No,Yes,Positive,YES,2011,YES,8,0,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Positive,BLACK OR AFRICAN AMERICAN,NA,NO,1,260,Primary,Female
TCGA.A7.A3IY.01,TCGA.A7.A3IY.01A.21R.A21T.07,0.954477,0.564935,0,0,TCGA-A7-A3IY,NO,71,11.33,DiseaseFree,11.33,LIVING,10,0.0079,M0,N0,Stage I,T1c,Breast Invasive Mixed Mucinous Carcinoma,143,Positive,NOT HISPANIC OR LATINO,3/19/12,Mucinous Carcinoma,NA,No,No,Negative,YES,2011,YES,0,NA,1,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IMMC,Close,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,130,Primary,Female
TCGA.A7.A3IZ.01,TCGA.A7.A3IZ.01A.11R.A213.07,0.101196,0.101196,0,0,TCGA-A7-A3IZ,NO,62,10.58,DiseaseFree,10.58,LIVING,61,0.1728,M0,N0 (i+),Stage IIA,T2,Breast Invasive Lobular Carcinoma,86,Positive,NOT HISPANIC OR LATINO,2003/12/12,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2011,YES,NA,1,1,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Positive,Right,Negative,WHITE,NA,NO,1,290,Primary,Female
TCGA.A7.A3J0.01,TCGA.A7.A3J0.01A.11R.A213.07,0.215288,0.215288,0,0,TCGA-A7-A3J0,NO,62,10.28,DiseaseFree,10.28,LIVING,24,0.224,M0,N0,Stage IIA,T2,Breast Invasive Mixed Mucinous Carcinoma,78,Positive,NOT HISPANIC OR LATINO,3/13/12,Mucinous Carcinoma,NA,No,No,Negative,YES,2011,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IMMC,Negative,Right,Positive,WHITE,NA,NO,1,110,Primary,Female
TCGA.A7.A3J1.01,TCGA.A7.A3J1.01A.11R.A213.07,4.626508,4.115791,0.363623,0.088348266,TCGA-A7-A3J1,NO,63,11.27,DiseaseFree,11.27,LIVING,16,0.2148,MX,N0,Stage IA,T1c,Breast Invasive Lobular Carcinoma,49,Positive,NOT HISPANIC OR LATINO,2003/12/12,Infiltrating Lobular Carcinoma,NA,No,Yes,Negative,YES,2011,YES,0,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Left,Positive,WHITE,NA,NO,1,100,Primary,Female
TCGA.A7.A3RF.01,TCGA.A7.A3RF.01A.11R.A22K.07,0.029646,0.019888,0,0,TCGA-A7-A3RF,NO,79,6.31,Recurred/Progressed,13.4,LIVING,43,0.0023,M0,N0,Stage IIA,T2,Breast Invasive Mixed Mucinous Carcinoma,61,Positive,NOT HISPANIC OR LATINO,2005/3/12,Mucinous Carcinoma,NA,No,No,Negative,YES,2012,YES,0,NA,2,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IMMC,Positive,Left Upper Outer Quadrant,Positive,WHITE,NA,NO,1,190,Primary,Female
TCGA.A7.A425.01,TCGA.A7.A425.01A.11R.A24H.07,0.221398,0.177325,0,0,TCGA-A7-A425,NO,70,14.55,Recurred/Progressed,14.68,LIVING,33,0.1447,MX,N3a,Stage IIIC,T3,Breast Invasive Lobular Carcinoma,198,Positive,NOT HISPANIC OR LATINO,2011/5/12,Infiltrating Lobular Carcinoma,NA,No,No,Indeterminate,YES,2012,YES,12,NA,19,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right,Positive,WHITE,YES,NO,1,400,Primary,Female
TCGA.A7.A426.01,TCGA.A7.A426.01A.22R.A24H.07,0.138616,0.127979,0,0,TCGA-A7-A426,NO,50,11.96,DiseaseFree,11.96,LIVING,27,0.1708,MX,N3a,Stage IIIC,T3,Breast Invasive Lobular Carcinoma,132,Positive,NOT HISPANIC OR LATINO,2011/5/12,Infiltrating Lobular Carcinoma,NA,No,Yes,Negative,YES,2012,YES,13,NA,20,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,ILC,Negative,Right,Positive,WHITE,YES,NO,1,180,Primary,Female
TCGA.A7.A4SA.01,TCGA.A7.A4SA.01A.11R.A266.07,1.93125,0.557409,0,0,TCGA-A7-A4SA,NO,40,14.91,DiseaseFree,14.91,LIVING,48,0.3754,M0,N1a,Stage IIB,T2,Breast Invasive Lobular Carcinoma,127,Positive,NOT HISPANIC OR LATINO,2/19/13,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2012,YES,1,0,10,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,ILC,Negative,Left Lower Outer Quadrant,Negative,WHITE,NO,NO,1,220,Primary,Female
TCGA.A7.A4SB.01,TCGA.A7.A4SB.01A.21R.A266.07,0.625399,0.352364,0,0,TCGA-A7-A4SB,NO,56,13.73,DiseaseFree,13.73,LIVING,31,0.5065,M0,N1mi,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,75,Positive,NOT HISPANIC OR LATINO,2/20/13,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2012,YES,0,1,2,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Positive,Right Upper Outer Quadrant,Positive,WHITE,YES,NO,1,120,Primary,Female
TCGA.A7.A4SC.01,TCGA.A7.A4SC.01A.12R.A266.07,0.253776,0.157532,0,0,TCGA-A7-A4SC,NO,62,14.65,DiseaseFree,14.65,LIVING,32,NA,MX,N0,Stage IIB,T3,Breast Invasive Lobular Carcinoma,110,Positive,NOT HISPANIC OR LATINO,2/20/13,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2012,YES,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right Upper Outer Quadrant,Negative,WHITE,YES,NO,1,360,Primary,Female
TCGA.A7.A4SF.01,TCGA.A7.A4SF.01A.11R.A266.07,0.136027,0.114389,0,0,TCGA-A7-A4SF,NO,54,17.9,DiseaseFree,17.9,LIVING,51,0.596,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,245,Positive,NOT HISPANIC OR LATINO,2/25/13,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2012,YES,0,0,2,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Positive,Right,Negative,BLACK OR AFRICAN AMERICAN,YES,NO,1,130,Primary,Female
TCGA.A7.A56D.01,TCGA.A7.A56D.01A.11R.A27Q.07,0.014817,0.014817,0,0,TCGA-A7-A56D,NO,84,14.72,DiseaseFree,14.72,LIVING,89,0.4656,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,140,Positive,NOT HISPANIC OR LATINO,2004/1/13,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2012,YES,0,0,8,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Inner Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NO,NO,1,80,Primary,Female
TCGA.A7.A5ZW.01,TCGA.A7.A5ZW.01A.12R.A29R.07,0.098586,0.098586,0,0,TCGA-A7-A5ZW,NO,47,10.71,DiseaseFree,10.71,LIVING,20,0.0489,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,77,Positive,NOT HISPANIC OR LATINO,5/13/13,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2012,YES,1,NA,1,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NO,NO,1,60,Primary,Female
TCGA.A7.A5ZX.01,TCGA.A7.A5ZX.01A.12R.A29R.07,0.084356,0.084356,0,0,TCGA-A7-A5ZX,NO,48,11.04,DiseaseFree,11.04,LIVING,24,0.0684,M0,N3a,Stage IIIC,T2,Breast Invasive Lobular Carcinoma,76,Positive,NOT HISPANIC OR LATINO,5/13/13,Infiltrating Lobular Carcinoma,NA,No,Yes,Negative,YES,2012,YES,21,NA,24,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,ILC,NA,Left,Positive,WHITE,NO,NO,1,70,Primary,Female
TCGA.A7.A6VX.01,TCGA.A7.A6VX.01A.12R.A33J.07,0.274351,0.240879,0,0,TCGA-A7-A6VX,NO,68,10.41,DiseaseFree,10.41,LIVING,NA,0.6347,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,73,Positive,NOT HISPANIC OR LATINO,10/29/13,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2013,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left|Left Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,YES,NO,1,200,Primary,Female
TCGA.A8.A06N.01,TCGA.A8.A06N.01A.11R.A00Z.07,0.031323,0.031323,0,0,TCGA-A8-A06N,NO,66,0,DiseaseFree,0,LIVING,26,0.5584,M0,N0,Stage IIIB,T4b,Breast Invasive Ductal Carcinoma,241,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Negative,NA,NA,YES,1,510,Primary,Female
TCGA.A8.A06O.01,TCGA.A8.A06O.01A.11R.A00Z.07,0.037233,0.037233,0,0,TCGA-A8-A06O,NO,60,13.01,DiseaseFree,13.01,LIVING,54,0.3914,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,272,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Positive,NA,NA,YES,1,100,Primary,Female
TCGA.A8.A06P.01,TCGA.A8.A06P.01A.11R.A00Z.07,0.03439,0.03439,0,0,TCGA-A8-A06P,NO,63,13.01,DiseaseFree,13.01,LIVING,37,0.0945,M0,N2a,Stage IIIA,T1c,Breast Invasive Ductal Carcinoma,241,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Positive,NA,NA,YES,1,210,Primary,Female
TCGA.A8.A06Q.01,TCGA.A8.A06Q.01A.11R.A034.07,0.019531,0.019531,0,0,TCGA-A8-A06Q,NO,63,1.02,DiseaseFree,1.02,LIVING,164,0.6549,M0,N2,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,1184,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,NA,NA,YES,1,50,Primary,Female
TCGA.A8.A06R.01,TCGA.A8.A06R.01A.11R.A00Z.07,0.032959,0.032959,0,0,TCGA-A8-A06R,NO,69,17.97,DiseaseFree,17.97,LIVING,44,0.5927,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1184,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2007,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,NA,NA,YES,1,220,Primary,Female
TCGA.A8.A06T.01,TCGA.A8.A06T.01A.11R.A00Z.07,2.241772,2.172805,0,0,TCGA-A8-A06T,NO,75,53.02,DiseaseFree,53.02,LIVING,23,0.7708,M0,N1a,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,941,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,Yes,Positive,YES,2007,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,NA,NA,YES,1,110,Primary,Female
TCGA.A8.A06U.01,TCGA.A8.A06U.01A.11R.A00Z.07,0.705114,0.705114,0,0,TCGA-A8-A06U,NO,80,NA,NA,29.01,DECEASED,46,0.6192,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,759,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,Yes,Positive,YES,2008,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,NA,NA,YES,1,250,Primary,Female
TCGA.A8.A06X.01,TCGA.A8.A06X.01A.21R.A00Z.07,0.070458,0.070458,0,0,TCGA-A8-A06X,NO,77,NA,NA,30.98,DECEASED,143,0.6033,M0,N0,Stage IIB,T3,Breast Invasive Ductal Carcinoma,1276,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2006,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,NA,NA,YES,1,760,Primary,Female
TCGA.A8.A06Y.01,TCGA.A8.A06Y.01A.21R.A00Z.07,0.046306,0.046306,0,0,TCGA-A8-A06Y,NO,66,25.99,Recurred/Progressed,25.99,LIVING,24,0.3042,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,667,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,NA,NA,YES,1,130,Primary,Female
TCGA.A8.A06Z.01,TCGA.A8.A06Z.01A.11R.A00Z.07,0.01228,0.01228,0,0,TCGA-A8-A06Z,NO,84,1.02,DiseaseFree,1.02,LIVING,44,0.7074,M0,N0,Stage IIB,T3,Breast Invasive Ductal Carcinoma,1003,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,NA,Right Upper Outer Quadrant,Positive,NA,NA,YES,1,330,Primary,Female
TCGA.A8.A075.01,TCGA.A8.A075.01A.11R.A084.07,0.091759,0.091759,0,0,TCGA-A8-A075,NO,42,17.02,DiseaseFree,17.02,LIVING,55,0.5033,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,394,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2009,NA,NA,NA,NA,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,NA,NA,YES,1,120,Primary,Female
TCGA.A8.A076.01,TCGA.A8.A076.01A.21R.A00Z.07,0.360123,0.318426,0,0,TCGA-A8-A076,NO,66,53.94,DiseaseFree,53.94,LIVING,44,0.5527,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,1518,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2006,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,NA,NA,YES,1,210,Primary,Female
TCGA.A8.A079.01,TCGA.A8.A079.01A.21R.A00Z.07,0.007671,0.007671,0,0,TCGA-A8-A079,NO,69,9,DiseaseFree,9,LIVING,40,0.3639,M0,N3,Stage IIIB,T4b,Breast Invasive Ductal Carcinoma,1033,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,NA,NA,YES,1,380,Primary,Female
TCGA.A8.A07B.01,TCGA.A8.A07B.01A.11R.A00Z.07,0.011562,0.011562,0,0,TCGA-A8-A07B,NO,69,42.97,DiseaseFree,42.97,LIVING,48,0.3844,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,880,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2007,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Outer Quadrant,Positive,NA,NA,YES,1,90,Primary,Female
TCGA.A8.A07E.01,TCGA.A8.A07E.01A.11R.A034.07,0.237723,0.21021,0,0,TCGA-A8-A07E,NO,81,19.97,DiseaseFree,19.97,LIVING,65,0.2136,MX,N3a,Stage X,T4b,Breast Invasive Ductal Carcinoma,545,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,Yes,Negative,YES,2008,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,NA,NA,YES,1,260,Primary,Female
TCGA.A8.A07F.01,TCGA.A8.A07F.01A.11R.A00Z.07,1.111701,1.111701,0,0,TCGA-A8-A07F,NO,65,18.96,DiseaseFree,18.96,LIVING,23,0.6103,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,453,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,NA,NA,YES,1,150,Primary,Female
TCGA.A8.A07G.01,TCGA.A8.A07G.01A.11R.A034.07,0.346194,0.346194,0,0,TCGA-A8-A07G,NO,65,18.96,DiseaseFree,18.96,LIVING,40,0.2875,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,453,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,NA,NA,YES,1,60,Primary,Female
TCGA.A8.A07I.01,TCGA.A8.A07I.01A.11R.A00Z.07,0.271845,0.246608,0.025237,0.102336502,TCGA-A8-A07I,NO,69,13.99,DiseaseFree,13.99,LIVING,29,0.2446,M0,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,302,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,NA,NA,YES,1,130,Primary,Female
TCGA.A8.A07J.01,TCGA.A8.A07J.01A.11R.A00Z.07,0.460422,0.460422,0,0,TCGA-A8-A07J,NO,35,11.99,DiseaseFree,11.99,LIVING,31,0.1612,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,241,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,NA,NA,YES,1,130,Primary,Female
TCGA.A8.A07L.01,TCGA.A8.A07L.01A.11R.A00Z.07,0.258841,0.258841,0,0,TCGA-A8-A07L,NO,58,32.03,DiseaseFree,32.03,LIVING,76,0.4588,M0,N1a,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,394,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,NA,NA,YES,1,80,Primary,Female
TCGA.A8.A07P.01,TCGA.A8.A07P.01A.11R.A00Z.07,0.147996,0.147996,0,0,TCGA-A8-A07P,NO,68,10.97,DiseaseFree,10.97,LIVING,37,0.283,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,210,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,NA,NA,YES,1,120,Primary,Female
TCGA.A8.A07R.01,TCGA.A8.A07R.01A.21R.A034.07,0.150669,0.150669,0,0,TCGA-A8-A07R,NO,80,8.97,DiseaseFree,8.97,LIVING,355,0.7041,M0,N3a,Stage IIIC,T2,Breast Invasive Ductal Carcinoma,149,Negative,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2009,NA,NA,NA,NA,NA,NA,NA,NA,NA,IDC,Positive,Left Upper Outer Quadrant,Negative,NA,NA,YES,1,170,Primary,Female
TCGA.A8.A07S.01,TCGA.A8.A07S.01A.11R.A034.07,0.012169,0.012169,0,0,TCGA-A8-A07S,NO,73,7.98,DiseaseFree,7.98,LIVING,NA,0.1065,M0,N0,Stage IIA,T2,Breast Mixed Ductal and Lobular Carcinoma,119,Positive,NA,5/27/11,Mixed Histology (please specify),lobular/ductal,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,MDLC,Positive,Left Upper Outer Quadrant,Negative,NA,NA,YES,1,220,Primary,Female
TCGA.A8.A07U.01,TCGA.A8.A07U.01A.11R.A034.07,0.311004,0.311004,0,0,TCGA-A8-A07U,NO,66,24.97,DiseaseFree,24.97,LIVING,28,0.0901,M0,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,210,Negative,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,NA,NA,YES,1,100,Primary,Female
TCGA.A8.A07W.01,TCGA.A8.A07W.01A.11R.A00Z.07,0.041801,0.041801,0,0,TCGA-A8-A07W,NO,76,9.99,DiseaseFree,9.99,LIVING,56,0.4787,M1,NX,Stage IV,T2,Breast Invasive Ductal Carcinoma,180,Positive,NA,5/25/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Positive,Left Upper Outer Quadrant,Positive,NA,NA,YES,1,180,Primary,Female
TCGA.A8.A07Z.01,TCGA.A8.A07Z.01A.11R.A00Z.07,0.398478,0.23978,0,0,TCGA-A8-A07Z,NO,85,45.04,DiseaseFree,45.04,LIVING,19,0.8203,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,698,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Positive,NA,NA,YES,1,130,Primary,Female
TCGA.A8.A081.01,TCGA.A8.A081.01A.11R.A00Z.07,0.028889,0.028889,0,0,TCGA-A8-A081,NO,80,0,DiseaseFree,0,LIVING,65,0.645,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,637,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Positive,NA,NA,YES,1,150,Primary,Female
TCGA.A8.A082.01,TCGA.A8.A082.01A.11R.A00Z.07,0.042946,0.042946,0,0,TCGA-A8-A082,NO,58,18.04,DiseaseFree,18.04,LIVING,19,0.1231,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,606,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Positive,NA,NA,YES,1,130,Primary,Female
TCGA.A8.A083.01,TCGA.A8.A083.01A.21R.A00Z.07,0,0,0,NA,TCGA-A8-A083,NO,67,0,DiseaseFree,0,LIVING,29,0.1819,M0,N0,Stage IIB,T3,Breast Invasive Ductal Carcinoma,575,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Positive,NA,NA,YES,1,300,Primary,Female
TCGA.A8.A084.01,TCGA.A8.A084.01A.21R.A00Z.07,0.161853,0.149632,0,0,TCGA-A8-A084,NO,81,15.05,DiseaseFree,15.05,LIVING,55,0.4237,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1033,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,Yes,Yes,Negative,YES,2007,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Positive,Left,Negative,NA,NA,YES,1,270,Primary,Female
TCGA.A8.A085.01,TCGA.A8.A085.01A.11R.A00Z.07,0,0,0,NA,TCGA-A8-A085,NO,44,36.93,DiseaseFree,36.93,LIVING,53,0.2398,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,788,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,NA,NA,NA,NA,NA,NA,NA,NA,IDC,Negative,Left,Positive,NA,NA,YES,1,130,Primary,Male
TCGA.A8.A086.01,TCGA.A8.A086.01A.11R.A00Z.07,0.130851,0.130851,0,0,TCGA-A8-A086,NO,59,13.01,DiseaseFree,13.01,LIVING,17,0.2758,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,272,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Positive,NA,NA,YES,1,150,Primary,Female
TCGA.A8.A08A.01,TCGA.A8.A08A.01A.11R.A32Y.07,0.792543,0.748437,0.022688,0.030313841,TCGA-A8-A08A,NO,89,0.99,DiseaseFree,0.99,LIVING,23,0.0864,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,1033,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant,Positive,NA,NA,YES,1,160,Primary,Female
TCGA.A8.A08B.01,TCGA.A8.A08B.01A.11R.A00Z.07,0.034084,0.034084,0,0,TCGA-A8-A08B,NO,52,37.98,DiseaseFree,37.98,LIVING,18,0.3997,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,759,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2008,NA,NA,NA,NA,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant,Negative,NA,NA,YES,1,100,Primary,Female
TCGA.A8.A08C.01,TCGA.A8.A08C.01A.11R.A00Z.07,0.028639,0.028639,0,0,TCGA-A8-A08C,NO,65,28.94,DiseaseFree,28.94,LIVING,2,0.6502,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,484,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2008,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant,Positive,NA,NA,YES,1,110,Primary,Female
TCGA.A8.A08F.01,TCGA.A8.A08F.01A.11R.A00Z.07,0.15667,0.15667,0,0,TCGA-A8-A08F,NO,59,32.98,DiseaseFree,32.98,LIVING,87,0.6614,M0,N3a,Stage IIIC,T2,Breast Invasive Ductal Carcinoma,637,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,Yes,Yes,Negative,YES,2008,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant,Positive,NA,NA,YES,1,100,Primary,Female
TCGA.A8.A08G.01,TCGA.A8.A08G.01A.11R.A00Z.07,0.385245,0.385245,0,0,TCGA-A8-A08G,NO,41,19.94,DiseaseFree,19.94,LIVING,29,0.5338,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,422,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2009,NA,NA,NA,NA,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant,Positive,NA,NA,YES,1,180,Primary,Female
TCGA.A8.A08H.01,TCGA.A8.A08H.01A.21R.A00Z.07,0.204055,0.204055,0,0,TCGA-A8-A08H,NO,66,0,DiseaseFree,0,LIVING,45,0,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,1184,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2007,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant,Positive,NA,NA,YES,1,250,Primary,Female
TCGA.A8.A08I.01,TCGA.A8.A08I.01A.11R.A00Z.07,0.717878,0.717878,0,0,TCGA-A8-A08I,NO,53,11.99,DiseaseFree,11.99,LIVING,30,0.6372,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,241,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant,Positive,NA,NA,YES,1,80,Primary,Female
TCGA.A8.A08J.01,TCGA.A8.A08J.01A.11R.A00Z.07,0.272734,0.256676,0,0,TCGA-A8-A08J,NO,52,NA,NA,37.02,DECEASED,27,0.4491,M1,N3,Stage IV,T4b,Paget Disease of the Nipple,1733,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2005,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,PD,Positive,Right,Negative,NA,NA,YES,1,630,Primary,Female
TCGA.A8.A08L.01,TCGA.A8.A08L.01A.11R.A00Z.07,0.136177,0.136177,0,0,TCGA-A8-A08L,NO,89,NA,NA,9.99,DECEASED,155,0.5383,M0,N2a,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,698,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Negative,NA,NA,YES,1,200,Primary,Female
TCGA.A8.A08O.01,TCGA.A8.A08O.01A.21R.A056.07,0.041208,0.041208,0,0,TCGA-A8-A08O,NO,45,25.03,Recurred/Progressed,30.98,LIVING,20,0.6432,M1,N3a,Stage IV,T2,Breast Invasive Ductal Carcinoma,819,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,NA,NA,NA,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Positive,Right,Positive,NA,NA,YES,1,130,Primary,Female
TCGA.A8.A08P.01,TCGA.A8.A08P.01A.11R.A00Z.07,0.468653,0.468653,0,0,TCGA-A8-A08P,NO,70,30.98,DiseaseFree,30.98,LIVING,31,0.5434,M0,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,819,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2008,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Positive,NA,NA,YES,1,210,Primary,Female
TCGA.A8.A08S.01,TCGA.A8.A08S.01A.11R.A034.07,0.708633,0.663373,0.04526,0.068227076,TCGA-A8-A08S,NO,71,32.98,DiseaseFree,32.98,LIVING,38,0.4019,M0,N1,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,637,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,Yes,Yes,Positive,YES,2008,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Positive,NA,NA,YES,1,80,Primary,Female
TCGA.A8.A08T.01,TCGA.A8.A08T.01A.21R.A00Z.07,0.201934,0.201934,0,0,TCGA-A8-A08T,NO,64,84,Recurred/Progressed,111.99,DECEASED,39,0.2105,M1,N1a,Stage IV,T2,Breast Invasive Ductal Carcinoma,2767,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2002,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Positive,Right,Positive,NA,NA,YES,1,190,Primary,Female
TCGA.A8.A08X.01,TCGA.A8.A08X.01A.21R.A00Z.07,0.21986,0.21986,0,0,TCGA-A8-A08X,NO,43,12.02,Recurred/Progressed,42.97,LIVING,13,0.3454,M0,N3a,Stage IIIC,T4d,Breast Invasive Ductal Carcinoma,941,Negative,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2007,NA,NA,NA,NA,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left,Negative,NA,NA,YES,1,170,Primary,Female
TCGA.A8.A08Z.01,TCGA.A8.A08Z.01A.21R.A00Z.07,0.268145,0.268145,0,0,TCGA-A8-A08Z,NO,76,39.98,DiseaseFree,39.98,LIVING,23,0.1054,M0,N3a,NA,T4b,Breast Invasive Ductal Carcinoma,2036,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2004,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Positive,NA,NA,YES,1,350,Primary,Female
TCGA.A8.A090.01,TCGA.A8.A090.01A.11R.A00Z.07,0.123675,0.050697,0,0,TCGA-A8-A090,NO,74,0,DiseaseFree,0,LIVING,26,0.2863,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,667,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2008,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Positive,NA,NA,YES,1,110,Primary,Female
TCGA.A8.A091.01,TCGA.A8.A091.01A.11R.A00Z.07,0.023235,0,0.023235,Inf,TCGA-A8-A091,NO,61,7.98,Recurred/Progressed,32.98,LIVING,20,0.3068,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,637,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,Yes,Negative,YES,2008,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Negative,NA,NA,YES,1,180,Primary,Female
TCGA.A8.A092.01,TCGA.A8.A092.01A.11R.A00Z.07,0.016373,0.016373,0,0,TCGA-A8-A092,NO,48,30.95,DiseaseFree,30.95,LIVING,63,0.5728,M0,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,575,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,NA,NA,NA,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left,Positive,NA,NA,YES,1,100,Primary,Female
TCGA.A8.A093.01,TCGA.A8.A093.01A.11R.A00Z.07,0.014162,0.014162,0,0,TCGA-A8-A093,NO,61,17.94,DiseaseFree,17.94,LIVING,75,0.4219,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,422,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,Yes,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Positive,NA,NA,YES,1,100,Primary,Female
TCGA.A8.A094.01,TCGA.A8.A094.01A.11R.A00Z.07,0.317187,0.161174,0,0,TCGA-A8-A094,NO,75,0,DiseaseFree,0,LIVING,129,0.4871,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,363,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Negative,NA,NA,YES,1,400,Primary,Female
TCGA.A8.A095.01,TCGA.A8.A095.01A.11R.A00Z.07,0.009281,0.009281,0,0,TCGA-A8-A095,NO,45,41.95,DiseaseFree,41.95,LIVING,85,0.0741,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,1153,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,NA,NA,NA,NA,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left,Positive,NA,NA,YES,1,160,Primary,Female
TCGA.A8.A096.01,TCGA.A8.A096.01A.11R.A00Z.07,2.117189,1.740623,0.303099,0.17413248,TCGA-A8-A096,NO,73,0,DiseaseFree,0,LIVING,26,0.0683,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,394,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Positive,NA,NA,YES,1,110,Primary,Female
TCGA.A8.A097.01,TCGA.A8.A097.01A.11R.A034.07,0.051238,0.051238,0,0,TCGA-A8-A097,NO,65,11.99,DiseaseFree,11.99,LIVING,85,0.3867,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,241,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Positive,NA,NA,YES,1,100,Primary,Female
TCGA.A8.A099.01,TCGA.A8.A099.01A.11R.A00Z.07,0.527091,0.527091,0,0,TCGA-A8-A099,NO,76,9.99,DiseaseFree,9.99,LIVING,16,0.1923,MX,N3a,Stage X,T4b,Breast Invasive Ductal Carcinoma,180,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,NA,Right,Positive,NA,NA,YES,1,210,Primary,Female
TCGA.A8.A09A.01,TCGA.A8.A09A.01A.11R.A00Z.07,0.247468,0.179629,0,0,TCGA-A8-A09A,NO,40,9.99,DiseaseFree,9.99,LIVING,76,0.426,M0,NX,Stage X,T2,Breast Invasive Ductal Carcinoma,180,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Positive,Left,Positive,NA,NA,YES,1,170,Primary,Female
TCGA.A8.A09B.01,TCGA.A8.A09B.01A.11R.A00Z.07,0.102845,0.102845,0,0,TCGA-A8-A09B,NO,58,11.99,DiseaseFree,11.99,LIVING,25,0.5104,M0,N1a,Stage IIIB,T4b,Breast Invasive Ductal Carcinoma,210,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Positive,NA,NA,YES,1,170,Primary,Female
TCGA.A8.A09C.01,TCGA.A8.A09C.01A.11R.A00Z.07,0.029932,0.029932,0,0,TCGA-A8-A09C,NO,69,1.02,DiseaseFree,1.02,LIVING,17,0.4981,MX,N0,Stage X,T2,Breast Invasive Ductal Carcinoma,180,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,Yes,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,NA,Right,Positive,NA,NA,YES,1,120,Primary,Female
TCGA.A8.A09D.01,TCGA.A8.A09D.01A.11R.A00Z.07,0.061811,0.061811,0,0,TCGA-A8-A09D,NO,47,50,DiseaseFree,50,LIVING,30,0.2338,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1033,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Lower Outer Quadrant,Positive,NA,NA,YES,1,100,Primary,Female
TCGA.A8.A09E.01,TCGA.A8.A09E.01A.11R.A00Z.07,0.097666,0.022356,0,0,TCGA-A8-A09E,NO,73,49.01,DiseaseFree,49.01,LIVING,36,0.5448,M0,N1a,Stage IIIB,T4b,Breast Invasive Ductal Carcinoma,819,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,Yes,Yes,Positive,YES,2008,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Positive,Left Lower Outer Quadrant,Positive,NA,NA,YES,1,220,Primary,Female
TCGA.A8.A09G.01,TCGA.A8.A09G.01A.21R.A00Z.07,0.0958,0.0958,0,0,TCGA-A8-A09G,NO,79,0,DiseaseFree,0,LIVING,188,0.2213,M0,N3a,Stage IIIC,T3,Breast Invasive Ductal Carcinoma,759,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2008,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Lower Outer Quadrant,Negative,NA,NA,YES,1,270,Primary,Female
TCGA.A8.A09I.01,TCGA.A8.A09I.01A.22R.A034.07,0.085517,0.085517,0,0,TCGA-A8-A09I,NO,84,45.04,DiseaseFree,45.04,LIVING,97,0.3571,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,698,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,Yes,Positive,YES,2008,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Lower Outer Quadrant,Positive,NA,NA,YES,1,430,Primary,Female
TCGA.A8.A09K.01,TCGA.A8.A09K.01A.11R.A00Z.07,0.302586,0.195827,0,0,TCGA-A8-A09K,NO,68,29.96,DiseaseFree,29.96,LIVING,28,0.5029,M0,N1,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,788,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,Yes,Yes,Negative,YES,2008,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Outer Quadrant,Positive,NA,NA,YES,1,240,Primary,Female
TCGA.A8.A09M.01,TCGA.A8.A09M.01A.11R.A00Z.07,0.233738,0.233738,0,0,TCGA-A8-A09M,NO,75,33.05,DiseaseFree,33.05,LIVING,68,0.4565,M0,N3a,Stage IIIC,T2,Breast Invasive Ductal Carcinoma,333,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Lower Outer Quadrant,Positive,NA,NA,YES,1,170,Primary,Female
TCGA.A8.A09N.01,TCGA.A8.A09N.01A.11R.A00Z.07,0.08479,0.012195,0,0,TCGA-A8-A09N,NO,57,1.02,DiseaseFree,1.02,LIVING,51,0.6977,M0,N3a,Stage IIIC,T2,Breast Invasive Ductal Carcinoma,1276,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2006,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Lower Outer Quadrant,Positive,NA,NA,YES,1,70,Primary,Female
TCGA.A8.A09Q.01,TCGA.A8.A09Q.01A.11R.A00Z.07,0.068431,0.068431,0,0,TCGA-A8-A09Q,NO,83,25,DiseaseFree,25,LIVING,72,0.5959,M0,N2a,Stage IIIB,T4b,Breast Invasive Ductal Carcinoma,637,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Positive,Left Lower Inner Quadrant,Positive,NA,NA,YES,1,100,Primary,Female
TCGA.A8.A09R.01,TCGA.A8.A09R.01A.11R.A00Z.07,0.537657,0.537657,0,0,TCGA-A8-A09R,NO,82,8.97,DiseaseFree,8.97,LIVING,40,0.4749,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,149,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Inner Quadrant,Positive,NA,NA,YES,1,180,Primary,Female
TCGA.A8.A09T.01,TCGA.A8.A09T.01A.11R.A00Z.07,0.021546,0.021546,0,0,TCGA-A8-A09T,NO,68,19.02,DiseaseFree,19.02,LIVING,24,0.093,MX,N0,NA,T1c,Breast Invasive Lobular Carcinoma,394,Positive,NA,5/27/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left,Positive,NA,NA,YES,1,100,Primary,Female
TCGA.A8.A09V.01,TCGA.A8.A09V.01A.11R.A034.07,0.022785,0.022785,0,0,TCGA-A8-A09V,NO,51,15.01,DiseaseFree,15.01,LIVING,20,0.0703,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,333,Positive,NA,5/27/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,ILC,Negative,Right Upper Inner Quadrant,Positive,NA,NA,YES,1,60,Primary,Female
TCGA.A8.A09W.01,TCGA.A8.A09W.01A.11R.A00Z.07,0.080167,0.080167,0,0,TCGA-A8-A09W,NO,70,0.99,DiseaseFree,0.99,LIVING,58,0.3816,M0,N3,Stage IIIB,T2,Breast Invasive Lobular Carcinoma,1033,Positive,NA,5/27/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2007,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,NA,Right Upper Inner Quadrant,Positive,NA,NA,YES,1,180,Primary,Female
TCGA.A8.A09Z.01,TCGA.A8.A09Z.01A.11R.A00Z.07,0.728903,0.561635,0.167268,0.297823319,TCGA-A8-A09Z,NO,83,0,DiseaseFree,0,LIVING,980,0.1205,M0,N0,Stage IIB,T3,Breast Invasive Lobular Carcinoma,728,Positive,NA,5/27/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2008,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Positive,Right,Negative,NA,NA,YES,1,320,Primary,Female
TCGA.A8.A0A1.01,TCGA.A8.A0A1.01A.11R.A00Z.07,1.978932,1.028349,0.219699,0.21364245,TCGA-A8-A0A1,NO,84,11.99,DiseaseFree,11.99,LIVING,28,0.117,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,241,Positive,NA,5/27/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right,Positive,NA,NA,YES,1,90,Primary,Female
TCGA.A8.A0A2.01,TCGA.A8.A0A2.01A.11R.A034.07,1.526768,1.32461,0,0,TCGA-A8-A0A2,NO,66,19.02,DiseaseFree,19.02,LIVING,22,0.3321,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,394,Positive,NA,5/27/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right Lower Outer Quadrant,Positive,NA,NA,YES,1,70,Primary,Female
TCGA.A8.A0A4.01,TCGA.A8.A0A4.01A.11R.A00Z.07,0.236476,0.162847,0.073629,0.452136054,TCGA-A8-A0A4,NO,73,13.01,DiseaseFree,13.01,LIVING,23,0.2609,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,272,Positive,NA,5/27/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left,Positive,NA,NA,YES,1,160,Primary,Female
TCGA.A8.A0A6.01,TCGA.A8.A0A6.01A.12R.A056.07,1.630393,1.406975,0,0,TCGA-A8-A0A6,NO,64,21.02,DiseaseFree,21.02,LIVING,1985,0.1429,M0,N3a,Stage IIIC,T2,Breast Invasive Lobular Carcinoma,394,Positive,NA,5/27/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left Upper Outer Quadrant,Positive,NA,NA,YES,1,90,Primary,Female
TCGA.A8.A0A7.01,TCGA.A8.A0A7.01A.11R.A00Z.07,0.078313,0.078313,0,0,TCGA-A8-A0A7,NO,57,0.99,DiseaseFree,0.99,LIVING,70,0.0491,M0,N1a,Stage IIB,T2,Breast Invasive Lobular Carcinoma,302,Negative,NA,5/27/11,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right Upper Outer Quadrant,Negative,NA,NA,YES,1,130,Primary,Female
TCGA.A8.A0A9.01,TCGA.A8.A0A9.01A.11R.A00Z.07,0.051094,0.051094,0,0,TCGA-A8-A0A9,NO,80,27,DiseaseFree,27,LIVING,39,0.4832,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,272,Positive,NA,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,NA,NA,YES,1,100,Primary,Female
TCGA.A8.A0AB.01,TCGA.A8.A0AB.01A.11R.A034.07,0.02273,0.02273,0,0,TCGA-A8-A0AB,NO,54,17.02,DiseaseFree,17.02,LIVING,20,0.2947,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,394,Positive,NA,5/27/11,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2009,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left Upper Outer Quadrant,Positive,NA,NA,YES,1,70,Primary,Female
TCGA.A8.A0AD.01,TCGA.A8.A0AD.01A.11R.A056.07,0.029138,0.029138,0,0,TCGA-A8-A0AD,NO,83,38.01,DiseaseFree,38.01,LIVING,20,0.1633,M0,N0,Stage I,T1c,Breast Mixed Ductal and Lobular Carcinoma,1033,Positive,NA,5/27/11,Mixed Histology (please specify),lobular/ductal,No,No,Negative,YES,2007,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,MDLC,Negative,Right Upper Outer Quadrant,Positive,NA,NA,YES,1,90,Primary,Female
TCGA.AC.A23C.01,TCGA.AC.A23C.01A.12R.A169.07,0.156581,0.156581,0,0,TCGA-AC-A23C,NO,62,19.22,DiseaseFree,19.22,LIVING,79,0.1676,MX,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,198,Positive,NA,7/14/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,YES,1,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left,Positive,WHITE,NA,YES,1,100,Primary,Female
TCGA.AC.A23E.01,TCGA.AC.A23E.01A.11R.A157.07,0.020754,0.020754,0,0,TCGA-AC-A23E,NO,50,22.93,DiseaseFree,22.93,LIVING,15,0.1121,MX,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,158,Positive,NA,7/18/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2010,YES,1,NA,2,NA,NA,NA,NA,NO,IDC,Negative,Right,Positive,WHITE,NA,NA,1,130,Primary,Female
TCGA.AC.A23G.01,TCGA.AC.A23G.01A.11R.A213.07,0.386637,0.386637,0,0,TCGA-AC-A23G,NO,76,73.85,DiseaseFree,73.85,LIVING,18,0.0984,MX,N1,Stage IIA,T1c,Breast Invasive Lobular Carcinoma,1590,Positive,NA,7/14/11,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2006,YES,2,NA,8,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Right Upper Inner Quadrant,Positive,WHITE,NA,YES,1,40,Primary,Female
TCGA.AC.A23H.01,TCGA.AC.A23H.01A.11R.A157.07,0.115477,0.115477,0,0,TCGA-AC-A23H,NO,90,NA,NA,5.72,DECEASED,3410,0.2724,M0,NX,Stage IIA,T2,Breast Invasive Ductal Carcinoma,478,Positive,NOT HISPANIC OR LATINO,7/13/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2009,NO,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Inner Quadrant|Right Lower Inner Quadrant,Negative,WHITE,NA,YES,1,70,Primary,Female
TCGA.AC.A2B8.01,TCGA.AC.A2B8.01A.11R.A17B.07,0.822206,0.788656,0,0,TCGA-AC-A2B8,NO,84,21.48,Recurred/Progressed,22.24,LIVING,71,0.1088,M0,N0 (i-),Stage IIB,T3,Breast Invasive Lobular Carcinoma,101,Positive,NOT HISPANIC OR LATINO,2009/12/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2011,YES,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Right,Positive,WHITE,NA,NO,1,150,Primary,Female
TCGA.AC.A2BM.01,TCGA.AC.A2BM.01A.11R.A21T.07,1.519332,1.519332,0,0,TCGA-AC-A2BM,NO,41,99.28,DiseaseFree,99.28,LIVING,16,0.3919,MX,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,2164,Positive,NA,2009/12/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2005,YES,1,1,13,NA,NA,NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,120,Primary,Female
TCGA.AC.A2FB.01,TCGA.AC.A2FB.01A.11R.A17B.07,0.444877,0.337862,0,0,TCGA-AC-A2FB,NO,65,40.54,DiseaseFree,40.54,LIVING,12,0.0024,MX,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,576,Positive,NOT HISPANIC OR LATINO,9/20/11,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2009,YES,0,NA,1,NA,NA,NA,NA,NO,ILC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,YES,1,140,Primary,Female
TCGA.AC.A2FE.01,TCGA.AC.A2FE.01A.11R.A19W.07,1.402829,1.385256,0,0,TCGA-AC-A2FE,NO,62,82,Recurred/Progressed,86.6,DECEASED,18,0.1862,MX,N3a,Stage IIIC,T3,Breast Invasive Lobular Carcinoma,2228,Positive,NOT HISPANIC OR LATINO,2012/3/12,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2005,YES,18,NA,18,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right Upper Outer Quadrant,Positive,WHITE,YES,YES,1,120,Primary,Female
TCGA.AC.A2FF.01,TCGA.AC.A2FF.01A.11R.A17B.07,1.520794,1.058318,0.036431,0.034423491,TCGA-AC-A2FF,NO,40,90.64,DiseaseFree,90.64,LIVING,15,0.0011,MX,N1,Stage IIB,T2,Breast Invasive Lobular Carcinoma,1904,Positive,NOT HISPANIC OR LATINO,9/23/11,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2006,YES,3,0,7,NA,NA,NA,NA,NO,ILC,Negative,Right,Positive,ASIAN,NA,YES,1,130,Primary,Female
TCGA.AC.A2FG.01,TCGA.AC.A2FG.01A.11R.A17B.07,0.0027,0.0027,0,0,TCGA-AC-A2FG,NO,79,60.87,DiseaseFree,60.87,LIVING,36,0.0788,MX,N1a,Stage IIB,T2,Breast Invasive Lobular Carcinoma,1517,Positive,NA,9/21/11,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2007,YES,1,1,11,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,120,Primary,Female
TCGA.AC.A2FK.01,TCGA.AC.A2FK.01A.12R.A180.07,0.051688,0.051688,0,0,TCGA-AC-A2FK,NO,45,87.06,DiseaseFree,87.06,LIVING,NA,0,M0,N3a,Stage IIIC,T2,Breast Invasive Lobular Carcinoma,1833,Positive,HISPANIC OR LATINO,9/13/11,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2006,YES,3,NA,3,NA,NA,NA,NA,NO,ILC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,80,Primary,Female
TCGA.AC.A2FM.01,TCGA.AC.A2FM.01A.11R.A19W.07,0.059411,0.059411,0,0,TCGA-AC-A2FM,NO,87,25.62,Recurred/Progressed,26.02,DECEASED,33,0.4843,M0,N1mi,Stage IIB,T2,Breast Invasive Lobular Carcinoma,2606,NA,NOT HISPANIC OR LATINO,2/22/12,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2004,YES,0,0,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,YES,ILC,Negative,Right Upper Inner Quadrant,NA,WHITE,NA,YES,1,170,Primary,Female
TCGA.AC.A2FO.01,TCGA.AC.A2FO.01A.11R.A180.07,0.074738,0.074738,0,0,TCGA-AC-A2FO,NO,65,74.08,DiseaseFree,74.08,LIVING,21,0.1185,MX,N1,Stage IIB,T2,Breast Invasive Lobular Carcinoma,2051,Positive,NOT HISPANIC OR LATINO,9/21/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2005,YES,2,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,120,Primary,Female
TCGA.AC.A2QI.01,TCGA.AC.A2QI.01A.12R.A19W.07,0.435692,0.435692,0,0,TCGA-AC-A2QI,NO,76,19.32,DiseaseFree,19.32,LIVING,53,0.0938,MX,N1a,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,91,Positive,NOT HISPANIC OR LATINO,10/18/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2011,YES,2,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Right,Negative,WHITE,NA,NO,1,140,Primary,Female
TCGA.AC.A3BB.01,TCGA.AC.A3BB.01A.21R.A19W.07,0.315377,0.315377,0,0,TCGA-AC-A3BB,NO,46,32.42,DiseaseFree,32.42,LIVING,55,0.1171,MX,N2a,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,106,Positive,NOT HISPANIC OR LATINO,2002/3/12,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2011,NA,5,NA,14,NA,NA,NA,NA,NO,ILC,Negative,Right Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NA,NO,1,160,Primary,Female
TCGA.AC.A3EH.01,TCGA.AC.A3EH.01A.22R.A22K.07,0.982358,0.961749,0,0,TCGA-AC-A3EH,NO,79,NA,NA,6.47,DECEASED,33,0.3579,M0,N3,Stage IIIC,T3,Breast Invasive Ductal Carcinoma,67,Positive,NOT HISPANIC OR LATINO,9/24/12,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2011,YES,12,NA,12,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Negative,WHITE,NA,NO,1,150,Primary,Female
TCGA.AC.A3HN.01,TCGA.AC.A3HN.01A.11R.A213.07,0.3069,0.200126,0,0,TCGA-AC-A3HN,NO,87,16.29,DiseaseFree,16.29,LIVING,14,0.1499,MX,N1a,Stage IIB,T2,Breast Invasive Lobular Carcinoma,97,Positive,NOT HISPANIC OR LATINO,4/13/12,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2011,YES,2,0,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,NO,1,160,Primary,Female
TCGA.AC.A3OD.01,TCGA.AC.A3OD.01A.11R.A21T.07,0.128401,0.025515,0.020151,0.789770723,TCGA-AC-A3OD,NO,68,14.82,DiseaseFree,14.82,LIVING,91,0.267,MX,N1mi,Stage IIB,T2,Breast Invasive Lobular Carcinoma,63,Positive,NOT HISPANIC OR LATINO,4/19/12,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2011,YES,1,NA,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Left,Positive,WHITE,NA,NO,1,30,Primary,Female
TCGA.AC.A3QP.01,TCGA.AC.A3QP.01A.11R.A22U.07,0.425157,0.388827,0.026319,0.067688201,TCGA-AC-A3QP,NO,79,22.17,DiseaseFree,22.17,LIVING,23,0.0716,MX,N1mi,Stage IIB,T2,Breast Invasive Lobular Carcinoma,184,Positive,NOT HISPANIC OR LATINO,2007/5/12,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2011,YES,1,1,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Right,Positive,WHITE,NA,NO,1,150,Primary,Female
TCGA.AC.A3QQ.01,TCGA.AC.A3QQ.01A.11R.A22K.07,0.064412,0.011878,0.043225,3.639080653,TCGA-AC-A3QQ,NO,54,24.11,DiseaseFree,24.11,LIVING,NA,0.1273,MX,N0 (i-),Stage IA,T1c,Breast Invasive Lobular Carcinoma,77,Positive,NOT HISPANIC OR LATINO,2012/3/12,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2011,YES,0,0,5,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,ILC,Close,Right,Positive,WHITE,NA,NO,1,30,Primary,Female
TCGA.AC.A3TM.01,TCGA.AC.A3TM.01A.11R.A22K.07,0.045106,0.045106,0,0,TCGA-AC-A3TM,NO,50,25.03,DiseaseFree,25.03,LIVING,37,0.1223,M0,N1mi,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,136,Positive,NOT HISPANIC OR LATINO,2008/1/12,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2011,YES,0,2,4,NA,Peri (6-12 months since last menstrual period),NA,NA,NO,ILC,Negative,Right,Positive,WHITE,NA,NO,1,160,Primary,Female
TCGA.AC.A3TN.01,TCGA.AC.A3TN.01A.11R.A22K.07,0.003661,0.003661,0,0,TCGA-AC-A3TN,NO,75,14.98,DiseaseFree,14.98,LIVING,65,0.071,MX,N0,Stage IIB,T3,Breast Invasive Lobular Carcinoma,78,Positive,NOT HISPANIC OR LATINO,2008/1/12,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2012,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Right,Positive,WHITE,NA,NO,1,140,Primary,Female
TCGA.AC.A3W5.01,TCGA.AC.A3W5.01A.11R.A22K.07,0.340134,0.340134,0,0,TCGA-AC-A3W5,NO,65,16.56,DiseaseFree,16.56,LIVING,98,0.3754,MX,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,120,Positive,NOT HISPANIC OR LATINO,9/24/12,Infiltrating Lobular Carcinoma,NA,No,Yes,NA,YES,2011,YES,0,0,3,NA,NA,NA,NA,NA,ILC,Close,Right,Positive,BLACK OR AFRICAN AMERICAN,NA,NO,1,130,Primary,Female
TCGA.AC.A3W6.01,TCGA.AC.A3W6.01A.12R.A22K.07,2.803053,2.622349,0.159096,0.06066927,TCGA-AC-A3W6,NO,90,19.78,DiseaseFree,19.78,LIVING,148,0.1051,MX,N1,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,101,Positive,NOT HISPANIC OR LATINO,9/24/12,Infiltrating Lobular Carcinoma,NA,No,Yes,Negative,YES,2012,YES,3,3,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right,Positive,WHITE,NA,NO,1,140,Primary,Female
TCGA.AC.A3W7.01,TCGA.AC.A3W7.01A.11R.A22K.07,0.988176,0.974154,0,0,TCGA-AC-A3W7,NO,66,15.47,DiseaseFree,15.47,LIVING,49,0.1454,MX,N1a,Stage IIB,T2,Breast Invasive Lobular Carcinoma,65,Positive,NOT HISPANIC OR LATINO,10/17/12,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2012,YES,1,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,NO,1,210,Primary,Female
TCGA.AC.A3YI.01,TCGA.AC.A3YI.01A.21R.A239.07,0.056707,0.056707,0,0,TCGA-AC-A3YI,NO,74,23.23,DiseaseFree,23.23,LIVING,12,0.0325,MX,N3a,Stage IIIC,T1c,Breast Invasive Lobular Carcinoma,87,Positive,NOT HISPANIC OR LATINO,2010/8/12,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2012,YES,12,NA,13,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right,Positive,WHITE,NA,NO,1,120,Primary,Female
TCGA.AC.A3YJ.01,TCGA.AC.A3YJ.01A.11R.A22U.07,0.102843,0.102843,0,0,TCGA-AC-A3YJ,NO,66,24.77,DiseaseFree,24.77,LIVING,19,0.0443,MX,N0 (i-),Stage IIA,T2,Solid Papillary Carcinoma of the Breast,114,Positive,NOT HISPANIC OR LATINO,2010/3/12,"Other, specify",NA,No,No,NA,YES,2012,YES,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,SPC,Negative,Right,Positive,WHITE,NA,NO,1,220,Primary,Female
TCGA.AC.A4ZE.01,TCGA.AC.A4ZE.01A.11R.A41B.07,0.10685,0.10685,0,0,TCGA-AC-A4ZE,NO,63,29.24,DiseaseFree,29.24,LIVING,NA,0.182,M0,N0,Stage IIB,T3,Breast Invasive Lobular Carcinoma,169,Positive,NOT HISPANIC OR LATINO,2006/9/15,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2012,YES,0,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right Lower Outer Quadrant,Positive,WHITE,NO,NO,1,180,Primary,Female
TCGA.AC.A5EH.01,TCGA.AC.A5EH.01A.11R.A28M.07,0.322115,0.322115,0,0,TCGA-AC-A5EH,NO,76,16.79,DiseaseFree,16.79,LIVING,102,0.2183,MX,N1mi,Stage IIB,T2,Breast Invasive Ductal Carcinoma,86,Positive,NOT HISPANIC OR LATINO,2007/12/13,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2012,YES,1,NA,14,NA,NA,NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,NO,1,100,Primary,Female
TCGA.AC.A5XS.01,TCGA.AC.A5XS.01A.11R.A29R.07,0.016226,0.016226,0,0,TCGA-AC-A5XS,NO,74,19.32,DiseaseFree,19.32,LIVING,357,0.2478,MX,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,127,Positive,NOT HISPANIC OR LATINO,7/15/13,Infiltrating Lobular Carcinoma,NA,No,Yes,Negative,YES,2012,YES,0,NA,8,NA,NA,NA,NA,NA,ILC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,NO,1,110,Primary,Female
TCGA.AC.A5XU.01,TCGA.AC.A5XU.01A.11R.A28M.07,0.271336,0.252508,0,0,TCGA-AC-A5XU,NO,74,14.95,DiseaseFree,14.95,LIVING,39,0.5906,MX,N0 (i-),Stage IIB,T3,Breast Invasive Ductal Carcinoma,44,Positive,NOT HISPANIC OR LATINO,7/15/13,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2013,YES,0,NA,2,NA,NA,NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NA,NO,1,150,Primary,Female
TCGA.AC.A62V.01,TCGA.AC.A62V.01A.11R.A31O.07,0.130217,0.121791,0,0,TCGA-AC-A62V,NO,58,NA,NA,11.43,DECEASED,NA,0.4895,M1,N1a,Stage IV,T2,Breast Invasive Ductal Carcinoma,38,Positive,NOT HISPANIC OR LATINO,10/21/13,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2013,YES,3,NA,17,NA,NA,NA,Bone,NA,IDC,Negative,Right Lower Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NA,NO,1,120,Primary,Male
TCGA.AC.A62X.01,TCGA.AC.A62X.01A.11R.A29R.07,0.085002,0.085002,0,0,TCGA-AC-A62X,NO,72,13.7,DiseaseFree,13.7,LIVING,46,0.5697,MX,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,70,Positive,NOT HISPANIC OR LATINO,10/21/13,Infiltrating Ductal Carcinoma,NA,No,Yes,NA,YES,2013,YES,0,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,NO,1,130,Primary,Female
TCGA.AC.A62Y.01,TCGA.AC.A62Y.01A.11R.A29R.07,0.01282,0.01282,0,0,TCGA-AC-A62Y,NO,79,17.41,DiseaseFree,17.41,LIVING,51,0.4145,MX,N1,Stage IIB,T2,Breast Invasive Lobular Carcinoma,112,Positive,NOT HISPANIC OR LATINO,9/19/13,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2012,YES,1,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Positive,Right,Positive,WHITE,NA,NO,1,50,Primary,Female
TCGA.AC.A6IV.01,TCGA.AC.A6IV.01A.12R.A33J.07,1.575383,0.37691,0,0,TCGA-AC-A6IV,NO,47,18.66,DiseaseFree,18.66,LIVING,NA,0.0215,MX,N1,Stage IIB,T2,Breast Invasive Lobular Carcinoma,289,Positive,NOT HISPANIC OR LATINO,9/19/13,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2012,YES,1,1,1,NA,NA,NA,NA,NA,ILC,Negative,Right,Positive,WHITE,NA,NO,1,110,Primary,Female
TCGA.AC.A6IX.01,TCGA.AC.A6IX.01A.12R.A32P.07,0.965504,0.794173,0.171331,0.215735111,TCGA-AC-A6IX,NO,49,12.25,DiseaseFree,12.25,LIVING,NA,0.1912,MX,N3a,Stage IIIC,T2,Breast Invasive Lobular Carcinoma,107,Positive,NOT HISPANIC OR LATINO,10/21/13,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2013,YES,19,NA,21,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,ILC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,NO,2,110,Primary,Female
TCGA.AC.A6NO.01,TCGA.AC.A6NO.01A.12R.A33J.07,0.114163,0.114163,0,0,TCGA-AC-A6NO,NO,43,1.68,DiseaseFree,1.68,LIVING,NA,0.1481,MX,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,605,Positive,NOT HISPANIC OR LATINO,2004/10/14,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2011,YES,2,NA,16,NA,NA,NA,NA,NA,IDC,Negative,Right,Positive,BLACK OR AFRICAN AMERICAN,NA,NO,1,150,Primary,Female
TCGA.AC.A7VB.01,TCGA.AC.A7VB.01A.11R.A352.07,0.063735,0.063735,0,0,TCGA-AC-A7VB,NO,51,8.21,DiseaseFree,8.21,LIVING,NA,0.2511,MX,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,131,Positive,NOT HISPANIC OR LATINO,2/26/14,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2013,YES,3,NA,15,NA,NA,NA,NA,NA,IDC,Negative,Right Lower Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,NO,1,60,Primary,Female
TCGA.AC.A8OP.01,TCGA.AC.A8OP.01A.11R.A36F.07,0.25733,0.25733,0,0,TCGA-AC-A8OP,NO,72,20.17,DiseaseFree,20.17,LIVING,NA,0.2658,MX,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,921,Positive,NOT HISPANIC OR LATINO,2/26/14,Infiltrating Ductal Carcinoma,NA,No,No,Indeterminate,YES,2011,YES,0,0,6,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Lower Inner Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NA,NO,1,80,Primary,Female
TCGA.AC.A8OQ.01,TCGA.AC.A8OQ.01A.11R.A41B.07,2.590598,2.555237,0,0,TCGA-AC-A8OQ,NO,72,1.12,DiseaseFree,1.12,LIVING,NA,0.2666,MX,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,742,Negative,NOT HISPANIC OR LATINO,2/26/14,Infiltrating Ductal Carcinoma,NA,No,No,Indeterminate,YES,2011,YES,1,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,NO,1,100,Primary,Female
TCGA.AC.A8OR.01,TCGA.AC.A8OR.01A.21R.A41B.07,0.021342,0.021342,0,0,TCGA-AC-A8OR,NO,75,1.31,DiseaseFree,1.31,LIVING,NA,0.0328,MX,N0 (i-),Stage IA,T1c,Breast Invasive Mixed Mucinous Carcinoma,98,Positive,NOT HISPANIC OR LATINO,2/26/14,Mucinous Carcinoma,NA,No,No,Negative,YES,2013,YES,0,0,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IMMC,Negative,Left,Positive,WHITE,NA,NO,1,120,Primary,Female
TCGA.AC.A8OS.01,TCGA.AC.A8OS.01A.12R.A41B.07,0.081649,0.081649,0,0,TCGA-AC-A8OS,NO,71,2.3,DiseaseFree,2.3,LIVING,NA,0.1344,MX,N0 (i-),Stage IIA,T2,Breast Invasive Lobular Carcinoma,106,Positive,NOT HISPANIC OR LATINO,2/26/14,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2013,YES,0,0,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,70,Primary,Female
TCGA.AN.A03X.01,TCGA.AN.A03X.01A.21R.A00Z.07,0.152415,0,0,NA,TCGA-AN-A03X,NO,74,0.33,DiseaseFree,0.33,LIVING,36,0.3072,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,36,Positive,NOT HISPANIC OR LATINO,12/28/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,NA,0,0,19,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,170,Primary,Female
TCGA.AN.A03Y.01,TCGA.AN.A03Y.01A.21R.A00Z.07,2.452407,2.388073,0.064334,0.026939712,TCGA-AN-A03Y,NO,66,0.33,DiseaseFree,0.33,LIVING,21,0.3773,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,36,Positive,NOT HISPANIC OR LATINO,12/29/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,0,0,9,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,160,Primary,Female
TCGA.AN.A041.01,TCGA.AN.A041.01A.11R.A034.07,0.034075,0.034075,0,0,TCGA-AN-A041,NO,29,0.23,DiseaseFree,0.23,LIVING,17,0.3265,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,33,Positive,NOT HISPANIC OR LATINO,2004/1/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,YES,1,NA,18,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,280,Primary,Female
TCGA.AN.A046.01,TCGA.AN.A046.01A.21R.A034.07,1.855584,1.855584,0,0,TCGA-AN-A046,NO,68,0.33,DiseaseFree,0.33,LIVING,4271,0.0264,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,27,Positive,NOT HISPANIC OR LATINO,12/28/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,0,0,19,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Lower Inner Quadrant,Positive,WHITE,NA,YES,1,150,Primary,Female
TCGA.AN.A049.01,TCGA.AN.A049.01A.21R.A00Z.07,0.593921,0.335724,0.258197,0.769075193,TCGA-AN-A049,NO,62,0.62,DiseaseFree,0.62,LIVING,27,0.3796,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,769,Positive,NOT HISPANIC OR LATINO,12/29/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,0,0,9,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Positive,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,330,Primary,Female
TCGA.AN.A04A.01,TCGA.AN.A04A.01A.21R.A034.07,0.101406,0.101406,0,0,TCGA-AN-A04A,NO,36,2.96,DiseaseFree,2.96,LIVING,17,0.5374,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,743,Positive,NOT HISPANIC OR LATINO,12/29/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,4,0,7,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,IDC,Positive,Left Lower Inner Quadrant|Left Lower Outer Quadrant,Positive,WHITE,NA,YES,1,370,Primary,Female
TCGA.AN.A04C.01,TCGA.AN.A04C.01A.21R.A034.07,0.290069,0.290069,0,0,TCGA-AN-A04C,NO,51,1.77,DiseaseFree,1.77,LIVING,62,0.339,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,656,Negative,NOT HISPANIC OR LATINO,12/29/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2008,NA,2,0,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Positive,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,190,Primary,Female
TCGA.AN.A0AJ.01,TCGA.AN.A0AJ.01A.11R.A00Z.07,0.108667,0.082856,0,0,TCGA-AN-A0AJ,NO,79,9.95,DiseaseFree,9.95,LIVING,54,0.6855,M0,N0,Stage IIB,T3,Breast Mixed Ductal and Lobular Carcinoma,63,Positive,NOT HISPANIC OR LATINO,12/20/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,NA,0,0,9,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,MDLC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,310,Primary,Female
TCGA.AN.A0AK.01,TCGA.AN.A0AK.01A.21R.A00Z.07,0.077635,0.024624,0,0,TCGA-AN-A0AK,NO,76,7.36,DiseaseFree,7.36,LIVING,908,0.2818,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,58,Positive,NOT HISPANIC OR LATINO,12/21/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,NA,0,0,11,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,290,Primary,Female
TCGA.AN.A0AM.01,TCGA.AN.A0AM.01A.11R.A034.07,0.24815,0.24815,0,0,TCGA-AN-A0AM,NO,56,0.16,DiseaseFree,0.16,LIVING,40,0.2787,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,47,Positive,NOT HISPANIC OR LATINO,12/28/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,0,0,20,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,350,Primary,Female
TCGA.AN.A0AS.01,TCGA.AN.A0AS.01A.11R.A00Z.07,0.003893,0.003893,0,0,TCGA-AN-A0AS,NO,70,0.33,DiseaseFree,0.33,LIVING,39,0.2493,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,33,Positive,NOT HISPANIC OR LATINO,12/28/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,4,0,9,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,290,Primary,Female
TCGA.AN.A0FD.01,TCGA.AN.A0FD.01A.11R.A034.07,0.241323,0.241323,0,0,TCGA-AN-A0FD,NO,71,6.44,DiseaseFree,6.44,LIVING,31,0.171,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,84,Positive,NOT HISPANIC OR LATINO,12/20/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,NA,0,0,14,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,260,Primary,Female
TCGA.AN.A0FF.01,TCGA.AN.A0FF.01A.11R.A034.07,0.383251,0.383251,0,0,TCGA-AN-A0FF,NO,32,5.65,DiseaseFree,5.65,LIVING,20,0.1509,M0,N0,Stage IA,T1b,Breast Invasive Ductal Carcinoma,75,Positive,NOT HISPANIC OR LATINO,12/27/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,0,0,14,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,300,Primary,Female
TCGA.AN.A0FJ.01,TCGA.AN.A0FJ.01A.11R.A00Z.07,0.166408,0.166408,0,0,TCGA-AN-A0FJ,NO,59,7.95,DiseaseFree,7.95,LIVING,66,0.6191,M1,N2,Stage IV,T2,Breast Invasive Ductal Carcinoma,70,Positive,NOT HISPANIC OR LATINO,12/27/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,NA,8,0,14,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,280,Primary,Female
TCGA.AN.A0FK.01,TCGA.AN.A0FK.01A.11R.A034.07,0.21772,0.21772,0,0,TCGA-AN-A0FK,NO,88,7,DiseaseFree,7,LIVING,27,0.5521,M0,N0,Stage IIIB,T4,Breast Invasive Ductal Carcinoma,69,Positive,NOT HISPANIC OR LATINO,12/20/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,NA,0,0,7,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Lower Outer Quadrant,Positive,WHITE,NA,YES,1,340,Primary,Female
TCGA.AN.A0FL.01,TCGA.AN.A0FL.01A.11R.A034.07,0,0,0,NA,TCGA-AN-A0FL,NO,62,7.59,DiseaseFree,7.59,LIVING,135,0.5381,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,69,Negative,NOT HISPANIC OR LATINO,12/28/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,NA,0,0,8,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant,Negative,WHITE,NA,YES,1,310,Primary,Female
TCGA.AN.A0FN.01,TCGA.AN.A0FN.01A.11R.A034.07,0.178972,0.178972,0,0,TCGA-AN-A0FN,NO,61,7.16,DiseaseFree,7.16,LIVING,24,4.00E-04,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,57,Positive,NOT HISPANIC OR LATINO,12/28/10,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2010,NA,0,0,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Lower Outer Quadrant,Positive,WHITE,NA,YES,1,110,Primary,Female
TCGA.AN.A0FS.01,TCGA.AN.A0FS.01A.11R.A034.07,0.057713,0.057713,0,0,TCGA-AN-A0FS,NO,55,6.9,DiseaseFree,6.9,LIVING,46,0.1049,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,44,Positive,NOT HISPANIC OR LATINO,12/20/10,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2010,NA,0,0,14,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,IDC,Negative,Right Lower Outer Quadrant,Negative,WHITE,NA,YES,1,170,Primary,Female
TCGA.AN.A0FT.01,TCGA.AN.A0FT.01A.11R.A034.07,0.023503,0.023503,0,0,TCGA-AN-A0FT,NO,63,7.03,DiseaseFree,7.03,LIVING,66,0.5805,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,44,Positive,NOT HISPANIC OR LATINO,12/28/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,NA,1,0,7,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Lower Outer Quadrant,Positive,WHITE,NA,YES,1,130,Primary,Female
TCGA.AN.A0FV.01,TCGA.AN.A0FV.01A.11R.A00Z.07,0.05284,0.05284,0,0,TCGA-AN-A0FV,NO,58,0.33,DiseaseFree,0.33,LIVING,58,0.5399,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,42,Negative,NOT HISPANIC OR LATINO,12/28/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,NA,0,0,12,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,180,Primary,Female
TCGA.AN.A0FW.01,TCGA.AN.A0FW.01A.11R.A034.07,0.122793,0.122793,0,0,TCGA-AN-A0FW,NO,67,0.36,DiseaseFree,0.36,LIVING,78,0.1949,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,41,Positive,NOT HISPANIC OR LATINO,12/28/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,2,0,14,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Indeterminate,WHITE,NA,YES,1,180,Primary,Female
TCGA.AN.A0FX.01,TCGA.AN.A0FX.01A.11R.A034.07,0.03454,0.03454,0,0,TCGA-AN-A0FX,NO,52,0.33,DiseaseFree,0.33,LIVING,120,0.5402,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,34,Negative,NOT HISPANIC OR LATINO,11/28/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,NA,0,0,12,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,230,Primary,Female
TCGA.AN.A0FY.01,TCGA.AN.A0FY.01A.11R.A034.07,0.296468,0.290244,0.006224,0.021444026,TCGA-AN-A0FY,NO,55,0.33,DiseaseFree,0.33,LIVING,51,0.35,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,34,Positive,NOT HISPANIC OR LATINO,12/29/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,0,0,11,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,170,Primary,Female
TCGA.AN.A0FZ.01,TCGA.AN.A0FZ.01A.11R.A034.07,0.01354,0.01354,0,0,TCGA-AN-A0FZ,NO,45,0.33,DiseaseFree,0.33,LIVING,35,0.4504,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,34,Positive,NOT HISPANIC OR LATINO,12/29/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,NA,1,0,14,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,230,Primary,Female
TCGA.AN.A0XL.01,TCGA.AN.A0XL.01A.11R.A10J.07,0.004494,0.004494,0,0,TCGA-AN-A0XL,NO,61,5.35,DiseaseFree,5.35,LIVING,19,0.3332,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,169,Positive,NOT HISPANIC OR LATINO,3/25/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,0,NA,14,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,130,Primary,Female
TCGA.AN.A0XN.01,TCGA.AN.A0XN.01A.21R.A109.07,1.90113,1.90113,0,0,TCGA-AN-A0XN,NO,68,0.33,DiseaseFree,0.33,LIVING,86,0.5133,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,163,Negative,NOT HISPANIC OR LATINO,3/25/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,1,NA,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Inner Quadrant,Positive,WHITE,NA,YES,1,180,Primary,Female
TCGA.AN.A0XO.01,TCGA.AN.A0XO.01A.11R.A109.07,0.027926,0.027926,0,0,TCGA-AN-A0XO,NO,59,12.32,DiseaseFree,12.32,LIVING,19,0.2092,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,163,Positive,NOT HISPANIC OR LATINO,2005/1/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,2,NA,12,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,190,Primary,Female
TCGA.AN.A0XP.01,TCGA.AN.A0XP.01A.11R.A109.07,0.078095,0.078095,0,0,TCGA-AN-A0XP,NO,69,0.3,DiseaseFree,0.3,LIVING,19,0.1617,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,162,Positive,NOT HISPANIC OR LATINO,3/25/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,YES,1,NA,19,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Inner Quadrant,Positive,WHITE,NA,YES,1,160,Primary,Female
TCGA.AN.A0XR.01,TCGA.AN.A0XR.01A.11R.A109.07,0.187026,0.187026,0,0,TCGA-AN-A0XR,NO,55,0.33,DiseaseFree,0.33,LIVING,26,0.1201,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,155,Positive,NOT HISPANIC OR LATINO,3/25/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,7,NA,14,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,130,Primary,Female
TCGA.AN.A0XS.01,TCGA.AN.A0XS.01A.22R.A109.07,2.057518,2.057518,0,0,TCGA-AN-A0XS,NO,63,0.33,DiseaseFree,0.33,LIVING,23,0.0804,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,120,Negative,NOT HISPANIC OR LATINO,3/28/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,1,NA,11,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,210,Primary,Female
TCGA.AN.A0XT.01,TCGA.AN.A0XT.01A.11R.A109.07,0.02894,0.02894,0,0,TCGA-AN-A0XT,NO,54,0.33,DiseaseFree,0.33,LIVING,7,0.3076,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,114,Positive,NOT HISPANIC OR LATINO,3/28/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,1,NA,17,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,160,Primary,Female
TCGA.AN.A0XV.01,TCGA.AN.A0XV.01A.11R.A109.07,0.207456,0.207456,0,0,TCGA-AN-A0XV,NO,67,5.32,DiseaseFree,5.32,LIVING,22,0.0851,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,121,Positive,NOT HISPANIC OR LATINO,3/29/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,YES,7,NA,16,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,100,Primary,Female
TCGA.AN.A0XW.01,TCGA.AN.A0XW.01A.11R.A109.07,0.286426,0.286426,0,0,TCGA-AN-A0XW,NO,36,5.58,DiseaseFree,5.58,LIVING,167,0.2488,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,121,Positive,NOT HISPANIC OR LATINO,3/29/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,YES,1,NA,14,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,270,Primary,Female
TCGA.AO.A03L.01,TCGA.AO.A03L.01A.41R.A056.07,1.222105,1.16014,0.043586,0.037569604,TCGA-AO-A03L,NO,34,80.22,DiseaseFree,80.22,LIVING,20,0.6527,M0,N2,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,2456,Positive,NOT HISPANIC OR LATINO,2012/7/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2003,NA,4,NA,17,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right,Positive,ASIAN,NA,YES,1,680,Primary,Female
TCGA.AO.A03M.01,TCGA.AO.A03M.01B.11R.A10J.07,1.768729,1.768729,0,0,TCGA-AO-A03M,NO,29,61.3,DiseaseFree,61.3,LIVING,551,0.163,M0,N0 (i-),Stage I,T1c,Breast Invasive Ductal Carcinoma,1414,Positive,NOT HISPANIC OR LATINO,2001/9/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,NA,0,0,2,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant|Left,Positive,WHITE,NA,YES,1,310,Primary,Female
TCGA.AO.A03N.01,TCGA.AO.A03N.01B.11R.A10J.07,0.578924,0.539801,0,0,TCGA-AO-A03N,NO,59,54.04,Recurred/Progressed,66.72,LIVING,67,0.4975,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1596,Positive,NOT HISPANIC OR LATINO,1/13/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,NA,2,NA,19,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left,Positive,WHITE,NA,YES,1,360,Primary,Female
TCGA.AO.A03O.01,TCGA.AO.A03O.01A.11R.A00Z.07,0.700224,0.700224,0,0,TCGA-AO-A03O,NO,69,NA,NA,81.57,DECEASED,54,0.3537,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,2694,Positive,NOT HISPANIC OR LATINO,9/19/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2002,NA,0,0,17,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant|Right,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,690,Primary,Female
TCGA.AO.A03P.01,TCGA.AO.A03P.01A.11R.A00Z.07,0.428638,0.428638,0,0,TCGA-AO-A03P,NO,54,63.14,Recurred/Progressed,95.63,DECEASED,36,0.4219,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,2414,Positive,NOT HISPANIC OR LATINO,9/19/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2003,NA,0,2,26,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Close,Right Upper Outer Quadrant|Right,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,370,Primary,Female
TCGA.AO.A03R.01,TCGA.AO.A03R.01A.21R.A034.07,0.113515,0.086976,0,0,TCGA-AO-A03R,NO,57,68.69,DiseaseFree,68.69,LIVING,31,0.2442,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1608,Positive,NOT HISPANIC OR LATINO,9/19/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2005,NA,3,0,26,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left,Positive,WHITE,NA,YES,1,140,Primary,Female
TCGA.AO.A03T.01,TCGA.AO.A03T.01A.21R.A034.07,0.33779,0.33779,0,0,TCGA-AO-A03T,NO,42,69.78,DiseaseFree,69.78,LIVING,68,0.2679,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1031,Positive,NOT HISPANIC OR LATINO,9/19/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,NA,2,NA,12,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant|Left,Positive,WHITE,NA,YES,1,140,Primary,Female
TCGA.AO.A03V.01,TCGA.AO.A03V.01A.11R.A115.07,0.109338,0.109338,0,0,TCGA-AO-A03V,NO,41,44.38,DiseaseFree,44.38,LIVING,46,0.3132,M0,N0 (i-),Stage I,T1c,Breast Invasive Ductal Carcinoma,670,Positive,NOT HISPANIC OR LATINO,2001/9/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,0,0,2,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant|Left,Positive,WHITE,NA,YES,1,70,Primary,Female
TCGA.AO.A0J3.01,TCGA.AO.A0J3.01A.11R.A034.07,0.127283,0.127283,0,0,TCGA-AO-A0J3,NO,67,21.39,DiseaseFree,21.39,LIVING,59,0.5363,M0,N1b,Stage IIB,T2,Breast Invasive Ductal Carcinoma,220,Positive,NOT HISPANIC OR LATINO,9/19/10,"Other, specify",NA,No,No,Equivocal,YES,2009,NA,1,0,36,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right,Positive,WHITE,NA,YES,1,1180,Primary,Female
TCGA.AO.A0J5.01,TCGA.AO.A0J5.01A.11R.A034.07,0,0,0,NA,TCGA-AO-A0J5,NO,48,NA,NA,26.02,DECEASED,43,0.1273,M1,N1a,Stage IV,T4,Breast Invasive Ductal Carcinoma,554,Positive,NOT HISPANIC OR LATINO,2012/7/10,"Other, specify",NA,Yes,No,Equivocal,YES,2008,NA,2,NA,2,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,Lung|Bone|Liver,NA,IDC,Close,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right,Negative,WHITE,NA,YES,1,500,Primary,Female
TCGA.AO.A0J7.01,TCGA.AO.A0J7.01A.11R.A034.07,0.018593,0.018593,0,0,TCGA-AO-A0J7,NO,71,20.3,DiseaseFree,20.3,LIVING,21,0.7671,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,177,Positive,NOT HISPANIC OR LATINO,9/19/10,"Other, specify",NA,No,No,Negative,YES,2009,NA,3,0,11,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left,Positive,WHITE,NA,YES,1,300,Primary,Female
TCGA.AO.A0J8.01,TCGA.AO.A0J8.01A.21R.A034.07,0.283304,0.283304,0,0,TCGA-AO-A0J8,NO,61,22.34,DiseaseFree,22.34,LIVING,17,0.1308,M0,N0 (i+),Stage IIA,T2,Breast Invasive Lobular Carcinoma,241,Positive,NOT HISPANIC OR LATINO,9/19/10,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2009,NA,0,1,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right Upper Outer Quadrant|Right,Positive,WHITE,NA,YES,1,670,Primary,Female
TCGA.AO.A0J9.01,TCGA.AO.A0J9.01A.11R.A034.07,3.23446,3.23446,0,0,TCGA-AO-A0J9,NO,61,35.02,Recurred/Progressed,52.99,LIVING,74,0.3623,M0,N3,Stage IIIC,T2,Breast Invasive Lobular Carcinoma,1207,Positive,NOT HISPANIC OR LATINO,9/19/10,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2007,NA,15,0,32,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Positive,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right,Positive,WHITE,NA,YES,1,430,Primary,Female
TCGA.AO.A0JA.01,TCGA.AO.A0JA.01A.11R.A056.07,0.372622,0.32254,0.050082,0.155273764,TCGA-AO-A0JA,NO,36,4.7,Recurred/Progressed,21.52,LIVING,24,0.3029,M0,N3,Stage IIIC,T2,Breast Invasive Ductal Carcinoma,258,Positive,NOT HISPANIC OR LATINO,9/19/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,11,NA,11,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,100,Primary,Female
TCGA.AO.A0JB.01,TCGA.AO.A0JB.01A.11R.A32Y.07,0.359887,0.359887,0,0,TCGA-AO-A0JB,NO,50,50.66,DiseaseFree,50.66,LIVING,66,0.4249,M0,N1a,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,1178,Positive,NOT HISPANIC OR LATINO,9/19/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,NA,1,0,14,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left,Positive,WHITE,NA,YES,1,510,Primary,Female
TCGA.AO.A0JC.01,TCGA.AO.A0JC.01A.11R.A056.07,0.739846,0.739846,0,0,TCGA-AO-A0JC,NO,64,50.82,DiseaseFree,50.82,LIVING,7,1.00E-04,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,1522,Positive,NOT HISPANIC OR LATINO,9/20/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,NA,0,0,12,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant|Right Lower Outer Quadrant|Right,Positive,WHITE,NA,YES,1,550,Primary,Female
TCGA.AO.A0JD.01,TCGA.AO.A0JD.01A.11R.A056.07,0.434554,0.419119,0,0,TCGA-AO-A0JD,NO,59,71.94,DiseaseFree,71.94,LIVING,82,0.3929,M0,N1a,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,1863,Positive,NOT HISPANIC OR LATINO,9/20/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2005,NA,3,0,27,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant|Left,Positive,WHITE,NA,YES,1,230,Primary,Female
TCGA.AO.A0JE.01,TCGA.AO.A0JE.01A.11R.A056.07,1.757819,1.742457,0,0,TCGA-AO-A0JE,NO,53,76.71,DiseaseFree,76.71,LIVING,29,0.3619,M0,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,1910,Negative,NOT HISPANIC OR LATINO,9/20/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2005,NA,8,0,29,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Positive,Right Lower Outer Quadrant|Right,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,550,Primary,Female
TCGA.AO.A0JF.01,TCGA.AO.A0JF.01A.11R.A056.07,0.064914,0.064914,0,0,TCGA-AO-A0JF,NO,68,65.05,DiseaseFree,65.05,LIVING,22,0.0531,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,273,Positive,NOT HISPANIC OR LATINO,9/20/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,2,0,14,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant|Left,Positive,WHITE,NA,YES,1,410,Primary,Female
TCGA.AO.A0JG.01,TCGA.AO.A0JG.01A.31R.A084.07,0.463847,0.463847,0,0,TCGA-AO-A0JG,NO,49,26.22,DiseaseFree,26.22,LIVING,NA,0.2284,M0,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,395,Positive,NOT HISPANIC OR LATINO,9/20/10,"Other, specify",NA,No,No,Negative,YES,2009,NA,4,0,19,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Close,Right Lower Outer Quadrant|Right,Positive,WHITE,NA,YES,1,410,Primary,Female
TCGA.AO.A0JI.01,TCGA.AO.A0JI.01A.21R.A056.07,0.066926,0.066926,0,0,TCGA-AO-A0JI,NO,56,50.2,DiseaseFree,50.2,LIVING,14,0.2489,M0,N1,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,1011,Positive,NOT HISPANIC OR LATINO,2012/7/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,NA,0,1,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant|Left,Negative,WHITE,NA,YES,1,330,Primary,Female
TCGA.AO.A0JJ.01,TCGA.AO.A0JJ.01A.11R.A056.07,0.674583,0.595977,0,0,TCGA-AO-A0JJ,NO,54,61.99,DiseaseFree,61.99,LIVING,11,0.1567,M0,N1a,Stage IIB,T2,Breast Invasive Lobular Carcinoma,1477,Positive,NOT HISPANIC OR LATINO,9/20/10,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2006,NA,2,NA,44,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left Upper Outer Quadrant|Left,Positive,WHITE,NA,YES,1,260,Primary,Female
TCGA.AO.A0JL.01,TCGA.AO.A0JL.01A.11R.A056.07,0.022252,0.022252,0,0,TCGA-AO-A0JL,NO,59,55.29,DiseaseFree,55.29,LIVING,48,0.631,M0,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,1332,Negative,NOT HISPANIC OR LATINO,9/20/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,NA,7,NA,26,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left,Negative,WHITE,NA,YES,1,380,Primary,Female
TCGA.AO.A0JM.01,TCGA.AO.A0JM.01A.21R.A056.07,1.017328,0.40749,0,0,TCGA-AO-A0JM,NO,40,71.75,DiseaseFree,71.75,LIVING,25,0.3307,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1828,Positive,HISPANIC OR LATINO,9/20/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2005,NA,2,NA,23,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right,Positive,NA,NA,YES,1,710,Primary,Female
TCGA.AO.A125.01,TCGA.AO.A125.01A.11R.A10J.07,0.062245,0.037253,0,0,TCGA-AO-A125,NO,72,113.53,DiseaseFree,113.53,LIVING,31,0.1154,M0,N0 (i-),Stage IIA,T2,Solid Papillary Carcinoma of the Breast,3193,Positive,NOT HISPANIC OR LATINO,2012/7/10,"Other, specify",NA,No,No,Negative,YES,2002,NA,0,0,5,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,SPC,Negative,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,90,Primary,Female
TCGA.AO.A126.01,TCGA.AO.A126.01A.11R.A10J.07,0.358345,0.358345,0,0,TCGA-AO-A126,NO,39,8.77,Recurred/Progressed,108.64,LIVING,16,0.1535,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,3033,Positive,NOT HISPANIC OR LATINO,2012/7/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2002,NA,0,0,5,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right,Positive,ASIAN,NA,YES,1,450,Primary,Female
TCGA.AO.A12A.01,TCGA.AO.A12A.01A.21R.A115.07,0.117862,0.117862,0,0,TCGA-AO-A12A,NO,47,102.23,DiseaseFree,102.23,LIVING,11,0.1372,M0,N0 (i+),Stage IIA,T2,Breast Invasive Ductal Carcinoma,2793,Positive,NOT HISPANIC OR LATINO,2012/8/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2003,NA,0,1,27,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Close,Right Upper Outer Quadrant|Right,Positive,WHITE,NA,YES,1,220,Primary,Female
TCGA.AO.A12B.01,TCGA.AO.A12B.01A.11R.A10J.07,0.076975,0,0,NA,TCGA-AO-A12B,NO,63,98.19,DiseaseFree,98.19,LIVING,13,0.1121,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,2365,Positive,HISPANIC OR LATINO,2012/8/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2004,NA,0,0,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right,Positive,WHITE,NA,YES,1,570,Primary,Female
TCGA.AO.A12C.01,TCGA.AO.A12C.01A.11R.A10J.07,0.151891,0.151891,0,0,TCGA-AO-A12C,NO,42,77.92,DiseaseFree,77.92,LIVING,NA,NA,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,2086,Positive,NOT HISPANIC OR LATINO,2012/8/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2005,NA,2,NA,31,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Positive,Left Upper Outer Quadrant|Left,Positive,WHITE,NA,YES,1,350,Primary,Female
TCGA.AO.A12D.01,TCGA.AO.A12D.01A.11R.A115.07,0.766057,0.766057,0,0,TCGA-AO-A12D,NO,43,82.62,DiseaseFree,82.62,LIVING,24,0.325,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,1948,Negative,NOT HISPANIC OR LATINO,2012/8/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2005,NA,1,0,16,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant|Left,Negative,WHITE,NA,YES,1,750,Primary,Female
TCGA.AO.A12E.01,TCGA.AO.A12E.01A.11R.A10J.07,0.069717,0.069717,0,0,TCGA-AO-A12E,NO,51,70.37,DiseaseFree,70.37,LIVING,314,0.4013,M0,N0 (i+),Stage IIB,T3,Breast Invasive Lobular Carcinoma,1822,Positive,NOT HISPANIC OR LATINO,2012/8/10,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2005,NA,0,1,13,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,ILC,Negative,Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right,Positive,WHITE,NA,YES,1,630,Primary,Female
TCGA.AO.A12G.01,TCGA.AO.A12G.01A.11R.A10J.07,0.053972,0.053972,0,0,TCGA-AO-A12G,NO,75,53.84,DiseaseFree,53.84,LIVING,27,0.2741,M0,N0 (i+),Stage IIA,T2,Breast Invasive Ductal Carcinoma,1415,Positive,NOT HISPANIC OR LATINO,2012/8/10,"Other, specify",NA,No,No,Positive,YES,2006,NA,0,1,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant|Right,Positive,WHITE,NA,YES,1,280,Primary,Female
TCGA.AO.A12H.01,TCGA.AO.A12H.01A.11R.A115.07,0.016545,0.016545,0,0,TCGA-AO-A12H,NO,69,40.54,DiseaseFree,40.54,LIVING,16,0,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,1017,Positive,NOT HISPANIC OR LATINO,2012/8/10,"Other, specify",NA,No,No,Negative,YES,2008,NA,0,0,10,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant|Right,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,290,Primary,Female
TCGA.AO.A1KO.01,TCGA.AO.A1KO.01A.31R.A13Q.07,0.141785,0.141785,0,0,TCGA-AO-A1KO,NO,46,20.43,DiseaseFree,20.43,LIVING,25,0,M0,N0 (i+),Stage IIB,T3,Breast Invasive Lobular Carcinoma,832,Positive,NOT HISPANIC OR LATINO,2004/1/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2008,YES,0,1,19,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,ILC,Negative,Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left,Positive,WHITE,NA,YES,1,580,Primary,Female
TCGA.AO.A1KP.01,TCGA.AO.A1KP.01A.11R.A13Q.07,0.071044,0.071044,0,0,TCGA-AO-A1KP,NO,77,97.01,DiseaseFree,97.01,LIVING,14,0.1817,M0,N1,Stage IIA,T1,Breast Invasive Ductal Carcinoma,2604,Positive,NOT HISPANIC OR LATINO,2004/1/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2003,YES,0,1,9,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left,Positive,WHITE,NA,YES,1,360,Primary,Female
TCGA.AO.A1KQ.01,TCGA.AO.A1KQ.01A.11R.A13Q.07,0.310031,0.310031,0,0,TCGA-AO-A1KQ,NO,84,61.83,DiseaseFree,61.83,LIVING,NA,0.5026,M0,N1,Stage IIIB,T4,Breast Invasive Ductal Carcinoma,1553,Positive,NOT HISPANIC OR LATINO,2004/1/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,YES,2,0,9,NA,NA,NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left,Positive,WHITE,NA,YES,1,540,Primary,Male
TCGA.AO.A1KS.01,TCGA.AO.A1KS.01A.11R.A13Q.07,0.372276,0.372276,0,0,TCGA-AO-A1KS,NO,69,11.5,DiseaseFree,11.5,LIVING,29,0.4859,M0,N0 (i-),Stage IIA,T2,Breast Invasive Lobular Carcinoma,147,Positive,NOT HISPANIC OR LATINO,2004/1/11,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2010,YES,0,0,5,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left,Positive,WHITE,NA,YES,1,420,Primary,Female
TCGA.AO.A1KT.01,TCGA.AO.A1KT.01A.11R.A13Q.07,0.087827,0.087827,0,0,TCGA-AO-A1KT,NO,78,17.77,DiseaseFree,17.77,LIVING,26,0.3513,M0,N1,Stage IIA,T1,Breast Invasive Ductal Carcinoma,617,Positive,NOT HISPANIC OR LATINO,2004/1/11,Infiltrating Ductal Carcinoma,NA,No,NA,Equivocal,YES,2009,YES,1,1,5,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant|Left,Positive,WHITE,NA,YES,1,200,Primary,Female
TCGA.AQ.A04H.01,TCGA.AQ.A04H.01B.11R.A10J.07,0.142047,0.070518,0,0,TCGA-AQ-A04H,NO,61,24.77,DiseaseFree,24.77,LIVING,51,0.4203,MX,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,365,Positive,NOT HISPANIC OR LATINO,12/15/10,Infiltrating Ductal Carcinoma,NA,No,No,Indeterminate,YES,2009,NA,4,NA,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Inner Quadrant,Positive,WHITE,NA,YES,1,100,Primary,Female
TCGA.AQ.A04L.01,TCGA.AQ.A04L.01B.21R.A10J.07,0.01575,0.01575,0,0,TCGA-AQ-A04L,NO,48,129.99,DiseaseFree,129.99,LIVING,33,0.5876,MX,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,3403,Positive,NOT HISPANIC OR LATINO,12/15/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2001,NA,0,NA,2,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,IDC,Negative,Right,Negative,WHITE,NA,YES,1,160,Primary,Female
TCGA.AQ.A0Y5.01,TCGA.AQ.A0Y5.01A.11R.A14M.07,0.009281,0.009281,0,0,TCGA-AQ-A0Y5,NO,70,NA,NA,5.65,DECEASED,35,0.4961,MX,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,212,Positive,NOT HISPANIC OR LATINO,2004/7/11,Infiltrating Ductal Carcinoma,NA,Yes,Yes,Positive,YES,2010,YES,5,NA,17,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right,Positive,WHITE,NA,NO,1,160,Primary,Female
TCGA.AQ.A1H2.01,TCGA.AQ.A1H2.01A.11R.A13Q.07,0.145708,0.145708,0,0,TCGA-AQ-A1H2,NO,84,15.6,DiseaseFree,15.6,LIVING,23,0.3295,MX,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,156,Positive,NOT HISPANIC OR LATINO,4/20/11,Infiltrating Ductal Carcinoma,NA,No,No,Indeterminate,YES,2010,YES,13,NA,19,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,210,Primary,Female
TCGA.AQ.A1H3.01,TCGA.AQ.A1H3.01A.31R.A13Q.07,0.025095,0.025095,0,0,TCGA-AQ-A1H3,NO,49,32.49,DiseaseFree,32.49,LIVING,18,0.2038,MX,N3a,Stage IIIC,T2,Breast Invasive Ductal Carcinoma,94,Positive,NOT HISPANIC OR LATINO,4/20/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,14,NA,23,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,300,Primary,Female
TCGA.AQ.A54O.01,TCGA.AQ.A54O.01A.11R.A266.07,0.43959,0.43959,0,0,TCGA-AQ-A54O,NO,51,32.88,DiseaseFree,32.88,LIVING,22,0.4149,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,617,Positive,NOT HISPANIC OR LATINO,2/26/13,Infiltrating Ductal Carcinoma,NA,No,Yes,Negative,YES,2011,YES,0,0,14,NA,NA,NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NO,NO,1,360,Primary,Male
TCGA.AQ.A7U7.01,TCGA.AQ.A7U7.01A.22R.A352.07,5.525666,5.316239,0,0,TCGA-AQ-A7U7,NO,55,NA,NA,19.19,DECEASED,NA,0.2481,M0,N2a,Stage IIIA,T2,Breast Invasive Lobular Carcinoma,223,Positive,NOT HISPANIC OR LATINO,12/18/13,Infiltrating Lobular Carcinoma,NA,No,Yes,Negative,YES,2013,YES,4,0,14,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left,Positive,WHITE,YES,NO,1,NA,Primary,Female
TCGA.AR.A0TP.01,TCGA.AR.A0TP.01A.11R.A084.07,0.171615,0.067934,0,0,TCGA-AR-A0TP,NO,43,140.44,DiseaseFree,140.44,LIVING,NA,0.5144,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,2512,Positive,NOT HISPANIC OR LATINO,2/25/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2003,NA,0,0,5,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant,Negative,WHITE,NA,YES,1,650,Primary,Female
TCGA.AR.A0TQ.01,TCGA.AR.A0TQ.01A.11R.A084.07,0.191925,0.191925,0,0,TCGA-AR-A0TQ,NO,27,98.26,DiseaseFree,98.26,LIVING,NA,0.1275,M0,N1,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,1512,Positive,NOT HISPANIC OR LATINO,2003/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2006,NA,2,NA,15,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,750,Primary,Female
TCGA.AR.A0TR.01,TCGA.AR.A0TR.01A.11R.A084.07,0.164188,0.073911,0,0,TCGA-AR-A0TR,NO,68,NA,NA,5.26,DECEASED,NA,0.6024,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1535,Positive,NOT HISPANIC OR LATINO,2003/8/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2006,NA,1,NA,27,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Positive,WHITE,NA,YES,1,520,Primary,Female
TCGA.AR.A0TT.01,TCGA.AR.A0TT.01A.31R.A084.07,0.76308,0.76308,0,0,TCGA-AR-A0TT,NO,53,108.94,DiseaseFree,108.94,LIVING,NA,0.3875,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,1567,Positive,NA,2003/8/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,NA,5,NA,19,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,310,Primary,Female
TCGA.AR.A0TV.01,TCGA.AR.A0TV.01A.21R.A084.07,0.044055,0.044055,0,0,TCGA-AR-A0TV,NO,66,75.16,DiseaseFree,75.16,LIVING,NA,0.3859,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,1716,Positive,NA,2003/10/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2005,NA,0,NA,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,NA,NA,YES,1,550,Primary,Female
TCGA.AR.A0TW.01,TCGA.AR.A0TW.01A.11R.A084.07,0.207121,0.207121,0,0,TCGA-AR-A0TW,NO,50,24.28,Recurred/Progressed,98.85,LIVING,NA,0.4849,M0,N1,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,1888,Positive,NOT HISPANIC OR LATINO,2003/10/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2005,NA,3,NA,27,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant|Right Lower Outer Quadrant,Positive,WHITE,NA,YES,1,760,Primary,Female
TCGA.AR.A0TX.01,TCGA.AR.A0TX.01A.11R.A084.07,0.901177,0.87442,0,0,TCGA-AR-A0TX,NO,64,64.78,DiseaseFree,64.78,LIVING,216,0.2237,M0,N1,Stage IIA,T1,Breast Invasive Ductal Carcinoma,1976,Positive,NA,2003/10/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2005,NA,3,NA,25,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,NA,NA,YES,1,470,Primary,Female
TCGA.AR.A0TY.01,TCGA.AR.A0TY.01A.12R.A115.07,0.023666,0.023666,0,0,TCGA-AR-A0TY,NO,54,17.87,Recurred/Progressed,55.81,DECEASED,94,0.3607,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,2141,Positive,NOT HISPANIC OR LATINO,2003/10/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2004,NA,0,NA,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,410,Primary,Female
TCGA.AR.A0TZ.01,TCGA.AR.A0TZ.01A.12R.A084.07,1.136394,1.079565,0,0,TCGA-AR-A0TZ,NO,43,43.13,Recurred/Progressed,107.16,DECEASED,NA,0.8185,M1,N2,NA,T2,Breast Invasive Ductal Carcinoma,2239,Positive,NOT HISPANIC OR LATINO,2003/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2004,NA,6,NA,30,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,Bone,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,290,Primary,Female
TCGA.AR.A0U0.01,TCGA.AR.A0U0.01A.11R.A109.07,0.132024,0.132024,0,0,TCGA-AR-A0U0,NO,73,65.31,DiseaseFree,65.31,LIVING,39,0.4875,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,2289,Negative,NA,2003/7/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2004,NA,0,2,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Inner Quadrant,Negative,WHITE,NA,YES,1,370,Primary,Female
TCGA.AR.A0U2.01,TCGA.AR.A0U2.01A.11R.A109.07,0.242714,0.242714,0,0,TCGA-AR-A0U2,NO,47,52.86,Recurred/Progressed,83.8,DECEASED,44,0.6621,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,2395,Positive,NOT HISPANIC OR LATINO,2/24/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2004,NA,4,0,16,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,Bone|Liver,NA,IDC,Negative,Left Lower Outer Quadrant,Positive,WHITE,NA,YES,1,150,Primary,Female
TCGA.AR.A0U3.01,TCGA.AR.A0U3.01A.11R.A109.07,0.292475,0.134354,0,0,TCGA-AR-A0U3,NO,59,134.03,DiseaseFree,134.03,LIVING,26,0.5081,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,2413,Positive,HISPANIC OR LATINO,2/25/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2004,NA,1,NA,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,270,Primary,Female
TCGA.AR.A1AH.01,TCGA.AR.A1AH.01A.11R.A12D.07,0.494709,0.494709,0,0,TCGA-AR-A1AH,NO,51,37.32,Recurred/Progressed,125.07,LIVING,57,0.9025,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,2368,Positive,NOT HISPANIC OR LATINO,6/13/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2004,YES,1,NA,9,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant,Negative,WHITE,NA,YES,1,140,Primary,Female
TCGA.AR.A1AJ.01,TCGA.AR.A1AJ.01A.21R.A12P.07,3.919528,3.861686,0,0,TCGA-AR-A1AJ,NO,83,100.92,DiseaseFree,100.92,LIVING,21,0.0657,M0,N0,Stage I,T1,Breast Invasive Ductal Carcinoma,1828,Positive,NOT HISPANIC OR LATINO,6/13/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2005,YES,0,NA,8,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Negative,WHITE,NA,YES,1,280,Primary,Female
TCGA.AR.A1AK.01,TCGA.AR.A1AK.01A.21R.A12P.07,0.552821,0.552821,0,0,TCGA-AR-A1AK,NO,70,103.78,DiseaseFree,103.78,LIVING,46,0.2941,M0,N0,Stage I,T1,Breast Invasive Lobular Carcinoma,1744,Positive,NOT HISPANIC OR LATINO,6/15/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2006,YES,0,NA,5,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right,Positive,WHITE,NA,YES,1,490,Primary,Female
TCGA.AR.A1AL.01,TCGA.AR.A1AL.01A.21R.A12P.07,0.492616,0.444159,0,0,TCGA-AR-A1AL,NO,60,97.6,DiseaseFree,97.6,LIVING,19,0.0817,M0,N1,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,1528,Positive,NOT HISPANIC OR LATINO,6/15/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2006,YES,3,NA,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,630,Primary,Female
TCGA.AR.A1AM.01,TCGA.AR.A1AM.01A.41R.A22K.07,0.202614,0.202614,0,0,TCGA-AR-A1AM,NO,52,98.26,DiseaseFree,98.26,LIVING,20,0.1216,M0,N1,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,1506,Positive,NOT HISPANIC OR LATINO,11/20/12,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2006,YES,1,NA,12,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NO,YES,1,290,Primary,Female
TCGA.AR.A1AN.01,TCGA.AR.A1AN.01A.11R.A12P.07,0.051417,0.051417,0,0,TCGA-AR-A1AN,NO,46,95.93,DiseaseFree,95.93,LIVING,14,0.3367,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,1463,Positive,HISPANIC OR LATINO,6/14/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,YES,0,NA,5,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,70,Primary,Female
TCGA.AR.A1AO.01,TCGA.AR.A1AO.01A.11R.A12P.07,1.041603,1.041603,0,0,TCGA-AR-A1AO,NO,47,86.01,DiseaseFree,86.01,LIVING,4,2.00E-04,M0,N1,Stage IIA,T1,Breast Invasive Ductal Carcinoma,1471,Positive,NOT HISPANIC OR LATINO,6/13/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,YES,2,NA,39,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant,Negative,WHITE,NA,YES,1,200,Primary,Female
TCGA.AR.A1AP.01,TCGA.AR.A1AP.01A.11R.A12P.07,0.316186,0.276609,0,0,TCGA-AR-A1AP,NO,80,93.82,DiseaseFree,93.82,LIVING,28,0.2882,M0,N0,Stage I,T1,Breast Invasive Ductal Carcinoma,1450,Positive,NOT HISPANIC OR LATINO,6/13/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2007,YES,0,NA,1,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Positive,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,310,Primary,Female
TCGA.AR.A1AS.01,TCGA.AR.A1AS.01A.11R.A12P.07,0.036171,0.036171,0,0,TCGA-AR-A1AS,NO,54,37.78,DiseaseFree,37.78,LIVING,28,0.1378,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1331,Positive,NA,6/14/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,YES,1,NA,17,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant,Positive,ASIAN,NA,YES,1,300,Primary,Female
TCGA.AR.A1AT.01,TCGA.AR.A1AT.01A.11R.A12P.07,0.469759,0.267233,0,0,TCGA-AR-A1AT,NO,62,NA,NA,41.79,DECEASED,21,NA,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,1339,Positive,NOT HISPANIC OR LATINO,6/14/11,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2007,YES,1,NA,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,250,Primary,Female
TCGA.AR.A1AU.01,TCGA.AR.A1AU.01A.11R.A12P.07,0.220368,0.220368,0,0,TCGA-AR-A1AU,NO,39,94.22,DiseaseFree,94.22,LIVING,14,0.2156,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,1317,Positive,NOT HISPANIC OR LATINO,6/14/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2007,YES,4,NA,37,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,260,Primary,Female
TCGA.AR.A1AV.01,TCGA.AR.A1AV.01A.21R.A12P.07,0.021188,0.021188,0,0,TCGA-AR-A1AV,NO,68,61.24,DiseaseFree,61.24,LIVING,32,0.189,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1233,Positive,HISPANIC OR LATINO,6/14/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,YES,1,NA,25,NA,NA,NA,NA,NA,IDC,Negative,Left,Positive,WHITE,NA,YES,1,420,Primary,Male
TCGA.AR.A1AW.01,TCGA.AR.A1AW.01A.21R.A12P.07,0.247537,0.247537,0,0,TCGA-AR-A1AW,NO,65,86.47,DiseaseFree,86.47,LIVING,14,0.1214,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,1157,Positive,NOT HISPANIC OR LATINO,6/14/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2007,YES,0,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,YES,1,800,Primary,Female
TCGA.AR.A1AX.01,TCGA.AR.A1AX.01A.11R.A12P.07,0.194285,0.194285,0,0,TCGA-AR-A1AX,NO,64,86.37,DiseaseFree,86.37,LIVING,12,0.0366,M0,N0,Stage I,T1,Breast Invasive Ductal Carcinoma,1140,Positive,NOT HISPANIC OR LATINO,6/14/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2007,YES,0,NA,8,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,340,Primary,Female
TCGA.AR.A24H.01,TCGA.AR.A24H.01A.11R.A169.07,2.780072,0.924361,0.040462,0.043772942,TCGA-AR-A24H,NO,65,160.78,DiseaseFree,160.78,LIVING,96,0.4579,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,3641,Positive,NOT HISPANIC OR LATINO,8/29/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2001,YES,0,NA,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right Lower Inner Quadrant|Right Lower Outer Quadrant,Positive,WHITE,NA,YES,1,40,Primary,Female
TCGA.AR.A24K.01,TCGA.AR.A24K.01A.11R.A169.07,0.073464,0.073464,0,0,TCGA-AR-A24K,NO,46,50.85,DiseaseFree,50.85,LIVING,22,0.2005,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,2325,Positive,NA,2008/12/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2004,YES,0,NA,2,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,200,Primary,Female
TCGA.AR.A24L.01,TCGA.AR.A24L.01A.11R.A169.07,0.242473,0.184461,0,0,TCGA-AR-A24L,NO,26,46.45,Recurred/Progressed,94.15,DECEASED,35,0.3426,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,2275,Positive,NOT HISPANIC OR LATINO,2008/12/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2005,YES,2,NA,12,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right,Positive,WHITE,NA,YES,1,1250,Primary,Female
TCGA.AR.A24M.01,TCGA.AR.A24M.01A.11R.A169.07,0.04871,0.04871,0,0,TCGA-AR-A24M,NO,38,120.24,DiseaseFree,120.24,LIVING,13,0.1579,M0,N2,Stage IIIA,T2,Breast Mixed Ductal and Lobular Carcinoma,2245,Positive,NOT HISPANIC OR LATINO,2008/12/11,Mixed Histology (please specify),Mixed invasive ductal and invasive lobular,No,No,Negative,YES,2005,YES,4,NA,28,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,MDLC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,400,Primary,Female
TCGA.AR.A24N.01,TCGA.AR.A24N.01A.11R.A169.07,0.077753,0.077753,0,0,TCGA-AR-A24N,NO,54,99.7,DiseaseFree,99.7,LIVING,22,0.1106,M0,N0,Stage I,T1,Breast Invasive Ductal Carcinoma,2219,Positive,NOT HISPANIC OR LATINO,8/16/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2005,YES,0,NA,4,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,YES,1,310,Primary,Female
TCGA.AR.A24O.01,TCGA.AR.A24O.01A.11R.A169.07,0.109186,0.109186,0,0,TCGA-AR-A24O,NO,43,84.13,Recurred/Progressed,118.5,LIVING,14,0.0332,M0,N2,Stage IIIA,T3,Breast Mixed Ductal and Lobular Carcinoma,2213,Positive,NOT HISPANIC OR LATINO,8/16/11,Mixed Histology (please specify),Lobular carcinoma with ductal features,No,No,Negative,YES,2005,YES,7,NA,19,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,MDLC,Positive,Left,Positive,WHITE,NA,YES,1,700,Primary,Female
TCGA.AR.A24P.01,TCGA.AR.A24P.01A.11R.A169.07,0.082897,0.082897,0,0,TCGA-AR-A24P,NO,47,2.76,DiseaseFree,2.76,LIVING,19,0.1587,M0,N0,Stage I,T1,Breast Invasive Ductal Carcinoma,2161,Positive,NOT HISPANIC OR LATINO,8/16/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2005,YES,0,NA,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,130,Primary,Female
TCGA.AR.A24Q.01,TCGA.AR.A24Q.01A.12R.A169.07,0.543765,0.543765,0,0,TCGA-AR-A24Q,NO,49,104.2,DiseaseFree,104.2,LIVING,103,0.664,M0,N0,Stage IIB,T3,Breast Invasive Ductal Carcinoma,1932,Positive,NA,8/30/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant,Negative,WHITE,NA,YES,1,590,Primary,Female
TCGA.AR.A24R.01,TCGA.AR.A24R.01A.11R.A169.07,0.390692,0.313935,0,0,TCGA-AR-A24R,NO,45,112.68,DiseaseFree,112.68,LIVING,18,0.3412,M0,N2,Stage IIIA,T1,Breast Invasive Ductal Carcinoma,1913,Positive,NOT HISPANIC OR LATINO,8/26/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,YES,6,NA,28,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,300,Primary,Female
TCGA.AR.A24S.01,TCGA.AR.A24S.01A.11R.A169.07,1.620883,1.463029,0,0,TCGA-AR-A24S,NO,61,97.77,DiseaseFree,97.77,LIVING,29,0.3411,M0,N0,Stage I,T1,Breast Invasive Ductal Carcinoma,1812,Positive,NOT HISPANIC OR LATINO,8/30/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,YES,0,NA,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Lower Outer Quadrant,Positive,WHITE,NA,YES,1,520,Primary,Female
TCGA.AR.A24T.01,TCGA.AR.A24T.01A.11R.A169.07,0.081604,0.081604,0,0,TCGA-AR-A24T,NO,46,105.19,DiseaseFree,105.19,LIVING,19,0.2168,M0,N3,Stage IIIC,T3,Breast Invasive Lobular Carcinoma,1786,Positive,NOT HISPANIC OR LATINO,8/30/11,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2006,YES,15,NA,17,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,ILC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,490,Primary,Female
TCGA.AR.A24U.01,TCGA.AR.A24U.01A.11R.A169.07,3.982421,3.697636,0.241553,0.065326333,TCGA-AR-A24U,NO,47,102.76,DiseaseFree,102.76,LIVING,13,0.1646,M0,N1,Stage IIA,T1,Breast Invasive Ductal Carcinoma,1763,Negative,NOT HISPANIC OR LATINO,8/26/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2006,YES,2,NA,25,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Positive,Left Upper Outer Quadrant|Left Lower Outer Quadrant,Negative,WHITE,NA,YES,1,320,Primary,Female
TCGA.AR.A24V.01,TCGA.AR.A24V.01A.21R.A169.07,1.211499,1.161993,0.049506,0.042604387,TCGA-AR-A24V,NO,52,105.22,DiseaseFree,105.22,LIVING,16,0.2671,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1720,Positive,NOT HISPANIC OR LATINO,8/29/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,YES,1,NA,2,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,400,Primary,Female
TCGA.AR.A24W.01,TCGA.AR.A24W.01A.11R.A169.07,0.027237,0.027237,0,0,TCGA-AR-A24W,NO,55,50.92,DiseaseFree,50.92,LIVING,6,0.1024,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1720,Positive,NA,2011/10/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,YES,3,NA,22,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Lower Inner Quadrant,Positive,WHITE,NA,YES,1,110,Primary,Female
TCGA.AR.A24X.01,TCGA.AR.A24X.01A.11R.A169.07,0.069188,0.069188,0,0,TCGA-AR-A24X,NO,52,98.69,DiseaseFree,98.69,LIVING,19,0.0713,M0,N0,Stage IIA,T2,Breast Mixed Ductal and Lobular Carcinoma,1717,Positive,NA,8/30/11,Mixed Histology (please specify),Mixed invasive ductal and invasive lobular,No,No,Equivocal,YES,2006,YES,0,NA,7,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,MDLC,Negative,Right Upper Inner Quadrant,Positive,WHITE,NA,YES,1,210,Primary,Female
TCGA.AR.A24Z.01,TCGA.AR.A24Z.01A.11R.A169.07,0.166996,0.147054,0,0,TCGA-AR-A24Z,NO,57,98.59,DiseaseFree,98.59,LIVING,26,0.5036,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,1673,Positive,NA,8/30/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,YES,0,NA,8,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,120,Primary,Female
TCGA.AR.A250.01,TCGA.AR.A250.01A.31R.A169.07,1.790675,1.790675,0,0,TCGA-AR-A250,NO,58,88.93,DiseaseFree,88.93,LIVING,51,0.3845,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,1629,Positive,NOT HISPANIC OR LATINO,8/30/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2006,YES,0,NA,4,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Positive,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,300,Primary,Female
TCGA.AR.A251.01,TCGA.AR.A251.01A.12R.A169.07,0.44576,0.398142,0.047618,0.119600545,TCGA-AR-A251,NO,51,99.54,DiseaseFree,99.54,LIVING,119,0.6718,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,1611,Positive,NOT HISPANIC OR LATINO,8/30/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2006,YES,4,NA,7,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Positive,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,450,Primary,Female
TCGA.AR.A252.01,TCGA.AR.A252.01A.11R.A169.07,0.556669,0.556669,0,0,TCGA-AR-A252,NO,50,93.23,DiseaseFree,93.23,LIVING,7,0.0162,M0,N0,Stage I,T1,Breast Invasive Ductal Carcinoma,1405,Positive,NOT HISPANIC OR LATINO,8/30/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,YES,0,NA,4,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant|Left Lower Outer Quadrant,Positive,WHITE,NA,YES,1,480,Primary,Female
TCGA.AR.A254.01,TCGA.AR.A254.01A.21R.A169.07,0.106356,0.046198,0,0,TCGA-AR-A254,NO,50,85.58,DiseaseFree,85.58,LIVING,24,0.2369,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,1381,Positive,NOT HISPANIC OR LATINO,8/31/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2007,YES,9,NA,30,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant|Left Lower Inner Quadrant,Positive,WHITE,NA,YES,1,990,Primary,Female
TCGA.AR.A255.01,TCGA.AR.A255.01A.11R.A169.07,3.573362,3.573362,0,0,TCGA-AR-A255,NO,62,70.99,DiseaseFree,70.99,LIVING,44,0.6568,M0,N0,Stage I,T1,Breast Invasive Ductal Carcinoma,1225,Positive,NOT HISPANIC OR LATINO,8/31/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2007,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Lower Inner Quadrant,Positive,WHITE,NA,YES,1,250,Primary,Female
TCGA.AR.A2LE.01,TCGA.AR.A2LE.01A.11R.A180.07,0.007923,0,0,NA,TCGA-AR-A2LE,NO,69,138.07,Recurred/Progressed,166.29,LIVING,212,0.0725,M0,N0,Stage I,T1,Breast Invasive Lobular Carcinoma,3755,Positive,NOT HISPANIC OR LATINO,2001/12/12,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2001,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Right,Negative,WHITE,NA,YES,1,320,Primary,Female
TCGA.AR.A2LJ.01,TCGA.AR.A2LJ.01A.12R.A19W.07,0.3523,0.3523,0,0,TCGA-AR-A2LJ,NO,40,86.47,DiseaseFree,86.47,LIVING,10,0.0874,MX,N1,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,1382,Positive,NOT HISPANIC OR LATINO,2001/12/12,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2007,YES,1,NA,18,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,ILC,Negative,Left,Positive,WHITE,NA,YES,1,540,Primary,Female
TCGA.AR.A2LK.01,TCGA.AR.A2LK.01A.11R.A180.07,0.709575,0.709575,0,0,TCGA-AR-A2LK,NO,62,42.84,Recurred/Progressed,54.17,DECEASED,28,0.6563,M0,N2,Stage III,T3,Breast Invasive Lobular Carcinoma,1340,Positive,NOT HISPANIC OR LATINO,1/25/12,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2007,YES,5,NA,18,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Positive,Right Upper Outer Quadrant|Right Lower Outer Quadrant,Positive,WHITE,NA,YES,1,650,Primary,Female
TCGA.AR.A2LL.01,TCGA.AR.A2LL.01A.11R.A180.07,0.068054,0.068054,0,0,TCGA-AR-A2LL,NO,70,66.1,DiseaseFree,66.1,LIVING,25,0.3178,M0,N0,Stage IIB,T3,Breast Invasive Lobular Carcinoma,1315,Positive,NOT HISPANIC OR LATINO,2/14/12,Infiltrating Lobular Carcinoma,NA,No,Yes,Equivocal,YES,2007,YES,0,NA,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Left,Positive,WHITE,NA,YES,1,1300,Primary,Female
TCGA.AR.A2LM.01,TCGA.AR.A2LM.01A.11R.A180.07,0.153643,0.153643,0,0,TCGA-AR-A2LM,NO,49,63.57,DiseaseFree,63.57,LIVING,11,0.1,M0,N1,Stage II,T1,Breast Invasive Lobular Carcinoma,1339,Positive,NOT HISPANIC OR LATINO,2001/12/12,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2007,YES,1,NA,3,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,ILC,Negative,Right,Positive,WHITE,NA,YES,1,490,Primary,Female
TCGA.AR.A2LN.01,TCGA.AR.A2LN.01A.21R.A18M.07,0.027946,0.027946,0,0,TCGA-AR-A2LN,NO,65,38.14,DiseaseFree,38.14,LIVING,25,0.0982,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,513,Positive,NOT HISPANIC OR LATINO,2001/12/12,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2010,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,1460,Primary,Female
TCGA.AR.A2LO.01,TCGA.AR.A2LO.01A.31R.A18M.07,0.558286,0.40743,0.014618,0.035878556,TCGA-AR-A2LO,NO,46,39.36,DiseaseFree,39.36,LIVING,10,0.2232,M0,N1,Stage IIB,T2,Breast Invasive Lobular Carcinoma,486,Positive,NOT HISPANIC OR LATINO,2001/12/12,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2010,YES,1,NA,16,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,ILC,Negative,Left Lower Outer Quadrant,Positive,WHITE,NA,YES,1,1650,Primary,Female
TCGA.AR.A2LQ.01,TCGA.AR.A2LQ.01A.22R.A18M.07,0.060058,0.039134,0,0,TCGA-AR-A2LQ,NO,59,40.51,DiseaseFree,40.51,LIVING,5,0,M0,N0,Stage IIB,T3,Breast Invasive Lobular Carcinoma,449,Positive,NOT HISPANIC OR LATINO,2001/12/12,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2010,YES,0,NA,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Right Upper Inner Quadrant|Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,1270,Primary,Female
TCGA.AR.A5QM.01,TCGA.AR.A5QM.01A.11R.A27Q.07,0.117496,0.117496,0,0,TCGA-AR-A5QM,NO,62,31.8,Recurred/Progressed,73.29,LIVING,21,0.3151,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,1541,Positive,NOT HISPANIC OR LATINO,5/15/13,Infiltrating Lobular Carcinoma,NA,No,Yes,Equivocal,YES,2008,YES,0,NA,9,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,NA,Left,Positive,WHITE,YES,YES,1,350,Primary,Female
TCGA.AR.A5QN.01,TCGA.AR.A5QN.01A.12R.A28M.07,0.528593,0.477952,0,0,TCGA-AR-A5QN,NO,68,33.28,DiseaseFree,33.28,LIVING,25,0.2012,M0,N3,Stage IIIC,T2,Breast Invasive Lobular Carcinoma,328,Positive,NOT HISPANIC OR LATINO,5/15/13,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2012,YES,10,NA,19,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,NA,Left,Positive,WHITE,YES,YES,1,510,Primary,Female
TCGA.AR.A5QP.01,TCGA.AR.A5QP.01A.11R.A28M.07,0.539986,0.528161,0,0,TCGA-AR-A5QP,NO,54,38.93,DiseaseFree,38.93,LIVING,22,0.1282,M0,N1,Stage IIB,T2,Breast Invasive Lobular Carcinoma,498,Positive,NOT HISPANIC OR LATINO,5/15/13,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2011,YES,1,NA,40,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,NA,Left,Positive,WHITE,YES,YES,1,230,Primary,Female
TCGA.B6.A0I1.01,TCGA.B6.A0I1.01A.11R.A21T.07,0.450304,0.41995,0,0,TCGA-B6-A0I1,NO,73,36.79,Recurred/Progressed,77.56,DECEASED,38,0.3742,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,4248,Negative,NOT HISPANIC OR LATINO,2001/11/12,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1998,YES,0,NA,7,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,100,Primary,Female
TCGA.B6.A0I2.01,TCGA.B6.A0I2.01A.11R.A034.07,0.381953,0.381953,0,0,TCGA-B6-A0I2,NO,45,143.27,DiseaseFree,143.27,LIVING,37,0.8535,M0,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,5305,NA,NOT HISPANIC OR LATINO,2011/2/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1995,NA,0,NA,8,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,NA,Left Upper Outer Quadrant|Left,NA,WHITE,NA,YES,1,200,Primary,Female
TCGA.B6.A0I5.01,TCGA.B6.A0I5.01A.11R.A034.07,0.059252,0.059252,0,0,TCGA-B6-A0I5,NO,49,281.08,DiseaseFree,281.08,LIVING,17,0.2451,M0,N1b,Stage IIB,T2,Breast Invasive Ductal Carcinoma,7820,Positive,NOT HISPANIC OR LATINO,2011/2/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1988,NA,5,NA,13,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Negative,Right Lower Inner Quadrant,Positive,WHITE,NA,YES,1,50,Primary,Female
TCGA.B6.A0I6.01,TCGA.B6.A0I6.01A.11R.A034.07,0.006532,0.006532,0,0,TCGA-B6-A0I6,NO,49,28.22,Recurred/Progressed,32.56,DECEASED,69,NA,M0,N1,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,7362,Negative,NOT HISPANIC OR LATINO,2011/2/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1990,NA,6,NA,32,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant|Left,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,200,Primary,Female
TCGA.B6.A0I8.01,TCGA.B6.A0I8.01A.11R.A034.07,0.046634,0.008205,0,0,TCGA-B6-A0I8,NO,46,24.51,Recurred/Progressed,24.61,DECEASED,74,NA,M0,NX,Stage X,T1,Breast Invasive Ductal Carcinoma,6372,NA,NOT HISPANIC OR LATINO,2011/2/10,Infiltrating Ductal Carcinoma,NA,No,Yes,NA,YES,1992,NA,NA,NA,0,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,NA,Right Upper Inner Quadrant|Right,NA,WHITE,NA,YES,1,190,Primary,Female
TCGA.B6.A0I9.01,TCGA.B6.A0I9.01A.11R.A034.07,0.776663,0.751017,0,0,TCGA-B6-A0I9,NO,62,NA,NA,11.89,DECEASED,58,0.495,M1,NX,Stage IV,T3,Breast Invasive Ductal Carcinoma,6687,Indeterminate,NOT HISPANIC OR LATINO,2011/2/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1992,NA,NA,NA,NA,NA,Indeterminate (neither Pre or Postmenopausal),NA,Bone,NA,IDC,NA,Left Lower Outer Quadrant|Left,Positive,WHITE,NA,YES,1,180,Primary,Female
TCGA.B6.A0IA.01,TCGA.B6.A0IA.01A.11R.A034.07,0.063586,0.063586,0,0,TCGA-B6-A0IA,NO,51,275.66,DiseaseFree,275.66,LIVING,41,0.2386,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,6664,Positive,NOT HISPANIC OR LATINO,2011/2/10,"Other, specify",NA,No,No,NA,YES,1992,NA,0,NA,15,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Negative,Right,Positive,WHITE,NA,YES,1,70,Primary,Female
TCGA.B6.A0IB.01,TCGA.B6.A0IB.01A.11R.A034.07,0.10225,0.10225,0,0,TCGA-B6-A0IB,NO,64,89.26,Recurred/Progressed,129.47,DECEASED,48,0.5461,M1,N3,Stage IV,T3,Breast Invasive Ductal Carcinoma,6660,Positive,NOT HISPANIC OR LATINO,2011/2/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1992,NA,8,NA,15,NA,Indeterminate (neither Pre or Postmenopausal),Skin,"Other, specify",NA,IDC,Negative,Right Upper Inner Quadrant|Right,Positive,WHITE,NA,YES,1,150,Primary,Female
TCGA.B6.A0IC.01,TCGA.B6.A0IC.01A.11R.A034.07,0.43894,0.425144,0,0,TCGA-B6-A0IC,NO,90,NA,NA,50.66,DECEASED,35,0.0787,MX,NX,Stage X,T2,Breast Invasive Ductal Carcinoma,6475,Positive,NOT HISPANIC OR LATINO,2011/2/10,"Other, specify",NA,No,No,NA,YES,1992,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Positive,WHITE,NA,YES,1,100,Primary,Female
TCGA.B6.A0IE.01,TCGA.B6.A0IE.01A.11R.A034.07,0.083794,0.083794,0,0,TCGA-B6-A0IE,NO,38,27.4,Recurred/Progressed,65.47,DECEASED,26,0.349,M0,N1b,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,5557,Negative,NOT HISPANIC OR LATINO,2011/2/10,Mixed Histology (please specify),Lobular/Ductal,No,No,NA,YES,1995,NA,6,NA,24,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,ILC,Close,Left Upper Outer Quadrant|Left,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,90,Primary,Female
TCGA.B6.A0IG.01,TCGA.B6.A0IG.01A.11R.A034.07,0.555905,0.555905,0,0,TCGA-B6-A0IG,NO,50,NA,NA,146.39,DECEASED,39,0.3174,M0,N1b,Stage IIB,T2,Breast Invasive Ductal Carcinoma,5836,Positive,NOT HISPANIC OR LATINO,2011/2/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1994,NA,4,NA,16,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Negative,Left,Positive,WHITE,NA,YES,1,200,Primary,Female
TCGA.B6.A0IH.01,TCGA.B6.A0IH.01A.11R.A115.07,0.273984,0.273984,0,0,TCGA-B6-A0IH,NO,81,NA,NA,112.29,DECEASED,17,0.1988,M0,N1b,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,5388,Positive,NOT HISPANIC OR LATINO,3/15/11,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,1995,YES,25,NA,27,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Positive,Left Upper Outer Quadrant|Left,Positive,WHITE,NA,YES,1,110,Primary,Female
TCGA.B6.A0IJ.01,TCGA.B6.A0IJ.01A.11R.A034.07,7.181982,6.914356,0.213565,0.030887186,TCGA-B6-A0IJ,NO,42,233.44,DiseaseFree,233.44,LIVING,110,0.5979,M0,N0 (i-),Stage IIB,T3,Breast Invasive Ductal Carcinoma,5350,Positive,NOT HISPANIC OR LATINO,2011/2/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1995,NA,0,NA,27,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant|Right,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,170,Primary,Female
TCGA.B6.A0IK.01,TCGA.B6.A0IK.01A.12R.A056.07,0.817122,0.47399,0,0,TCGA-B6-A0IK,NO,63,16.06,Recurred/Progressed,18.76,DECEASED,106,0.3518,M0,N1,Stage IIIB,T4,Breast Invasive Ductal Carcinoma,5724,Negative,NOT HISPANIC OR LATINO,2011/2/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1994,NA,1,NA,14,Negative,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Positive,Left,Negative,WHITE,NA,YES,1,140,Primary,Female
TCGA.B6.A0IM.01,TCGA.B6.A0IM.01A.11R.A034.07,0.039746,0.039746,0,0,TCGA-B6-A0IM,NO,75,NA,NA,127.23,DECEASED,30,0.2215,M0,N0 (i-),Stage IIB,T3,Breast Invasive Ductal Carcinoma,4754,Positive,NOT HISPANIC OR LATINO,2011/2/10,"Other, specify",NA,No,No,NA,YES,1997,NA,0,NA,9,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Positive,Right Upper Outer Quadrant|Right,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,110,Primary,Female
TCGA.B6.A0IN.01,TCGA.B6.A0IN.01A.11R.A034.07,0.08062,0.08062,0,0,TCGA-B6-A0IN,NO,45,46.39,Recurred/Progressed,84.53,DECEASED,24,0.2325,MX,NX,Stage X,T1c,Breast Invasive Ductal Carcinoma,5073,Positive,NOT HISPANIC OR LATINO,2011/2/10,"Other, specify",NA,No,No,NA,YES,1996,NA,NA,NA,NA,Negative,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Positive,Right Upper Outer Quadrant|Right,Negative,WHITE,NA,YES,1,20,Primary,Female
TCGA.B6.A0IO.01,TCGA.B6.A0IO.01A.11R.A034.07,0.172115,0.132237,0,0,TCGA-B6-A0IO,NO,66,165.64,DiseaseFree,165.64,LIVING,50,0.327,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,3278,Positive,NOT HISPANIC OR LATINO,2011/2/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2001,NA,0,NA,17,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Negative,Left,Indeterminate,WHITE,NA,YES,1,140,Primary,Female
TCGA.B6.A0IP.01,TCGA.B6.A0IP.01A.11R.A034.07,0.970774,0.970774,0,0,TCGA-B6-A0IP,NO,74,NA,NA,128.98,DECEASED,21,0.0661,M0,N0 (i-),Stage IA,T1c,Breast Invasive Lobular Carcinoma,4565,Positive,NOT HISPANIC OR LATINO,2011/2/10,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,1997,YES,0,NA,16,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,80,Primary,Female
TCGA.B6.A0IQ.01,TCGA.B6.A0IQ.01A.11R.A034.07,0.206462,0.20218,0,0,TCGA-B6-A0IQ,NO,40,140.77,DiseaseFree,140.77,LIVING,45,0.5981,M0,N1b,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,5238,Negative,NOT HISPANIC OR LATINO,2011/2/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1996,NA,1,NA,26,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant|Left,Negative,WHITE,NA,YES,1,210,Primary,Female
TCGA.B6.A0RE.01,TCGA.B6.A0RE.01A.11R.A056.07,0.38241,0.211409,0,0,TCGA-B6-A0RE,NO,61,255.49,DiseaseFree,255.49,LIVING,80,0.5386,M0,N0 (i-),Stage X,TX,Breast Invasive Ductal Carcinoma,7492,Negative,NOT HISPANIC OR LATINO,2011/2/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1989,NA,0,NA,14,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant|Right,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,90,Primary,Female
TCGA.B6.A0RG.01,TCGA.B6.A0RG.01A.11R.A056.07,0.038064,0.026907,0,0,TCGA-B6-A0RG,NO,26,68.4,DiseaseFree,68.4,LIVING,49,0.3585,M0,N0 (i-),Stage IIB,T3,Breast Invasive Ductal Carcinoma,6869,Negative,NOT HISPANIC OR LATINO,2011/2/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1991,NA,0,NA,19,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Negative,Left,Negative,WHITE,NA,YES,1,160,Primary,Female
TCGA.B6.A0RH.01,TCGA.B6.A0RH.01A.21R.A115.07,1.097786,1.097786,0,0,TCGA-B6-A0RH,NO,51,71.12,Recurred/Progressed,212.09,DECEASED,29,0.2783,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,6821,Positive,NOT HISPANIC OR LATINO,3/15/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1991,YES,0,NA,23,Negative,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Positive,Left Lower Inner Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,130,Primary,Female
TCGA.B6.A0RI.01,TCGA.B6.A0RI.01A.11R.A056.07,0.051256,0.051256,0,0,TCGA-B6-A0RI,NO,44,36.14,Recurred/Progressed,234.1,LIVING,14,0.0928,M0,N1b,Stage IIIB,T4b,Breast Invasive Ductal Carcinoma,6755,Positive,NOT HISPANIC OR LATINO,2011/2/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1992,NA,6,NA,15,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant|Right,Positive,WHITE,NA,YES,1,50,Primary,Female
TCGA.B6.A0RL.01,TCGA.B6.A0RL.01A.11R.A084.07,0.19234,0.181534,0,0,TCGA-B6-A0RL,NO,60,NA,NA,81.11,DECEASED,NA,0.3215,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,6336,Positive,NOT HISPANIC OR LATINO,2011/2/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1993,NA,0,NA,16,NA,NA,NA,NA,NA,IDC,Negative,Left,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,170,Primary,Female
TCGA.B6.A0RM.01,TCGA.B6.A0RM.01A.11R.A084.07,0.014586,0.014586,0,0,TCGA-B6-A0RM,NO,57,NA,NA,77.96,DECEASED,NA,0.0804,MX,NX,Stage X,TX,Breast Invasive Ductal Carcinoma,6279,Positive,NOT HISPANIC OR LATINO,2011/2/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1993,NA,NA,NA,0,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,NA,Left,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,160,Primary,Female
TCGA.B6.A0RN.01,TCGA.B6.A0RN.01A.12R.A084.07,0.064033,0.064033,0,0,TCGA-B6-A0RN,NO,60,263.07,DiseaseFree,263.07,LIVING,27,0.0741,M0,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,6286,Negative,NOT HISPANIC OR LATINO,2011/2/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1993,NA,0,NA,19,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right,Negative,WHITE,NA,YES,1,130,Primary,Female
TCGA.B6.A0RO.01,TCGA.B6.A0RO.01A.22R.A084.07,0.234537,0.234537,0,0,TCGA-B6-A0RO,NO,71,161.93,DiseaseFree,161.93,LIVING,27,0.4705,M0,N1a,Stage IIIB,T4,Breast Invasive Ductal Carcinoma,6035,Positive,NOT HISPANIC OR LATINO,2011/2/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1993,NA,2,NA,17,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Positive,WHITE,NA,YES,1,140,Primary,Female
TCGA.B6.A0RP.01,TCGA.B6.A0RP.01A.21R.A084.07,0.025527,0.025527,0,0,TCGA-B6-A0RP,NO,73,91.56,Recurred/Progressed,102.69,DECEASED,17,0.4882,M0,N1b,NA,T2,Breast Mixed Ductal and Lobular Carcinoma,5890,Positive,NOT HISPANIC OR LATINO,2011/2/10,Mixed Histology (please specify),ductal/lobular,No,No,NA,YES,1994,NA,2,NA,15,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,MDLC,Positive,Left Upper Outer Quadrant|Left,Positive,WHITE,NA,YES,1,230,Primary,Female
TCGA.B6.A0RQ.01,TCGA.B6.A0RQ.01A.11R.A115.07,0.041105,0.041105,0,0,TCGA-B6-A0RQ,NO,68,NA,NA,140.18,DECEASED,10,0.0134,M0,N0 (i-),Stage IIB,T3,Breast Invasive Lobular Carcinoma,5890,Positive,NOT HISPANIC OR LATINO,3/15/11,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,1994,YES,0,NA,14,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,NA,Right Upper Outer Quadrant|Right,Positive,WHITE,NA,YES,1,160,Primary,Female
TCGA.B6.A0RS.01,TCGA.B6.A0RS.01A.11R.A084.07,1.224541,1.1903,0.017628,0.014809712,TCGA-B6-A0RS,NO,38,67.05,Recurred/Progressed,100.62,DECEASED,NA,0.4276,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,7858,Negative,NOT HISPANIC OR LATINO,2011/2/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1988,NA,0,NA,15,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Negative,Left Lower Inner Quadrant|Left,Negative,WHITE,NA,YES,1,80,Primary,Female
TCGA.B6.A0RT.01,TCGA.B6.A0RT.01A.21R.A084.07,9.928692,9.888556,0,0,TCGA-B6-A0RT,NO,39,89.39,DiseaseFree,89.39,LIVING,12,0.0237,M0,N1,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,5047,Negative,NOT HISPANIC OR LATINO,2011/3/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1996,NA,1,NA,23,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Close,Right Upper Outer Quadrant|Right,Negative,WHITE,NA,YES,1,230,Primary,Female
TCGA.B6.A0RU.01,TCGA.B6.A0RU.01A.11R.A084.07,0.085195,0.085195,0,0,TCGA-B6-A0RU,NO,40,101.05,Recurred/Progressed,282.69,LIVING,33,0.3834,M0,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,7290,Negative,NOT HISPANIC OR LATINO,2011/2/10,"Other, specify",NA,No,No,NA,YES,1990,NA,0,NA,15,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Negative,Right,Negative,WHITE,NA,YES,1,170,Primary,Female
TCGA.B6.A0RV.01,TCGA.B6.A0RV.01A.11R.A084.07,0.34124,0.34124,0,0,TCGA-B6-A0RV,NO,42,169.38,DiseaseFree,169.38,LIVING,29,0.1644,M0,N2,Stage IIIA,T3,Breast Mixed Ductal and Lobular Carcinoma,5165,Positive,NOT HISPANIC OR LATINO,2011/2/10,Mixed Histology (please specify),Lobular/Ductal,No,No,NA,YES,1996,NA,5,NA,10,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,MDLC,Negative,Right,Positive,WHITE,NA,YES,1,480,Primary,Female
TCGA.B6.A0WS.01,TCGA.B6.A0WS.01A.11R.A115.07,0.115788,0.115788,0,0,TCGA-B6-A0WS,NO,58,NA,NA,97.4,DECEASED,13,0.2277,MX,NX,Stage X,T1c,Breast Invasive Ductal Carcinoma,5113,Positive,NOT HISPANIC OR LATINO,3/15/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1996,NO,NA,NA,NA,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Positive,Left Upper Outer Quadrant|Left,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,110,Primary,Female
TCGA.B6.A0WT.01,TCGA.B6.A0WT.01A.11R.A109.07,0.303566,0.303566,0,0,TCGA-B6-A0WT,NO,61,126.87,Recurred/Progressed,188.53,LIVING,13,0.152,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,5606,Positive,NOT HISPANIC OR LATINO,12/14/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1995,NA,1,NA,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Inner Quadrant|Left,Positive,WHITE,NA,YES,1,90,Primary,Female
TCGA.B6.A0WV.01,TCGA.B6.A0WV.01A.11R.A109.07,0.082867,0.082867,0,0,TCGA-B6-A0WV,NO,67,NA,NA,79.4,DECEASED,22,0.4345,M0,N1b,Stage IIB,T2,Breast Invasive Ductal Carcinoma,5531,Positive,NOT HISPANIC OR LATINO,12/14/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1995,NA,4,NA,7,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Positive,WHITE,NA,YES,1,30,Primary,Female
TCGA.B6.A0WW.01,TCGA.B6.A0WW.01A.11R.A109.07,0.074645,0.074645,0,0,TCGA-B6-A0WW,NO,58,14.68,Recurred/Progressed,18.33,DECEASED,27,0.3127,MX,N1b,Stage X,T2,Breast Invasive Ductal Carcinoma,4664,Positive,NOT HISPANIC OR LATINO,12/14/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1997,NA,5,NA,18,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,30,Primary,Female
TCGA.B6.A0WX.01,TCGA.B6.A0WX.01A.11R.A109.07,0.365902,0.365902,0,0,TCGA-B6-A0WX,NO,40,18.5,Recurred/Progressed,20.99,DECEASED,21,0.4622,M0,N1b,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,4476,Negative,NOT HISPANIC OR LATINO,12/14/10,"Other, specify",NA,No,No,NA,YES,1998,NA,9,NA,21,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,ILC,Negative,Left,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,300,Primary,Female
TCGA.B6.A0WY.01,TCGA.B6.A0WY.01A.11R.A109.07,0.456807,0.456807,0,0,TCGA-B6-A0WY,NO,40,66.06,Recurred/Progressed,113.7,DECEASED,10,0.0836,M0,N1b,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,5294,Positive,NOT HISPANIC OR LATINO,12/14/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1996,NA,3,NA,21,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Lower Inner Quadrant|Left,Negative,WHITE,NA,YES,1,30,Primary,Female
TCGA.B6.A0WZ.01,TCGA.B6.A0WZ.01A.11R.A109.07,0.83762,0.755901,0.081719,0.108108072,TCGA-B6-A0WZ,NO,50,168.1,Recurred/Progressed,206.7,LIVING,22,0.2496,M0,N1b,Stage II,T2,Breast Invasive Ductal Carcinoma,5179,Positive,NOT HISPANIC OR LATINO,12/14/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1996,NA,11,NA,21,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,50,Primary,Female
TCGA.B6.A0X0.01,TCGA.B6.A0X0.01A.21R.A115.07,0.503511,0.503511,0,0,TCGA-B6-A0X0,NO,54,NA,NA,129.6,DECEASED,16,0.1143,M0,N0 (i-),Stage I,T1c,Adenoid Cystic Breast Cancer,5243,Positive,NOT HISPANIC OR LATINO,3/15/11,"Other, specify",NA,No,No,NA,YES,1996,YES,0,NA,31,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,ACBC,Negative,Right Upper Outer Quadrant|Right,Positive,WHITE,NA,YES,1,150,Primary,Female
TCGA.B6.A0X1.01,TCGA.B6.A0X1.01A.11R.A109.07,0.986141,0.316421,0,0,TCGA-B6-A0X1,NO,48,16.1,Recurred/Progressed,244.91,DECEASED,43,0.8331,M1,N1,NA,T2,Breast Invasive Ductal Carcinoma,6035,Negative,NOT HISPANIC OR LATINO,12/14/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1994,NA,16,NA,21,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Negative,Left,Negative,WHITE,NA,YES,1,240,Primary,Female
TCGA.B6.A0X4.01,TCGA.B6.A0X4.01A.11R.A109.07,0.042936,0.042936,0,0,TCGA-B6-A0X4,NO,62,23.52,Recurred/Progressed,28.25,DECEASED,15,0.0305,M0,N1b,Stage IIB,T2,Breast Invasive Ductal Carcinoma,5323,Positive,NOT HISPANIC OR LATINO,12/14/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1996,NA,2,NA,21,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Positive,WHITE,NA,YES,1,110,Primary,Female
TCGA.B6.A0X5.01,TCGA.B6.A0X5.01A.21R.A109.07,0.062155,0.014202,0,0,TCGA-B6-A0X5,NO,61,44.12,Recurred/Progressed,68.89,DECEASED,18,0.0827,M0,N1b,Stage IIB,T2,Breast Invasive Ductal Carcinoma,5600,Positive,NOT HISPANIC OR LATINO,12/14/10,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1995,NA,3,NA,14,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,80,Primary,Female
TCGA.B6.A0X7.01,TCGA.B6.A0X7.01A.11R.A10J.07,0.056914,0.056914,0,0,TCGA-B6-A0X7,NO,62,36.27,Recurred/Progressed,58.51,DECEASED,13,0.1698,MX,NX,Stage X,T1c,Breast Invasive Ductal Carcinoma,6002,Positive,NOT HISPANIC OR LATINO,12/14/10,Mixed Histology (please specify),Ductal/Lobular,No,No,NA,YES,1994,NA,NA,NA,0,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,NA,Right,Positive,WHITE,NA,YES,1,40,Primary,Female
TCGA.B6.A1KC.01,TCGA.B6.A1KC.01B.11R.A157.07,0.008954,0.008954,0,0,TCGA-B6-A1KC,NO,67,43.56,DiseaseFree,43.56,LIVING,17,0.5293,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,2781,Positive,NOT HISPANIC OR LATINO,7/19/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2003,YES,1,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Lower Outer Quadrant,Negative,WHITE,NA,YES,1,30,Primary,Female
TCGA.B6.A1KF.01,TCGA.B6.A1KF.01A.11R.A13Q.07,0.018984,0.018984,0,0,TCGA-B6-A1KF,NO,68,101.45,DiseaseFree,101.45,LIVING,36,0.5575,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,4536,Negative,NOT HISPANIC OR LATINO,7/19/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,1998,YES,2,NA,14,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Lower Outer Quadrant,Negative,WHITE,NA,YES,1,20,Primary,Female
TCGA.B6.A1KI.01,TCGA.B6.A1KI.01A.11R.A14M.07,0.029871,0.029871,0,0,TCGA-B6-A1KI,NO,63,73.46,DiseaseFree,73.46,LIVING,12,0.1086,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,2634,Positive,NOT HISPANIC OR LATINO,7/19/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2003,YES,0,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Inner Quadrant,Positive,WHITE,NA,YES,1,40,Primary,Female
TCGA.B6.A1KN.01,TCGA.B6.A1KN.01A.11R.A13Q.07,0.070079,0.070079,0,0,TCGA-B6-A1KN,NO,57,139.06,DiseaseFree,139.06,LIVING,44,0.2858,M0,N1,Stage IIIB,T4b,Breast Invasive Ductal Carcinoma,4537,Negative,NOT HISPANIC OR LATINO,7/19/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1998,YES,24,NA,30,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Inner Quadrant,Negative,WHITE,NA,YES,1,80,Primary,Female
TCGA.B6.A2IU.01,TCGA.B6.A2IU.01A.32R.A18M.07,0.221291,0.027011,0,0,TCGA-B6-A2IU,NO,62,138.76,Recurred/Progressed,170.04,LIVING,32,0.2248,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,4665,Positive,HISPANIC OR LATINO,2001/11/12,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,1998,YES,0,NA,28,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,ILC,Negative,Right,Positive,WHITE,NA,YES,1,140,Primary,Female
TCGA.B6.A401.01,TCGA.B6.A401.01A.11R.A239.07,1.096866,1.096866,0,0,TCGA-B6-A401,NO,47,85.28,DiseaseFree,85.28,LIVING,18,0.3026,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,1935,Positive,NOT HISPANIC OR LATINO,9/20/12,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,YES,1,NA,4,NA,NA,NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,YES,YES,1,30,Primary,Female
TCGA.B6.A408.01,TCGA.B6.A408.01A.12R.A24H.07,0.544969,0.544969,0,0,TCGA-B6-A408,NO,55,68.07,DiseaseFree,68.07,LIVING,30,0.2495,M0,N3a,Stage IIIC,T2,Breast Mixed Ductal and Lobular Carcinoma,1500,Positive,NOT HISPANIC OR LATINO,9/20/12,Mixed Histology (please specify),ductal and lobular,No,No,Equivocal,YES,2008,YES,10,NA,23,NA,NA,NA,NA,NA,MDLC,Negative,Left,Positive,BLACK OR AFRICAN AMERICAN,YES,YES,1,50,Primary,Female
TCGA.B6.A40B.01,TCGA.B6.A40B.01A.11R.A239.07,0.981382,0.981382,0,0,TCGA-B6-A40B,NO,76,103.55,DiseaseFree,103.55,LIVING,38,0.2049,M0,N0 (i-),Stage I,T1b,Breast Invasive Lobular Carcinoma,2467,Positive,NOT HISPANIC OR LATINO,9/20/12,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2005,YES,0,0,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NO,YES,1,10,Primary,Female
TCGA.B6.A40C.01,TCGA.B6.A40C.01A.11R.A239.07,0.40248,0.396005,0,0,TCGA-B6-A40C,NO,51,71.09,DiseaseFree,71.09,LIVING,29,0.2042,M0,N0 (i-),Stage IIB,T3,Breast Invasive Lobular Carcinoma,2677,Positive,NOT HISPANIC OR LATINO,9/20/12,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2005,YES,0,0,3,NA,NA,NA,NA,NA,ILC,Negative,Left Upper Outer Quadrant,Positive,WHITE,YES,YES,1,20,Primary,Female
TCGA.BH.A0AU.01,TCGA.BH.A0AU.01A.11R.A12P.07,0.088625,0.088625,0,0,TCGA-BH-A0AU,NO,45,62.88,DiseaseFree,62.88,LIVING,14,0.4255,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,583,Positive,NOT HISPANIC OR LATINO,7/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2008,YES,0,NA,2,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,YES,1,200,Primary,Female
TCGA.BH.A0AW.01,TCGA.BH.A0AW.01A.11R.A056.07,0.378412,0.378412,0,0,TCGA-BH-A0AW,NO,56,20.43,DiseaseFree,20.43,LIVING,105,0.2907,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,545,Positive,NA,2011/3/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2008,NA,2,0,12,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left,Negative,WHITE,NA,YES,1,50,Primary,Female
TCGA.BH.A0AY.01,TCGA.BH.A0AY.01A.21R.A00Z.07,0.06888,0.06888,0,0,TCGA-BH-A0AY,NO,62,25.53,DiseaseFree,25.53,LIVING,43,0.2207,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,587,Positive,NA,2011/3/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,0,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Outer Quadrant|Left,Positive,WHITE,NA,YES,1,210,Primary,Female
TCGA.BH.A0AZ.01,TCGA.BH.A0AZ.01A.21R.A12P.07,0.545581,0.379795,0,0,TCGA-BH-A0AZ,NO,47,63.04,DiseaseFree,63.04,LIVING,44,0.2853,cM0 (i+),N1a,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,575,Positive,NOT HISPANIC OR LATINO,7/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,YES,1,NA,13,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right,Positive,WHITE,NA,YES,1,490,Primary,Female
TCGA.BH.A0B0.01,TCGA.BH.A0B0.01A.21R.A115.07,0.041938,0.041938,0,0,TCGA-BH-A0B0,NO,56,81.37,DiseaseFree,81.37,LIVING,34,0.2342,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,1223,Positive,NA,7/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,YES,0,NA,2,NA,Peri (6-12 months since last menstrual period),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,320,Primary,Female
TCGA.BH.A0B1.01,TCGA.BH.A0B1.01A.12R.A056.07,0.065724,0.065724,0,0,TCGA-BH-A0B1,NO,66,37.71,DiseaseFree,37.71,LIVING,44,NA,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1071,Positive,NA,2011/3/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,NA,1,0,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant|Right,Positive,WHITE,NA,YES,1,740,Primary,Female
TCGA.BH.A0B2.01,TCGA.BH.A0B2.01A.11R.A10J.07,2.452226,2.39848,0,0,TCGA-BH-A0B2,NO,NA,NA,NA,NA,NA,NA,0.2464,NA,NA,NA,NA,NA,1031,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,BRCA,NA,NA,NA,NA,NA,NA,1,220,Primary,NA
TCGA.BH.A0B4.01,TCGA.BH.A0B4.01A.11R.A00Z.07,0.2729,0.2729,0,0,TCGA-BH-A0B4,NO,65,39.13,DiseaseFree,39.13,LIVING,51,0.3681,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,995,Positive,NA,2011/4/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2007,NA,6,NA,10,NA,NA,NA,NA,NA,IDC,Negative,Left,Positive,WHITE,NA,YES,1,340,Primary,Male
TCGA.BH.A0B5.01,TCGA.BH.A0B5.01A.11R.A12P.07,1.648638,1.558708,0.020101,0.012895937,TCGA-BH-A0B5,NO,40,70.17,DiseaseFree,70.17,LIVING,50,0.2328,M0,N2a,Stage IIIA,T2,Breast Invasive Lobular Carcinoma,1008,Positive,NOT HISPANIC OR LATINO,2008/2/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2007,YES,5,NA,24,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,ILC,Positive,Left,Positive,WHITE,NA,YES,1,700,Primary,Female
TCGA.BH.A0B6.01,TCGA.BH.A0B6.01A.11R.A19W.07,0.971535,0.971535,0,0,TCGA-BH-A0B6,NO,47,81.57,DiseaseFree,81.57,LIVING,484,0.1574,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,1405,Positive,NOT HISPANIC OR LATINO,2008/4/11,Infiltrating Ductal Carcinoma,NA,Yes,Yes,Positive,YES,2006,YES,0,NA,4,NA,NA,NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,250,Primary,Female
TCGA.BH.A0B7.01,TCGA.BH.A0B7.01A.12R.A115.07,0.2878,0.2878,0,0,TCGA-BH-A0B7,NO,42,84.07,DiseaseFree,84.07,LIVING,11,0.1253,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1391,Positive,NOT HISPANIC OR LATINO,2008/4/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2006,YES,1,NA,17,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right,Positive,WHITE,NA,YES,1,320,Primary,Female
TCGA.BH.A0B8.01,TCGA.BH.A0B8.01A.21R.A056.07,0.024035,0.024035,0,0,TCGA-BH-A0B8,NO,64,51.54,DiseaseFree,51.54,LIVING,32,NA,M0,N0 (i-),Stage I,T1b,Breast Invasive Ductal Carcinoma,1401,Positive,NA,2011/3/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2006,NA,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right,Positive,WHITE,NA,YES,1,150,Primary,Female
TCGA.BH.A0BA.01,TCGA.BH.A0BA.01A.11R.A056.07,0.157417,0.071645,0,0,TCGA-BH-A0BA,NO,51,37.19,DiseaseFree,37.19,LIVING,24,0.8633,M0,N3a,Stage IIIC,T3,Breast Mixed Ductal and Lobular Carcinoma,1266,Positive,NA,2011/4/10,Mixed Histology (please specify),Infiltrating ductal & lobular,No,No,Negative,YES,2006,NA,27,NA,27,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,MDLC,Negative,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left,Positive,WHITE,NA,YES,1,360,Primary,Female
TCGA.BH.A0BC.01,TCGA.BH.A0BC.01A.22R.A084.07,3.902094,3.836165,0.065929,0.017186174,TCGA-BH-A0BC,NO,60,32,DiseaseFree,32,LIVING,24,0.1967,M0,N3,Stage IIIC,T2,Breast Invasive Ductal Carcinoma,1098,Positive,NA,2011/4/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,NA,12,NA,18,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right,Positive,WHITE,NA,YES,1,160,Primary,Female
TCGA.BH.A0BD.01,TCGA.BH.A0BD.01A.11R.A034.07,0.090971,0.090971,0,0,TCGA-BH-A0BD,NO,47,18.2,DiseaseFree,18.2,LIVING,17,0.1794,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,364,Positive,NA,2011/4/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,2,NA,9,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left,Positive,WHITE,NA,YES,1,90,Primary,Female
TCGA.BH.A0BF.01,TCGA.BH.A0BF.01A.21R.A12P.07,5.570127,5.307798,0,0,TCGA-BH-A0BF,NO,56,NA,NA,43.5,DECEASED,18,0.2904,M0,N1mi,Stage IIB,T2,Breast Invasive Ductal Carcinoma,413,Positive,NOT HISPANIC OR LATINO,2008/5/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,YES,1,NA,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,260,Primary,Female
TCGA.BH.A0BJ.01,TCGA.BH.A0BJ.01A.11R.A056.07,0.334505,0.334505,0,0,TCGA-BH-A0BJ,NO,41,21.68,DiseaseFree,21.68,LIVING,24,0.4003,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,595,Positive,NA,2011/8/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,2,NA,18,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant|Left,Positive,WHITE,NA,YES,1,110,Primary,Female
TCGA.BH.A0BM.01,TCGA.BH.A0BM.01A.11R.A056.07,0.009783,0.009783,0,0,TCGA-BH-A0BM,NO,54,61.63,DiseaseFree,61.63,LIVING,33,0.0936,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1080,Positive,NA,2011/8/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,NA,3,NA,24,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right,Negative,WHITE,NA,YES,1,100,Primary,Female
TCGA.BH.A0BO.01,TCGA.BH.A0BO.01A.23R.A12D.07,0.041911,0.041911,0,0,TCGA-BH-A0BO,NO,54,72.17,DiseaseFree,72.17,LIVING,19,0.018,M0,N0,Stage I,T1b,Breast Invasive Ductal Carcinoma,1162,Positive,NOT HISPANIC OR LATINO,2008/9/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,YES,0,NA,3,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,YES,1,290,Primary,Female
TCGA.BH.A0BP.01,TCGA.BH.A0BP.01A.11R.A115.07,0.206755,0.206755,0,0,TCGA-BH-A0BP,NO,76,NA,NA,75.43,DECEASED,102,0.6741,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,1217,Positive,NOT HISPANIC OR LATINO,2008/9/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,YES,0,NA,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,150,Primary,Female
TCGA.BH.A0BQ.01,TCGA.BH.A0BQ.01A.21R.A115.07,0.406177,0.406177,0,0,TCGA-BH-A0BQ,NO,39,56.14,Recurred/Progressed,74.08,LIVING,16,0.1009,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,1197,Positive,NOT HISPANIC OR LATINO,2008/10/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2007,YES,0,NA,2,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left,Positive,WHITE,NA,YES,1,120,Primary,Female
TCGA.BH.A0BR.01,TCGA.BH.A0BR.01A.21R.A115.07,0.680502,0.680502,0,0,TCGA-BH-A0BR,NO,59,76.54,DiseaseFree,76.54,LIVING,53,0.4653,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,1170,Positive,NOT HISPANIC OR LATINO,2008/10/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,YES,0,NA,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Lower Inner Quadrant,Positive,WHITE,NA,YES,1,160,Primary,Female
TCGA.BH.A0BS.01,TCGA.BH.A0BS.01A.11R.A12P.07,0.004935,0.004935,0,0,TCGA-BH-A0BS,NO,55,85.81,DiseaseFree,85.81,LIVING,9,0.0493,M0,N1c,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,1164,Positive,NOT HISPANIC OR LATINO,8/18/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2007,YES,0,NA,11,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left,Positive,WHITE,NA,YES,1,180,Primary,Female
TCGA.BH.A0BT.01,TCGA.BH.A0BT.01A.11R.A12P.07,0.095446,0.095446,0,0,TCGA-BH-A0BT,NO,56,77.69,DiseaseFree,77.69,LIVING,28,0.3749,M0,N1mi,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,1167,Positive,NOT HISPANIC OR LATINO,2008/2/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,NA,NA,NA,NA,NA,NA,NA,NA,NO,IDC,Negative,Right Upper Inner Quadrant,Positive,WHITE,NA,YES,1,140,Primary,Female
TCGA.BH.A0BV.01,TCGA.BH.A0BV.01A.11R.A00Z.07,0.19281,0.19281,0,0,TCGA-BH-A0BV,NO,78,49.9,DiseaseFree,49.9,LIVING,27,0.1734,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1328,Positive,NA,2011/9/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,NA,2,NA,25,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right,Positive,WHITE,NA,YES,1,450,Primary,Female
TCGA.BH.A0BZ.01,TCGA.BH.A0BZ.01A.31R.A12P.07,4.181765,3.371182,0.456183,0.135318414,TCGA-BH-A0BZ,NO,59,74.08,DiseaseFree,74.08,LIVING,173,0.15,M0,N1a,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,1084,Positive,NOT HISPANIC OR LATINO,2008/10/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,YES,1,NA,23,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left,Positive,WHITE,NA,YES,1,830,Primary,Female
TCGA.BH.A0C0.01,TCGA.BH.A0C0.01A.21R.A056.07,1.240176,1.240176,0,0,TCGA-BH-A0C0,NO,62,41.72,DiseaseFree,41.72,LIVING,59,0.3023,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,1094,Positive,NA,2011/8/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2007,NA,1,NA,35,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant|Left,Positive,WHITE,NA,YES,1,220,Primary,Female
TCGA.BH.A0C1.01,TCGA.BH.A0C1.01B.11R.A12D.07,2.616046,1.521426,0.9935,0.653005799,TCGA-BH-A0C1,NO,61,36.89,Recurred/Progressed,46.35,DECEASED,21,0.1678,M0,N2a,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,891,Positive,NOT HISPANIC OR LATINO,2008/11/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2007,YES,8,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,YES,ILC,Negative,Right,Positive,WHITE,NA,YES,1,1130,Primary,Female
TCGA.BH.A0C3.01,TCGA.BH.A0C3.01A.21R.A12P.07,0.375805,0.375805,0,0,TCGA-BH-A0C3,NO,47,87.84,Recurred/Progressed,88.99,LIVING,11,0.1667,M0,N0,Stage I,T1c,Breast Mixed Ductal and Lobular Carcinoma,1335,Positive,NA,2008/11/11,Mixed Histology (please specify),with ductal and lobular phenotypes,No,No,Negative,YES,2006,YES,0,NA,4,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,MDLC,Negative,Left,Negative,WHITE,NA,YES,1,160,Primary,Female
TCGA.BH.A0C7.01,TCGA.BH.A0C7.01B.11R.A115.07,0.200544,0.200544,0,0,TCGA-BH-A0C7,NO,48,90.9,DiseaseFree,90.9,LIVING,24,0.3045,M0,N1mi,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1338,Positive,NOT HISPANIC OR LATINO,2008/11/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2006,YES,1,NA,18,NA,Peri (6-12 months since last menstrual period),NA,NA,NO,IDC,Negative,Left,Negative,WHITE,NA,YES,1,340,Primary,Female
TCGA.BH.A0DD.01,TCGA.BH.A0DD.01A.31R.A12P.07,0.059953,0.059953,0,0,TCGA-BH-A0DD,NO,58,81.67,DiseaseFree,81.67,LIVING,12,0.3503,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1248,Positive,NA,8/18/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2006,YES,0,NA,22,NA,NA,NA,NA,NO,IDC,Negative,Right,Positive,WHITE,NA,YES,1,430,Primary,Male
TCGA.BH.A0DE.01,TCGA.BH.A0DE.01A.11R.A115.07,0.044305,0.044305,0,0,TCGA-BH-A0DE,NO,62,77.92,DiseaseFree,77.92,LIVING,20,0.1869,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,1130,Positive,NOT HISPANIC OR LATINO,2008/11/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,140,Primary,Female
TCGA.BH.A0DG.01,TCGA.BH.A0DG.01A.21R.A12P.07,1.470992,1.196722,0.0559,0.046710932,TCGA-BH-A0DG,NO,30,67.05,DiseaseFree,67.05,LIVING,23,0.1591,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,972,Positive,NOT HISPANIC OR LATINO,2008/2/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,YES,0,NA,3,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,1360,Primary,Female
TCGA.BH.A0DH.01,TCGA.BH.A0DH.01A.11R.A084.07,0.592465,0.496796,0,0,TCGA-BH-A0DH,NO,63,37.98,DiseaseFree,37.98,LIVING,32,0.2305,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,968,Positive,NA,2011/8/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,NA,3,NA,28,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Positive,Left Upper Outer Quadrant|Left,Positive,WHITE,NA,YES,1,260,Primary,Female
TCGA.BH.A0DI.01,TCGA.BH.A0DI.01A.21R.A12P.07,0.421347,0.421347,0,0,TCGA-BH-A0DI,NO,63,29.96,DiseaseFree,29.96,LIVING,22,0.2622,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,267,Positive,NOT HISPANIC OR LATINO,2008/11/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,YES,3,NA,28,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right,Positive,WHITE,NA,YES,1,200,Primary,Female
TCGA.BH.A0DK.01,TCGA.BH.A0DK.01A.21R.A056.07,2.548012,2.548012,0,0,TCGA-BH-A0DK,NO,49,13.9,DiseaseFree,13.9,LIVING,67,0.2171,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,254,Positive,NA,2011/8/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,0,NA,3,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant|Left,Positive,WHITE,NA,YES,1,240,Primary,Female
TCGA.BH.A0DL.01,TCGA.BH.A0DL.01A.11R.A115.07,0.483501,0.279626,0,0,TCGA-BH-A0DL,NO,64,78.22,DiseaseFree,78.22,LIVING,35,0.2605,M0,N0,Stage IIA,T2,Metaplastic Breast Cancer,1074,Positive,NOT HISPANIC OR LATINO,2008/11/11,"Other, specify",NA,No,No,Negative,YES,2007,YES,0,NA,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,MBC,Negative,Left,Negative,WHITE,NA,YES,1,350,Primary,Female
TCGA.BH.A0DO.01,TCGA.BH.A0DO.01B.11R.A12D.07,0.066198,0.066198,0,0,TCGA-BH-A0DO,NO,78,54.01,DiseaseFree,54.01,LIVING,15,0.1608,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,454,Positive,NOT HISPANIC OR LATINO,2008/11/11,Infiltrating Ductal Carcinoma,NA,No,Yes,Negative,YES,2009,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,YES,1,80,Primary,Female
TCGA.BH.A0DP.01,TCGA.BH.A0DP.01A.21R.A056.07,0.227326,0.227326,0,0,TCGA-BH-A0DP,NO,60,15.64,DiseaseFree,15.64,LIVING,32,0.2568,M0,N0 (i-),Stage IIB,T3,Breast Invasive Lobular Carcinoma,293,Positive,NA,2011/9/10,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2009,NA,0,NA,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right,Positive,WHITE,NA,YES,1,510,Primary,Female
TCGA.BH.A0DQ.01,TCGA.BH.A0DQ.01A.11R.A084.07,0.183539,0.183539,0,0,TCGA-BH-A0DQ,NO,42,3.22,DiseaseFree,3.22,LIVING,21,0.2833,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,190,Positive,NA,2011/9/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,1,NA,25,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right,Positive,WHITE,NA,YES,1,110,Primary,Female
TCGA.BH.A0DS.01,TCGA.BH.A0DS.01A.11R.A056.07,0.005282,0.005282,0,0,TCGA-BH-A0DS,NO,71,2.56,DiseaseFree,2.56,LIVING,23,0.3395,M0,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,79,Positive,NA,2011/9/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,8,NA,14,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right,Positive,WHITE,NA,YES,1,200,Primary,Female
TCGA.BH.A0DT.01,TCGA.BH.A0DT.01A.21R.A12D.07,0.065582,0.065582,0,0,TCGA-BH-A0DT,NO,41,78.94,DiseaseFree,78.94,LIVING,11,0.1927,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,1044,Positive,NA,2008/11/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,YES,1,NA,18,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right,Positive,WHITE,NA,YES,1,160,Primary,Female
TCGA.BH.A0DV.01,TCGA.BH.A0DV.01A.21R.A12P.07,0.066369,0.066369,0,0,TCGA-BH-A0DV,NO,54,67.81,DiseaseFree,67.81,LIVING,4,0.0082,M0,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,975,Positive,NA,2008/2/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,YES,9,NA,9,NA,Peri (6-12 months since last menstrual period),NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left,Positive,WHITE,NA,YES,1,370,Primary,Female
TCGA.BH.A0DX.01,TCGA.BH.A0DX.01A.11R.A115.07,0.836525,0.836525,0,0,TCGA-BH-A0DX,NO,62,70.83,DiseaseFree,70.83,LIVING,50,0.1997,M0,N0,Stage I,T1b,Breast Invasive Ductal Carcinoma,997,Positive,NOT HISPANIC OR LATINO,2008/11/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,YES,0,NA,11,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,YES,1,50,Primary,Female
TCGA.BH.A0DZ.01,TCGA.BH.A0DZ.01A.11R.A00Z.07,0.415119,0.241588,0,0,TCGA-BH-A0DZ,NO,43,16.26,DiseaseFree,16.26,LIVING,173,0.213,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,308,Positive,NA,2011/9/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2009,NA,1,NA,5,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right,Positive,WHITE,NA,YES,1,170,Primary,Female
TCGA.BH.A0E1.01,TCGA.BH.A0E1.01A.11R.A056.07,0.111856,0.111856,0,0,TCGA-BH-A0E1,NO,52,15.67,DiseaseFree,15.67,LIVING,24,0.0595,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,301,Positive,NA,2011/9/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2009,NA,2,NA,17,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant|Left,Positive,WHITE,NA,YES,1,990,Primary,Female
TCGA.BH.A0E2.01,TCGA.BH.A0E2.01A.11R.A056.07,0.269184,0.269184,0,0,TCGA-BH-A0E2,NO,49,14.29,DiseaseFree,14.29,LIVING,30,0.2837,M0,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,210,Positive,NA,2011/9/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,4,NA,26,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,160,Primary,Female
TCGA.BH.A0E7.01,TCGA.BH.A0E7.01A.11R.A034.07,0.085953,0.063737,0,0,TCGA-BH-A0E7,NO,79,44.78,DiseaseFree,44.78,LIVING,37,0.079,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1259,Positive,NA,2011/9/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2006,NA,1,NA,17,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant|Left,Positive,WHITE,NA,YES,1,140,Primary,Female
TCGA.BH.A0E9.01,TCGA.BH.A0E9.01B.11R.A115.07,0.77854,0.535928,0.242612,0.452695138,TCGA-BH-A0E9,NO,53,81.77,DiseaseFree,81.77,LIVING,9,0.2195,M0,N1a,Stage IIB,T2,Breast Invasive Lobular Carcinoma,1357,Positive,NA,2008/11/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2006,YES,3,NA,12,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Right,Positive,WHITE,NA,YES,1,480,Primary,Female
TCGA.BH.A0EA.01,TCGA.BH.A0EA.01A.11R.A115.07,0.271183,0.066921,0,0,TCGA-BH-A0EA,NO,72,NA,NA,32.56,DECEASED,15,0.0603,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,567,Positive,NOT HISPANIC OR LATINO,2008/11/11,Infiltrating Ductal Carcinoma,NA,No,Yes,Negative,YES,2008,YES,2,NA,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left,Positive,WHITE,NA,YES,1,220,Primary,Female
TCGA.BH.A0EB.01,TCGA.BH.A0EB.01A.11R.A034.07,0.104935,0.104935,0,0,TCGA-BH-A0EB,NO,69,24.47,DiseaseFree,24.47,LIVING,25,0.1316,M0,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,552,Positive,NA,2011/9/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2008,NA,0,NA,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Lower Inner Quadrant|Right,Positive,WHITE,NA,YES,1,200,Primary,Female
TCGA.BH.A0EE.01,TCGA.BH.A0EE.01A.11R.A034.07,0.18377,0.18377,0,0,TCGA-BH-A0EE,NO,68,30.98,DiseaseFree,30.98,LIVING,60,0.4417,M0,N0 (i-),Stage IIB,T3,Breast Invasive Ductal Carcinoma,946,Negative,NA,2011/9/10,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2007,NA,0,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right,Negative,WHITE,NA,YES,1,890,Primary,Female
TCGA.BH.A0EI.01,TCGA.BH.A0EI.01A.11R.A115.07,0.057377,0.057377,0,0,TCGA-BH-A0EI,NO,51,63.27,DiseaseFree,63.27,LIVING,13,0.1622,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,541,Positive,NOT HISPANIC OR LATINO,2008/11/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,YES,2,NA,2,NA,Peri (6-12 months since last menstrual period),NA,NA,NO,IDC,Negative,Right,Positive,WHITE,NA,YES,1,240,Primary,Female
TCGA.BH.A0GY.01,TCGA.BH.A0GY.01A.11R.A056.07,0.410033,0.410033,0,0,TCGA-BH-A0GY,NO,67,30.32,DiseaseFree,30.32,LIVING,41,0.2656,M0,N1,Stage IIA,T2,Breast Invasive Ductal Carcinoma,745,Positive,NA,2011/10/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,3,NA,26,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Outer Quadrant|Left,Positive,WHITE,NA,YES,1,200,Primary,Female
TCGA.BH.A0GZ.01,TCGA.BH.A0GZ.01A.11R.A056.07,0.031896,0.031896,0,0,TCGA-BH-A0GZ,NO,62,10.78,DiseaseFree,10.78,LIVING,21,0.2724,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,206,Positive,NA,2011/10/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2009,NA,1,NA,14,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant|Left,Positive,WHITE,NA,YES,1,60,Primary,Female
TCGA.BH.A0H0.01,TCGA.BH.A0H0.01A.11R.A056.07,0.114889,0.114889,0,0,TCGA-BH-A0H0,NO,69,15.14,DiseaseFree,15.14,LIVING,14,0.2534,M0,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,344,Positive,NA,2011/10/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant|Right,Positive,WHITE,NA,YES,1,70,Primary,Female
TCGA.BH.A0H3.01,TCGA.BH.A0H3.01A.11R.A12P.07,0.793895,0.793895,0,0,TCGA-BH-A0H3,NO,46,63.34,DiseaseFree,63.34,LIVING,14,0.0606,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,773,Positive,NOT HISPANIC OR LATINO,2008/11/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2008,YES,0,NA,2,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,80,Primary,Female
TCGA.BH.A0H5.01,TCGA.BH.A0H5.01A.21R.A115.07,3.401449,3.401449,0,0,TCGA-BH-A0H5,NO,45,53.22,DiseaseFree,53.22,LIVING,6,0,M0,N0 (i-),Stage I,T1c,Breast Invasive Ductal Carcinoma,815,Positive,NOT HISPANIC OR LATINO,2008/12/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2008,YES,0,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,410,Primary,Female
TCGA.BH.A0H6.01,TCGA.BH.A0H6.01A.21R.A056.07,0.176949,0.176949,0,0,TCGA-BH-A0H6,NO,82,24.54,DiseaseFree,24.54,LIVING,13,0.0982,M0,NX,Stage I,T1b,Breast Invasive Ductal Carcinoma,583,Positive,NA,2011/10/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,0,0,0,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right,Positive,WHITE,NA,YES,1,330,Primary,Female
TCGA.BH.A0H7.01,TCGA.BH.A0H7.01A.13R.A056.07,0.026747,0.026747,0,0,TCGA-BH-A0H7,NO,65,23.06,DiseaseFree,23.06,LIVING,52,0.4407,M0,N2a,Stage IIIA,T1c,Breast Invasive Ductal Carcinoma,542,Positive,NA,2011/10/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,6,NA,16,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right,Positive,WHITE,NA,YES,1,440,Primary,Female
TCGA.BH.A0H9.01,TCGA.BH.A0H9.01A.11R.A056.07,0.075853,0.075853,0,0,TCGA-BH-A0H9,NO,69,40.97,DiseaseFree,40.97,LIVING,31,0.3068,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,1088,Positive,NA,11/17/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2007,NA,0,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant|Right,Positive,WHITE,NA,YES,1,120,Primary,Female
TCGA.BH.A0HA.01,TCGA.BH.A0HA.01A.11R.A12P.07,0.101843,0.101843,0,0,TCGA-BH-A0HA,NO,31,52.92,DiseaseFree,52.92,LIVING,229,0.0838,M0,N0 (i-),Stage I,T1c,Breast Invasive Ductal Carcinoma,675,Positive,NOT HISPANIC OR LATINO,2008/2/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2008,YES,0,NA,4,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right,Positive,WHITE,NA,YES,1,230,Primary,Female
TCGA.BH.A0HB.01,TCGA.BH.A0HB.01A.11R.A056.07,0.235252,0.235252,0,0,TCGA-BH-A0HB,NO,55,26.48,DiseaseFree,26.48,LIVING,28,0.2922,M0,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,739,Positive,NA,2011/10/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2008,NA,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant|Right,Positive,WHITE,NA,YES,1,70,Primary,Female
TCGA.BH.A0HF.01,TCGA.BH.A0HF.01A.11R.A056.07,0.152747,0.152747,0,0,TCGA-BH-A0HF,NO,77,23.88,DiseaseFree,23.88,LIVING,551,NA,M0,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,549,Positive,NA,2011/10/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant|Right,Positive,WHITE,NA,YES,1,40,Primary,Female
TCGA.BH.A0HI.01,TCGA.BH.A0HI.01A.11R.A084.07,0.231568,0.231568,0,0,TCGA-BH-A0HI,NO,78,20.37,DiseaseFree,20.37,LIVING,21,0.0729,M0,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,554,Positive,NA,2011/10/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right,Positive,WHITE,NA,YES,1,20,Primary,Female
TCGA.BH.A0HK.01,TCGA.BH.A0HK.01A.11R.A056.07,0.029243,0.029243,0,0,TCGA-BH-A0HK,NO,81,5.85,DiseaseFree,5.85,LIVING,78,0.0924,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,35,Positive,NA,2011/10/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,2,NA,17,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right,Negative,WHITE,NA,YES,1,700,Primary,Female
TCGA.BH.A0HL.01,TCGA.BH.A0HL.01A.11R.A10U.07,0.046417,0.046417,0,0,TCGA-BH-A0HL,NO,56,2.37,DiseaseFree,2.37,LIVING,30,NA,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,352,Positive,NA,2011/10/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2009,NA,2,NA,17,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right,Positive,WHITE,NA,YES,1,250,Primary,Female
TCGA.BH.A0HN.01,TCGA.BH.A0HN.01A.11R.A10U.07,0.076794,0.076794,0,0,TCGA-BH-A0HN,NO,67,16.95,DiseaseFree,16.95,LIVING,20,NA,M0,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,359,Positive,NA,2011/11/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2009,NA,0,NA,2,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Positive,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left,Positive,WHITE,NA,YES,1,130,Primary,Female
TCGA.BH.A0HO.01,TCGA.BH.A0HO.01A.11R.A034.07,0.102406,0.102406,0,0,TCGA-BH-A0HO,NO,48,2.5,DiseaseFree,2.5,LIVING,16,0.0493,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,224,Positive,NA,2011/11/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,1,1,18,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant|Right,Positive,WHITE,NA,YES,1,110,Primary,Female
TCGA.BH.A0HP.01,TCGA.BH.A0HP.01A.12R.A084.07,0.172013,0.172013,0,0,TCGA-BH-A0HP,NO,65,13.6,DiseaseFree,13.6,LIVING,168,0.1767,M0,N2a,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,346,Positive,NA,2011/11/10,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2009,NA,8,NA,17,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left,Negative,WHITE,NA,YES,1,720,Primary,Female
TCGA.BH.A0HQ.01,TCGA.BH.A0HQ.01A.11R.A034.07,0.107359,0.107359,0,0,TCGA-BH-A0HQ,NO,56,36.83,DiseaseFree,36.83,LIVING,24,0.1281,M0,N0 (i+),Stage IIA,T2,Breast Invasive Ductal Carcinoma,962,Positive,NA,2011/11/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,NA,0,NA,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant|Left,Positive,WHITE,NA,YES,1,110,Primary,Female
TCGA.BH.A0HU.01,TCGA.BH.A0HU.01A.11R.A034.07,0.580747,0.580747,0,0,TCGA-BH-A0HU,NO,52,12.88,DiseaseFree,12.88,LIVING,29,0.3924,M0,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,394,Positive,NA,2011/11/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,0,NA,1,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant|Right,Positive,WHITE,NA,YES,1,140,Primary,Female
TCGA.BH.A0HW.01,TCGA.BH.A0HW.01A.11R.A034.07,0.01869,0.01869,0,0,TCGA-BH-A0HW,NO,62,51.28,DiseaseFree,51.28,LIVING,29,0.23,M0,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,1591,Positive,NA,2011/11/10,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2006,NA,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left,Negative,ASIAN,NA,YES,1,200,Primary,Female
TCGA.BH.A0HX.01,TCGA.BH.A0HX.01A.21R.A056.07,1.481158,1.449427,0,0,TCGA-BH-A0HX,NO,54,27.23,DiseaseFree,27.23,LIVING,42,0.5678,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,672,Positive,NA,2011/11/10,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,2,2,24,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left,Positive,WHITE,NA,YES,1,190,Primary,Female
TCGA.BH.A0HY.01,TCGA.BH.A0HY.01A.11R.A056.07,0.071585,0.071585,0,0,TCGA-BH-A0HY,NO,60,50.76,DiseaseFree,50.76,LIVING,39,0.6304,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,470,Positive,NOT HISPANIC OR LATINO,2008/2/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2009,YES,0,NA,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left,Negative,WHITE,NA,YES,1,150,Primary,Female
TCGA.BH.A0W3.01,TCGA.BH.A0W3.01A.11R.A109.07,0.309909,0.309909,0,0,TCGA-BH-A0W3,NO,58,23.92,DiseaseFree,23.92,LIVING,13,0.1333,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,85,Positive,NOT HISPANIC OR LATINO,2/14/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,NA,1,1,4,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,NA,Left Upper Inner Quadrant,Positive,WHITE,NA,YES,1,120,Primary,Female
TCGA.BH.A0W4.01,TCGA.BH.A0W4.01A.11R.A109.07,0.866359,0.806546,0,0,TCGA-BH-A0W4,NO,46,24.93,DiseaseFree,24.93,LIVING,25,0.0207,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,119,Positive,NOT HISPANIC OR LATINO,2/15/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,NA,NA,3,NA,NA,NA,NA,NA,IDC,NA,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,170,Primary,Female
TCGA.BH.A0W5.01,TCGA.BH.A0W5.01A.11R.A109.07,0.222082,0.222082,0,0,TCGA-BH-A0W5,NO,77,42.31,DiseaseFree,42.31,LIVING,21,0.0719,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,906,Positive,NOT HISPANIC OR LATINO,2/15/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2008,NA,1,1,11,NA,NA,NA,NA,NA,IDC,Negative,Left,Positive,WHITE,NA,YES,1,80,Primary,Female
TCGA.BH.A0W7.01,TCGA.BH.A0W7.01A.11R.A115.07,2.990983,2.647048,0,0,TCGA-BH-A0W7,NO,49,44.78,DiseaseFree,44.78,LIVING,113,0.3048,M0,N0 (i-),Stage I,T1c,Breast Invasive Ductal Carcinoma,869,Positive,NOT HISPANIC OR LATINO,2/15/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,0,0,2,NA,NA,NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,80,Primary,Female
TCGA.BH.A18F.01,TCGA.BH.A18F.01A.11R.A12D.07,0.597773,0.597773,0,0,TCGA-BH-A18F,NO,50,32.88,DiseaseFree,32.88,LIVING,35,0.2284,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,114,Positive,NOT HISPANIC OR LATINO,2006/1/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,0,NA,1,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,IDC,Negative,Right Lower Outer Quadrant,Positive,WHITE,NA,YES,1,200,Primary,Female
TCGA.BH.A18H.01,TCGA.BH.A18H.01A.11R.A12D.07,11.506158,1.657496,0.032962,0.019886624,TCGA-BH-A18H,NO,63,21.42,DiseaseFree,21.42,LIVING,21,0.263,M0,N0,Stage IA,T1b,Breast Invasive Ductal Carcinoma,16,Positive,NOT HISPANIC OR LATINO,2006/6/11,Infiltrating Ductal Carcinoma,NA,No,Yes,Positive,YES,2010,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,80,Primary,Female
TCGA.BH.A18I.01,TCGA.BH.A18I.01A.11R.A12D.07,0.903904,0.474453,0.354748,0.747698929,TCGA-BH-A18I,NO,53,35.91,DiseaseFree,35.91,LIVING,19,0.146,cM0 (i+),N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,80,Positive,NOT HISPANIC OR LATINO,2006/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,YES,1,1,3,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Positive,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,100,Primary,Female
TCGA.BH.A18J.01,TCGA.BH.A18J.01A.11R.A12D.07,0.541827,0.529753,0,0,TCGA-BH-A18J,NO,56,NA,NA,20.11,DECEASED,44,0.2358,M1,N2,Stage IV,T4b,Breast Invasive Ductal Carcinoma,3948,Positive,NOT HISPANIC OR LATINO,2006/8/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2000,NA,NA,NA,NA,NA,NA,NA,Bone,YES,IDC,Negative,Right,Positive,WHITE,NA,YES,1,640,Primary,Female
TCGA.BH.A18K.01,TCGA.BH.A18K.01A.11R.A12D.07,0.115269,0.115269,0,0,TCGA-BH-A18K,NO,46,NA,NA,90.77,DECEASED,29,0.4274,M0,N0,Stage I,T1,Breast Invasive Ductal Carcinoma,4011,Positive,NOT HISPANIC OR LATINO,2006/9/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,1999,YES,0,NA,11,NA,NA,NA,NA,NO,IDC,Negative,Left Lower Inner Quadrant,Positive,WHITE,NA,YES,1,100,Primary,Female
TCGA.BH.A18L.01,TCGA.BH.A18L.01A.32R.A12D.07,0.008678,0.008678,0,0,TCGA-BH-A18L,NO,50,NA,NA,26.64,DECEASED,26,0.5814,M0,N1mi,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,2669,Positive,NOT HISPANIC OR LATINO,2006/9/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2003,YES,1,1,3,NA,NA,NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,260,Primary,Female
TCGA.BH.A18M.01,TCGA.BH.A18M.01A.11R.A12D.07,0.288788,0.134107,0.154681,1.153414811,TCGA-BH-A18M,NO,39,NA,NA,72.5,DECEASED,11,0.1771,M0,N1,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,3629,Positive,NOT HISPANIC OR LATINO,6/15/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2001,YES,4,4,6,NA,NA,NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,YES,1,360,Primary,Female
TCGA.BH.A18N.01,TCGA.BH.A18N.01A.11R.A12D.07,0.156967,0.097886,0.059081,0.603569458,TCGA-BH-A18N,NO,88,NA,NA,37.71,DECEASED,24,0.1399,M0,N1b,Stage IIA,T2,Breast Invasive Ductal Carcinoma,3374,Positive,NOT HISPANIC OR LATINO,6/15/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2001,YES,2,2,26,NA,NA,NA,NA,NO,IDC,Negative,Left,Positive,WHITE,NA,YES,1,350,Primary,Female
TCGA.BH.A18P.01,TCGA.BH.A18P.01A.11R.A12D.07,0.36727,0.36727,0,0,TCGA-BH-A18P,NO,60,NA,NA,30.26,DECEASED,217,0.1673,M0,N0,Stage I,T1,Breast Invasive Ductal Carcinoma,2639,Positive,NA,6/22/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2003,YES,0,NA,2,NA,NA,NA,NA,NA,IDC,Negative,Left Lower Inner Quadrant,Negative,WHITE,NA,YES,1,230,Primary,Female
TCGA.BH.A18Q.01,TCGA.BH.A18Q.01A.12R.A12D.07,2.028167,1.888495,0.098641,0.052232598,TCGA-BH-A18Q,NO,56,NA,NA,55.58,DECEASED,54,0.7399,M0,N1b,Stage IIB,T2,Breast Invasive Ductal Carcinoma,3417,Negative,NOT HISPANIC OR LATINO,6/24/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2001,YES,2,2,25,NA,NA,NA,NA,NA,IDC,Negative,Left,Negative,WHITE,NA,YES,1,130,Primary,Female
TCGA.BH.A18R.01,TCGA.BH.A18R.01A.11R.A12D.07,0.272244,0.272244,0,0,TCGA-BH-A18R,NO,50,NA,NA,37.52,DECEASED,18,0.2866,M0,N1,Stage IIA,T2b,Breast Invasive Ductal Carcinoma,3571,Indeterminate,NOT HISPANIC OR LATINO,2007/3/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2001,YES,10,NA,15,NA,NA,NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,250,Primary,Female
TCGA.BH.A18S.01,TCGA.BH.A18S.01A.11R.A12D.07,0.096006,0.096006,0,0,TCGA-BH-A18S,NO,79,NA,NA,66,DECEASED,18,0.1516,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,2695,Positive,NOT HISPANIC OR LATINO,2007/2/11,Mucinous Carcinoma,NA,No,No,Negative,YES,2003,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Lower Inner Quadrant,Positive,WHITE,NA,YES,1,320,Primary,Female
TCGA.BH.A18T.01,TCGA.BH.A18T.01A.11R.A12D.07,0.349098,0.321244,0,0,TCGA-BH-A18T,NO,70,NA,NA,7.36,DECEASED,51,0.6652,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,2737,Negative,NOT HISPANIC OR LATINO,2007/2/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2003,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,210,Primary,Female
TCGA.BH.A18U.01,TCGA.BH.A18U.01A.21R.A12D.07,0.772862,0.772862,0,0,TCGA-BH-A18U,NO,72,NA,NA,51.35,DECEASED,61,0.6182,M0,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,2697,Positive,NOT HISPANIC OR LATINO,2007/2/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2003,YES,9,NA,16,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Positive,WHITE,NA,YES,1,530,Primary,Female
TCGA.BH.A1EN.01,TCGA.BH.A1EN.01A.11R.A13Q.07,0.031228,0.031228,0,0,TCGA-BH-A1EN,NO,78,NA,NA,69.88,DECEASED,32,0.6267,M0,NX,Stage IIA,T2,Breast Invasive Ductal Carcinoma,4343,Negative,NOT HISPANIC OR LATINO,2009/3/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,1999,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right,Negative,WHITE,NA,YES,1,140,Primary,Female
TCGA.BH.A1EO.01,TCGA.BH.A1EO.01A.11R.A137.07,0.389386,0.389386,0,0,TCGA-BH-A1EO,NO,68,NA,NA,91.92,DECEASED,27,0.2619,M0,N1,Stage IIA,T1c,Breast Mixed Ductal and Lobular Carcinoma,4330,Positive,NOT HISPANIC OR LATINO,2009/6/11,Mixed Histology (please specify),ductal and lobular features,No,No,Negative,YES,1999,YES,1,NA,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,MDLC,NA,Right,Positive,WHITE,NA,YES,1,100,Primary,Female
TCGA.BH.A1ES.01,TCGA.BH.A1ES.01A.11R.A137.07,0.182963,0.182963,0,0,TCGA-BH-A1ES,NO,35,NA,NA,113.73,DECEASED,15,0.2309,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,4242,Positive,NOT HISPANIC OR LATINO,2009/6/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,1999,YES,1,NA,4,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,NA,Right Upper Inner Quadrant,Positive,WHITE,NA,YES,2,220,Primary,Female
TCGA.BH.A1ET.01,TCGA.BH.A1ET.01A.11R.A137.07,0.318636,0.318636,0,0,TCGA-BH-A1ET,NO,55,NA,NA,82.79,DECEASED,16,0.0892,M0,N0,Stage I,T1,Breast Invasive Ductal Carcinoma,4137,Positive,NOT HISPANIC OR LATINO,2009/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,1999,YES,1,NA,19,NA,NA,NA,NA,NA,IDC,NA,Left,Positive,WHITE,NA,YES,1,590,Primary,Female
TCGA.BH.A1EU.01,TCGA.BH.A1EU.01A.11R.A137.07,0.668854,0.650414,0,0,TCGA-BH-A1EU,NO,83,NA,NA,42.25,DECEASED,13,0.1179,M0,N0,Stage I,T1,Breast Invasive Ductal Carcinoma,4106,Positive,NOT HISPANIC OR LATINO,2009/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,1999,NO,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,NA,Right,Positive,WHITE,NA,YES,1,410,Primary,Female
TCGA.BH.A1EV.01,TCGA.BH.A1EV.01A.11R.A137.07,0.109139,0.109139,0,0,TCGA-BH-A1EV,NO,45,NA,NA,11.99,DECEASED,63,0.4189,M0,N1b,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,4103,Positive,NOT HISPANIC OR LATINO,2009/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,1999,YES,3,NA,10,NA,NA,NA,NA,NA,IDC,NA,Left,Positive,WHITE,NA,YES,1,600,Primary,Female
TCGA.BH.A1EX.01,TCGA.BH.A1EX.01A.11R.A13Q.07,1.025502,1.025502,0,0,TCGA-BH-A1EX,NO,67,NA,NA,49.54,DECEASED,13,0.2258,M0,N1b,Stage IIB,T2,Breast Invasive Ductal Carcinoma,3752,Positive,NOT HISPANIC OR LATINO,2009/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2000,YES,2,NA,24,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,NA,Right Lower Inner Quadrant,Positive,WHITE,NA,YES,1,200,Primary,Female
TCGA.BH.A1EY.01,TCGA.BH.A1EY.01A.11R.A13Q.07,1.418595,1.418595,0,0,TCGA-BH-A1EY,NO,79,13.01,Recurred/Progressed,17.67,DECEASED,30,0.3632,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,3840,Positive,NOT HISPANIC OR LATINO,2009/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2000,YES,0,NA,12,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,NA,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,290,Primary,Female
TCGA.BH.A1F0.01,TCGA.BH.A1F0.01A.11R.A137.07,0.277084,0.263739,0,0,TCGA-BH-A1F0,NO,80,NA,NA,25.79,DECEASED,15,0.0288,M0,N1c,Stage IIA,T1a,Breast Invasive Ductal Carcinoma,3879,Negative,NOT HISPANIC OR LATINO,2009/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2000,YES,1,NA,9,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,NA,Left,Indeterminate,WHITE,NA,YES,1,180,Primary,Female
TCGA.BH.A1F2.01,TCGA.BH.A1F2.01A.31R.A13Q.07,0.014782,0.014782,0,0,TCGA-BH-A1F2,NO,53,NA,NA,31.5,DECEASED,32,0.4715,M0,N1b,Stage IIIB,T4b,Paget Disease of the Nipple,4147,Positive,NOT HISPANIC OR LATINO,2009/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,1999,YES,6,NA,19,NA,NA,NA,NA,NA,PD,NA,Left,Positive,WHITE,NA,YES,1,230,Primary,Female
TCGA.BH.A1F5.01,TCGA.BH.A1F5.01A.12R.A13Q.07,0.070493,0.070493,0,0,TCGA-BH-A1F5,NO,62,NA,NA,89.09,DECEASED,24,0.1457,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,3091,Positive,NOT HISPANIC OR LATINO,2009/7/11,Infiltrating Ductal Carcinoma,NA,No,Yes,Negative,YES,2002,YES,1,NA,4,NA,NA,NA,NA,NA,IDC,NA,Right,Positive,WHITE,NA,YES,1,120,Primary,Female
TCGA.BH.A1F8.01,TCGA.BH.A1F8.01A.11R.A13Q.07,0.17273,0.17273,0,0,TCGA-BH-A1F8,NO,90,NA,NA,25.07,DECEASED,101,0.9971,M0,N2,Stage IIIB,T4b,Breast Invasive Ductal Carcinoma,4301,Positive,NOT HISPANIC OR LATINO,2009/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,1999,YES,12,NA,13,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,NA,Left,Positive,WHITE,NA,YES,1,90,Primary,Female
TCGA.BH.A1FB.01,TCGA.BH.A1FB.01A.11R.A13Q.07,0.276389,0.276389,0,0,TCGA-BH-A1FB,NO,60,NA,NA,120.53,DECEASED,NA,0.0542,M0,N1b,Stage IIB,T2,Breast Invasive Ductal Carcinoma,3871,Positive,NOT HISPANIC OR LATINO,2009/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2000,YES,0,NA,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,NA,Right,Positive,WHITE,NA,YES,1,280,Primary,Female
TCGA.BH.A1FD.01,TCGA.BH.A1FD.01A.11R.A13Q.07,0.025667,0.025667,0,0,TCGA-BH-A1FD,NO,68,NA,NA,33.15,DECEASED,21,0.4385,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,4420,Positive,NOT HISPANIC OR LATINO,2009/8/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,1998,YES,0,NA,19,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,NA,Left,Positive,WHITE,NA,YES,1,120,Primary,Female
TCGA.BH.A1FE.01,TCGA.BH.A1FE.01A.11R.A13Q.07,0.385352,0.385352,0,0,TCGA-BH-A1FE,NO,31,NA,NA,74.67,DECEASED,10,0.1298,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,4456,Positive,NOT HISPANIC OR LATINO,2009/8/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1998,YES,1,NA,12,NA,NA,NA,NA,NA,IDC,NA,Left,Positive,WHITE,NA,YES,2,130,Primary,Female
TCGA.BH.A1FG.01,TCGA.BH.A1FG.01A.11R.A13Q.07,0.022031,0.022031,0,0,TCGA-BH-A1FG,NO,88,NA,NA,122.73,DECEASED,13,0.1163,M0,NX,Stage I,T1c,Breast Invasive Ductal Carcinoma,4460,Positive,NOT HISPANIC OR LATINO,2009/8/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,1998,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,NA,Left,Positive,WHITE,NA,YES,1,120,Primary,Female
TCGA.BH.A1FH.01,TCGA.BH.A1FH.01A.12R.A13Q.07,0.029968,0.029968,0,0,TCGA-BH-A1FH,NO,47,NA,NA,33.97,DECEASED,2,0.0222,M1,N1b,Stage IV,T2,Breast Invasive Ductal Carcinoma,4670,Positive,NOT HISPANIC OR LATINO,2009/8/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1998,YES,8,NA,13,NA,NA,NA,Bone,YES,IDC,NA,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,430,Primary,Female
TCGA.BH.A1FJ.01,TCGA.BH.A1FJ.01A.11R.A13Q.07,0.063744,0.063744,0,0,TCGA-BH-A1FJ,NO,66,NA,NA,63.3,DECEASED,18,0.1001,M0,N1b,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,4574,Negative,NOT HISPANIC OR LATINO,2009/8/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1998,YES,6,NA,35,NA,NA,NA,NA,NA,IDC,NA,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,190,Primary,Female
TCGA.BH.A1FL.01,TCGA.BH.A1FL.01A.11R.A13Q.07,0.073481,0.073481,0,0,TCGA-BH-A1FL,NO,69,NA,NA,54.96,DECEASED,19,0.0908,M0,N1b,Stage IIB,T2,Breast Invasive Ductal Carcinoma,4572,Positive,NOT HISPANIC OR LATINO,2009/8/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1998,YES,4,NA,22,NA,NA,NA,NA,NA,IDC,NA,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,100,Primary,Female
TCGA.BH.A1FM.01,TCGA.BH.A1FM.01A.11R.A13Q.07,0.046191,0.046191,0,0,TCGA-BH-A1FM,NO,44,NA,NA,45.6,DECEASED,31,0.5273,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,4753,Positive,NOT HISPANIC OR LATINO,2009/8/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1998,YES,8,NA,10,NA,NA,NA,NA,NA,IDC,NA,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,260,Primary,Female
TCGA.BH.A1FN.01,TCGA.BH.A1FN.01A.11R.A13Q.07,0.364166,0.364166,0,0,TCGA-BH-A1FN,NO,34,NA,NA,72.01,DECEASED,83,0.5352,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,4838,Positive,NOT HISPANIC OR LATINO,2009/8/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1997,YES,0,NA,29,NA,NA,NA,NA,NA,IDC,NA,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,80,Primary,Female
TCGA.BH.A1FR.01,TCGA.BH.A1FR.01A.11R.A13Q.07,0.545321,0.502989,0,0,TCGA-BH-A1FR,NO,73,NA,NA,53.94,DECEASED,12,5.00E-04,M0,N1a,Stage IIIB,T4b,Breast Invasive Ductal Carcinoma,4876,Positive,NOT HISPANIC OR LATINO,2009/8/11,"Other, specify",NA,No,No,NA,YES,1997,YES,4,NA,10,NA,NA,NA,NA,NA,IDC,NA,Right Upper Inner Quadrant,Positive,WHITE,NA,YES,1,110,Primary,Female
TCGA.BH.A1FU.01,TCGA.BH.A1FU.01A.11R.A14D.07,0.41064,0.41064,0,0,TCGA-BH-A1FU,NO,44,NA,NA,55.45,DECEASED,20,0.0641,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,5041,Negative,NOT HISPANIC OR LATINO,2009/8/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1997,YES,0,NA,5,NA,NA,NA,NA,NA,IDC,NA,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,110,Primary,Female
TCGA.BH.A201.01,TCGA.BH.A201.01A.11R.A14M.07,0.044979,0.044979,0,0,TCGA-BH-A201,NO,64,28.12,DiseaseFree,28.12,LIVING,15,0.1268,M0,N0,Stage IA,T1,Breast Invasive Ductal Carcinoma,86,Positive,NOT HISPANIC OR LATINO,2009/8/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2011,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,NA,Left,Positive,WHITE,NA,YES,1,120,Primary,Female
TCGA.BH.A202.01,TCGA.BH.A202.01A.11R.A14M.07,2.966788,2.865579,0,0,TCGA-BH-A202,NO,60,26.12,DiseaseFree,26.12,LIVING,22,0.2689,M0,N0,Stage II,T2,Breast Invasive Ductal Carcinoma,62,Positive,NOT HISPANIC OR LATINO,2009/8/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2011,YES,0,NA,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,NA,Left,Positive,WHITE,NA,YES,1,200,Primary,Female
TCGA.BH.A203.01,TCGA.BH.A203.01A.12R.A169.07,1.008904,0.921325,0,0,TCGA-BH-A203,NO,78,NA,NA,38.57,DECEASED,36,0.3623,M0,N1b,Stage IIB,T2,Breast Invasive Ductal Carcinoma,5418,NA,NOT HISPANIC OR LATINO,2009/8/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1996,YES,35,NA,39,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,NA,Right,NA,WHITE,NA,YES,1,340,Primary,Female
TCGA.BH.A204.01,TCGA.BH.A204.01A.11R.A157.07,0.012934,0.012934,0,0,TCGA-BH-A204,NO,80,NA,NA,83.25,DECEASED,31,0.2346,M0,N1b,Stage IIB,T2,Breast Invasive Ductal Carcinoma,5538,NA,NOT HISPANIC OR LATINO,2009/8/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1996,YES,2,NA,16,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,NA,Left,NA,WHITE,NA,YES,1,420,Primary,Female
TCGA.BH.A208.01,TCGA.BH.A208.01A.11R.A157.07,0.133449,0.133449,0,0,TCGA-BH-A208,NO,48,NA,NA,57.79,DECEASED,45,0.1644,M0,N1b,Stage IIB,T2,Breast Invasive Ductal Carcinoma,5893,NA,NOT HISPANIC OR LATINO,2009/8/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,1995,YES,3,NA,15,NA,NA,NA,NA,NA,IDC,NA,Left,NA,WHITE,NA,YES,1,620,Primary,Female
TCGA.BH.A209.01,TCGA.BH.A209.01A.11R.A157.07,1.563345,1.473224,0,0,TCGA-BH-A209,NO,77,NA,NA,130.06,DECEASED,53,0.3066,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,5392,Positive,NOT HISPANIC OR LATINO,2009/8/11,Medullary Carcinoma,NA,No,No,NA,YES,1996,YES,0,NA,12,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,NA,Left Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,390,Primary,Female
TCGA.BH.A28O.01,TCGA.BH.A28O.01A.11R.A22K.07,0.145196,0.145196,0,0,TCGA-BH-A28O,NO,50,36.79,DiseaseFree,36.79,LIVING,11,3.00E-04,M0,N3,Stage IIIC,T3a,Breast Invasive Lobular Carcinoma,163,Positive,NOT HISPANIC OR LATINO,2007/2/12,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2010,YES,14,NA,14,NA,NA,NA,NA,NO,ILC,Negative,Right Lower Outer Quadrant,Positive,WHITE,NA,NO,1,80,Primary,Female
TCGA.BH.A28Q.01,TCGA.BH.A28Q.01A.11R.A16F.07,0.029932,0.029932,0,0,TCGA-BH-A28Q,NO,46,36.76,DiseaseFree,36.76,LIVING,16,0.1605,M0,N1a,Stage IIB,T2,Breast Invasive Lobular Carcinoma,223,Positive,NOT HISPANIC OR LATINO,9/29/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2010,YES,2,NA,18,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,ILC,NA,Right,Positive,WHITE,NA,YES,1,400,Primary,Female
TCGA.BH.A2L8.01,TCGA.BH.A2L8.01A.11R.A18M.07,0.450775,0.40209,0,0,TCGA-BH-A2L8,NO,45,20.11,DiseaseFree,20.11,LIVING,279,0.0149,M0,N0 (i-),Stage IIA,T2,Breast Invasive Lobular Carcinoma,86,Positive,NOT HISPANIC OR LATINO,3/27/12,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2011,YES,0,0,1,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,ILC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,210,Primary,Female
TCGA.BH.A42T.01,TCGA.BH.A42T.01A.11R.A24H.07,0.616619,0.616619,0,0,TCGA-BH-A42T,NO,75,NA,NA,10.51,DECEASED,24,0.401,M0,N0 (i+),Stage IIA,T2,Breast Invasive Lobular Carcinoma,80,Positive,NOT HISPANIC OR LATINO,9/28/12,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2012,YES,NA,1,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left,Positive,BLACK OR AFRICAN AMERICAN,NO,NO,1,130,Primary,Female
TCGA.BH.A42V.01,TCGA.BH.A42V.01A.11R.A24H.07,0.227248,0.201948,0.0253,0.125279775,TCGA-BH-A42V,NO,41,20.86,DiseaseFree,20.86,LIVING,27,0.0894,M0,N1mi,Stage IB,T1c,Breast Invasive Ductal Carcinoma,197,Positive,NOT HISPANIC OR LATINO,1/17/13,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2012,YES,1,NA,3,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Positive,Left Lower Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NO,NO,1,60,Primary,Female
TCGA.BH.A5IZ.01,TCGA.BH.A5IZ.01A.11R.A27Q.07,0.086885,0.086885,0,0,TCGA-BH-A5IZ,NO,51,18.63,DiseaseFree,18.63,LIVING,58,0.7932,cM0 (i+),N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,140,Positive,NOT HISPANIC OR LATINO,2/13/14,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2012,YES,1,NA,6,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Negative,BLACK OR AFRICAN AMERICAN,YES,NO,1,70,Primary,Female
TCGA.BH.A5J0.01,TCGA.BH.A5J0.01A.11R.A27Q.07,0.218543,0.207064,0.011479,0.055436966,TCGA-BH-A5J0,NO,63,23.49,DiseaseFree,23.49,LIVING,48,0.4572,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,184,Positive,NOT HISPANIC OR LATINO,2/13/14,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2012,YES,0,NA,5,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Positive,BLACK OR AFRICAN AMERICAN,NO,NO,1,70,Primary,Female
TCGA.BH.A6R8.01,TCGA.BH.A6R8.01A.21R.A33J.07,0.567752,0.567752,0,0,TCGA-BH-A6R8,NO,46,9.63,DiseaseFree,9.63,LIVING,NA,0.3293,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,260,Positive,NOT HISPANIC OR LATINO,2/13/14,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2012,YES,0,NA,4,NA,NA,NA,NA,NA,IDC,Negative,Left,Positive,BLACK OR AFRICAN AMERICAN,YES,NO,1,170,Primary,Female
TCGA.BH.A6R9.01,TCGA.BH.A6R9.01A.21R.A32P.07,2.258904,2.209454,0,0,TCGA-BH-A6R9,NO,61,5.26,DiseaseFree,5.26,LIVING,NA,2.00E-04,M0,N0,Stage IIA,T2,Metaplastic Breast Cancer,237,Negative,NOT HISPANIC OR LATINO,2/13/14,Metaplastic Carcinoma,NA,No,No,Negative,YES,2012,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,MBC,Negative,Left,Positive,WHITE,NO,NO,1,220,Primary,Female
TCGA.BH.A8FY.01,TCGA.BH.A8FY.01A.11R.A36F.07,0.036198,0.019748,0,0,TCGA-BH-A8FY,NO,87,NA,NA,9.69,DECEASED,NA,0.1798,M0,N0 (i+),Stage IA,T1c,Breast Invasive Lobular Carcinoma,477,Positive,NOT HISPANIC OR LATINO,3/25/14,Infiltrating Lobular Carcinoma,NA,No,Yes,Negative,YES,2012,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left|Left Upper Outer Quadrant|Left Lower Outer Quadrant,Positive,WHITE,NO,NO,1,200,Primary,Female
TCGA.BH.A8FZ.01,TCGA.BH.A8FZ.01A.11R.A352.07,1.9212,1.431018,0.455741,0.318473283,TCGA-BH-A8FZ,NO,58,18.86,DiseaseFree,18.86,LIVING,NA,0.1891,M0,N0,Stage IA,T1b,Breast Invasive Lobular Carcinoma,468,Positive,NOT HISPANIC OR LATINO,3/25/14,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2012,YES,0,NA,7,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left,Positive,WHITE,YES,NO,1,190,Primary,Female
TCGA.BH.A8G0.01,TCGA.BH.A8G0.01A.11R.A352.07,0.790424,0.769532,0,0,TCGA-BH-A8G0,NO,54,21.75,DiseaseFree,21.75,LIVING,NA,7.00E-04,M0,N1a,Stage IIB,T2,Breast Invasive Lobular Carcinoma,436,Positive,NOT HISPANIC OR LATINO,3/26/14,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2012,YES,3,NA,3,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,ILC,Negative,Left,Positive,WHITE,NO,NO,1,110,Primary,Female
TCGA.BH.AB28.01,TCGA.BH.AB28.01A.31R.A41B.07,0.771664,0.749053,0,0,TCGA-BH-AB28,NO,53,9.43,DiseaseFree,9.43,LIVING,NA,0.1393,M0,N1a,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,105,Positive,NOT HISPANIC OR LATINO,6/30/14,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2013,YES,3,NA,20,NA,NA,NA,NA,NA,ILC,Negative,Left,Positive,WHITE,NO,NO,1,440,Primary,Female
TCGA.C8.A12K.01,TCGA.C8.A12K.01A.21R.A115.07,0.434681,0.434681,0,0,TCGA-C8-A12K,NO,80,0,DiseaseFree,0,LIVING,77,0.4856,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,57,NA,NOT HISPANIC OR LATINO,2004/12/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2010,NA,1,NA,7,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant,NA,ASIAN,NA,NO,1,970,Primary,Female
TCGA.C8.A12L.01,TCGA.C8.A12L.01A.11R.A115.07,0.327832,0.327832,0,0,TCGA-C8-A12L,NO,67,11.93,DiseaseFree,11.93,LIVING,55,0.6096,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,62,Negative,NOT HISPANIC OR LATINO,2004/12/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,NA,NA,NA,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Negative,ASIAN,NA,NO,1,460,Primary,Female
TCGA.C8.A12M.01,TCGA.C8.A12M.01A.11R.A115.07,0.057384,0.057384,0,0,TCGA-C8-A12M,NO,70,11.76,DiseaseFree,11.76,LIVING,45,0.4491,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,57,Positive,NOT HISPANIC OR LATINO,2004/12/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,NA,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Negative,ASIAN,NA,NO,1,510,Primary,Female
TCGA.C8.A12N.01,TCGA.C8.A12N.01A.11R.A115.07,0.038118,0.038118,0,0,TCGA-C8-A12N,NO,58,11.76,DiseaseFree,11.76,LIVING,15,0.0757,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,57,Positive,NOT HISPANIC OR LATINO,2004/12/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,NA,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Positive,ASIAN,NA,NO,1,290,Primary,Female
TCGA.C8.A12O.01,TCGA.C8.A12O.01A.11R.A115.07,0.089583,0.089583,0,0,TCGA-C8-A12O,NO,50,12.65,DiseaseFree,12.65,LIVING,25,0.3342,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,57,Positive,NOT HISPANIC OR LATINO,4/13/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,NA,NA,10,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left,Positive,ASIAN,NA,NO,1,650,Primary,Female
TCGA.C8.A12P.01,TCGA.C8.A12P.01A.11R.A115.07,0.251491,0.223043,0,0,TCGA-C8-A12P,NO,55,11.76,DiseaseFree,11.76,LIVING,107,0.3385,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,57,Negative,NOT HISPANIC OR LATINO,4/13/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,NA,NA,NA,8,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Negative,ASIAN,NA,NO,1,380,Primary,Female
TCGA.C8.A12Q.01,TCGA.C8.A12Q.01A.11R.A115.07,0.292504,0.292504,0,0,TCGA-C8-A12Q,NO,78,NA,NA,12.65,DECEASED,73,0.4088,M0,N2,Stage IIIA,T1,Breast Invasive Ductal Carcinoma,57,Negative,NOT HISPANIC OR LATINO,4/13/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,NA,NA,NA,7,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Negative,ASIAN,NA,NO,1,810,Primary,Female
TCGA.C8.A12T.01,TCGA.C8.A12T.01A.11R.A115.07,0.359805,0.32035,0,0,TCGA-C8-A12T,NO,43,0,DiseaseFree,0,LIVING,119,0.2311,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,51,Positive,NOT HISPANIC OR LATINO,2004/11/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,YES,0,NA,5,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left,Positive,ASIAN,NA,NO,1,540,Primary,Female
TCGA.C8.A12U.01,TCGA.C8.A12U.01A.11R.A115.07,0.304161,0.286259,0,0,TCGA-C8-A12U,NO,46,12.65,DiseaseFree,12.65,LIVING,29,0.5344,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,57,Positive,NOT HISPANIC OR LATINO,4/13/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,NA,NA,7,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right,Positive,ASIAN,NA,NO,1,580,Primary,Female
TCGA.C8.A12W.01,TCGA.C8.A12W.01A.11R.A115.07,0.607472,0.551534,0,0,TCGA-C8-A12W,NO,49,12.65,DiseaseFree,12.65,LIVING,35,0.3504,M0,N1,Stage IIIB,T4,Breast Invasive Ductal Carcinoma,57,Positive,NOT HISPANIC OR LATINO,4/13/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,NA,NA,7,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left,Positive,ASIAN,NA,NO,1,890,Primary,Female
TCGA.C8.A12X.01,TCGA.C8.A12X.01A.11R.A115.07,0.558751,0.506872,0,0,TCGA-C8-A12X,NO,62,12.65,DiseaseFree,12.65,LIVING,32,0.2971,M0,N1,Stage IIB,T2,Breast Invasive Mixed Mucinous Carcinoma,57,Positive,NOT HISPANIC OR LATINO,4/13/11,Mucinous Carcinoma,NA,No,No,Negative,YES,2010,YES,NA,NA,6,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IMMC,Negative,Left,Positive,ASIAN,NA,NO,1,410,Primary,Female
TCGA.C8.A12Y.01,TCGA.C8.A12Y.01A.11R.A12D.07,0.018686,0.018686,0,0,TCGA-C8-A12Y,NO,44,48.49,DiseaseFree,48.49,LIVING,21,0.2329,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,57,NA,NOT HISPANIC OR LATINO,4/13/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2010,YES,NA,NA,9,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left,NA,ASIAN,NA,NO,1,380,Primary,Female
TCGA.C8.A12Z.01,TCGA.C8.A12Z.01A.11R.A115.07,0.005291,0.005291,0,0,TCGA-C8-A12Z,NO,45,12.55,DiseaseFree,12.55,LIVING,35,0.2697,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,69,Negative,NOT HISPANIC OR LATINO,4/13/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,YES,2,NA,2,Negative,Peri (6-12 months since last menstrual period),NA,NA,NO,IDC,Negative,Right,Negative,ASIAN,NA,NO,1,490,Primary,Female
TCGA.C8.A130.01,TCGA.C8.A130.01A.31R.A115.07,0.380992,0.374951,0,0,TCGA-C8-A130,NO,52,12.16,DiseaseFree,12.16,LIVING,21,0.5081,M0,N2,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,89,Positive,NOT HISPANIC OR LATINO,4/13/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,YES,NA,NA,8,NA,Peri (6-12 months since last menstrual period),NA,NA,NO,IDC,Negative,Left,Positive,ASIAN,NA,NO,1,550,Primary,Female
TCGA.C8.A132.01,TCGA.C8.A132.01A.31R.A115.07,4.147393,3.730437,0.047221,0.012658302,TCGA-C8-A132,NO,56,12.58,DiseaseFree,12.58,LIVING,37,0.1483,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,162,Positive,NOT HISPANIC OR LATINO,4/15/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2010,YES,1,NA,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left,Positive,ASIAN,NA,NO,1,420,Primary,Female
TCGA.C8.A133.01,TCGA.C8.A133.01A.32R.A12D.07,0.066382,0.066382,0,0,TCGA-C8-A133,NO,65,0,DiseaseFree,0,LIVING,18,0.0053,M0,N1,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,119,Positive,NOT HISPANIC OR LATINO,4/15/11,"Other, specify",NA,No,No,NA,YES,2010,YES,NA,NA,26,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Positive,WHITE,NA,NO,1,480,Primary,Female
TCGA.C8.A135.01,TCGA.C8.A135.01A.11R.A115.07,0.149744,0.149744,0,0,TCGA-C8-A135,NO,64,12.91,DiseaseFree,12.91,LIVING,36,0.2977,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,162,Negative,NOT HISPANIC OR LATINO,4/15/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,YES,1,NA,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left,Negative,ASIAN,NA,NO,1,760,Primary,Female
TCGA.C8.A137.01,TCGA.C8.A137.01A.11R.A115.07,0.056681,0.056681,0,0,TCGA-C8-A137,NO,34,4.47,Recurred/Progressed,12.45,LIVING,35,0.2233,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,102,Negative,NOT HISPANIC OR LATINO,4/15/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,YES,NA,NA,2,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left,Negative,ASIAN,NA,NO,1,610,Primary,Female
TCGA.C8.A138.01,TCGA.C8.A138.01A.11R.A115.07,0.380209,0.380209,0,0,TCGA-C8-A138,NO,54,12.48,DiseaseFree,12.48,LIVING,37,0.3556,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,93,Positive,NOT HISPANIC OR LATINO,4/15/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,YES,NA,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left,Negative,ASIAN,NA,NO,1,230,Primary,Female
TCGA.C8.A1HE.01,TCGA.C8.A1HE.01A.11R.A13Q.07,0.053982,0.053982,0,0,TCGA-C8-A1HE,NO,59,12.32,DiseaseFree,12.32,LIVING,28,0.1178,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,109,Positive,NOT HISPANIC OR LATINO,5/24/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,YES,NA,NA,5,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right,Positive,ASIAN,NA,NO,1,280,Primary,Female
TCGA.C8.A1HF.01,TCGA.C8.A1HF.01A.11R.A137.07,1.393851,1.24308,0,0,TCGA-C8-A1HF,NO,48,10.91,DiseaseFree,10.91,LIVING,21,0.2475,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,109,Negative,NOT HISPANIC OR LATINO,5/24/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,YES,NA,NA,12,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left,Positive,ASIAN,NA,NO,1,460,Primary,Female
TCGA.C8.A1HG.01,TCGA.C8.A1HG.01A.11R.A137.07,0.290937,0.290937,0,0,TCGA-C8-A1HG,NO,50,11.33,DiseaseFree,11.33,LIVING,24,0.3587,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,122,Positive,NOT HISPANIC OR LATINO,5/24/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NO,NA,NA,NA,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right,Positive,ASIAN,NA,NO,1,300,Primary,Female
TCGA.C8.A1HI.01,TCGA.C8.A1HI.01A.11R.A137.07,0.096266,0.096266,0,0,TCGA-C8-A1HI,NO,40,11.27,DiseaseFree,11.27,LIVING,24,0.2579,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,120,Positive,NOT HISPANIC OR LATINO,2006/1/11,Infiltrating Ductal Carcinoma,NA,Yes,No,Negative,YES,2010,YES,NA,NA,6,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right,Positive,ASIAN,NA,NO,1,490,Primary,Female
TCGA.C8.A1HK.01,TCGA.C8.A1HK.01A.21R.A13Q.07,2.404977,2.252358,0,0,TCGA-C8-A1HK,NO,53,12.02,DiseaseFree,12.02,LIVING,36,0.518,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,116,Negative,NOT HISPANIC OR LATINO,2006/1/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,YES,NA,NA,8,NA,Peri (6-12 months since last menstrual period),NA,NA,NO,IDC,Negative,Right,Negative,ASIAN,NA,NO,1,460,Primary,Female
TCGA.C8.A1HL.01,TCGA.C8.A1HL.01A.11R.A137.07,0.262788,0.262788,0,0,TCGA-C8-A1HL,NO,38,10.41,DiseaseFree,10.41,LIVING,22,0.2376,M0,N1,Stage IIIA,T3,Breast Invasive Mixed Mucinous Carcinoma,94,Positive,NOT HISPANIC OR LATINO,2006/2/11,"Other, specify",NA,No,Yes,Equivocal,YES,2010,YES,NA,NA,9,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IMMC,Negative,Left,Negative,ASIAN,NA,NO,1,980,Primary,Female
TCGA.C8.A1HM.01,TCGA.C8.A1HM.01A.12R.A137.07,0.239834,0.239834,0,0,TCGA-C8-A1HM,NO,74,12.32,DiseaseFree,12.32,LIVING,222,0.5116,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,100,Positive,NOT HISPANIC OR LATINO,2006/2/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NO,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left,Positive,ASIAN,NA,NO,1,680,Primary,Female
TCGA.C8.A1HN.01,TCGA.C8.A1HN.01A.11R.A137.07,0.245528,0.122489,0,0,TCGA-C8-A1HN,NO,56,12.94,DiseaseFree,12.94,LIVING,33,0.436,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,88,Positive,NOT HISPANIC OR LATINO,2006/2/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,NO,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left,Positive,ASIAN,NA,NO,1,280,Primary,Female
TCGA.C8.A1HO.01,TCGA.C8.A1HO.01A.11R.A13Q.07,0.501024,0.501024,0,0,TCGA-C8-A1HO,NO,34,12.32,DiseaseFree,12.32,LIVING,16,0.3198,M0,N3,Stage IIIC,T3,Breast Invasive Ductal Carcinoma,52,Positive,NOT HISPANIC OR LATINO,2007/12/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NO,NA,NA,NA,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant,Positive,ASIAN,NA,NO,1,380,Primary,Female
TCGA.C8.A26V.01,TCGA.C8.A26V.01A.11R.A16F.07,0.164126,0.120821,0,0,TCGA-C8-A26V,NO,47,20.24,DiseaseFree,20.24,LIVING,54,0.1835,M0,N2,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,143,Positive,NOT HISPANIC OR LATINO,7/21/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NO,NA,NA,NA,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,IDC,Negative,Right,Positive,ASIAN,NA,NO,1,310,Primary,Female
TCGA.C8.A26W.01,TCGA.C8.A26W.01A.11R.A16F.07,0.080883,0.080883,0,0,TCGA-C8-A26W,NO,58,12.52,DiseaseFree,12.52,LIVING,37,0.3238,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,142,Positive,NOT HISPANIC OR LATINO,7/21/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,NO,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,ASIAN,NA,NO,1,300,Primary,Female
TCGA.C8.A26Z.01,TCGA.C8.A26Z.01A.11R.A16F.07,0.275102,0.153721,0,0,TCGA-C8-A26Z,NO,59,15.44,DiseaseFree,15.44,LIVING,33,0.5299,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,125,Positive,NOT HISPANIC OR LATINO,7/21/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NO,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Inner Quadrant,Positive,ASIAN,NA,NO,1,470,Primary,Female
TCGA.C8.A273.01,TCGA.C8.A273.01A.11R.A16F.07,0.20745,0.20745,0,0,TCGA-C8-A273,NO,29,16.85,DiseaseFree,16.85,LIVING,13,0.2254,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,168,Positive,NOT HISPANIC OR LATINO,7/21/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,2,NA,7,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant,Positive,ASIAN,NA,NO,1,590,Primary,Female
TCGA.C8.A274.01,TCGA.C8.A274.01A.11R.A16F.07,0.335634,0.335634,0,0,TCGA-C8-A274,NO,63,16.69,DiseaseFree,16.69,LIVING,124,0.4187,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,163,Positive,NOT HISPANIC OR LATINO,7/21/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NO,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Positive,ASIAN,NA,NO,1,470,Primary,Female
TCGA.C8.A275.01,TCGA.C8.A275.01A.21R.A16F.07,0.826684,0.619354,0,0,TCGA-C8-A275,NO,56,0.03,DiseaseFree,0.03,LIVING,90,0.2019,M0,N1,Stage IIA,T1,Breast Invasive Ductal Carcinoma,169,NA,NOT HISPANIC OR LATINO,7/21/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2010,NO,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,NA,ASIAN,NA,NO,1,300,Primary,Female
TCGA.C8.A278.01,TCGA.C8.A278.01A.11R.A169.07,2.946175,2.900057,0,0,TCGA-C8-A278,NO,61,9.76,DiseaseFree,9.76,LIVING,23,0.1661,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,163,Negative,NOT HISPANIC OR LATINO,7/21/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,NO,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Negative,ASIAN,NA,NO,1,630,Primary,Female
TCGA.C8.A27A.01,TCGA.C8.A27A.01A.11R.A169.07,0.844094,0.844094,0,0,TCGA-C8-A27A,NO,48,24.54,DiseaseFree,24.54,LIVING,17,0.3008,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,435,Positive,NOT HISPANIC OR LATINO,7/21/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NO,NA,NA,NA,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,ASIAN,NA,NO,1,230,Primary,Female
TCGA.C8.A3M8.01,TCGA.C8.A3M8.01A.11R.A213.07,0.191888,0.191888,0,0,TCGA-C8-A3M8,NO,68,12.94,DiseaseFree,12.94,LIVING,40,0.2516,M0,N0,Stage IA,T1c,Breast Invasive Lobular Carcinoma,264,Positive,NOT HISPANIC OR LATINO,2003/6/12,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2011,YES,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Right Upper Outer Quadrant,Positive,ASIAN,NA,NO,1,280,Primary,Female
TCGA.C8.A8HP.01,TCGA.C8.A8HP.01A.11R.A36F.07,2.852946,1.397477,0,0,TCGA-C8-A8HP,NO,59,13.01,DiseaseFree,13.01,LIVING,NA,0.0419,M0,N2,Stage IIIA,T2,Metaplastic Breast Cancer,231,Negative,NOT HISPANIC OR LATINO,12/29/14,Metaplastic Carcinoma,NA,No,No,Positive,YES,2013,YES,6,NA,9,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,MBC,Negative,Left Upper Outer Quadrant,Negative,ASIAN,NO,NO,1,240,Primary,Female
TCGA.C8.A8HQ.01,TCGA.C8.A8HQ.01A.11R.A36F.07,3.305077,3.305077,0,0,TCGA-C8-A8HQ,NO,53,12.48,DiseaseFree,12.48,LIVING,NA,0.2302,M0,N1,Stage IIB,T2,Breast Invasive Mixed Mucinous Carcinoma,185,Positive,NOT HISPANIC OR LATINO,12/29/14,Mucinous Carcinoma,NA,No,No,Negative,YES,2013,YES,3,4,7,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IMMC,Negative,Left,Positive,ASIAN,NO,NO,1,300,Primary,Female
TCGA.C8.A8HR.01,TCGA.C8.A8HR.01A.11R.A36F.07,2.349963,2.279853,0.043389,0.01903149,TCGA-C8-A8HR,NO,49,13.4,DiseaseFree,13.4,LIVING,NA,0.012,M0,N2,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,162,NA,NOT HISPANIC OR LATINO,12/29/14,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2013,YES,5,NA,8,NA,Peri (6-12 months since last menstrual period),NA,NA,NA,ILC,Negative,Right,NA,ASIAN,NO,NO,1,420,Primary,Female
TCGA.D8.A13Y.01,TCGA.D8.A13Y.01A.11R.A115.07,0.061995,0.061995,0,0,TCGA-D8-A13Y,NO,52,56.77,DiseaseFree,56.77,LIVING,49,0.947,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,184,Positive,NOT HISPANIC OR LATINO,2/23/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,0,NA,6,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,430,Primary,Female
TCGA.D8.A140.01,TCGA.D8.A140.01A.11R.A115.07,1.222892,1.021494,0,0,TCGA-D8-A140,NO,62,13.24,DiseaseFree,13.24,LIVING,66,0.2323,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,204,Positive,NOT HISPANIC OR LATINO,2/26/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,YES,1,NA,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant|Left,Positive,WHITE,NA,NO,1,400,Primary,Female
TCGA.D8.A141.01,TCGA.D8.A141.01A.11R.A115.07,1.160262,1.160262,0,0,TCGA-D8-A141,NO,40,20.57,DiseaseFree,20.57,LIVING,13,0.049,M0,N1,NA,T1c,Breast Invasive Ductal Carcinoma,205,Positive,NOT HISPANIC OR LATINO,2/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,1,NA,15,NA,Indeterminate (neither Pre or Postmenopausal),NA,NA,NA,IDC,Negative,Right,Positive,WHITE,NA,NO,1,120,Primary,Female
TCGA.D8.A145.01,TCGA.D8.A145.01A.11R.A115.07,0.266382,0.266382,0,0,TCGA-D8-A145,NO,80,13.47,DiseaseFree,13.47,LIVING,19,0.0845,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,191,Positive,NOT HISPANIC OR LATINO,2/25/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,YES,1,NA,7,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant|Right,Positive,WHITE,NA,NO,1,190,Primary,Female
TCGA.D8.A146.01,TCGA.D8.A146.01A.31R.A115.07,0.592467,0.556802,0,0,TCGA-D8-A146,NO,57,21.12,DiseaseFree,21.12,LIVING,26,0.164,MX,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,221,Positive,NOT HISPANIC OR LATINO,3/30/11,Infiltrating Ductal Carcinoma,NA,Yes,Yes,Negative,YES,2010,YES,0,NA,11,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant|Right,Positive,WHITE,NA,NO,1,230,Primary,Female
TCGA.D8.A1J8.01,TCGA.D8.A1J8.01A.11R.A13Q.07,0.079045,0.079045,0,0,TCGA-D8-A1J8,NO,77,14.16,DiseaseFree,14.16,LIVING,543,0.8977,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,272,Positive,NOT HISPANIC OR LATINO,3/23/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,3,NA,16,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,260,Primary,Female
TCGA.D8.A1J9.01,TCGA.D8.A1J9.01A.11R.A13Q.07,0.116637,0.116637,0,0,TCGA-D8-A1J9,NO,48,17.48,DiseaseFree,17.48,LIVING,117,0.3573,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,211,Positive,NOT HISPANIC OR LATINO,3/29/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,NA,0,NA,6,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,NO,1,230,Primary,Female
TCGA.D8.A1JA.01,TCGA.D8.A1JA.01A.11R.A13Q.07,1.513018,1.499327,0,0,TCGA-D8-A1JA,NO,60,14.16,Recurred/Progressed,16.49,LIVING,674,0.2448,M0,NX,NA,T4b,Breast Invasive Ductal Carcinoma,194,Negative,NOT HISPANIC OR LATINO,3/29/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,NO,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,NO,1,310,Primary,Female
TCGA.D8.A1JB.01,TCGA.D8.A1JB.01A.11R.A13Q.07,1.376668,1.376668,0,0,TCGA-D8-A1JB,NO,54,55.45,DiseaseFree,55.45,LIVING,18,0.0338,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,232,Positive,NOT HISPANIC OR LATINO,3/29/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,YES,1,NA,8,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,350,Primary,Female
TCGA.D8.A1JC.01,TCGA.D8.A1JC.01A.11R.A13Q.07,0.378605,0.378605,0,0,TCGA-D8-A1JC,NO,59,15.77,DiseaseFree,15.77,LIVING,54,0.3667,M0,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,201,Positive,NOT HISPANIC OR LATINO,3/29/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,4,NA,11,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,NO,1,180,Primary,Female
TCGA.D8.A1JD.01,TCGA.D8.A1JD.01A.11R.A13Q.07,1.418559,0.315551,0,0,TCGA-D8-A1JD,NO,41,18.13,DiseaseFree,18.13,LIVING,63,0.4688,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,230,Positive,NOT HISPANIC OR LATINO,3/29/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,NA,3,0,14,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,NO,1,400,Primary,Female
TCGA.D8.A1JE.01,TCGA.D8.A1JE.01A.11R.A13Q.07,0.095345,0.095345,0,0,TCGA-D8-A1JE,NO,62,18.89,DiseaseFree,18.89,LIVING,26,0.6207,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,238,Positive,NOT HISPANIC OR LATINO,3/28/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,3,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,NO,1,260,Primary,Female
TCGA.D8.A1JH.01,TCGA.D8.A1JH.01A.11R.A13Q.07,1.970363,1.970363,0,0,TCGA-D8-A1JH,NO,56,13.99,DiseaseFree,13.99,LIVING,15,1.00E-04,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,263,Positive,NOT HISPANIC OR LATINO,3/28/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,NA,NA,9,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Lower Outer Quadrant,Positive,WHITE,NA,NO,1,140,Primary,Female
TCGA.D8.A1JI.01,TCGA.D8.A1JI.01A.11R.A13Q.07,0.096121,0.065071,0,0,TCGA-D8-A1JI,NO,54,18.96,DiseaseFree,18.96,LIVING,22,0.39,MX,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,226,Positive,NOT HISPANIC OR LATINO,3/30/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,2,NA,22,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,190,Primary,Female
TCGA.D8.A1JJ.01,TCGA.D8.A1JJ.01A.31R.A14M.07,0.195578,0.195578,0,0,TCGA-D8-A1JJ,NO,54,20.07,DiseaseFree,20.07,LIVING,48,0.4374,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,260,Positive,NOT HISPANIC OR LATINO,3/29/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,0,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Inner Quadrant,Positive,WHITE,NA,NO,1,240,Primary,Female
TCGA.D8.A1JK.01,TCGA.D8.A1JK.01A.11R.A13Q.07,1.390058,1.390058,0,0,TCGA-D8-A1JK,NO,90,20.11,DiseaseFree,20.11,LIVING,127,0.4906,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,261,Negative,NOT HISPANIC OR LATINO,3/29/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,0,NA,13,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Positive,WHITE,NA,NO,1,270,Primary,Female
TCGA.D8.A1JM.01,TCGA.D8.A1JM.01A.11R.A13Q.07,0.063409,0.063409,0,0,TCGA-D8-A1JM,NO,59,19.38,DiseaseFree,19.38,LIVING,28,0.6736,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,243,Positive,NOT HISPANIC OR LATINO,3/29/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,3,NA,11,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,NO,1,350,Primary,Female
TCGA.D8.A1JN.01,TCGA.D8.A1JN.01A.11R.A13Q.07,0.753153,0.599468,0,0,TCGA-D8-A1JN,NO,80,20.37,DiseaseFree,20.37,LIVING,104,0.1263,MX,N3a,Stage IIIC,T3,Breast Invasive Lobular Carcinoma,273,Positive,NOT HISPANIC OR LATINO,3/29/11,Infiltrating Lobular Carcinoma,NA,No,No,Indeterminate,YES,2010,YES,11,NA,13,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left,Positive,WHITE,NA,NO,1,180,Primary,Female
TCGA.D8.A1JP.01,TCGA.D8.A1JP.01A.11R.A13Q.07,0.478707,0.442294,0,0,TCGA-D8-A1JP,NO,73,20.99,DiseaseFree,20.99,LIVING,81,0.4267,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,292,Positive,NOT HISPANIC OR LATINO,3/29/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,NA,NA,1,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,NO,1,430,Primary,Female
TCGA.D8.A1JS.01,TCGA.D8.A1JS.01A.11R.A13Q.07,0.984799,0.942909,0,0,TCGA-D8-A1JS,NO,77,12.19,DiseaseFree,12.19,LIVING,13,0.0619,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,212,Positive,NOT HISPANIC OR LATINO,3/28/11,"Other, specify",NA,No,No,Negative,YES,2010,YES,0,NA,13,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,190,Primary,Female
TCGA.D8.A1JT.01,TCGA.D8.A1JT.01A.31R.A13Q.07,0,0,0,NA,TCGA-D8-A1JT,NO,70,13.3,DiseaseFree,13.3,LIVING,22,0.4147,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,250,Positive,NOT HISPANIC OR LATINO,3/28/11,"Other, specify",NA,No,No,Equivocal,YES,2010,YES,0,NA,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Outer Quadrant,Positive,WHITE,NA,NO,1,250,Primary,Female
TCGA.D8.A1JU.01,TCGA.D8.A1JU.01A.11R.A13Q.07,0.032128,0.032128,0,0,TCGA-D8-A1JU,NO,51,14.68,DiseaseFree,14.68,LIVING,7,0.1035,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,295,Positive,NOT HISPANIC OR LATINO,3/28/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,0,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,NO,1,450,Primary,Female
TCGA.D8.A1X5.01,TCGA.D8.A1X5.01A.11R.A14D.07,0.027004,0.027004,0,0,TCGA-D8-A1X5,NO,81,18.56,DiseaseFree,18.56,LIVING,31,0.631,MX,N3a,Stage IIIC,T2,Breast Invasive Ductal Carcinoma,197,Positive,NOT HISPANIC OR LATINO,2006/9/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,YES,14,NA,16,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant,Positive,WHITE,NA,NO,1,240,Primary,Female
TCGA.D8.A1X6.01,TCGA.D8.A1X6.01A.11R.A14M.07,0.602651,0.602651,0,0,TCGA-D8-A1X6,NO,80,17.77,DiseaseFree,17.77,LIVING,34,0.3619,MX,N2a,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,173,Positive,NOT HISPANIC OR LATINO,2006/9/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,5,NA,7,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Positive,WHITE,NA,NO,1,550,Primary,Female
TCGA.D8.A1X7.01,TCGA.D8.A1X7.01A.11R.A14M.07,0.094344,0.094344,0,0,TCGA-D8-A1X7,NO,40,16.72,DiseaseFree,16.72,LIVING,20,0.0853,MX,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,141,Positive,NOT HISPANIC OR LATINO,2006/9/11,"Other, specify",NA,No,No,Negative,YES,2010,YES,0,NA,3,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,170,Primary,Female
TCGA.D8.A1X8.01,TCGA.D8.A1X8.01A.11R.A14M.07,0.144418,0.144418,0,0,TCGA-D8-A1X8,NO,62,25.72,DiseaseFree,25.72,LIVING,18,0.1153,M0,N2a,Stage IIIA,T1c,Breast Invasive Lobular Carcinoma,225,Positive,NOT HISPANIC OR LATINO,5/16/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2010,YES,9,0,11,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Left Lower Outer Quadrant,Indeterminate,WHITE,NA,NO,1,360,Primary,Female
TCGA.D8.A1X9.01,TCGA.D8.A1X9.01A.12R.A157.07,0.710626,0.710626,0,0,TCGA-D8-A1X9,NO,66,23.88,DiseaseFree,23.88,LIVING,66,0.2815,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,399,Positive,NOT HISPANIC OR LATINO,5/16/11,Infiltrating Ductal Carcinoma,NA,No,No,Indeterminate,YES,2010,YES,3,0,23,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,NA,Left Lower Outer Quadrant,Positive,WHITE,NA,NO,1,170,Primary,Female
TCGA.D8.A1XA.01,TCGA.D8.A1XA.01A.11R.A14D.07,0.105655,0.105655,0,0,TCGA-D8-A1XA,NO,64,27.56,DiseaseFree,27.56,LIVING,21,0.8612,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,218,Positive,NOT HISPANIC OR LATINO,5/18/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,YES,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,NO,1,140,Primary,Female
TCGA.D8.A1XB.01,TCGA.D8.A1XB.01A.11R.A14D.07,0.058273,0.058273,0,0,TCGA-D8-A1XB,NO,62,18.13,DiseaseFree,18.13,LIVING,22,0.217,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,251,Positive,NOT HISPANIC OR LATINO,5/16/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,1,0,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,210,Primary,Female
TCGA.D8.A1XC.01,TCGA.D8.A1XC.01A.11R.A14D.07,0.006005,0.006005,0,0,TCGA-D8-A1XC,NO,85,NA,NA,12.39,DECEASED,22,0.0566,M0,N1a,Stage IIIB,T4b,Breast Invasive Mixed Mucinous Carcinoma,215,Positive,NOT HISPANIC OR LATINO,5/16/11,Mucinous Carcinoma,NA,No,No,Negative,YES,2010,YES,1,0,20,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IMMC,Negative,Right Upper Inner Quadrant,Positive,WHITE,NA,NO,1,260,Primary,Female
TCGA.D8.A1XD.01,TCGA.D8.A1XD.01A.11R.A14D.07,0.276836,0.276836,0,0,TCGA-D8-A1XD,NO,36,17.15,DiseaseFree,17.15,LIVING,NA,0.148,M0,N2a,Stage IIIA,T1c,Breast Invasive Ductal Carcinoma,188,Positive,NOT HISPANIC OR LATINO,5/16/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,6,NA,18,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,NO,1,210,Primary,Female
TCGA.D8.A1XF.01,TCGA.D8.A1XF.01A.11R.A14D.07,0.049645,0.003672,0,0,TCGA-D8-A1XF,NO,45,15.21,DiseaseFree,15.21,LIVING,28,0.6723,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,170,Positive,NOT HISPANIC OR LATINO,5/16/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,0,0,8,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,NA,Left Upper Outer Quadrant,Positive,WHITE,NA,NO,1,180,Primary,Female
TCGA.D8.A1XG.01,TCGA.D8.A1XG.01A.11R.A14D.07,0.08327,0.049832,0,0,TCGA-D8-A1XG,NO,86,14.72,DiseaseFree,14.72,LIVING,19,0.1533,M0,N1a,Stage IIIB,T4b,Breast Invasive Ductal Carcinoma,169,Positive,NOT HISPANIC OR LATINO,5/16/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,2,0,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Inner Quadrant,Negative,WHITE,NA,NO,1,590,Primary,Female
TCGA.D8.A1XJ.01,TCGA.D8.A1XJ.01A.11R.A14M.07,0.068517,0.068517,0,0,TCGA-D8-A1XJ,NO,76,21.81,DiseaseFree,21.81,LIVING,57,0.3525,MX,N1a,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,295,Positive,NOT HISPANIC OR LATINO,2006/9/11,"Other, specify",NA,No,No,Positive,YES,2010,YES,2,NA,43,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant|Left Lower Outer Quadrant,Positive,WHITE,NA,NO,1,440,Primary,Female
TCGA.D8.A1XL.01,TCGA.D8.A1XL.01A.11R.A14M.07,0.064681,0.064681,0,0,TCGA-D8-A1XL,NO,34,19.91,DiseaseFree,19.91,LIVING,79,0.5466,MX,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,282,Positive,NOT HISPANIC OR LATINO,2006/9/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,YES,2,NA,13,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,NO,1,260,Primary,Female
TCGA.D8.A1XM.01,TCGA.D8.A1XM.01A.21R.A14M.07,0.193685,0.193685,0,0,TCGA-D8-A1XM,NO,57,17.67,DiseaseFree,17.67,LIVING,38,0.1667,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,189,Positive,NOT HISPANIC OR LATINO,5/16/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Inner Quadrant,Positive,WHITE,NA,NO,1,200,Primary,Female
TCGA.D8.A1XO.01,TCGA.D8.A1XO.01A.11R.A14M.07,0.044807,0.044807,0,0,TCGA-D8-A1XO,NO,56,55.26,DiseaseFree,55.26,LIVING,11,0.2323,M0,N1a,Stage IIB,T2,Breast Invasive Lobular Carcinoma,193,Positive,NOT HISPANIC OR LATINO,5/16/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2010,YES,1,0,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Left Lower Outer Quadrant,Positive,WHITE,NA,NO,1,360,Primary,Female
TCGA.D8.A1XR.01,TCGA.D8.A1XR.01A.11R.A14M.07,0.009311,0.009311,0,0,TCGA-D8-A1XR,NO,56,15.83,DiseaseFree,15.83,LIVING,21,0.2173,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,162,Positive,NOT HISPANIC OR LATINO,5/16/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,2,0,7,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,170,Primary,Female
TCGA.D8.A1XS.01,TCGA.D8.A1XS.01A.11R.A14M.07,0.045253,0.045253,0,0,TCGA-D8-A1XS,NO,48,16.29,DiseaseFree,16.29,LIVING,12,0.2212,M0,N3a,Stage IIIC,T2,Invasive Breast Carcinoma,164,Positive,NOT HISPANIC OR LATINO,5/16/11,"Other, specify",NA,No,No,Positive,YES,2010,YES,25,0,28,NA,NA,NA,NA,NO,BRCA,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,NO,1,340,Primary,Male
TCGA.D8.A1XT.01,TCGA.D8.A1XT.01A.11R.A14M.07,0.053061,0.053061,0,0,TCGA-D8-A1XT,NO,61,16.62,DiseaseFree,16.62,LIVING,31,0.3942,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,144,Negative,NOT HISPANIC OR LATINO,5/16/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,YES,3,0,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,NO,1,230,Primary,Female
TCGA.D8.A1XU.01,TCGA.D8.A1XU.01A.11R.A14M.07,0.009616,0.009616,0,0,TCGA-D8-A1XU,NO,56,12.98,DiseaseFree,12.98,LIVING,13,0.9465,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,102,Positive,NOT HISPANIC OR LATINO,5/16/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,0,0,1,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,NO,1,210,Primary,Female
TCGA.D8.A1XV.01,TCGA.D8.A1XV.01A.11R.A14M.07,0.027377,0.027377,0,0,TCGA-D8-A1XV,NO,84,15.14,DiseaseFree,15.14,LIVING,18,0.0342,M0,N0,Stage IIA,T2,Breast Invasive Mixed Mucinous Carcinoma,103,Positive,NOT HISPANIC OR LATINO,5/16/11,Mucinous Carcinoma,NA,No,No,Equivocal,YES,2010,YES,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IMMC,Negative,Right Lower Inner Quadrant,Positive,WHITE,NA,NO,1,420,Primary,Female
TCGA.D8.A1XW.01,TCGA.D8.A1XW.01A.11R.A14M.07,0.064264,0.064264,0,0,TCGA-D8-A1XW,NO,53,43,DiseaseFree,43,LIVING,67,0.3797,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,76,Negative,NOT HISPANIC OR LATINO,5/16/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2011,YES,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,NO,1,310,Primary,Female
TCGA.D8.A1XY.01,TCGA.D8.A1XY.01A.11R.A14M.07,1.299031,1.299031,0,0,TCGA-D8-A1XY,NO,74,16.52,DiseaseFree,16.52,LIVING,27,0.3139,MX,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,135,Positive,NOT HISPANIC OR LATINO,2006/9/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,YES,0,NA,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,NA,Left Upper Outer Quadrant,Positive,WHITE,NA,NO,1,190,Primary,Female
TCGA.D8.A1XZ.01,TCGA.D8.A1XZ.01A.11R.A14M.07,0.637443,0.637443,0,0,TCGA-D8-A1XZ,NO,81,15.31,DiseaseFree,15.31,LIVING,46,0.356,MX,N2a,Stage IIIA,T1c,Breast Invasive Ductal Carcinoma,98,Positive,NOT HISPANIC OR LATINO,2006/9/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,6,NA,14,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Lower Inner Quadrant,Negative,WHITE,NA,NO,1,130,Primary,Female
TCGA.D8.A1Y0.01,TCGA.D8.A1Y0.01A.11R.A14M.07,0.102135,0.102135,0,0,TCGA-D8-A1Y0,NO,65,15.51,DiseaseFree,15.51,LIVING,43,0.3854,MX,N2a,Stage IIIA,T1c,Breast Invasive Ductal Carcinoma,104,Positive,NOT HISPANIC OR LATINO,2006/9/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,9,NA,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,NA,Left,Positive,WHITE,NA,NO,1,190,Primary,Female
TCGA.D8.A1Y1.01,TCGA.D8.A1Y1.01A.21R.A14M.07,0.053426,0.053426,0,0,TCGA-D8-A1Y1,NO,80,NA,NA,9.92,DECEASED,162,0.5329,MX,N1a,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,93,Positive,NOT HISPANIC OR LATINO,2006/9/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,1,NA,22,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,NA,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Positive,WHITE,NA,NO,1,200,Primary,Female
TCGA.D8.A1Y2.01,TCGA.D8.A1Y2.01A.11R.A157.07,0.591502,0.583013,0,0,TCGA-D8-A1Y2,NO,71,14.22,DiseaseFree,14.22,LIVING,16,0.3094,MX,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,65,Positive,NOT HISPANIC OR LATINO,2006/9/11,Infiltrating Ductal Carcinoma,NA,No,No,Indeterminate,YES,2011,YES,0,NA,7,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Lower Outer Quadrant,Positive,WHITE,NA,NO,1,470,Primary,Female
TCGA.D8.A1Y3.01,TCGA.D8.A1Y3.01A.11R.A157.07,0.255944,0.241427,0,0,TCGA-D8-A1Y3,NO,61,14.13,DiseaseFree,14.13,LIVING,37,0.612,MX,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,62,Positive,NOT HISPANIC OR LATINO,2006/9/11,Infiltrating Ductal Carcinoma,NA,No,No,Indeterminate,YES,2011,YES,5,NA,8,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,300,Primary,Female
TCGA.D8.A27E.01,TCGA.D8.A27E.01A.11R.A16F.07,0.179282,0.179282,0,0,TCGA-D8-A27E,NO,66,17.41,DiseaseFree,17.41,LIVING,8,1.00E-04,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,204,Positive,NOT HISPANIC OR LATINO,7/21/11,"Other, specify",NA,No,No,Negative,YES,2010,YES,0,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,NO,1,110,Primary,Female
TCGA.D8.A27G.01,TCGA.D8.A27G.01A.11R.A16F.07,0.204047,0.204047,0,0,TCGA-D8-A27G,NO,75,13.44,DiseaseFree,13.44,LIVING,712,0.1084,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,156,Positive,NOT HISPANIC OR LATINO,7/18/11,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2010,YES,0,0,31,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Left Lower Outer Quadrant,Positive,WHITE,NA,NO,1,170,Primary,Female
TCGA.D8.A27I.01,TCGA.D8.A27I.01A.11R.A16F.07,0.024737,0.024737,0,0,TCGA-D8-A27I,NO,58,14.42,DiseaseFree,14.42,LIVING,25,0.0458,M0,N2a,Stage IIIA,T1c,Breast Invasive Lobular Carcinoma,132,Positive,NOT HISPANIC OR LATINO,7/18/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2010,YES,4,0,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,900,Primary,Female
TCGA.D8.A27K.01,TCGA.D8.A27K.01A.11R.A16F.07,0.26235,0.217644,0,0,TCGA-D8-A27K,NO,47,48,DiseaseFree,48,LIVING,19,0.1153,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,77,Positive,NOT HISPANIC OR LATINO,7/18/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2011,YES,2,NA,17,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,NO,1,190,Primary,Female
TCGA.D8.A27L.01,TCGA.D8.A27L.01A.11R.A16F.07,0.132318,0.132318,0,0,TCGA-D8-A27L,NO,49,16.39,DiseaseFree,16.39,LIVING,27,0.1113,M0,N2a,Stage IIIA,T1c,Breast Invasive Ductal Carcinoma,84,Positive,NOT HISPANIC OR LATINO,7/18/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2011,YES,2,NA,16,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Inner Quadrant,Positive,WHITE,NA,NO,1,220,Primary,Female
TCGA.D8.A27N.01,TCGA.D8.A27N.01A.11R.A16F.07,0.015889,0.015889,0,0,TCGA-D8-A27N,NO,36,17.05,DiseaseFree,17.05,LIVING,36,0.2527,M0,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,75,Positive,NOT HISPANIC OR LATINO,7/18/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2011,YES,4,0,19,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,170,Primary,Female
TCGA.D8.A27P.01,TCGA.D8.A27P.01A.11R.A16F.07,0.083615,0.039792,0,0,TCGA-D8-A27P,NO,64,1.61,DiseaseFree,1.61,LIVING,15,0.0485,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,37,Positive,NOT HISPANIC OR LATINO,7/18/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2011,YES,0,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Inner Quadrant,Positive,WHITE,NA,NO,1,100,Primary,Female
TCGA.D8.A27R.01,TCGA.D8.A27R.01A.11R.A16F.07,0.045216,0.045216,0,0,TCGA-D8-A27R,NO,41,10.09,DiseaseFree,10.09,LIVING,21,0.3549,M0,N3a,Stage IIIC,T2,Breast Invasive Ductal Carcinoma,50,Positive,NOT HISPANIC OR LATINO,7/18/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2011,YES,11,NA,11,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,440,Primary,Female
TCGA.D8.A27T.01,TCGA.D8.A27T.01A.11R.A16F.07,0.043205,0.043205,0,0,TCGA-D8-A27T,NO,53,13.07,DiseaseFree,13.07,LIVING,18,0.1924,M0,N3a,Stage IIIC,T2,Breast Invasive Lobular Carcinoma,68,Positive,NOT HISPANIC OR LATINO,7/21/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2011,YES,12,NA,12,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Right Upper Outer Quadrant|Right Lower Outer Quadrant,Positive,WHITE,NA,NO,1,170,Primary,Female
TCGA.D8.A27V.01,TCGA.D8.A27V.01A.12R.A17B.07,0.179724,0.179724,0,0,TCGA-D8-A27V,NO,62,12.52,DiseaseFree,12.52,LIVING,155,0.3774,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,51,Positive,NOT HISPANIC OR LATINO,7/21/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2011,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Right Upper Outer Quadrant|Right Lower Outer Quadrant,Positive,WHITE,NA,NO,1,230,Primary,Female
TCGA.D8.A27W.01,TCGA.D8.A27W.01A.11R.A16F.07,0.05444,0.043206,0,0,TCGA-D8-A27W,NO,55,12.25,DiseaseFree,12.25,LIVING,18,0.4452,M0,N0,Stage IIIB,T4b,Breast Invasive Mixed Mucinous Carcinoma,43,Positive,NOT HISPANIC OR LATINO,7/21/11,Mucinous Carcinoma,NA,No,No,Equivocal,YES,2011,YES,0,NA,12,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IMMC,Negative,Right,Positive,WHITE,NA,NO,1,390,Primary,Female
TCGA.D8.A3Z5.01,TCGA.D8.A3Z5.01A.41R.A24H.07,0.052992,0.023637,0,0,TCGA-D8-A3Z5,NO,54,33.34,DiseaseFree,33.34,LIVING,13,0.1265,M0,N3a,Stage IIIC,T2,Breast Invasive Lobular Carcinoma,418,Positive,NOT HISPANIC OR LATINO,2007/3/12,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2011,YES,19,NA,21,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Right,Positive,WHITE,NA,NO,1,320,Primary,Female
TCGA.D8.A3Z6.01,TCGA.D8.A3Z6.01A.11R.A239.07,0.229306,0.084655,0,0,TCGA-D8-A3Z6,NO,56,18.5,DiseaseFree,18.5,LIVING,23,0.2634,M0,N3a,Stage IIIC,T3,Breast Invasive Lobular Carcinoma,160,Positive,NOT HISPANIC OR LATINO,2007/3/12,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2011,YES,19,NA,22,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Left,Positive,WHITE,NA,NO,1,60,Primary,Female
TCGA.D8.A4Z1.01,TCGA.D8.A4Z1.01A.21R.A266.07,0.916614,0.304347,0.204656,0.672442968,TCGA-D8-A4Z1,NO,68,21.65,DiseaseFree,21.65,LIVING,8,0.0031,M0,N0,Stage IA,T1c,Breast Invasive Lobular Carcinoma,114,Positive,NOT HISPANIC OR LATINO,2002/1/13,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2012,YES,0,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right|Right Upper Inner Quadrant,Positive,WHITE,NO,NO,1,140,Primary,Female
TCGA.D8.A73U.01,TCGA.D8.A73U.01A.11R.A33J.07,0.942233,0.942233,0,0,TCGA-D8-A73U,NO,88,16.16,DiseaseFree,16.16,LIVING,NA,0.0535,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,285,Positive,NOT HISPANIC OR LATINO,3/28/14,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2012,NO,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NO,NO,1,90,Primary,Female
TCGA.D8.A73W.01,TCGA.D8.A73W.01A.22R.A352.07,0.040409,0.040409,0,0,TCGA-D8-A73W,NO,79,0.69,Recurred/Progressed,12.65,DECEASED,NA,0.1276,MX,N1a,Stage IIIA,T3,Breast Invasive Mixed Mucinous Carcinoma,191,Positive,NOT HISPANIC OR LATINO,3/28/14,Mucinous Carcinoma,NA,No,No,Negative,YES,2013,YES,1,NA,13,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Lung|Bone,NA,IMMC,Negative,Right Upper Outer Quadrant,Negative,WHITE,YES,NO,1,230,Primary,Female
TCGA.D8.A73X.01,TCGA.D8.A73X.01A.11R.A32P.07,0.355986,0.355986,0,0,TCGA-D8-A73X,NO,53,25.2,DiseaseFree,25.2,LIVING,NA,0.0989,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,140,Positive,NOT HISPANIC OR LATINO,3/28/14,"Other, specify",NA,No,No,Negative,YES,2013,NO,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,YES,NO,1,140,Primary,Female
TCGA.E2.A105.01,TCGA.E2.A105.01A.11R.A10J.07,0.050842,0.050842,0,0,TCGA-E2-A105,NO,79,42.97,DiseaseFree,42.97,LIVING,45,0.1353,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,1171,Positive,NOT HISPANIC OR LATINO,2002/11/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2007,NA,0,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,YES,1,120,Primary,Female
TCGA.E2.A106.01,TCGA.E2.A106.01A.11R.A10J.07,0.052094,0.003923,0,0,TCGA-E2-A106,NO,34,83.48,DiseaseFree,83.48,LIVING,NA,NA,M0,N1mi,Stage IB,T1c,Breast Invasive Ductal Carcinoma,1495,Positive,NOT HISPANIC OR LATINO,2002/11/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2006,NA,1,NA,16,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Close,Right Upper Outer Quadrant,Positive,ASIAN,NA,YES,1,60,Primary,Female
TCGA.E2.A107.01,TCGA.E2.A107.01A.11R.A10J.07,0.178888,0.178888,0,0,TCGA-E2-A107,NO,54,34.4,DiseaseFree,34.4,LIVING,21,0.3303,M0,N2a,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,715,Positive,NOT HISPANIC OR LATINO,2002/11/11,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2008,NA,4,NA,27,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right Upper Inner Quadrant,Negative,WHITE,NA,YES,1,170,Primary,Female
TCGA.E2.A108.01,TCGA.E2.A108.01A.13R.A10J.07,0.423123,0.423123,0,0,TCGA-E2-A108,NO,64,27.5,DiseaseFree,27.5,LIVING,38,0.0338,M0,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,596,Positive,NOT HISPANIC OR LATINO,2002/11/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,NA,4,NA,27,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,280,Primary,Female
TCGA.E2.A109.01,TCGA.E2.A109.01A.11R.A10J.07,0.44403,0.122489,0.321541,2.625060209,TCGA-E2-A109,NO,64,46.55,DiseaseFree,46.55,LIVING,64,0.4427,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,1155,Positive,NOT HISPANIC OR LATINO,2002/11/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2007,NA,0,NA,6,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,190,Primary,Female
TCGA.E2.A10A.01,TCGA.E2.A10A.01A.21R.A115.07,0.12103,0.12103,0,0,TCGA-E2-A10A,NO,41,3.02,Recurred/Progressed,40.37,LIVING,14,0.2109,M0,N0 (i-),Stage IIB,T3,Breast Invasive Ductal Carcinoma,1096,Positive,NOT HISPANIC OR LATINO,2002/11/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2007,NA,0,0,3,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,370,Primary,Female
TCGA.E2.A10B.01,TCGA.E2.A10B.01A.11R.A10J.07,0.376719,0.376719,0,0,TCGA-E2-A10B,NO,67,6.41,Recurred/Progressed,37.48,LIVING,29,0.2365,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1065,Positive,NOT HISPANIC OR LATINO,2/22/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2007,NA,2,0,28,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Close,Left Lower Outer Quadrant,Positive,WHITE,NA,YES,1,210,Primary,Female
TCGA.E2.A10C.01,TCGA.E2.A10C.01A.21R.A10J.07,0.096659,0.096659,0,0,TCGA-E2-A10C,NO,54,40.08,DiseaseFree,40.08,LIVING,249,0.5337,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,995,Positive,NOT HISPANIC OR LATINO,2002/11/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,NA,1,NA,13,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,150,Primary,Female
TCGA.E2.A10E.01,TCGA.E2.A10E.01A.21R.A10J.07,0.011186,0.011186,0,0,TCGA-E2-A10E,NO,64,28.42,DiseaseFree,28.42,LIVING,20,0.1522,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,869,Positive,NOT HISPANIC OR LATINO,2002/11/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2008,NA,2,NA,21,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Positive,WHITE,NA,YES,1,240,Primary,Female
TCGA.E2.A10F.01,TCGA.E2.A10F.01A.11R.A10J.07,0.086988,0.086988,0,0,TCGA-E2-A10F,NO,47,28.84,DiseaseFree,28.84,LIVING,20,0.1319,M0,N0 (i-),Stage IIA,T2,Breast Invasive Lobular Carcinoma,801,Positive,NOT HISPANIC OR LATINO,2002/11/11,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2008,NA,0,NA,2,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,ILC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,110,Primary,Female
TCGA.E2.A14O.01,TCGA.E2.A14O.01A.31R.A115.07,0.132748,0.079038,0,0,TCGA-E2-A14O,NO,76,44.65,DiseaseFree,44.65,LIVING,32,0.7348,M0,N1a,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,1064,Positive,NOT HISPANIC OR LATINO,3/31/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2008,YES,2,NA,18,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,210,Primary,Female
TCGA.E2.A14P.01,TCGA.E2.A14P.01A.31R.A12D.07,0.848541,0.848541,0,0,TCGA-E2-A14P,NO,79,40.93,DiseaseFree,40.93,LIVING,52,0.2736,M0,N3,Stage IIIC,T2,Breast Invasive Ductal Carcinoma,965,Negative,NOT HISPANIC OR LATINO,3/31/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2008,YES,10,NA,24,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,290,Primary,Female
TCGA.E2.A14Q.01,TCGA.E2.A14Q.01A.11R.A12D.07,0.30268,0.30268,0,0,TCGA-E2-A14Q,NO,50,38.21,DiseaseFree,38.21,LIVING,16,0.1835,M0,N1mi,Stage IIB,T2,Breast Invasive Ductal Carcinoma,960,Positive,NOT HISPANIC OR LATINO,3/31/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,YES,1,NA,7,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,110,Primary,Female
TCGA.E2.A14S.01,TCGA.E2.A14S.01A.11R.A12D.07,0.241713,0.241713,0,0,TCGA-E2-A14S,NO,65,33.15,DiseaseFree,33.15,LIVING,23,0.2502,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,827,Positive,NOT HISPANIC OR LATINO,2004/6/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2008,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Lower Outer Quadrant,Positive,WHITE,NA,YES,1,120,Primary,Female
TCGA.E2.A14T.01,TCGA.E2.A14T.01A.11R.A115.07,0.0374,0.0374,0,0,TCGA-E2-A14T,NO,52,75.92,DiseaseFree,75.92,LIVING,24,0.4914,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,792,Positive,NOT HISPANIC OR LATINO,2004/6/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,YES,0,NA,7,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,YES,1,210,Primary,Female
TCGA.E2.A14U.01,TCGA.E2.A14U.01A.11R.A22K.07,0.157128,0.157128,0,0,TCGA-E2-A14U,NO,74,43.3,DiseaseFree,43.3,LIVING,11,0,M0,N0,Stage I,T1c,Breast Invasive Lobular Carcinoma,796,Positive,NOT HISPANIC OR LATINO,2004/6/11,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2008,YES,0,NA,8,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,70,Primary,Female
TCGA.E2.A14V.01,TCGA.E2.A14V.01A.11R.A12D.07,0.092603,0.092603,0,0,TCGA-E2-A14V,NO,53,34.23,DiseaseFree,34.23,LIVING,54,0.38,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,722,Positive,NOT HISPANIC OR LATINO,2004/6/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2008,YES,3,NA,24,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Lower Inner Quadrant,Positive,WHITE,NA,YES,1,160,Primary,Female
TCGA.E2.A14W.01,TCGA.E2.A14W.01A.11R.A12D.07,0.072294,0.072294,0,0,TCGA-E2-A14W,NO,78,32,DiseaseFree,32,LIVING,64,0.3133,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,716,Positive,NOT HISPANIC OR LATINO,4/25/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2008,YES,0,NA,5,NA,NA,NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,150,Primary,Male
TCGA.E2.A14Y.01,TCGA.E2.A14Y.01A.21R.A12D.07,0.03292,0.03292,0,0,TCGA-E2-A14Y,NO,35,69.28,DiseaseFree,69.28,LIVING,25,0.2263,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,597,Positive,NOT HISPANIC OR LATINO,2004/6/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2009,YES,0,NA,5,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right,Positive,WHITE,NA,YES,1,190,Primary,Female
TCGA.E2.A14Z.01,TCGA.E2.A14Z.01A.11R.A115.07,6.42791,5.884092,0.151608,0.025765743,TCGA-E2-A14Z,NO,64,6.18,Recurred/Progressed,18.5,DECEASED,42,0.4779,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,519,Positive,NOT HISPANIC OR LATINO,2004/6/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,YES,0,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,120,Primary,Female
TCGA.E2.A152.01,TCGA.E2.A152.01A.11R.A12D.07,0.382788,0.382788,0,0,TCGA-E2-A152,NO,56,31.73,Recurred/Progressed,69.91,LIVING,90,0.6421,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,484,Positive,NOT HISPANIC OR LATINO,2004/6/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2009,YES,0,NA,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Inner Quadrant,Negative,WHITE,NA,YES,1,140,Primary,Female
TCGA.E2.A153.01,TCGA.E2.A153.01A.12R.A12D.07,0.032295,0.032295,0,0,TCGA-E2-A153,NO,51,23.23,DiseaseFree,23.23,LIVING,17,0.1942,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,475,Positive,NOT HISPANIC OR LATINO,2004/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,YES,3,NA,15,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left,Positive,WHITE,NA,YES,1,270,Primary,Female
TCGA.E2.A154.01,TCGA.E2.A154.01A.11R.A115.07,0.016328,0.016328,0,0,TCGA-E2-A154,NO,68,19.42,DiseaseFree,19.42,LIVING,32,0.3826,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,461,Positive,NOT HISPANIC OR LATINO,2004/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,400,Primary,Female
TCGA.E2.A155.01,TCGA.E2.A155.01A.11R.A12D.07,0.180018,0.180018,0,0,TCGA-E2-A155,NO,58,21.02,DiseaseFree,21.02,LIVING,38,0.2209,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,457,Positive,NOT HISPANIC OR LATINO,2004/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,YES,2,NA,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant|Left Lower Inner Quadrant,Negative,WHITE,NA,YES,1,280,Primary,Female
TCGA.E2.A156.01,TCGA.E2.A156.01A.11R.A12D.07,0.295545,0.295545,0,0,TCGA-E2-A156,NO,61,23.85,DiseaseFree,23.85,LIVING,16,0.0482,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,447,Positive,NOT HISPANIC OR LATINO,2004/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,YES,0,NA,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left,Positive,WHITE,NA,YES,1,190,Primary,Female
TCGA.E2.A15A.01,TCGA.E2.A15A.01A.11R.A12D.07,0.157346,0.157346,0,0,TCGA-E2-A15A,NO,45,23.32,DiseaseFree,23.32,LIVING,34,0.4767,M0,N3a,Stage IIIC,T2,Breast Invasive Ductal Carcinoma,426,Positive,NOT HISPANIC OR LATINO,2004/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,YES,13,NA,19,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left,Positive,WHITE,NA,YES,2,330,Primary,Female
TCGA.E2.A15C.01,TCGA.E2.A15C.01A.31R.A12D.07,0.231091,0.231091,0,0,TCGA-E2-A15C,NO,61,22.8,DiseaseFree,22.8,LIVING,20,0.1347,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,393,Positive,NOT HISPANIC OR LATINO,4/13/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2009,YES,0,NA,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Lower Outer Quadrant,Positive,WHITE,NA,YES,1,200,Primary,Female
TCGA.E2.A15D.01,TCGA.E2.A15D.01A.11R.A115.07,0.08044,0.08044,0,0,TCGA-E2-A15D,NO,47,17.28,DiseaseFree,17.28,LIVING,24,0.2234,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,393,Positive,NOT HISPANIC OR LATINO,4/13/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2009,YES,0,NA,4,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right,Positive,WHITE,NA,YES,1,330,Primary,Female
TCGA.E2.A15E.01,TCGA.E2.A15E.01A.11R.A12D.07,0.777012,0.490962,0,0,TCGA-E2-A15E,NO,40,20.7,DiseaseFree,20.7,LIVING,23,0.2998,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,387,Positive,NOT HISPANIC OR LATINO,4/25/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2009,YES,1,NA,9,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left,Positive,WHITE,NA,YES,2,520,Primary,Female
TCGA.E2.A15F.01,TCGA.E2.A15F.01A.11R.A115.07,0.127098,0.127098,0,0,TCGA-E2-A15F,NO,64,21.62,DiseaseFree,21.62,LIVING,19,0.2419,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,360,Positive,NOT HISPANIC OR LATINO,4/13/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,YES,0,NA,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,190,Primary,Female
TCGA.E2.A15G.01,TCGA.E2.A15G.01A.11R.A12D.07,0.077234,0.077234,0,0,TCGA-E2-A15G,NO,76,18.2,DiseaseFree,18.2,LIVING,38,0.0763,M0,N0,Stage IIA,T2,Breast Mixed Ductal and Lobular Carcinoma,358,Positive,NOT HISPANIC OR LATINO,4/13/11,Mixed Histology (please specify),Invasive ductal and lobular carcinoma,No,No,Negative,YES,2009,YES,0,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,MDLC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,110,Primary,Female
TCGA.E2.A15H.01,TCGA.E2.A15H.01A.11R.A12D.07,0.011804,0.011804,0,0,TCGA-E2-A15H,NO,38,12.91,DiseaseFree,12.91,LIVING,26,0.1888,M0,N1mi,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,357,Positive,NOT HISPANIC OR LATINO,4/13/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2009,YES,1,NA,4,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,90,Primary,Female
TCGA.E2.A15I.01,TCGA.E2.A15I.01A.21R.A137.07,0.416179,0.416179,0,0,TCGA-E2-A15I,NO,44,55.58,DiseaseFree,55.58,LIVING,108,0.1498,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,344,Positive,NOT HISPANIC OR LATINO,4/13/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2009,YES,0,NA,4,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant|Left Lower Outer Quadrant,Positive,WHITE,NA,YES,1,100,Primary,Female
TCGA.E2.A15J.01,TCGA.E2.A15J.01A.11R.A12P.07,0.011964,0,0.011964,Inf,TCGA-E2-A15J,NO,51,53.88,DiseaseFree,53.88,LIVING,18,0.1094,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,344,Positive,NOT HISPANIC OR LATINO,4/13/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2009,YES,0,NA,12,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,210,Primary,Female
TCGA.E2.A15K.01,TCGA.E2.A15K.01A.11R.A12P.07,0.081053,0.081053,0,0,TCGA-E2-A15K,NO,58,9.03,DiseaseFree,9.03,LIVING,30,0.1946,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,309,Positive,NOT HISPANIC OR LATINO,4/13/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,YES,2,NA,17,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,2,170,Primary,Female
TCGA.E2.A15L.01,TCGA.E2.A15L.01A.11R.A12D.07,0.025735,0.025735,0,0,TCGA-E2-A15L,NO,65,20.57,DiseaseFree,20.57,LIVING,27,0.1145,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,289,Positive,NOT HISPANIC OR LATINO,4/13/11,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2010,YES,0,NA,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Right,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,240,Primary,Female
TCGA.E2.A15M.01,TCGA.E2.A15M.01A.11R.A12D.07,0.303575,0.303575,0,0,TCGA-E2-A15M,NO,66,NA,NA,11.04,DECEASED,46,0.2774,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,287,Positive,NOT HISPANIC OR LATINO,4/14/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2010,YES,0,NA,5,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Right Lower Outer Quadrant,Positive,WHITE,NA,YES,1,270,Primary,Female
TCGA.E2.A15O.01,TCGA.E2.A15O.01A.11R.A115.07,0.413726,0.413726,0,0,TCGA-E2-A15O,NO,89,39.75,Recurred/Progressed,50.76,LIVING,26,0.2935,M0,NX,Stage I,T1c,Breast Invasive Ductal Carcinoma,273,Positive,NOT HISPANIC OR LATINO,4/14/11,Infiltrating Ductal Carcinoma,NA,No,Yes,Equivocal,YES,2010,NO,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,110,Primary,Female
TCGA.E2.A15P.01,TCGA.E2.A15P.01A.11R.A115.07,0.143118,0.105916,0,0,TCGA-E2-A15P,NO,61,19.55,DiseaseFree,19.55,LIVING,37,0.1936,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,269,Positive,NOT HISPANIC OR LATINO,4/14/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,110,Primary,Female
TCGA.E2.A15R.01,TCGA.E2.A15R.01A.11R.A115.07,0.3545,0.3545,0,0,TCGA-E2-A15R,NO,64,56.9,DiseaseFree,56.9,LIVING,30,0.3571,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,247,Positive,NOT HISPANIC OR LATINO,4/14/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,YES,3,NA,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,140,Primary,Female
TCGA.E2.A15S.01,TCGA.E2.A15S.01A.11R.A115.07,0.042211,0.042211,0,0,TCGA-E2-A15S,NO,34,14.06,DiseaseFree,14.06,LIVING,32,0.4632,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,247,Positive,NOT HISPANIC OR LATINO,4/14/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,YES,1,NA,17,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,560,Primary,Female
TCGA.E2.A15T.01,TCGA.E2.A15T.01A.11R.A115.07,0.143173,0.143173,0,0,TCGA-E2-A15T,NO,65,51.35,DiseaseFree,51.35,LIVING,33,0.1639,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,162,Positive,NOT HISPANIC OR LATINO,4/14/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,360,Primary,Female
TCGA.E2.A1B0.01,TCGA.E2.A1B0.01A.11R.A12P.07,0.355798,0.355798,0,0,TCGA-E2-A1B0,NO,50,53.58,DiseaseFree,53.58,LIVING,27,0.2357,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,1315,Negative,NOT HISPANIC OR LATINO,4/25/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2007,YES,6,NA,28,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,110,Primary,Female
TCGA.E2.A1B1.01,TCGA.E2.A1B1.01A.21R.A12P.07,0.532733,0.500378,0.016341,0.032657311,TCGA-E2-A1B1,NO,45,87.16,DiseaseFree,87.16,LIVING,8,0.0269,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1268,Positive,NOT HISPANIC OR LATINO,4/25/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2007,YES,1,NA,6,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,300,Primary,Female
TCGA.E2.A1B4.01,TCGA.E2.A1B4.01A.11R.A12P.07,0.640223,0.640223,0,0,TCGA-E2-A1B4,NO,74,NA,NA,32.98,DECEASED,27,0.0302,M0,N2a,Stage IIIA,T1c,Breast Invasive Ductal Carcinoma,798,Positive,NOT HISPANIC OR LATINO,4/25/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,YES,3,NA,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,YES,1,110,Primary,Female
TCGA.E2.A1B5.01,TCGA.E2.A1B5.01A.21R.A12P.07,0.709649,0.709649,0,0,TCGA-E2-A1B5,NO,46,32.33,DiseaseFree,32.33,LIVING,12,0.0291,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,783,Positive,NOT HISPANIC OR LATINO,4/25/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2008,YES,0,NA,5,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,ILC,Negative,Left,Positive,WHITE,NA,YES,1,260,Primary,Female
TCGA.E2.A1BC.01,TCGA.E2.A1BC.01A.11R.A12P.07,0.126684,0,0,NA,TCGA-E2-A1BC,NO,63,16.46,DiseaseFree,16.46,LIVING,24,0.1381,M0,N0,Stage IA,T1c,Breast Invasive Lobular Carcinoma,275,Positive,NA,4/25/11,Infiltrating Ductal Carcinoma,NA,No,Yes,Negative,YES,2010,YES,0,NA,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Positive,Right,Positive,NA,NA,YES,1,100,Primary,Female
TCGA.E2.A1BD.01,TCGA.E2.A1BD.01A.11R.A12P.07,0.154553,0.154553,0,0,TCGA-E2-A1BD,NO,53,37.22,DiseaseFree,37.22,LIVING,23,0.4632,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,260,Positive,NOT HISPANIC OR LATINO,4/25/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,YES,0,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,100,Primary,Female
TCGA.E2.A1IE.01,TCGA.E2.A1IE.01A.11R.A13Q.07,0.008759,0.008759,0,0,TCGA-E2-A1IE,NO,61,59.46,Recurred/Progressed,77.6,LIVING,15,0.2631,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,938,Positive,NOT HISPANIC OR LATINO,4/26/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2008,YES,1,NA,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right,Positive,WHITE,NA,YES,1,80,Primary,Female
TCGA.E2.A1IF.01,TCGA.E2.A1IF.01A.11R.A144.07,0.122463,0.122463,0,0,TCGA-E2-A1IF,NO,74,37.39,DiseaseFree,37.39,LIVING,16,0.118,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,932,Positive,NOT HISPANIC OR LATINO,4/28/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,YES,0,NA,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,70,Primary,Female
TCGA.E2.A1IG.01,TCGA.E2.A1IG.01A.11R.A144.07,0.347052,0.347052,0,0,TCGA-E2-A1IG,NO,45,70.3,DiseaseFree,70.3,LIVING,31,0.1263,M0,N1mi,Stage IIB,T2,Breast Invasive Ductal Carcinoma,679,Positive,NOT HISPANIC OR LATINO,4/28/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,YES,1,NA,3,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right Upper Inner Quadrant,Positive,WHITE,NA,YES,1,180,Primary,Female
TCGA.E2.A1IH.01,TCGA.E2.A1IH.01A.11R.A13Q.07,3.480684,3.438696,0.034315,0.009979073,TCGA-E2-A1IH,NO,80,33.71,DiseaseFree,33.71,LIVING,50,0.3813,M0,N0,Stage I,T1c,Breast Invasive Lobular Carcinoma,883,Positive,NOT HISPANIC OR LATINO,4/28/11,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2008,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Right Upper Inner Quadrant,Positive,WHITE,NA,YES,1,80,Primary,Female
TCGA.E2.A1II.01,TCGA.E2.A1II.01A.11R.A144.07,0.235523,0.235523,0,0,TCGA-E2-A1II,NO,51,33.67,DiseaseFree,33.67,LIVING,18,0.5139,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,854,Negative,NOT HISPANIC OR LATINO,4/28/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,YES,0,NA,5,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left,Positive,WHITE,NA,YES,1,70,Primary,Female
TCGA.E2.A1IJ.01,TCGA.E2.A1IJ.01A.11R.A144.07,0.32341,0.32341,0,0,TCGA-E2-A1IJ,NO,57,28.42,DiseaseFree,28.42,LIVING,14,0.1163,M0,N0,Stage I,T1c,Breast Invasive Lobular Carcinoma,707,Positive,NOT HISPANIC OR LATINO,4/29/11,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2009,YES,0,NA,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,70,Primary,Female
TCGA.E2.A1IK.01,TCGA.E2.A1IK.01A.11R.A144.07,0.082893,0.082893,0,0,TCGA-E2-A1IK,NO,71,59.13,DiseaseFree,59.13,LIVING,10,0,M0,N1mi,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,423,Positive,NOT HISPANIC OR LATINO,5/17/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,YES,1,NA,6,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left,Positive,WHITE,NA,YES,1,70,Primary,Female
TCGA.E2.A1IL.01,TCGA.E2.A1IL.01A.11R.A14D.07,0.464452,0.464452,0,0,TCGA-E2-A1IL,NO,78,3.88,DiseaseFree,3.88,LIVING,16,0.1685,M0,N1a,Stage IIA,T1c,Breast Invasive Lobular Carcinoma,417,Positive,NOT HISPANIC OR LATINO,4/29/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2009,YES,1,NA,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,120,Primary,Female
TCGA.E2.A1IN.01,TCGA.E2.A1IN.01A.11R.A13Q.07,0.074498,0.074498,0,0,TCGA-E2-A1IN,NO,60,22.17,DiseaseFree,22.17,LIVING,129,0.449,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,368,Positive,NOT HISPANIC OR LATINO,4/29/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right,Positive,WHITE,NA,YES,1,20,Primary,Female
TCGA.E2.A1IO.01,TCGA.E2.A1IO.01A.11R.A144.07,0.126889,0.10959,0,0,TCGA-E2-A1IO,NO,37,60.94,DiseaseFree,60.94,LIVING,12,0.4112,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,416,Positive,NOT HISPANIC OR LATINO,4/29/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2009,YES,0,NA,1,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right,Positive,WHITE,NA,YES,1,70,Primary,Female
TCGA.E2.A1IU.01,TCGA.E2.A1IU.01A.11R.A14D.07,0.205189,0.205189,0,0,TCGA-E2-A1IU,NO,60,11.07,DiseaseFree,11.07,LIVING,15,0.0515,M0,N0 (mol+),Stage IA,T1c,Breast Invasive Ductal Carcinoma,136,Positive,NOT HISPANIC OR LATINO,4/29/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,0,NA,11,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,270,Primary,Female
TCGA.E2.A1L6.01,TCGA.E2.A1L6.01A.11R.A13Q.07,0.043789,0.043789,0,0,TCGA-E2-A1L6,NO,44,54.14,DiseaseFree,54.14,LIVING,13,0.1288,M0,N1mi,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,1325,Positive,NOT HISPANIC OR LATINO,2006/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2007,YES,1,NA,6,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,110,Primary,Female
TCGA.E2.A1L8.01,TCGA.E2.A1L8.01A.11R.A13Q.07,0.014455,0.014455,0,0,TCGA-E2-A1L8,NO,52,73.59,DiseaseFree,73.59,LIVING,22,0.1645,M0,N1a,Stage IIB,T2,Breast Invasive Lobular Carcinoma,912,Positive,NOT HISPANIC OR LATINO,2006/7/11,Infiltrating Lobular Carcinoma,NA,No,Yes,Equivocal,YES,2008,YES,2,NA,13,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Left Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,180,Primary,Female
TCGA.E2.A1L9.01,TCGA.E2.A1L9.01A.11R.A13Q.07,1.506891,1.447616,0,0,TCGA-E2-A1L9,NO,40,19.65,DiseaseFree,19.65,LIVING,17,0.0944,M0,N1mi,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,465,Positive,NOT HISPANIC OR LATINO,2006/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,YES,1,NA,2,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right,Positive,WHITE,NA,YES,1,40,Primary,Female
TCGA.E2.A1LA.01,TCGA.E2.A1LA.01A.11R.A144.07,0.252296,0.252296,0,0,TCGA-E2-A1LA,NO,59,24.57,DiseaseFree,24.57,LIVING,60,0.3391,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,581,Positive,NOT HISPANIC OR LATINO,2006/1/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2009,YES,1,NA,35,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Inner Quadrant,Positive,NA,NA,YES,1,40,Primary,Female
TCGA.E2.A1LB.01,TCGA.E2.A1LB.01A.11R.A144.07,0.20705,0.20705,0,0,TCGA-E2-A1LB,NO,41,75.76,DiseaseFree,75.76,LIVING,31,0.1072,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,909,Negative,NOT HISPANIC OR LATINO,2006/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2008,YES,2,NA,25,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,190,Primary,Female
TCGA.E2.A1LE.01,TCGA.E2.A1LE.01A.12R.A19W.07,2.380876,2.380876,0,0,TCGA-E2-A1LE,NO,71,11.86,Recurred/Progressed,28.88,DECEASED,50,0.4304,M0,N3a,Stage IIIC,T2,Breast Invasive Ductal Carcinoma,986,Negative,NOT HISPANIC OR LATINO,2006/7/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2008,YES,27,NA,28,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Inner Quadrant|Right Lower Inner Quadrant,Negative,WHITE,NA,YES,1,600,Primary,Female
TCGA.E2.A2P5.01,TCGA.E2.A2P5.01A.11R.A19W.07,0.897658,0.897658,0,0,TCGA-E2-A2P5,NO,78,19.61,Recurred/Progressed,26.97,DECEASED,64,0.6636,M0,N3,Stage IIIC,T2,Breast Invasive Lobular Carcinoma,219,Positive,NOT HISPANIC OR LATINO,12/19/11,Infiltrating Lobular Carcinoma,NA,No,Yes,NA,YES,2011,YES,21,NA,25,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Left,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,260,Primary,Female
TCGA.E2.A2P6.01,TCGA.E2.A2P6.01A.11R.A19W.07,0.027711,0.01605,0.011661,0.726542056,TCGA-E2-A2P6,NO,77,34.53,DiseaseFree,34.53,LIVING,93,0.1405,M0,N1,Stage IIB,T2,Breast Invasive Lobular Carcinoma,174,Positive,HISPANIC OR LATINO,12/19/11,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2011,YES,1,NA,5,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Positive,Left Upper Outer Quadrant,Positive,NA,NA,YES,1,80,Primary,Female
TCGA.E2.A3DX.01,TCGA.E2.A3DX.01A.21R.A213.07,0.423694,0.423694,0,0,TCGA-E2-A3DX,NO,43,43.53,DiseaseFree,43.53,LIVING,9,0.0199,M0,N3,Stage IIIC,T2,Breast Invasive Lobular Carcinoma,142,Positive,NOT HISPANIC OR LATINO,1/17/12,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2011,YES,25,NA,36,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,ILC,Positive,Right,Positive,WHITE,NA,YES,1,180,Primary,Female
TCGA.E2.A56Z.01,TCGA.E2.A56Z.01A.12R.A29R.07,0.128553,0.128553,0,0,TCGA-E2-A56Z,NO,69,8.28,DiseaseFree,8.28,LIVING,40,0.4799,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,254,Positive,NOT HISPANIC OR LATINO,6/20/13,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2012,YES,1,NA,16,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Positive,BLACK OR AFRICAN AMERICAN,YES,YES,1,150,Primary,Female
TCGA.E2.A570.01,TCGA.E2.A570.01A.11R.A29R.07,0.589227,0.079462,0,0,TCGA-E2-A570,NO,47,30.58,DiseaseFree,30.58,LIVING,21,0.1371,M0,N1mi,Stage IB,T1c,Breast Invasive Ductal Carcinoma,416,Positive,NOT HISPANIC OR LATINO,6/21/13,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2011,YES,1,NA,7,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Lower Inner Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NO,YES,1,80,Primary,Female
TCGA.E2.A572.01,TCGA.E2.A572.01A.13R.A31O.07,0.052383,0.03464,0,0,TCGA-E2-A572,NO,72,39.68,DiseaseFree,39.68,LIVING,NA,NA,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,560,Positive,NOT HISPANIC OR LATINO,2009/10/13,Infiltrating Ductal Carcinoma,NA,No,Yes,Equivocal,YES,2011,YES,0,8,13,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Positive,BLACK OR AFRICAN AMERICAN,YES,YES,1,140,Primary,Female
TCGA.E2.A576.01,TCGA.E2.A576.01A.11R.A31O.07,0.476611,0.466526,0,0,TCGA-E2-A576,NO,69,34.26,DiseaseFree,34.26,LIVING,NA,0.3103,MX,N0,Stage IA,T1c,Breast Invasive Lobular Carcinoma,343,Positive,NOT HISPANIC OR LATINO,2009/10/13,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2011,YES,0,0,5,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,YES,YES,1,80,Primary,Female
TCGA.E2.A9RU.01,TCGA.E2.A9RU.01A.11R.A41B.07,0.351358,0.351358,0,0,TCGA-E2-A9RU,NO,90,17.67,DiseaseFree,17.67,LIVING,NA,0.4619,MX,N3a,Stage IIIC,T2,Breast Invasive Ductal Carcinoma,188,Positive,NOT HISPANIC OR LATINO,6/16/14,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2013,YES,12,NA,22,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Lower Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,YES,YES,1,220,Primary,Female
TCGA.E9.A1N3.01,TCGA.E9.A1N3.01A.12R.A157.07,0.011759,0.011759,0,0,TCGA-E9-A1N3,NO,70,34.79,DiseaseFree,34.79,LIVING,21,0.0779,M0,N2,Stage IIIA,T1c,Breast Mixed Ductal and Lobular Carcinoma,65,NA,NOT HISPANIC OR LATINO,5/26/11,Mixed Histology (please specify),Infiltrating ductal and lobular carcinoma,No,No,NA,YES,2010,YES,7,NA,7,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,MDLC,Negative,Right Upper Inner Quadrant,NA,WHITE,NA,NO,1,230,Primary,Female
TCGA.E9.A1N4.01,TCGA.E9.A1N4.01A.11R.A14M.07,0.129828,0.129828,0,0,TCGA-E9-A1N4,NO,41,32.85,DiseaseFree,32.85,LIVING,17,0.1888,M0,N2,Stage IIIA,T2,Breast Invasive Lobular Carcinoma,65,Positive,NOT HISPANIC OR LATINO,5/26/11,Mixed Histology (please specify),Infiltrating ductal and lobular carcinoma,No,No,Positive,YES,2010,YES,4,0,7,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,ILC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,NO,1,310,Primary,Female
TCGA.E9.A1N5.01,TCGA.E9.A1N5.01A.11R.A14D.07,0.276195,0.276195,0,0,TCGA-E9-A1N5,NO,45,36.79,DiseaseFree,36.79,LIVING,23,0.1846,M0,N1,Stage IIB,T2,Breast Mixed Ductal and Lobular Carcinoma,63,Positive,NOT HISPANIC OR LATINO,6/23/11,Mixed Histology (please specify),Infiltrating ductal and lobular carcinoma,No,No,Positive,YES,2010,YES,2,0,11,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,MDLC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,NO,1,190,Primary,Female
TCGA.E9.A1N6.01,TCGA.E9.A1N6.01A.11R.A144.07,0.532474,0.532474,0,0,TCGA-E9-A1N6,NO,52,22.08,Recurred/Progressed,22.27,DECEASED,NA,0.2459,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,63,Positive,NOT HISPANIC OR LATINO,6/23/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2010,YES,2,0,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,NO,1,220,Primary,Female
TCGA.E9.A1N8.01,TCGA.E9.A1N8.01A.11R.A144.07,0.083277,0.083277,0,0,TCGA-E9-A1N8,NO,48,34.13,DiseaseFree,34.13,LIVING,23,0.7276,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,66,Negative,NOT HISPANIC OR LATINO,6/23/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,0,0,8,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,NA,WHITE,NA,NO,1,680,Primary,Female
TCGA.E9.A1N9.01,TCGA.E9.A1N9.01A.11R.A14D.07,0.675487,0.675487,0,0,TCGA-E9-A1N9,NO,58,36.17,DiseaseFree,36.17,LIVING,39,0.4243,M0,N0,Stage IIA,T2,Breast Mixed Ductal and Lobular Carcinoma,44,Negative,NOT HISPANIC OR LATINO,6/23/11,Mixed Histology (please specify),Infiltrating ductal and lobular carcinoma,No,No,Positive,YES,2011,YES,0,0,8,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,MDLC,Negative,Right Lower Outer Quadrant,Positive,WHITE,NA,NO,1,230,Primary,Female
TCGA.E9.A1NA.01,TCGA.E9.A1NA.01A.11R.A144.07,0.248116,0.248116,0,0,TCGA-E9-A1NA,NO,58,36.53,DiseaseFree,36.53,LIVING,73,0.3875,M0,N0,Stage IIA,T2,Breast Mixed Ductal and Lobular Carcinoma,42,Positive,NOT HISPANIC OR LATINO,6/23/11,Mixed Histology (please specify),Infiltrating ductal and lobular carcinoma,No,No,Positive,YES,2011,YES,0,0,11,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,MDLC,Negative,Left Lower Outer Quadrant,Positive,WHITE,NA,NO,1,110,Primary,Female
TCGA.E9.A1NC.01,TCGA.E9.A1NC.01A.21R.A26B.07,0.973747,0.961097,0,0,TCGA-E9-A1NC,NO,61,39.52,DiseaseFree,39.52,LIVING,129,0.423,M0,N1,Stage IIB,T2,Breast Mixed Ductal and Lobular Carcinoma,38,Negative,NOT HISPANIC OR LATINO,6/23/11,Mixed Histology (please specify),Infiltrating ductal and lobular carcinoma,No,No,Positive,YES,2011,YES,1,0,9,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,MDLC,Negative,Right Upper Inner Quadrant,Positive,WHITE,NA,NO,1,200,Primary,Female
TCGA.E9.A1ND.01,TCGA.E9.A1ND.01A.11R.A144.07,6.40439,6.373222,0,0,TCGA-E9-A1ND,NO,75,41.59,DiseaseFree,41.59,LIVING,50,0.1313,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,37,Negative,NOT HISPANIC OR LATINO,6/23/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2011,YES,1,0,11,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,NO,1,420,Primary,Female
TCGA.E9.A1NE.01,TCGA.E9.A1NE.01A.21R.A14M.07,2.500573,2.469285,0.031288,0.012670874,TCGA-E9-A1NE,NO,28,35.74,DiseaseFree,35.74,LIVING,30,0.0132,M0,N1,Stage IIB,T2,Breast Mixed Ductal and Lobular Carcinoma,31,Positive,NOT HISPANIC OR LATINO,6/23/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2011,YES,1,0,2,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,MDLC,Negative,Right Lower Outer Quadrant,Positive,WHITE,NA,NO,1,280,Primary,Female
TCGA.E9.A1NF.01,TCGA.E9.A1NF.01A.11R.A14D.07,0.149385,0.149385,0,0,TCGA-E9-A1NF,NO,60,2.96,Recurred/Progressed,35.22,DECEASED,36,0.4963,M0,N0,Stage IIA,T2,Breast Mixed Ductal and Lobular Carcinoma,31,Positive,NOT HISPANIC OR LATINO,6/23/11,Mixed Histology (please specify),Infiltrating ductal and lobular carcinoma,No,No,Negative,YES,2011,YES,0,0,9,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,MDLC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,240,Primary,Female
TCGA.E9.A1NG.01,TCGA.E9.A1NG.01A.21R.A14M.07,0.21982,0.21982,0,0,TCGA-E9-A1NG,NO,62,NA,NA,25.82,DECEASED,14,0.0874,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,30,Positive,NOT HISPANIC OR LATINO,6/23/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2011,YES,0,0,5,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,380,Primary,Female
TCGA.E9.A1NH.01,TCGA.E9.A1NH.01A.11R.A14D.07,0.077078,0.077078,0,0,TCGA-E9-A1NH,NO,71,18.92,DiseaseFree,18.92,LIVING,17,0.123,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,30,Positive,NOT HISPANIC OR LATINO,6/23/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2011,YES,3,0,5,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,NO,1,140,Primary,Female
TCGA.E9.A1NI.01,TCGA.E9.A1NI.01A.11R.A14D.07,0.063012,0.063012,0,0,TCGA-E9-A1NI,NO,51,9.86,DiseaseFree,9.86,LIVING,121,0.3954,M0,N0,Stage IIA,T2,Breast Mixed Ductal and Lobular Carcinoma,21,Positive,NOT HISPANIC OR LATINO,6/23/11,Mixed Histology (please specify),Infiltrating ductal and lobular carcinoma,No,No,Negative,YES,2011,YES,0,0,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,MDLC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,NO,1,280,Primary,Female
TCGA.E9.A1QZ.01,TCGA.E9.A1QZ.01A.21R.A169.07,0.286029,0.274238,0,0,TCGA-E9-A1QZ,NO,61,24.8,DiseaseFree,24.8,LIVING,9,0.104,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,58,NA,NOT HISPANIC OR LATINO,7/28/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,0,NA,19,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Lower Inner Quadrant,NA,WHITE,NA,NO,1,590,Primary,Female
TCGA.E9.A1R0.01,TCGA.E9.A1R0.01A.22R.A16F.07,0.013493,0.013493,0,0,TCGA-E9-A1R0,NO,58,28.25,DiseaseFree,28.25,LIVING,17,0.097,M0,N1,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,44,NA,NOT HISPANIC OR LATINO,7/28/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,1,NA,12,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,NA,Left Upper Outer Quadrant,NA,WHITE,NA,NO,1,400,Primary,Female
TCGA.E9.A1R2.01,TCGA.E9.A1R2.01A.11R.A14D.07,2.07801,1.97431,0.1037,0.05252468,TCGA-E9-A1R2,NO,51,34.92,DiseaseFree,34.92,LIVING,43,0.3226,MX,N3,Stage IIIC,T2,Breast Invasive Ductal Carcinoma,64,Positive,NOT HISPANIC OR LATINO,7/28/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2011,YES,17,NA,19,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Positive,Left Upper Outer Quadrant,Negative,WHITE,NA,NO,1,160,Primary,Female
TCGA.E9.A1R3.01,TCGA.E9.A1R3.01A.31R.A14M.07,0.041523,0.041523,0,0,TCGA-E9-A1R3,NO,70,2.56,DiseaseFree,2.56,LIVING,18,0.3326,M0,N3,Stage IIIC,T2,Breast Invasive Ductal Carcinoma,80,NA,NOT HISPANIC OR LATINO,7/28/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2010,YES,10,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,NA,WHITE,NA,NO,1,420,Primary,Female
TCGA.E9.A1R4.01,TCGA.E9.A1R4.01A.21R.A14D.07,0.327685,0.327685,0,0,TCGA-E9-A1R4,NO,66,6.11,DiseaseFree,6.11,LIVING,70,0.3172,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,45,NA,NOT HISPANIC OR LATINO,7/28/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,0,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,NA,WHITE,NA,NO,1,430,Primary,Female
TCGA.E9.A1R5.01,TCGA.E9.A1R5.01A.11R.A14M.07,0.068401,0.068401,0,0,TCGA-E9-A1R5,NO,63,3.02,DiseaseFree,3.02,LIVING,25,0.2577,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,58,NA,NOT HISPANIC OR LATINO,7/28/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,0,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,NA,WHITE,NA,NO,1,370,Primary,Female
TCGA.E9.A1R6.01,TCGA.E9.A1R6.01A.11R.A14D.07,0.040744,0.040744,0,0,TCGA-E9-A1R6,NO,63,11.14,DiseaseFree,11.14,LIVING,19,0.4507,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,100,NA,NOT HISPANIC OR LATINO,7/28/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2010,YES,0,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,NA,WHITE,NA,NO,1,730,Primary,Female
TCGA.E9.A1R7.01,TCGA.E9.A1R7.01A.11R.A14M.07,0.059618,0.059618,0,0,TCGA-E9-A1R7,NO,64,48.19,DiseaseFree,48.19,LIVING,36,0.3827,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,51,NA,NOT HISPANIC OR LATINO,7/28/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,0,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,NA,WHITE,NA,NO,1,400,Primary,Female
TCGA.E9.A1RA.01,TCGA.E9.A1RA.01A.11R.A14D.07,0.152837,0.152837,0,0,TCGA-E9-A1RA,NO,48,44.97,DiseaseFree,44.97,LIVING,13,0.0886,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,45,NA,NOT HISPANIC OR LATINO,7/28/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,0,NA,10,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,NA,WHITE,NA,NO,1,200,Primary,Female
TCGA.E9.A1RB.01,TCGA.E9.A1RB.01A.11R.A157.07,0.040481,0.040481,0,0,TCGA-E9-A1RB,NO,40,NA,NA,32.06,DECEASED,17,0.6044,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,39,NA,NOT HISPANIC OR LATINO,7/28/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,0,0,10,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant,NA,WHITE,NA,NO,1,490,Primary,Female
TCGA.E9.A1RC.01,TCGA.E9.A1RC.01A.11R.A157.07,0.005001,0.005001,0,0,TCGA-E9-A1RC,NO,56,40.21,DiseaseFree,40.21,LIVING,35,0.2996,M0,N3,Stage IIIC,T4b,Breast Mixed Ductal and Lobular Carcinoma,1246,NA,NOT HISPANIC OR LATINO,7/28/11,Mixed Histology (please specify),Infiltrating ductal and lobular carcinoma,No,No,NA,YES,2007,YES,10,0,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,MDLC,Negative,Right Upper Outer Quadrant,NA,WHITE,NA,NO,1,620,Primary,Female
TCGA.E9.A1RD.01,TCGA.E9.A1RD.01A.11R.A157.07,0.113549,0.113549,0,0,TCGA-E9-A1RD,NO,67,1.12,DiseaseFree,1.12,LIVING,19,0.2262,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,38,NA,NOT HISPANIC OR LATINO,7/28/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,0,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Lower Inner Quadrant,NA,WHITE,NA,NO,1,340,Primary,Female
TCGA.E9.A1RE.01,TCGA.E9.A1RE.01A.11R.A157.07,0.08058,0.08058,0,0,TCGA-E9-A1RE,NO,74,46.62,DiseaseFree,46.62,LIVING,35,0.5125,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,65,NA,NOT HISPANIC OR LATINO,7/28/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,9,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,NA,WHITE,NA,NO,1,730,Primary,Female
TCGA.E9.A1RF.01,TCGA.E9.A1RF.01A.11R.A157.07,0.630438,0.630438,0,0,TCGA-E9-A1RF,NO,68,6.57,DiseaseFree,6.57,LIVING,97,0.4068,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,56,NA,NOT HISPANIC OR LATINO,2008/2/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,5,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,NA,WHITE,NA,NO,1,330,Primary,Female
TCGA.E9.A1RG.01,TCGA.E9.A1RG.01A.11R.A14D.07,0.110831,0.110831,0,0,TCGA-E9-A1RG,NO,62,21.25,DiseaseFree,21.25,LIVING,32,0.6107,M0,N2,Stage IIIA,T1c,Breast Invasive Ductal Carcinoma,53,NA,NOT HISPANIC OR LATINO,2008/2/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,4,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,NA,WHITE,NA,NO,1,540,Primary,Female
TCGA.E9.A1RH.01,TCGA.E9.A1RH.01A.21R.A169.07,0.044179,0.044179,0,0,TCGA-E9-A1RH,NO,63,46.55,DiseaseFree,46.55,LIVING,59,0.4291,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,32,NA,NOT HISPANIC OR LATINO,2008/2/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,0,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Lower Outer Quadrant,NA,WHITE,NA,NO,1,410,Primary,Female
TCGA.E9.A1RI.01,TCGA.E9.A1RI.01A.11R.A169.07,0.191773,0.184496,0,0,TCGA-E9-A1RI,NO,43,47.6,DiseaseFree,47.6,LIVING,12,0.1189,M0,N2,Stage IIIA,T1c,Breast Mixed Ductal and Lobular Carcinoma,64,NA,NOT HISPANIC OR LATINO,7/28/11,Mixed Histology (please specify),Infiltrating ductal and lobular carcinoma,No,No,NA,YES,2011,YES,5,NA,10,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,MDLC,Negative,Left Upper Outer Quadrant,NA,WHITE,NA,NO,1,290,Primary,Female
TCGA.E9.A226.01,TCGA.E9.A226.01A.21R.A157.07,0.135324,0.083861,0,0,TCGA-E9-A226,NO,45,25.95,Recurred/Progressed,34.43,DECEASED,22,0.2557,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,48,NA,NOT HISPANIC OR LATINO,2008/3/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,6,NA,10,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Lower Inner Quadrant,NA,WHITE,NA,NO,1,510,Primary,Female
TCGA.E9.A227.01,TCGA.E9.A227.01A.11R.A157.07,0.024374,0.024374,0,0,TCGA-E9-A227,NO,42,32.03,DiseaseFree,32.03,LIVING,11,0.0506,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,66,Positive,NOT HISPANIC OR LATINO,7/28/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2011,YES,1,NA,17,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Positive,Left Upper Outer Quadrant,Positive,WHITE,NA,NO,1,180,Primary,Female
TCGA.E9.A228.01,TCGA.E9.A228.01A.31R.A157.07,0.023944,0.023944,0,0,TCGA-E9-A228,NO,58,42.21,DiseaseFree,42.21,LIVING,30,0.1701,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,42,NA,NOT HISPANIC OR LATINO,2008/2/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,2,NA,12,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Lower Inner Quadrant,NA,WHITE,NA,NO,1,740,Primary,Female
TCGA.E9.A229.01,TCGA.E9.A229.01A.31R.A157.07,0.102311,0.102311,0,0,TCGA-E9-A229,NO,37,37.71,DiseaseFree,37.71,LIVING,14,0.1635,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,56,NA,NOT HISPANIC OR LATINO,2008/2/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,0,NA,14,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right Lower Inner Quadrant,NA,WHITE,NA,NO,1,160,Primary,Female
TCGA.E9.A22A.01,TCGA.E9.A22A.01A.11R.A157.07,0.129501,0.129501,0,0,TCGA-E9-A22A,NO,74,39.06,DiseaseFree,39.06,LIVING,23,0.3124,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,59,Positive,NOT HISPANIC OR LATINO,2008/2/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2011,YES,0,0,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Lower Outer Quadrant,Negative,WHITE,NA,NO,1,340,Primary,Female
TCGA.E9.A22B.01,TCGA.E9.A22B.01A.11R.A157.07,0.012038,0.012038,0,0,TCGA-E9-A22B,NO,71,38.34,DiseaseFree,38.34,LIVING,38,0.2412,M0,N0,Stage IA,T1c,Breast Mixed Ductal and Lobular Carcinoma,59,Positive,NOT HISPANIC OR LATINO,2008/2/11,Mixed Histology (please specify),Infiltrating ductal and lobular carcinoma,No,No,Negative,YES,2011,YES,0,0,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,MDLC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,NO,1,250,Primary,Female
TCGA.E9.A22D.01,TCGA.E9.A22D.01A.11R.A157.07,0.189257,0.189257,0,0,TCGA-E9-A22D,NO,38,41,DiseaseFree,41,LIVING,10,0.2295,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,52,Positive,NOT HISPANIC OR LATINO,2008/2/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2011,YES,0,0,10,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,620,Primary,Female
TCGA.E9.A22E.01,TCGA.E9.A22E.01A.11R.A157.07,0.193622,0.193622,0,0,TCGA-E9-A22E,NO,56,41.69,DiseaseFree,41.69,LIVING,64,0.4323,M0,N2,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,52,Positive,NOT HISPANIC OR LATINO,2008/2/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2011,YES,4,0,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Inner Quadrant,Positive,WHITE,NA,NO,1,620,Primary,Female
TCGA.E9.A22G.01,TCGA.E9.A22G.01A.11R.A157.07,0.285875,0.285875,0,0,TCGA-E9-A22G,NO,47,40.7,DiseaseFree,40.7,LIVING,73,0.8768,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,45,Negative,NOT HISPANIC OR LATINO,2008/2/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2011,YES,0,0,6,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,NO,1,650,Primary,Female
TCGA.E9.A22H.01,TCGA.E9.A22H.01A.11R.A157.07,0.038209,0.038209,0,0,TCGA-E9-A22H,NO,42,40.47,DiseaseFree,40.47,LIVING,18,0.1039,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,38,Positive,NOT HISPANIC OR LATINO,2008/2/11,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2011,YES,1,0,8,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,NO,1,500,Primary,Female
TCGA.E9.A243.01,TCGA.E9.A243.01A.21R.A169.07,0.589778,0.574459,0,0,TCGA-E9-A243,NO,52,10.02,Recurred/Progressed,20.11,LIVING,43,0.1011,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,94,NA,NOT HISPANIC OR LATINO,8/17/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,0,NA,10,NA,Peri (6-12 months since last menstrual period),NA,NA,NO,IDC,Negative,Right Upper Inner Quadrant,NA,WHITE,NA,NO,1,270,Primary,Female
TCGA.E9.A244.01,TCGA.E9.A244.01A.11R.A169.07,0.005687,0.005687,0,0,TCGA-E9-A244,NO,54,0.69,DiseaseFree,0.69,LIVING,59,0.3765,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,58,NA,NOT HISPANIC OR LATINO,3/15/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,0,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,NA,WHITE,NA,NO,1,310,Primary,Female
TCGA.E9.A245.01,TCGA.E9.A245.01A.22R.A16F.07,0.394368,0.312976,0,0,TCGA-E9-A245,NO,47,NA,NA,NA,DECEASED,13,0.0345,M0,N1,Stage IIB,T2,Breast Invasive Ductal Carcinoma,62,NA,NOT HISPANIC OR LATINO,3/16/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,3,NA,10,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,NA,WHITE,NA,NO,1,490,Primary,Female
TCGA.E9.A247.01,TCGA.E9.A247.01A.11R.A169.07,0.124654,0.124654,0,0,TCGA-E9-A247,NO,59,38.96,DiseaseFree,38.96,LIVING,26,0.7006,M0,N0 (i-),Stage IA,T1c,Breast Invasive Ductal Carcinoma,49,NA,NOT HISPANIC OR LATINO,8/18/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,0,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Inner Quadrant,NA,WHITE,NA,NO,1,370,Primary,Female
TCGA.E9.A248.01,TCGA.E9.A248.01A.11R.A169.07,0.451509,0.365723,0,0,TCGA-E9-A248,NO,51,1.94,DiseaseFree,1.94,LIVING,16,0.079,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,52,NA,NOT HISPANIC OR LATINO,3/22/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,0,NA,10,NA,Peri (6-12 months since last menstrual period),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,NA,WHITE,NA,NO,1,540,Primary,Female
TCGA.E9.A249.01,TCGA.E9.A249.01A.11R.A169.07,0.010726,0.010726,0,0,TCGA-E9-A249,NO,45,7.13,DiseaseFree,7.13,LIVING,9,0.4018,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,59,NA,NOT HISPANIC OR LATINO,3/22/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,0,NA,10,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,NA,WHITE,NA,NO,1,470,Primary,Female
TCGA.E9.A24A.01,TCGA.E9.A24A.01A.11R.A169.07,0.392177,0.221483,0,0,TCGA-E9-A24A,NO,69,24.54,DiseaseFree,24.54,LIVING,17,0.1266,M0,N1,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,41,NA,NOT HISPANIC OR LATINO,3/22/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,1,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,NA,WHITE,NA,NO,1,390,Primary,Female
TCGA.E9.A295.01,TCGA.E9.A295.01A.11R.A16F.07,0.047267,0.047267,0,0,TCGA-E9-A295,NO,71,12.32,DiseaseFree,12.32,LIVING,55,0.4456,M0,N0 (i-),Stage IIA,T2,Breast Invasive Lobular Carcinoma,63,Positive,NOT HISPANIC OR LATINO,2009/12/11,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2011,YES,0,0,7,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right Lower Outer Quadrant,Positive,WHITE,NA,NO,1,670,Primary,Female
TCGA.E9.A2JS.01,TCGA.E9.A2JS.01A.11R.A180.07,1.221102,1.221102,0,0,TCGA-E9-A2JS,NO,72,17.21,Recurred/Progressed,29.7,DECEASED,46,0.6188,M0,N1,Stage IIB,T2,Breast Invasive Lobular Carcinoma,79,NA,NOT HISPANIC OR LATINO,12/20/11,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2011,YES,1,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left Upper Outer Quadrant,NA,WHITE,NA,NO,1,420,Primary,Female
TCGA.E9.A2JT.01,TCGA.E9.A2JT.01A.22R.A18M.07,4.530337,4.057279,0.088554,0.021825958,TCGA-E9-A2JT,NO,63,9.46,DiseaseFree,9.46,LIVING,4,0.0019,M0,N0 (i-),Stage IIA,T2,Breast Invasive Lobular Carcinoma,94,NA,NOT HISPANIC OR LATINO,12/20/11,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2011,YES,0,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left Upper Outer Quadrant,NA,WHITE,NA,NO,1,260,Primary,Female
TCGA.E9.A3HO.01,TCGA.E9.A3HO.01A.11R.A213.07,0.676855,0.676855,0,0,TCGA-E9-A3HO,NO,49,38.04,DiseaseFree,38.04,LIVING,56,0.4019,M0,N0 (i-),Stage IIA,T2,Breast Invasive Lobular Carcinoma,245,NA,NOT HISPANIC OR LATINO,2/20/12,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2011,YES,0,NA,10,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,ILC,Negative,Left Upper Outer Quadrant,NA,WHITE,NA,NO,1,158,Primary,Female
TCGA.E9.A3Q9.01,TCGA.E9.A3Q9.01A.11R.A21T.07,0.295442,0.295442,0,0,TCGA-E9-A3Q9,NO,78,32.88,DiseaseFree,32.88,LIVING,35,0.0275,M0,N3,Stage IIIC,T3,Breast Invasive Lobular Carcinoma,198,Positive,NOT HISPANIC OR LATINO,4/30/12,Infiltrating Lobular Carcinoma,NA,No,No,Indeterminate,YES,2011,YES,22,0,22,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Right Lower Inner Quadrant,Positive,WHITE,NA,NO,1,580,Primary,Female
TCGA.E9.A3QA.01,TCGA.E9.A3QA.01A.61R.A22K.07,2.50953,2.50953,0,0,TCGA-E9-A3QA,NO,33,30.16,DiseaseFree,30.16,LIVING,47,0.0908,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,282,NA,NOT HISPANIC OR LATINO,4/30/12,Medullary Carcinoma,NA,No,No,NA,YES,2011,YES,0,NA,14,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Lower Inner Quadrant,NA,WHITE,NA,NO,1,750,Primary,Female
TCGA.E9.A3X8.01,TCGA.E9.A3X8.01A.31R.A22U.07,0.305606,0.305606,0,0,TCGA-E9-A3X8,NO,48,30.42,DiseaseFree,30.42,LIVING,13,0.0767,M0,N1,Stage IIB,T2,Breast Invasive Lobular Carcinoma,233,Positive,NOT HISPANIC OR LATINO,8/24/12,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2011,YES,4,0,8,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,NO,1,260,Primary,Female
TCGA.E9.A54X.01,TCGA.E9.A54X.01A.11R.A266.07,0.057319,0.057319,0,0,TCGA-E9-A54X,NO,85,23.88,DiseaseFree,23.88,LIVING,24,0.2207,M0,N0 (i-),Stage IA,T1b,Breast Invasive Mixed Mucinous Carcinoma,78,Positive,NOT HISPANIC OR LATINO,6/21/13,Mucinous Carcinoma,NA,No,No,Negative,YES,2012,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IMMC,Negative,Left|Left Upper Outer Quadrant,Positive,WHITE,NA,NO,1,220,Primary,Female
TCGA.E9.A54Y.01,TCGA.E9.A54Y.01A.11R.A466.07,0.068821,0.05983,0,0,TCGA-E9-A54Y,NO,63,23.82,DiseaseFree,23.82,LIVING,31,0.5066,M0,N2,Stage IIIA,T2,Breast Invasive Lobular Carcinoma,76,Positive,NOT HISPANIC OR LATINO,6/21/13,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2012,YES,8,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right,Positive,WHITE,NA,NO,1,370,Primary,Female
TCGA.E9.A5FK.01,TCGA.E9.A5FK.01A.11R.A27Q.07,0.512245,0.512245,0,0,TCGA-E9-A5FK,NO,60,26.68,DiseaseFree,26.68,LIVING,14,0.0837,M0,N3,Stage IIIC,T2,Breast Invasive Lobular Carcinoma,77,Positive,NOT HISPANIC OR LATINO,5/22/13,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2012,YES,10,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,NO,1,490,Primary,Female
TCGA.E9.A5UO.01,TCGA.E9.A5UO.01A.11R.A28M.07,0.029558,0.029558,0,0,TCGA-E9-A5UO,NO,41,25.79,DiseaseFree,25.79,LIVING,29,0.2246,M0,N0,Stage IIA,T2,Breast Invasive Mixed Mucinous Carcinoma,98,NA,NOT HISPANIC OR LATINO,5/23/13,Mucinous Carcinoma,NA,No,No,NA,YES,2012,YES,0,NA,10,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IMMC,Negative,Right Upper Outer Quadrant,NA,WHITE,NA,NO,1,400,Primary,Female
TCGA.E9.A5UP.01,TCGA.E9.A5UP.01A.11R.A28M.07,0.052524,0.052524,0,0,TCGA-E9-A5UP,NO,63,26.38,DiseaseFree,26.38,LIVING,23,0.5951,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,85,NA,NOT HISPANIC OR LATINO,5/23/13,"Other, specify",NA,No,No,NA,YES,2012,YES,0,NA,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,NA,WHITE,NA,NO,1,140,Primary,Female
TCGA.E9.A6HE.01,TCGA.E9.A6HE.01A.11R.A31O.07,0.115136,0.115136,0,0,TCGA-E9-A6HE,NO,45,27.83,DiseaseFree,27.83,LIVING,NA,0.1661,MX,N3,Stage IIIC,T3,Breast Invasive Lobular Carcinoma,203,Positive,NOT HISPANIC OR LATINO,10/16/13,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2012,YES,12,NA,12,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,ILC,Negative,Right,Positive,WHITE,NA,NO,1,580,Primary,Female
TCGA.EW.A1IW.01,TCGA.EW.A1IW.01A.11R.A13Q.07,0.036114,0.036114,0,0,TCGA-EW-A1IW,NO,80,12.19,DiseaseFree,12.19,LIVING,54,0.1756,MX,N1a,Stage IIB,T2,Breast Invasive Lobular Carcinoma,213,Positive,HISPANIC OR LATINO,5/27/11,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2010,YES,2,0,10,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Right Lower Inner Quadrant|Right Lower Outer Quadrant,Positive,WHITE,NA,YES,1,90,Primary,Female
TCGA.EW.A1IX.01,TCGA.EW.A1IX.01A.12R.A144.07,0.025638,0.025638,0,0,TCGA-EW-A1IX,NO,48,39.68,DiseaseFree,39.68,LIVING,18,0.0676,MX,N1a,Stage IIA,T1b,Breast Invasive Lobular Carcinoma,1030,Positive,HISPANIC OR LATINO,2006/10/11,"Other, specify",NA,No,No,Negative,YES,2008,YES,1,1,27,NA,Peri (6-12 months since last menstrual period),NA,NA,NO,ILC,Negative,Right Upper Outer Quadrant,Positive,ASIAN,NA,YES,1,130,Primary,Female
TCGA.EW.A1IY.01,TCGA.EW.A1IY.01A.11R.A13Q.07,0.059673,0.059673,0,0,TCGA-EW-A1IY,NO,38,8.48,DiseaseFree,8.48,LIVING,19,0.0644,MX,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,590,Positive,NOT HISPANIC OR LATINO,2005/10/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,YES,0,0,6,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right Upper Inner Quadrant,Positive,ASIAN,NA,YES,1,50,Primary,Female
TCGA.EW.A1IZ.01,TCGA.EW.A1IZ.01A.11R.A13Q.07,0.938698,0.938698,0,0,TCGA-EW-A1IZ,NO,53,18.2,DiseaseFree,18.2,LIVING,230,0.0078,MX,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,194,Positive,NOT HISPANIC OR LATINO,2005/11/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,5,NA,14,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Lower Outer Quadrant,Positive,WHITE,NA,YES,1,130,Primary,Female
TCGA.EW.A1J1.01,TCGA.EW.A1J1.01A.11R.A13Q.07,0.043276,0.043276,0,0,TCGA-EW-A1J1,NO,38,18.89,DiseaseFree,18.89,LIVING,12,0.2787,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,214,Positive,HISPANIC OR LATINO,2005/11/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,1,0,17,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right Upper Inner Quadrant,Positive,WHITE,NA,YES,1,170,Primary,Female
TCGA.EW.A1J2.01,TCGA.EW.A1J2.01A.21R.A13Q.07,0.104189,0.104189,0,0,TCGA-EW-A1J2,NO,50,13.24,DiseaseFree,13.24,LIVING,22,0.1378,MX,N1mi,NA,T1c,Breast Invasive Lobular Carcinoma,51,Positive,NOT HISPANIC OR LATINO,5/27/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2010,YES,1,1,21,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,ILC,Negative,Right Lower Inner Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,110,Primary,Female
TCGA.EW.A1J3.01,TCGA.EW.A1J3.01A.11R.A13Q.07,0.136249,0.136249,0,0,TCGA-EW-A1J3,NO,61,16.56,DiseaseFree,16.56,LIVING,22,0.1817,M0,N0,Stage IA,T1c,Breast Invasive Lobular Carcinoma,155,Positive,HISPANIC OR LATINO,5/18/11,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2010,YES,0,0,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Left Lower Outer Quadrant,Positive,WHITE,NA,YES,1,80,Primary,Female
TCGA.EW.A1J5.01,TCGA.EW.A1J5.01A.11R.A13Q.07,1.178245,1.178245,0,0,TCGA-EW-A1J5,NO,59,15.67,DiseaseFree,15.67,LIVING,291,0.1777,M0,N0 (i-),Stage IIB,T3,Breast Invasive Lobular Carcinoma,123,Positive,NOT HISPANIC OR LATINO,2006/10/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2010,YES,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Left,Positive,WHITE,NA,YES,1,180,Primary,Female
TCGA.EW.A1J6.01,TCGA.EW.A1J6.01A.11R.A13Q.07,0.122017,0.122017,0,0,TCGA-EW-A1J6,NO,70,28.75,DiseaseFree,28.75,LIVING,28,0.9022,M0,N0 (i-),Stage I,T1c,Breast Invasive Ductal Carcinoma,528,Positive,HISPANIC OR LATINO,2005/11/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,YES,0,0,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Inner Quadrant,Positive,WHITE,NA,YES,1,80,Primary,Female
TCGA.EW.A1OX.01,TCGA.EW.A1OX.01A.11R.A144.07,0.232412,0.137926,0,0,TCGA-EW-A1OX,NO,43,29.93,DiseaseFree,29.93,LIVING,13,0.0924,MX,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,550,Positive,HISPANIC OR LATINO,5/18/11,Mucinous Carcinoma,NA,No,No,Negative,YES,2009,YES,0,0,4,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right Upper Inner Quadrant,Positive,WHITE,NA,YES,1,140,Primary,Female
TCGA.EW.A1OY.01,TCGA.EW.A1OY.01A.11R.A144.07,0.300101,0.300101,0,0,TCGA-EW-A1OY,NO,63,29.83,DiseaseFree,29.83,LIVING,47,0.593,MX,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,526,Positive,HISPANIC OR LATINO,2006/10/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2009,YES,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left,Positive,WHITE,NA,YES,1,100,Primary,Female
TCGA.EW.A1OZ.01,TCGA.EW.A1OZ.01A.11R.A144.07,0.09135,0.09135,0,0,TCGA-EW-A1OZ,NO,56,40.37,DiseaseFree,40.37,LIVING,39,0.6261,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,928,Positive,NOT HISPANIC OR LATINO,2005/11/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2008,YES,0,0,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,210,Primary,Female
TCGA.EW.A1P0.01,TCGA.EW.A1P0.01A.11R.A144.07,0.310869,0.242748,0,0,TCGA-EW-A1P0,NO,55,35.94,Recurred/Progressed,41.1,LIVING,22,0.2439,MX,N1b,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1142,Positive,NOT HISPANIC OR LATINO,2005/10/11,"Other, specify",NA,No,No,Negative,YES,2008,YES,1,NA,21,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,YES,IDC,Negative,Left Upper Outer Quadrant,Negative,WHITE,NA,YES,1,190,Primary,Female
TCGA.EW.A1P3.01,TCGA.EW.A1P3.01A.11R.A144.07,0.562077,0.539769,0,0,TCGA-EW-A1P3,NO,48,52.92,DiseaseFree,52.92,LIVING,13,0.2396,MX,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,919,Positive,NOT HISPANIC OR LATINO,2006/10/11,Infiltrating Ductal Carcinoma,NA,No,Yes,Negative,YES,2008,YES,0,0,4,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Right Lower Outer Quadrant,Positive,WHITE,NA,YES,1,150,Primary,Female
TCGA.EW.A1P5.01,TCGA.EW.A1P5.01A.11R.A144.07,0.816429,0.816429,0,0,TCGA-EW-A1P5,NO,77,23.09,DiseaseFree,23.09,LIVING,13,0.2559,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,325,Positive,NOT HISPANIC OR LATINO,2005/11/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,3,0,40,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,110,Primary,Female
TCGA.EW.A1P6.01,TCGA.EW.A1P6.01A.11R.A144.07,0.689819,0.689819,0,0,TCGA-EW-A1P6,NO,64,18.46,DiseaseFree,18.46,LIVING,17,0.0919,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,249,Positive,HISPANIC OR LATINO,5/19/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,2,0,25,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Close,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,50,Primary,Female
TCGA.EW.A1PA.01,TCGA.EW.A1PA.01A.11R.A144.07,0.886596,0.886596,0,0,TCGA-EW-A1PA,NO,59,18.89,DiseaseFree,18.89,LIVING,24,0.3026,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,220,Positive,HISPANIC OR LATINO,2005/11/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,1,NA,13,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,60,Primary,Female
TCGA.EW.A1PC.01,TCGA.EW.A1PC.01B.11R.A21T.07,0.125857,0.125857,0,0,TCGA-EW-A1PC,NO,66,6.14,DiseaseFree,6.14,LIVING,85,0.59,MX,N0 (i-),Stage IIB,T3,Breast Invasive Ductal Carcinoma,146,Positive,NOT HISPANIC OR LATINO,9/28/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2011,YES,0,0,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,150,Primary,Female
TCGA.EW.A1PD.01,TCGA.EW.A1PD.01A.11R.A144.07,0.050262,0.02084,0.029422,1.411804223,TCGA-EW-A1PD,NO,61,13.93,DiseaseFree,13.93,LIVING,58,0.3329,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,112,Positive,HISPANIC OR LATINO,5/18/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2010,YES,2,NA,7,NA,NA,NA,NA,NO,IDC,Negative,Right,Positive,WHITE,NA,YES,1,120,Primary,Male
TCGA.EW.A1PE.01,TCGA.EW.A1PE.01A.11R.A144.07,1.57646,1.540696,0,0,TCGA-EW-A1PE,NO,56,10.51,DiseaseFree,10.51,LIVING,24,0.1758,M0,N1a,Stage IIA,T1c,Invasive Breast Carcinoma,44,Positive,HISPANIC OR LATINO,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2011,YES,1,NA,23,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,BRCA,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,150,Primary,Female
TCGA.EW.A1PF.01,TCGA.EW.A1PF.01A.11R.A144.07,0.229934,0.212883,0,0,TCGA-EW-A1PF,NO,50,14.42,DiseaseFree,14.42,LIVING,NA,0.2254,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,84,Positive,HISPANIC OR LATINO,5/27/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2010,YES,0,0,11,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,60,Primary,Female
TCGA.EW.A1PG.01,TCGA.EW.A1PG.01A.11R.A144.07,0.077485,0.077485,0,0,TCGA-EW-A1PG,NO,53,34.53,DiseaseFree,34.53,LIVING,6,4.00E-04,MX,N1a,Stage IIB,T2,Breast Invasive Lobular Carcinoma,829,Positive,HISPANIC OR LATINO,5/18/11,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2008,YES,1,1,25,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Left Lower Inner Quadrant|Left Lower Outer Quadrant,Positive,WHITE,NA,YES,1,210,Primary,Female
TCGA.EW.A2FR.01,TCGA.EW.A2FR.01A.11R.A21T.07,0.622444,0.622444,0,0,TCGA-EW-A2FR,NO,59,54.96,DiseaseFree,54.96,LIVING,40,0.0742,MX,N3a,Stage IIIC,T1b,Breast Invasive Ductal Carcinoma,1015,Negative,NOT HISPANIC OR LATINO,2010/12/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2008,YES,19,NA,21,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,100,Primary,Female
TCGA.EW.A2FS.01,TCGA.EW.A2FS.01A.11R.A17B.07,0.058795,0.058795,0,0,TCGA-EW-A2FS,NO,41,52.69,DiseaseFree,52.69,LIVING,19,0.1908,MX,N1mi,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1074,Positive,NOT HISPANIC OR LATINO,2010/12/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2008,YES,1,NA,8,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NA,YES,1,110,Primary,Female
TCGA.EW.A2FV.01,TCGA.EW.A2FV.01A.11R.A17B.07,1.052976,0.982228,0.01692,0.017226143,TCGA-EW-A2FV,NO,39,25.89,DiseaseFree,25.89,LIVING,17,0.1508,MX,N3a,Stage IIIC,T3,Invasive Breast Carcinoma,133,Positive,HISPANIC OR LATINO,2010/5/11,"Other, specify",NA,No,No,Negative,YES,2011,NA,29,NA,32,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NO,BRCA,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,YES,1,80,Primary,Female
TCGA.EW.A2FW.01,TCGA.EW.A2FW.01A.11R.A17B.07,0.015267,0.015267,0,0,TCGA-EW-A2FW,NO,52,22.08,DiseaseFree,22.08,LIVING,18,0.2122,MX,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,99,Positive,HISPANIC OR LATINO,2010/5/11,"Other, specify",NA,NA,No,Negative,YES,2011,YES,0,0,6,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,150,Primary,Female
TCGA.EW.A3E8.01,TCGA.EW.A3E8.01B.11R.A24H.07,3.29071,2.417345,0,0,TCGA-EW-A3E8,NO,60,34,DiseaseFree,34,LIVING,64,0.0997,MX,N0,Stage IIB,T3,Breast Invasive Lobular Carcinoma,505,Positive,HISPANIC OR LATINO,2002/8/13,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2011,YES,0,NA,2,NA,NA,NA,NA,NA,ILC,Negative,Left|Left Upper Outer Quadrant,Negative,WHITE,YES,NO,1,50,Primary,Female
TCGA.EW.A423.01,TCGA.EW.A423.01A.11R.A24H.07,1.279455,1.279455,0,0,TCGA-EW-A423,NO,75,17.51,DiseaseFree,17.51,LIVING,42,0.6939,MX,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,161,Positive,HISPANIC OR LATINO,2001/4/13,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2012,YES,0,0,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left Upper Inner Quadrant,Positive,WHITE,YES,NO,1,80,Primary,Female
TCGA.EW.A424.01,TCGA.EW.A424.01A.11R.A24H.07,0.227126,0.208444,0,0,TCGA-EW-A424,NO,51,23.49,DiseaseFree,23.49,LIVING,NA,0.1872,MX,N1,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,141,Positive,HISPANIC OR LATINO,3/26/13,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2012,YES,0,1,1,NA,NA,NA,NA,NA,ILC,Negative,Right,Positive,WHITE,YES,NO,1,140,Primary,Female
TCGA.EW.A6S9.01,TCGA.EW.A6S9.01A.22R.A33J.07,0.209973,0.209973,0,0,TCGA-EW-A6S9,NO,34,15.21,DiseaseFree,15.21,LIVING,NA,0.1839,M0,N1,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,139,Positive,NOT HISPANIC OR LATINO,3/13/15,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2013,YES,1,1,3,NA,NA,NA,NA,NA,IDC,NA,Right|Right Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NO,NA,1,190,Primary,Female
TCGA.EW.A6SA.01,TCGA.EW.A6SA.01A.21R.A32P.07,0.140291,0.125583,0,0,TCGA-EW-A6SA,NO,59,16.75,DiseaseFree,16.75,LIVING,NA,0.5613,MX,N0 (i+),Stage II,T2,Breast Invasive Ductal Carcinoma,152,Positive,NOT HISPANIC OR LATINO,2/27/15,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2013,YES,NA,1,4,NA,NA,NA,NA,NA,IDC,Negative,Left|Left Lower Inner Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NO,NO,1,80,Primary,Male
TCGA.EW.A6SC.01,TCGA.EW.A6SC.01A.12R.A32P.07,0.231469,0.198111,0.033358,0.168380352,TCGA-EW-A6SC,NO,60,31.27,DiseaseFree,31.27,LIVING,NA,0.1298,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,350,Positive,NOT HISPANIC OR LATINO,2003/12/15,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2012,YES,0,0,2,NA,NA,NA,NA,NA,ILC,Negative,Left|Left Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,YES,NA,1,160,Primary,Female
TCGA.EW.A6SD.01,TCGA.EW.A6SD.01A.12R.A33J.07,1.254262,1.254262,0,0,TCGA-EW-A6SD,NO,32,33.18,DiseaseFree,33.18,LIVING,NA,0.4194,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,441,Negative,HISPANIC OR LATINO,3/14/15,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2012,YES,2,0,31,NA,NA,NA,NA,NA,IDC,Negative,Left|Left Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,YES,NO,1,210,Primary,Female
TCGA.GI.A2C8.01,TCGA.GI.A2C8.01A.11R.A16F.07,0.034473,0.034473,0,0,TCGA-GI-A2C8,NO,63,7.39,DiseaseFree,7.39,LIVING,81,0.5576,MX,N0,Stage IIIB,T4b,Breast Invasive Ductal Carcinoma,2429,Positive,NOT HISPANIC OR LATINO,10/21/11,Infiltrating Ductal Carcinoma,NA,Yes,No,Negative,YES,2004,YES,0,NA,10,NA,NA,NA,NA,NO,IDC,Negative,Right,Positive,WHITE,NA,YES,1,100,Primary,Female
TCGA.GM.A2D9.01,TCGA.GM.A2D9.01A.11R.A18M.07,0.215602,0.215602,0,0,TCGA-GM-A2D9,NO,69,44.38,Recurred/Progressed,59.53,DECEASED,279,0.1545,M0,N0 (i-),Stage I,T1c,Breast Invasive Ductal Carcinoma,1910,Positive,NOT HISPANIC OR LATINO,9/28/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2006,YES,0,0,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Bone,YES,IDC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,YES,1,130,Primary,Female
TCGA.GM.A2DA.01,TCGA.GM.A2DA.01A.11R.A18M.07,0.302104,0.229893,0,0,TCGA-GM-A2DA,NO,46,214.72,Recurred/Progressed,216.59,DECEASED,21,0.1413,M0,N1b,Stage IIB,T2,Breast Invasive Ductal Carcinoma,6583,Positive,NOT HISPANIC OR LATINO,9/28/11,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,1993,YES,2,0,13,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,YES,IDC,Negative,Right Upper Inner Quadrant|Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,50,Primary,Female
TCGA.GM.A2DC.01,TCGA.GM.A2DC.01A.11R.A18M.07,0.218214,0.218214,0,0,TCGA-GM-A2DC,NO,57,83.28,DiseaseFree,83.28,LIVING,15,0.413,M0,N1a,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,1820,Positive,NOT HISPANIC OR LATINO,9/29/11,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2006,YES,1,0,21,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NA,YES,1,110,Primary,Female
TCGA.GM.A2DK.01,TCGA.GM.A2DK.01A.21R.A180.07,0.199999,0.177667,0,0,TCGA-GM-A2DK,NO,58,86.89,DiseaseFree,86.89,LIVING,14,0.1815,M0,N0 (i-),Stage I,T1c,Breast Invasive Ductal Carcinoma,2109,Positive,NOT HISPANIC OR LATINO,9/29/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2005,YES,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Upper Outer Quadrant,Negative,WHITE,NA,YES,1,120,Primary,Female
TCGA.GM.A2DL.01,TCGA.GM.A2DL.01A.11R.A18M.07,0.444762,0.444762,0,0,TCGA-GM-A2DL,NO,50,115.6,DiseaseFree,115.6,LIVING,37,0.1835,M0,N0 (i-),Stage I,T1c,Breast Invasive Ductal Carcinoma,2723,Positive,NOT HISPANIC OR LATINO,9/29/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2003,YES,0,0,2,NA,Peri (6-12 months since last menstrual period),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,130,Primary,Female
TCGA.GM.A2DM.01,TCGA.GM.A2DM.01A.11R.A180.07,0.076353,0.076353,0,0,TCGA-GM-A2DM,NO,57,105.98,DiseaseFree,105.98,LIVING,17,0.0055,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,2464,Positive,HISPANIC OR LATINO,9/30/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2004,YES,0,0,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Right Lower Outer Quadrant,Positive,WHITE,NA,YES,1,120,Primary,Female
TCGA.GM.A2DN.01,TCGA.GM.A2DN.01A.11R.A180.07,0.258028,0.258028,0,0,TCGA-GM-A2DN,NO,58,101.54,DiseaseFree,101.54,LIVING,17,0.0649,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,2436,Positive,NOT HISPANIC OR LATINO,9/30/11,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2004,YES,0,0,9,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,210,Primary,Female
TCGA.GM.A2DO.01,TCGA.GM.A2DO.01A.11R.A18M.07,2.244902,2.093849,0,0,TCGA-GM-A2DO,NO,54,85.28,DiseaseFree,85.28,LIVING,64,0.0343,M0,N0 (i-),Stage I,T1c,Breast Invasive Lobular Carcinoma,1932,Positive,NOT HISPANIC OR LATINO,9/30/11,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2006,YES,0,0,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Right Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NA,YES,1,110,Primary,Female
TCGA.GM.A3NW.01,TCGA.GM.A3NW.01A.21R.A22K.07,0.147749,0.147749,0,0,TCGA-GM-A3NW,NO,63,110.41,DiseaseFree,110.41,LIVING,59,0.2472,M0,N0 (i-),Stage IIA,T2,Breast Invasive Lobular Carcinoma,3110,Negative,NOT HISPANIC OR LATINO,2001/3/12,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2003,YES,0,0,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Left Upper Inner Quadrant,Positive,WHITE,NA,YES,1,150,Primary,Female
TCGA.GM.A3NY.01,TCGA.GM.A3NY.01A.11R.A21T.07,1.126782,1.119777,0,0,TCGA-GM-A3NY,NO,72,38.17,DiseaseFree,38.17,LIVING,46,0.1117,M0,N1a,Stage IIB,T2,Breast Invasive Lobular Carcinoma,778,Positive,NOT HISPANIC OR LATINO,2001/3/12,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2009,YES,1,0,13,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NO,ILC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NA,YES,1,140,Primary,Female
TCGA.GM.A3XG.01,TCGA.GM.A3XG.01A.31R.A24H.07,0.359982,0.348979,0,0,TCGA-GM-A3XG,NO,46,43.69,DiseaseFree,43.69,LIVING,5,0,M0,N1a,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,899,Positive,NOT HISPANIC OR LATINO,2010/1/12,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2009,YES,3,0,26,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,ILC,Negative,Right|Right Upper Outer Quadrant,Positive,WHITE,YES,YES,1,270,Primary,Female
TCGA.GM.A3XN.01,TCGA.GM.A3XN.01A.12R.A22U.07,0.132602,0.132602,0,0,TCGA-GM-A3XN,NO,44,66.33,DiseaseFree,66.33,LIVING,15,0.1675,M0,N2a,Stage IIIA,T1c,Breast Invasive Lobular Carcinoma,1627,Positive,NOT HISPANIC OR LATINO,2010/1/12,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2007,YES,5,0,34,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left|Left Upper Outer Quadrant,Positive,WHITE,YES,YES,1,100,Primary,Female
TCGA.GM.A4E0.01,TCGA.GM.A4E0.01A.12R.A266.07,0.14456,0.14456,0,0,TCGA-GM-A4E0,NO,67,71.98,DiseaseFree,71.98,LIVING,17,0.0133,M0,N3a,Stage IIIC,T3,Breast Invasive Lobular Carcinoma,1871,Positive,NOT HISPANIC OR LATINO,11/26/12,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2007,YES,10,1,22,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left|Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant,Positive,WHITE,YES,YES,1,210,Primary,Female
TCGA.GM.A5PV.01,TCGA.GM.A5PV.01A.11R.A28M.07,0.148695,0.148695,0,0,TCGA-GM-A5PV,NO,63,13.53,DiseaseFree,13.53,LIVING,17,0.0368,M0,N1a,Stage IIB,T2,Breast Invasive Lobular Carcinoma,499,Positive,NOT HISPANIC OR LATINO,2004/12/13,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2011,YES,1,NA,24,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right,Positive,WHITE,NO,YES,1,190,Primary,Female
TCGA.GM.A5PX.01,TCGA.GM.A5PX.01A.12R.A28M.07,0.098731,0.098731,0,0,TCGA-GM-A5PX,NO,65,18.1,DiseaseFree,18.1,LIVING,21,0.1005,M0,N1mi,Stage IIB,T2,Breast Invasive Lobular Carcinoma,616,Positive,NOT HISPANIC OR LATINO,2004/12/13,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2011,YES,1,2,13,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left,Positive,WHITE,NO,YES,1,110,Primary,Female
TCGA.HN.A2OB.01,TCGA.HN.A2OB.01A.21R.A27Q.07,0.731197,0.348414,0.014092,0.040446136,TCGA-HN-A2OB,NO,45,54.96,Recurred/Progressed,62.42,DECEASED,9,0.0273,M0,N1,Stage IIB,T2,Breast Invasive Lobular Carcinoma,NA,Positive,NA,9/26/13,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,NA,YES,2,NA,10,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,ILC,Negative,Right|Right Lower Outer Quadrant,Positive,NA,YES,YES,1,320,Primary,Female
TCGA.JL.A3YW.01,TCGA.JL.A3YW.01A.12R.A239.07,2.724404,2.526915,0.17783,0.07037435,TCGA-JL-A3YW,NO,49,11.83,DiseaseFree,11.83,LIVING,64,0.1167,M0,N1,Stage IIB,T2,Breast Invasive Lobular Carcinoma,312,Positive,NOT HISPANIC OR LATINO,2011/8/12,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2011,YES,3,0,16,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left,Positive,ASIAN,NO,NO,1,400,Primary,Female
TCGA.JL.A3YX.01,TCGA.JL.A3YX.01A.11R.A22U.07,0.047434,0.047434,0,0,TCGA-JL-A3YX,NO,46,11.56,DiseaseFree,11.56,LIVING,27,0.2097,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,306,Positive,NOT HISPANIC OR LATINO,2011/8/12,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2011,YES,0,0,16,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left,Positive,ASIAN,NO,NO,1,900,Primary,Female
TCGA.LD.A66U.01,TCGA.LD.A66U.01A.11R.A31O.07,0.110856,0.110856,0,0,TCGA-LD-A66U,NO,44,21.22,DiseaseFree,21.22,LIVING,NA,0.2001,MX,N1mi,Stage IIB,T2,Breast Invasive Lobular Carcinoma,183,Positive,NOT HISPANIC OR LATINO,6/27/13,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2012,YES,2,NA,15,NA,NA,NA,NA,NA,ILC,Negative,Right Upper Outer Quadrant,Positive,WHITE,YES,NO,1,160,Primary,Female
TCGA.LD.A74U.01,TCGA.LD.A74U.01A.13R.A33J.07,0.025396,0.025396,0,0,TCGA-LD-A74U,NO,79,13.21,DiseaseFree,13.21,LIVING,NA,0.0661,M0,N3a,Stage IIIC,T3,Breast Invasive Lobular Carcinoma,59,Positive,NOT HISPANIC OR LATINO,12/30/13,"Other, specify",NA,No,Yes,Negative,YES,2013,YES,11,NA,12,NA,NA,NA,NA,NA,ILC,Negative,Right,Negative,WHITE,NO,NO,1,210,Primary,Female
TCGA.LD.A7W5.01,TCGA.LD.A7W5.01A.22R.A352.07,1.345242,1.291919,0,0,TCGA-LD-A7W5,NO,52,7.1,DiseaseFree,7.1,LIVING,NA,0.217,M0,N3a,Stage IIIC,T2,Breast Invasive Ductal Carcinoma,83,Positive,NOT HISPANIC OR LATINO,2002/3/14,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2013,YES,23,NA,23,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Positive,Left Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NO,NO,1,360,Primary,Female
TCGA.LD.A7W6.01,TCGA.LD.A7W6.01A.81R.A352.07,0.829953,0.754039,0,0,TCGA-LD-A7W6,NO,54,13.27,DiseaseFree,13.27,LIVING,NA,0.127,M0,N1a,Stage IIB,T2,Breast Invasive Lobular Carcinoma,91,Positive,NOT HISPANIC OR LATINO,2002/3/14,"Other, specify",NA,No,No,Negative,YES,2013,YES,2,NA,18,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right|Right Upper Inner Quadrant,Positive,WHITE,NO,NO,1,630,Primary,Female
TCGA.LD.A9QF.01,TCGA.LD.A9QF.01A.32R.A41B.07,4.38676,4.363522,0.011589,0.002655882,TCGA-LD-A9QF,NO,73,10.61,DiseaseFree,10.61,LIVING,NA,0.0045,M0,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,85,Negative,NOT HISPANIC OR LATINO,2005/7/14,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2013,YES,0,NA,14,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left,Negative,BLACK OR AFRICAN AMERICAN,NA,NO,1,190,Primary,Female
TCGA.LL.A440.01,TCGA.LL.A440.01A.11R.A24H.07,0.809814,0.790124,0,0,TCGA-LL-A440,NO,61,24.93,DiseaseFree,24.93,LIVING,6,0.0068,MX,N0 (i-),Stage IA,T1c,Breast Invasive Lobular Carcinoma,32,Positive,NOT HISPANIC OR LATINO,10/26/12,Infiltrating Lobular Carcinoma,NA,No,Yes,Equivocal,YES,2012,YES,0,0,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NO,NO,1,200,Primary,Female
TCGA.LL.A442.01,TCGA.LL.A442.01A.11R.A24H.07,0.292817,0.272462,0,0,TCGA-LL-A442,NO,56,29.2,DiseaseFree,29.2,LIVING,NA,0.0052,MX,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,60,Positive,NOT HISPANIC OR LATINO,10/26/12,Infiltrating Ductal Carcinoma,NA,No,Yes,Equivocal,YES,2012,YES,0,0,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NO,NO,1,140,Primary,Female
TCGA.LL.A50Y.01,TCGA.LL.A50Y.01A.11R.A266.07,0.245443,0.245443,0,0,TCGA-LL-A50Y,NO,84,25.03,DiseaseFree,25.03,LIVING,25,0.0849,MX,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,91,Positive,NOT HISPANIC OR LATINO,2003/8/13,Infiltrating Lobular Carcinoma,NA,No,Yes,Equivocal,YES,2012,YES,0,0,8,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NO,NO,1,130,Primary,Female
TCGA.LL.A5YL.01,TCGA.LL.A5YL.01A.12R.A29R.07,0.068806,0.068806,0,0,TCGA-LL-A5YL,NO,64,17.05,DiseaseFree,17.05,LIVING,53,0.1994,MX,N1a,Stage IIB,T2,Breast Invasive Lobular Carcinoma,84,Positive,NOT HISPANIC OR LATINO,2006/3/13,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2012,YES,3,0,23,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right|Right Upper Inner Quadrant,Negative,WHITE,NO,NO,1,570,Primary,Female
TCGA.LL.A5YM.01,TCGA.LL.A5YM.01A.11R.A28M.07,0,0,0,NA,TCGA-LL-A5YM,NO,88,8.48,Recurred/Progressed,15.31,LIVING,19,0.4424,M0,NX,Stage IIIB,T4b,Paget Disease of the Nipple,131,Positive,NOT HISPANIC OR LATINO,2006/3/13,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2012,NO,NA,NA,NA,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,PD,Positive,Left|Left Upper Inner Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NO,NO,1,280,Primary,Female
TCGA.LL.A5YN.01,TCGA.LL.A5YN.01A.11R.A28M.07,3.755341,3.755341,0,0,TCGA-LL-A5YN,NO,46,14.68,DiseaseFree,14.68,LIVING,22,0.1778,M0,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,41,Positive,NOT HISPANIC OR LATINO,5/20/13,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2013,YES,0,0,5,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right|Right Upper Inner Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NO,NO,1,230,Primary,Female
TCGA.LL.A5YP.01,TCGA.LL.A5YP.01A.21R.A28M.07,0.636063,0.636063,0,0,TCGA-LL-A5YP,NO,49,14.78,DiseaseFree,14.78,LIVING,61,0.553,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,29,Positive,NOT HISPANIC OR LATINO,5/20/13,Infiltrating Ductal Carcinoma,NA,No,Yes,Negative,YES,2013,YES,2,NA,12,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right|Right Lower Inner Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NO,NO,1,490,Primary,Female
TCGA.LL.A6FP.01,TCGA.LL.A6FP.01A.11R.A31O.07,0.005928,0.005928,0,0,TCGA-LL-A6FP,NO,90,22.24,DiseaseFree,22.24,LIVING,NA,0.4119,MX,NX,Stage IIA,T2,Breast Invasive Lobular Carcinoma,259,Positive,NOT HISPANIC OR LATINO,2009/3/13,Infiltrating Lobular Carcinoma,NA,Yes,No,Equivocal,YES,2012,NO,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NO,NO,1,500,Primary,Female
TCGA.LL.A6FQ.01,TCGA.LL.A6FQ.01A.11R.A31O.07,0.025238,0.025238,0,0,TCGA-LL-A6FQ,NO,77,2.63,DiseaseFree,2.63,LIVING,NA,0.4664,MX,N2a,Stage IIIA,T2,Breast Invasive Ductal Carcinoma,128,Positive,NOT HISPANIC OR LATINO,8/30/13,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2013,YES,7,0,18,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NO,NO,1,250,Primary,Female
TCGA.LL.A6FR.01,TCGA.LL.A6FR.01A.12R.A31O.07,0.062504,0.051593,0,0,TCGA-LL-A6FR,NO,50,16.06,DiseaseFree,16.06,LIVING,NA,0.5897,MX,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,30,Negative,NOT HISPANIC OR LATINO,8/30/13,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2013,YES,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right|Right Lower Inner Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NO,NO,1,250,Primary,Female
TCGA.LL.A73Z.01,TCGA.LL.A73Z.01A.11R.A32P.07,0.186242,0.186242,0,0,TCGA-LL-A73Z,NO,55,6.31,Recurred/Progressed,7.46,DECEASED,NA,0.0598,M1,NX,Stage IV,T1c,Breast Invasive Ductal Carcinoma,40,Positive,NOT HISPANIC OR LATINO,11/15/13,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2013,NO,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),skin,"Other, specify",NA,IDC,Positive,Left|Left Lower Inner Quadrant,Positive,BLACK OR AFRICAN AMERICAN,YES,NO,1,240,Primary,Female
TCGA.LL.A7SZ.01,TCGA.LL.A7SZ.01A.32R.A352.07,1.754028,1.732592,0,0,TCGA-LL-A7SZ,NO,49,19.51,DiseaseFree,19.51,LIVING,NA,0.2933,MX,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,63,Positive,NOT HISPANIC OR LATINO,2001/7/14,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2013,YES,2,0,11,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NO,NO,1,240,Primary,Female
TCGA.LL.A7T0.01,TCGA.LL.A7T0.01A.31R.A352.07,0.888474,0.85098,0.037494,0.04405979,TCGA-LL-A7T0,NO,70,12.35,DiseaseFree,12.35,LIVING,NA,0.3326,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,70,Positive,NOT HISPANIC OR LATINO,2001/3/14,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2013,YES,1,NA,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Lower Inner Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NO,NO,1,380,Primary,Female
TCGA.LL.A8F5.01,TCGA.LL.A8F5.01A.11R.A36F.07,0.294852,0.294852,0,0,TCGA-LL-A8F5,NO,61,19.58,DiseaseFree,19.58,LIVING,NA,0.6392,MX,N0 (i-),Stage IIA,T2,Breast Invasive Ductal Carcinoma,78,Positive,NOT HISPANIC OR LATINO,2/19/14,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2013,YES,0,0,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right|Right Upper Inner Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NO,NO,1,230,Primary,Female
TCGA.LL.A9Q3.01,TCGA.LL.A9Q3.01A.11R.A41B.07,0.160348,0.160348,0,0,TCGA-LL-A9Q3,NO,69,17.48,DiseaseFree,17.48,LIVING,NA,0.2749,MX,N3a,Stage IIIC,T3,Breast Invasive Lobular Carcinoma,80,Positive,NOT HISPANIC OR LATINO,5/21/14,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2013,YES,28,0,28,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NO,NO,1,610,Primary,Female
TCGA.LQ.A4E4.01,TCGA.LQ.A4E4.01A.11R.A266.07,0.132589,0.132589,0,0,TCGA-LQ-A4E4,NO,73,22.37,Recurred/Progressed,27.89,LIVING,64,0.1878,MX,N1a,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,414,Positive,NOT HISPANIC OR LATINO,2012/5/12,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2011,YES,3,0,26,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Positive,Right Upper Outer Quadrant,Positive,WHITE,YES,YES,1,200,Primary,Female
TCGA.MS.A51U.01,TCGA.MS.A51U.01A.31R.A266.07,1.11116,0.675168,0,0,TCGA-MS-A51U,NO,44,22.37,DiseaseFree,22.37,LIVING,11,0.1797,M0,N1,Stage IIB,T2,Breast Invasive Lobular Carcinoma,129,Positive,NOT HISPANIC OR LATINO,2009/12/12,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2012,YES,2,NA,18,NA,NA,NA,NA,NO,ILC,Negative,Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left,Positive,WHITE,NA,NO,1,190,Primary,Female
TCGA.OK.A5Q2.01,TCGA.OK.A5Q2.01A.11R.A27Q.07,0.638037,0.638037,0,0,TCGA-OK-A5Q2,NO,59,2.1,DiseaseFree,2.1,LIVING,23,0.0911,MX,N1a,Stage II,T2,Breast Invasive Lobular Carcinoma,149,Positive,NA,1/22/13,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2012,YES,2,2,13,NA,NA,NA,NA,NA,ILC,Negative,Right,Positive,NA,NA,NO,1,20,Primary,Female
TCGA.OL.A5D8.01,TCGA.OL.A5D8.01A.11R.A27Q.07,0.47027,0.445424,0.024846,0.05578056,TCGA-OL-A5D8,NO,40,31.96,DiseaseFree,31.96,LIVING,23,0.1753,MX,N0,Stage IIB,T3,Breast Invasive Ductal Carcinoma,1357,Positive,NOT HISPANIC OR LATINO,4/19/13,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2009,YES,NA,NA,2,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,NA,Left Lower Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,YES,YES,1,370,Primary,Female
TCGA.OL.A5DA.01,TCGA.OL.A5DA.01A.11R.A27Q.07,1.167791,1.149149,0,0,TCGA-OL-A5DA,NO,61,58.57,DiseaseFree,58.57,LIVING,41,0.2379,MX,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,1407,Positive,NOT HISPANIC OR LATINO,4/23/13,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2009,YES,NA,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NO,YES,1,240,Primary,Female
TCGA.OL.A5RU.01,TCGA.OL.A5RU.01A.11R.A28M.07,3.272603,2.820101,0.452502,0.160455955,TCGA-OL-A5RU,NO,63,40.05,DiseaseFree,40.05,LIVING,21,0.0399,MX,N1,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,826,Positive,NA,5/16/13,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2010,YES,1,NA,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,YES,YES,1,430,Primary,Female
TCGA.OL.A5RV.01,TCGA.OL.A5RV.01A.12R.A28M.07,0.298275,0.298275,0,0,TCGA-OL-A5RV,NO,43,34.89,DiseaseFree,34.89,LIVING,12,0.0644,MX,N3,Stage IIIC,T2,Breast Invasive Ductal Carcinoma,755,Positive,NA,5/16/13,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,20,NA,29,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,YES,YES,1,370,Primary,Female
TCGA.OL.A5RX.01,TCGA.OL.A5RX.01A.11R.A28M.07,0.162905,0.162905,0,0,TCGA-OL-A5RX,NO,51,28.84,DiseaseFree,28.84,LIVING,20,0.1288,MX,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,561,Positive,NA,5/16/13,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,NA,NA,4,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NO,YES,1,260,Primary,Female
TCGA.OL.A5RY.01,TCGA.OL.A5RY.01A.21R.A28M.07,0.316936,0.251422,0,0,TCGA-OL-A5RY,NO,52,24.7,DiseaseFree,24.7,LIVING,8,0.0041,MX,N1,Stage IIA,T1c,Breast Invasive Ductal Carcinoma,421,Positive,NA,5/16/13,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2011,YES,1,NA,25,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Positive,Right,Negative,BLACK OR AFRICAN AMERICAN,YES,YES,1,300,Primary,Female
TCGA.OL.A5RZ.01,TCGA.OL.A5RZ.01A.11R.A28M.07,0.01972,0.01972,0,0,TCGA-OL-A5RZ,NO,57,22.31,DiseaseFree,22.31,LIVING,78,0.4698,MX,N0,Stage IA,T1b,Breast Invasive Ductal Carcinoma,343,Positive,NA,5/16/13,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2012,YES,NA,NA,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NO,YES,1,490,Primary,Female
TCGA.OL.A5S0.01,TCGA.OL.A5S0.01A.11R.A28M.07,0.315466,0.196457,0,0,TCGA-OL-A5S0,NO,66,20.37,DiseaseFree,20.37,LIVING,28,0.6208,MX,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,279,Positive,NA,5/16/13,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2012,YES,2,NA,12,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Negative,BLACK OR AFRICAN AMERICAN,YES,YES,1,530,Primary,Female
TCGA.OL.A66H.01,TCGA.OL.A66H.01A.11R.A29R.07,1.104318,1.07887,0,0,TCGA-OL-A66H,NO,NA,NA,DiseaseFree,NA,LIVING,18,0.0587,MX,N1mi,Stage IB,T1c,Breast Invasive Mixed Mucinous Carcinoma,441,Positive,NOT HISPANIC OR LATINO,2006/11/13,Mucinous Carcinoma,NA,No,No,NA,YES,NA,YES,NA,NA,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IMMC,Negative,Right,Positive,BLACK OR AFRICAN AMERICAN,YES,YES,1,80,Primary,Female
TCGA.OL.A66J.01,TCGA.OL.A66J.01A.11R.A29R.07,0.024462,0.024462,0,0,TCGA-OL-A66J,NO,80,65.57,DiseaseFree,65.57,LIVING,44,0.0664,MX,N0,Stage I,T1c,Breast Invasive Lobular Carcinoma,1645,Positive,NOT HISPANIC OR LATINO,2006/11/13,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2008,YES,0,NA,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right Upper Outer Quadrant,Positive,WHITE,YES,YES,1,210,Primary,Female
TCGA.OL.A66K.01,TCGA.OL.A66K.01A.11R.A29R.07,0.030924,0.011856,0,0,TCGA-OL-A66K,NO,72,NA,NA,41.89,DECEASED,19,0.1883,MX,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,981,Positive,NOT HISPANIC OR LATINO,2006/11/13,Infiltrating Lobular Carcinoma,NA,No,No,Equivocal,YES,2010,YES,NA,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right Upper Outer Quadrant,Positive,WHITE,NO,YES,1,230,Primary,Female
TCGA.OL.A66L.01,TCGA.OL.A66L.01A.12R.A31O.07,0.024407,0.018088,0,0,TCGA-OL-A66L,NO,71,42.74,DiseaseFree,42.74,LIVING,NA,0.111,MX,N0,Stage IA,T1c,Breast Invasive Ductal Carcinoma,952,Positive,NOT HISPANIC OR LATINO,2006/11/13,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2010,YES,NA,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right Lower Inner Quadrant,Positive,BLACK OR AFRICAN AMERICAN,YES,YES,1,170,Primary,Female
TCGA.OL.A66N.01,TCGA.OL.A66N.01A.12R.A31O.07,0.026441,0.026441,0,0,TCGA-OL-A66N,NO,59,26.02,DiseaseFree,26.02,LIVING,NA,0.2094,MX,N3,Stage IIIC,T3,Breast Invasive Lobular Carcinoma,505,Positive,NOT HISPANIC OR LATINO,2006/11/13,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2011,YES,13,NA,15,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left,Negative,WHITE,YES,YES,1,310,Primary,Female
TCGA.OL.A66O.01,TCGA.OL.A66O.01A.11R.A31O.07,0.077521,0.077521,0,0,TCGA-OL-A66O,NO,39,17.35,DiseaseFree,17.35,LIVING,NA,0.1667,MX,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,170,Positive,NOT HISPANIC OR LATINO,2006/11/13,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2012,YES,3,NA,17,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Right Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,YES,YES,1,260,Primary,Female
TCGA.OL.A6VQ.01,TCGA.OL.A6VQ.01A.12R.A41B.07,0.070058,0.070058,0,0,TCGA-OL-A6VQ,NO,49,19.71,DiseaseFree,19.71,LIVING,NA,0.1319,MX,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,278,Positive,NOT HISPANIC OR LATINO,2/20/14,Infiltrating Lobular Carcinoma,NA,No,No,NA,YES,2012,YES,0,NA,1,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,ILC,Positive,Right,Positive,WHITE,NA,YES,1,110,Primary,Female
TCGA.OL.A6VR.01,TCGA.OL.A6VR.01A.32R.A33J.07,0.075729,0.075729,0,0,TCGA-OL-A6VR,NO,48,40.08,DiseaseFree,40.08,LIVING,NA,0.1111,MX,N0,Stage IA,T1b,Breast Invasive Ductal Carcinoma,869,Positive,NOT HISPANIC OR LATINO,2012/5/13,Infiltrating Ductal Carcinoma,NA,No,No,Negative,YES,2011,YES,0,NA,2,NA,NA,NA,NA,NA,IDC,Negative,Right,Positive,BLACK OR AFRICAN AMERICAN,NO,YES,1,380,Primary,Female
TCGA.PE.A5DC.01,TCGA.PE.A5DC.01A.12R.A27Q.07,0.027209,0.027209,0,0,TCGA-PE-A5DC,NO,72,NA,NA,46.98,DECEASED,81,0.3159,M0,N2a,Stage IIIA,T2,Breast Invasive Lobular Carcinoma,2858,Positive,NOT HISPANIC OR LATINO,4/30/13,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2005,YES,5,NA,31,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,NA,Right Upper Inner Quadrant,Positive,WHITE,YES,YES,1,350,Primary,Female
TCGA.PE.A5DD.01,TCGA.PE.A5DD.01A.12R.A27Q.07,0.275273,0.275273,0,0,TCGA-PE-A5DD,NO,64,64.16,DiseaseFree,64.16,LIVING,42,0.2365,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,2411,Positive,NOT HISPANIC OR LATINO,2005/6/13,Infiltrating Lobular Carcinoma,NA,No,No,Positive,YES,2006,YES,0,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right Lower Inner Quadrant,Negative,ASIAN,NO,YES,1,270,Primary,Female
TCGA.PE.A5DE.01,TCGA.PE.A5DE.01A.11R.A27Q.07,0.417549,0.417549,0,0,TCGA-PE-A5DE,NO,41,86.89,DiseaseFree,86.89,LIVING,266,0.5284,M0,N0,Stage IIA,T2,Breast Invasive Lobular Carcinoma,2066,Positive,NA,4/24/13,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2007,YES,0,NA,1,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,ILC,NA,Left,Positive,WHITE,YES,YES,1,190,Primary,Female
TCGA.PL.A8LV.01,TCGA.PL.A8LV.01A.21R.A41B.07,1.145263,1.145263,0,0,TCGA-PL-A8LV,NO,54,-0.23,DiseaseFree,-0.23,LIVING,NA,0.7412,M0,N0,Stage IIIB,T4,Breast Invasive Ductal Carcinoma,240,NA,NOT HISPANIC OR LATINO,3/25/14,Medullary Carcinoma,NA,No,No,NA,YES,2013,NO,NA,NA,NA,NA,NA,NA,NA,NA,IDC,NA,Right|Right Upper Outer Quadrant,NA,BLACK OR AFRICAN AMERICAN,NO,NO,1,840,Primary,Female
TCGA.PL.A8LX.01,TCGA.PL.A8LX.01A.11R.A41B.07,0.136978,0.136978,0,0,TCGA-PL-A8LX,NO,35,0.16,DiseaseFree,0.16,LIVING,NA,0.1356,M1,N1a,Stage IV,T4,Breast Invasive Ductal Carcinoma,74,NA,NOT HISPANIC OR LATINO,3/25/14,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2013,YES,NA,NA,NA,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,Bone|Liver,NA,IDC,NA,Left|Left Upper Outer Quadrant,NA,BLACK OR AFRICAN AMERICAN,NO,NO,1,540,Primary,Female
TCGA.PL.A8LY.01,TCGA.PL.A8LY.01A.11R.A41B.07,0.150074,0.13243,0.017644,0.133232651,TCGA-PL-A8LY,NO,30,0.26,DiseaseFree,0.26,LIVING,NA,1.00E-04,M0,N0,Stage IIB,T3,Breast Invasive Ductal Carcinoma,129,NA,NOT HISPANIC OR LATINO,3/26/14,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2013,NO,NA,NA,NA,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,NA,Right|Right Upper Outer Quadrant,NA,BLACK OR AFRICAN AMERICAN,NO,NO,1,350,Primary,Female
TCGA.PL.A8LZ.01,TCGA.PL.A8LZ.01A.31R.A36F.07,0.606326,0.606326,0,0,TCGA-PL-A8LZ,NO,29,9.92,DiseaseFree,9.92,LIVING,NA,0.1729,M0,N2,Stage IIIB,T4b,Breast Invasive Ductal Carcinoma,157,NA,NOT HISPANIC OR LATINO,2005/5/14,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2013,NA,NA,NA,NA,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,NA,Left|Left Upper Outer Quadrant,NA,BLACK OR AFRICAN AMERICAN,NO,NO,1,830,Primary,Female
TCGA.S3.A6ZF.01,TCGA.S3.A6ZF.01A.32R.A32P.07,0.271791,0.271791,0,0,TCGA-S3-A6ZF,NO,64,18.79,DiseaseFree,18.79,LIVING,NA,0.602,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,107,Positive,NOT HISPANIC OR LATINO,2011/12/13,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2013,YES,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right|Right Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NO,NO,1,1350,Primary,Female
TCGA.S3.A6ZG.01,TCGA.S3.A6ZG.01A.22R.A32P.07,0.258524,0.237277,0.021247,0.089545131,TCGA-S3-A6ZG,NO,71,18.46,DiseaseFree,18.46,LIVING,NA,0.1632,M0,N1,Stage IIB,T2,Breast Invasive Lobular Carcinoma,102,Positive,NOT HISPANIC OR LATINO,2011/12/13,Mixed Histology (please specify),Invasive mixed ductal and lobular carcinoma,No,No,Negative,YES,2013,YES,1,0,3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left|Left Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NO,NO,1,980,Primary,Female
TCGA.S3.A6ZH.01,TCGA.S3.A6ZH.01A.22R.A32P.07,0.217792,0.217792,0,0,TCGA-S3-A6ZH,NO,29,21.06,DiseaseFree,21.06,LIVING,NA,0.3715,MX,N3a,Stage IIIC,T3,Breast Invasive Ductal Carcinoma,158,Positive,NOT HISPANIC OR LATINO,2011/12/13,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2013,YES,14,0,21,NA,NA,NA,NA,NA,IDC,Negative,Left|Left Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NO,NO,1,580,Primary,Female
TCGA.S3.AA0Z.01,TCGA.S3.AA0Z.01A.11R.A41B.07,0.307398,0.307398,0,0,TCGA-S3-AA0Z,NO,63,20.66,DiseaseFree,20.66,LIVING,NA,0.3953,M0,N1a,Stage IIB,T2,Breast Invasive Ductal Carcinoma,204,Positive,NOT HISPANIC OR LATINO,4/18/14,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2013,YES,2,0,12,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left|Left Upper Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NO,NO,1,330,Primary,Female
TCGA.S3.AA11.01,TCGA.S3.AA11.01A.31R.A41B.07,0.436429,0.436429,0,0,TCGA-S3-AA11,NO,67,13.83,DiseaseFree,13.83,LIVING,NA,0.056,M0,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,148,Positive,NOT HISPANIC OR LATINO,4/18/14,Infiltrating Ductal Carcinoma,NA,No,No,Equivocal,YES,2013,YES,0,0,1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Positive,BLACK OR AFRICAN AMERICAN,YES,NO,1,280,Primary,Female
TCGA.S3.AA12.01,TCGA.S3.AA12.01A.11R.A41B.07,0.157898,0.157898,0,0,TCGA-S3-AA12,NO,82,18.86,DiseaseFree,18.86,LIVING,NA,0.1373,MX,N1a,Stage IIIA,T3,Breast Invasive Ductal Carcinoma,156,Positive,NOT HISPANIC OR LATINO,4/18/14,Infiltrating Ductal Carcinoma,NA,No,Yes,Negative,YES,2013,YES,2,0,16,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),left adrenal gland,"Lung|Other, specify",NA,IDC,Negative,Left|Left Upper Inner Quadrant|Left Lower Inner Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NO,NO,1,2190,Primary,Female
TCGA.S3.AA14.01,TCGA.S3.AA14.01A.11R.A41B.07,0.123582,0.083476,0,0,TCGA-S3-AA14,NO,47,17.38,DiseaseFree,17.38,LIVING,NA,0.1821,cM0 (i+),N0 (i+),Stage I,T1,Breast Invasive Ductal Carcinoma,127,Positive,NOT HISPANIC OR LATINO,4/18/14,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2013,YES,0,3,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right,Positive,BLACK OR AFRICAN AMERICAN,YES,NO,1,290,Primary,Female
TCGA.S3.AA17.01,TCGA.S3.AA17.01A.11R.A41B.07,14.3977,4.90594,0,0,TCGA-S3-AA17,NO,64,13.93,DiseaseFree,13.93,LIVING,NA,0.346,cM0 (i+),N1mi,Stage IIB,T2,Breast Invasive Ductal Carcinoma,92,Positive,NOT HISPANIC OR LATINO,4/21/14,Infiltrating Ductal Carcinoma,NA,No,Yes,Equivocal,YES,2013,YES,0,1,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Right|Right Lower Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,YES,NO,1,520,Primary,Female
TCGA.UL.AAZ6.01,TCGA.UL.AAZ6.01A.11R.A41B.07,0.014276,0.014276,0,0,TCGA-UL-AAZ6,NO,73,17.02,DiseaseFree,17.02,LIVING,NA,0.5875,MX,N0,Stage IIA,T2,Breast Invasive Ductal Carcinoma,187,Positive,NOT HISPANIC OR LATINO,8/28/14,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2013,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,NA,Right,Positive,BLACK OR AFRICAN AMERICAN,YES,NO,1,170,Primary,Female
TCGA.UU.A93S.01,TCGA.UU.A93S.01A.21R.A41B.07,0.012558,0.012558,0,0,TCGA-UU-A93S,NO,63,NA,NA,3.81,DECEASED,NA,0.5014,M1,N3b,Stage IV,T4d,Breast Invasive Ductal Carcinoma,22,Negative,NOT HISPANIC OR LATINO,2011/11/14,Infiltrating Ductal Carcinoma,NA,No,No,Positive,YES,2013,NO,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Bone|Liver,NA,IDC,Positive,Right|Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant,Negative,BLACK OR AFRICAN AMERICAN,NO,NO,1,980,Primary,Female
TCGA.V7.A7HQ.01,TCGA.V7.A7HQ.01A.11R.A33J.07,0.049395,0.049395,0,0,TCGA-V7-A7HQ,NO,75,66.79,DiseaseFree,66.79,LIVING,NA,0.1209,M0,N2a,Stage IIIA,T1c,Breast Invasive Ductal Carcinoma,1493,Positive,NOT HISPANIC OR LATINO,3/31/15,Infiltrating Ductal Carcinoma,NA,No,No,NA,YES,2009,YES,5,NA,18,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Positive,Right Lower Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NO,YES,1,50,Primary,Female
TCGA.W8.A86G.01,TCGA.W8.A86G.01A.21R.A36F.07,0.267192,0.267192,0,0,TCGA-W8-A86G,NO,66,11.4,DiseaseFree,11.4,LIVING,NA,0.0915,MX,N0 (i-),Stage IIA,T2a,Breast Invasive Lobular Carcinoma,126,Positive,NOT HISPANIC OR LATINO,1/29/14,Infiltrating Lobular Carcinoma,NA,No,Yes,Negative,YES,2013,YES,0,0,1,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left|Left Lower Inner Quadrant,Positive,WHITE,NO,NO,1,210,Primary,Female
TCGA.WT.AB41.01,TCGA.WT.AB41.01A.11R.A41B.07,0.419824,0.419824,0,0,TCGA-WT-AB41,NO,55,52.92,DiseaseFree,52.92,LIVING,NA,0.3125,MX,N1mi,Stage IIB,T2,Breast Invasive Ductal Carcinoma,1415,Positive,NOT HISPANIC OR LATINO,7/16/14,Infiltrating Ductal Carcinoma,NA,No,Yes,NA,YES,2010,YES,1,NA,2,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant,Positive,BLACK OR AFRICAN AMERICAN,NO,YES,1,110,Primary,Female
TCGA.WT.AB44.01,TCGA.WT.AB44.01A.11R.A41B.07,0.470706,0.470706,0,0,TCGA-WT-AB44,NO,77,29.01,DiseaseFree,29.01,LIVING,NA,0.3436,MX,N0 (i-),Stage IA,T1c,Breast Invasive Lobular Carcinoma,656,Positive,NOT HISPANIC OR LATINO,7/16/14,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2012,YES,0,NA,4,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left,Positive,WHITE,YES,YES,1,20,Primary,Female
TCGA.XX.A899.01,TCGA.XX.A899.01A.11R.A36F.07,0.323933,0.323933,0,0,TCGA-XX-A899,NO,46,15.34,DiseaseFree,15.34,LIVING,NA,0.0625,MX,N2a,Stage IIIA,T1c,Breast Invasive Lobular Carcinoma,181,Positive,NOT HISPANIC OR LATINO,2/21/14,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2013,YES,5,0,22,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Right Lower Outer Quadrant,Positive,WHITE,YES,YES,1,260,Primary,Female
TCGA.XX.A89A.01,TCGA.XX.A89A.01A.11R.A36F.07,4.121651,3.097416,0.121958,0.039374111,TCGA-XX-A89A,NO,68,16.03,DiseaseFree,16.03,LIVING,NA,0.1764,MX,N0,Stage IIB,T3,Breast Invasive Lobular Carcinoma,174,Positive,NOT HISPANIC OR LATINO,2/21/14,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2013,YES,0,NA,11,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Negative,Left Upper Outer Quadrant,Positive,WHITE,YES,YES,1,250,Primary,Female
TCGA.Z7.A8R5.01,TCGA.Z7.A8R5.01A.42R.A41B.07,0.011584,0.011584,0,0,TCGA-Z7-A8R5,NO,61,107.98,Recurred/Progressed,107.98,LIVING,NA,0.0452,MX,N1a,Stage IIIA,T3,Breast Invasive Lobular Carcinoma,2928,Positive,NOT HISPANIC OR LATINO,2007/9/14,Infiltrating Lobular Carcinoma,NA,No,Yes,Negative,YES,2005,YES,3,3,5,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,ILC,Positive,Left Upper Outer Quadrant,Positive,WHITE,NO,YES,1,450,Primary,Female
TCGA.Z7.A8R6.01,TCGA.Z7.A8R6.01A.11R.A41B.07,0.120571,0.120571,0,0,TCGA-Z7-A8R6,NO,46,106.96,DiseaseFree,106.96,LIVING,NA,0.3367,M0,N0,Stage I,T1c,Breast Invasive Ductal Carcinoma,3020,Positive,NOT HISPANIC OR LATINO,2007/9/14,Infiltrating Lobular Carcinoma,NA,No,No,Negative,YES,2005,YES,0,0,2,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,NA,NA,IDC,Negative,Left Upper Outer Quadrant,Positive,WHITE,NO,YES,1,520,Primary,Female
